var graphJson = {"directed": false, "multigraph": false, "graph": {"node_default": {}, "edge_default": {}}, "nodes": [{"entity_type": "GENE", "description": "SEC16B is a gene that encodes the endoplasmic reticulum export factor.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "SEC16 HOMOLOG B"}, {"entity_type": "GENE", "description": "DNAJC27 is a gene that encodes a member of the Hsp40 family of chaperone proteins.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27"}, {"entity_type": "GENE", "description": "CDKAL1 is a gene that encodes a protein involved in insulin signaling.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1"}, {"entity_type": "GENE", "description": "TFAP2B is a gene that encodes a transcription factor involved in various cellular processes.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "TRANSCRIPTION FACTOR AP-2 BETA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A chronic medical condition characterized by excessive body fat accumulation.<SEP>Obesity is a chronic disease characterized by excessive body fat accumulation, leading to health complications.<SEP>Obesity is a condition characterized by excessive body fat accumulation.<SEP>Obesity is a condition characterized by excess body fat.<SEP>Obesity is a cardiovascular risk factor associated with increased sUA levels and HUA risk in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "OBESITY"}, {"entity_type": "DISEASE", "description": "A cluster of metabolic abnormalities including high blood pressure, elevated blood glucose levels, and abnormal lipid profiles.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "METABOLIC SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measurement of the circumference around the waist, often used as an indicator of abdominal fat.<SEP>Waist circumference is a measure of the distance around the waist.<SEP>Waist circumference is a measurement of the girth around the waist.<SEP>Waist circumference is a measure of abdominal fat and is associated with metabolic health.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 83}]", "id": "WAIST CIRCUMFERENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fat mass refers to the amount of adipose tissue in the body.<SEP>The amount of adipose tissue in the body.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "FAT MASS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The total amount of skeletal muscle tissue in the body.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "SKELETAL MUSCLE MASS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A measure of the total amount of cholesterol circulating in the blood.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "SERUM TOTAL CHOLESTEROL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Low-density lipoprotein cholesterol, a type of cholesterol that can contribute to cardiovascular disease.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "LDL CHOLESTEROL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A type of fat found in the blood.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM TRIGLYCERIDES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HDL cholesterol is a type of lipoprotein associated with cardiovascular health.<SEP>High-density lipoprotein cholesterol, often referred to as \'good\' cholesterol.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "HDL CHOLESTEROL"}, {"entity_type": "PROTEIN", "description": "C-reactive protein (hs-CRP) is an inflammatory marker that indicates the presence of inflammation in the body.<SEP>C-reactive protein, a marker of inflammation.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "HS-CRP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The pressure exerted by the blood against the artery walls during heart contraction.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SYSTOLIC BLOOD PRESSURE (SBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The pressure exerted by the blood against the artery walls during heart relaxation.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "DIASTOLIC BLOOD PRESSURE (DBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Estimated glomerular filtration rate, a measure of kidney function.<SEP>eGFR (estimated glomerular filtration rate) is a measure of kidney function.<SEP>eGFR represents estimated glomerular filtration rate, a measure of kidney function.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-45a965c3c3013c70d0fa0f1680283083", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "EGFR"}, {"entity_type": "PROTEIN", "description": "An enzyme found primarily in liver cells; elevated levels may indicate liver damage.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "ALANINE AMINOTRANSFERASE (ALT)"}, {"entity_type": "PROTEIN", "description": "An enzyme found in various tissues, including the heart and liver; elevated levels may indicate tissue damage.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "ASPARTATE AMINOTRANSFERASE (AST)"}, {"entity_type": "GENE", "description": "SEC16 Homolog B (SEC16B, endoplasmic reticulum export factor)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "SEC16B"}, {"entity_type": "GENE", "description": "DnaJ heat shock protein family (Hsp40) member C27", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "DNAJC27"}, {"entity_type": "GENE", "description": "CDK5 regulatory subunit-associated protein 1-like 1<SEP>CDKAL1 is a gene associated with type 2 diabetes.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 134}]", "id": "CDKAL1"}, {"entity_type": "GENE", "description": "Transcription factor AP-2 Beta<SEP>transcription factor AP-2 Beta", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "TFAP2B"}, {"entity_type": "GENE", "description": "Brain-derived neurotrophic factor<SEP>The Brain-Derived Neurotrophic Factor (BDNF) gene is involved in neuronal growth, survival, and function.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-814fe155e9cb953da61f6a79d1d25784", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "BDNF"}, {"entity_type": "GENE", "description": "MYL2 is a gene located in chromosome 12q24 and associated with coffee consumption.<SEP>Myosin light chain-2", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 135}]", "id": "MYL2"}, {"entity_type": "GENE", "description": "Olfactomedin-4", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "OLFM4"}, {"entity_type": "GENE", "description": "FTO is a gene associated with obesity and energy balance.<SEP>FTO is a gene associated with obesity.<SEP>Fat mass and obesity associated<SEP>The FTO gene is a genetic locus associated with obesity risk.<SEP>FTO is a gene previously associated with smoking, alcohol consumption, coffee consumption, and snoring.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 65}]", "id": "FTO"}, {"entity_type": "GENE", "description": "MC4R is a gene involved in appetite regulation and energy balance.<SEP>MC4R is a gene that may influence the response to weight loss interventions for diabetes prevention.<SEP>Melanocortin 4 receptor", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 69}]", "id": "MC4R"}, {"entity_type": "GENE", "description": "GIPR is a gene encoding the glucose-dependent insulinotropic polypeptide receptor and has been associated with altered AcAc or BHB levels.<SEP>GIPR is a gene that encodes a receptor for glucose-dependent insulinotropic polypeptide (GIP).<SEP>Glucose-dependent insulinotropic polypeptide receptor", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "GIPR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMI (Body Mass Index) is a measure of body fat based on height and weight.<SEP>BMI (Body Mass Index) is a measure of body fat based on height and weight.<SEP>BMI (Body Mass Index) is a measure of body fat based on height and weight.<SEP>BMI stands for Body Mass Index, calculated as weight divided by height squared, used as an indicator of body fatness.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>BMI stands for Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) can affect snoring.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>BMI (body mass index) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index is a measure of body fat based on height and weight.<SEP>BMI stands for Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index.<SEP>Body mass index (BMI) is a measure of body fat based on height and weight.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-b3d775642c43fa3524a531a3f6ec1e41<SEP>chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 127}]", "id": "BMI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Skinfold thickness measurement (SMI) is a method for assessing body fat.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "SMI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Menarche is the onset of menstruation.<SEP>Menarche refers to the first menstrual period, marking the onset of puberty in females.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 25}]", "id": "MENARCHE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Menopause is the cessation of menstruation.<SEP>Menopause refers to the cessation of menstruation, signaling the end of a woman\'s reproductive years.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MENOPAUSE"}, {"entity_type": "GENOMIC VARIANT", "description": "PRS refers to Polygenic Risk Score which is a measure of an individual\'s genetic predisposition for a particular trait or disease.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 75}]", "id": "PRS"}, {"entity_type": "DIETARY PATTERN", "description": "A plant-based diet emphasizes consuming foods derived primarily from plants, such as fruits, vegetables, grains, legumes, nuts, and seeds.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 75}]", "id": "PLANT-BASED DIET"}, {"entity_type": "NUTRIENT", "description": "Fried food refers to foods prepared by deep-frying in oil, often high in calories, saturated fat, and sodium.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 75}]", "id": "FRIED FOOD"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Covariates are factors other than the variables of primary interest that may influence the outcome variable. Examples include age, sex, socioeconomic status.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "COVARIATES"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-63d0b5be485a69f44e2799ccc9510487", "description": "Obesity risk is the likelihood of developing obesity, a chronic disease.<SEP>SNP rs543874 in the SEC16B gene affects obesity risk.)", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "OBESITY RISK"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "Participants with early menarche have higher BMI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 127}]", "id": "EARLY MENARCHE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located within the FTO gene that influences weight regulation.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "FTO RS1558902"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by a higher proportion of protein compared to carbohydrates and fats.<SEP>A high-protein diet is characterized by a higher proportion of protein intake compared to other macronutrients.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 80}]", "id": "HIGH-PROTEIN DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by a lower proportion of protein compared to carbohydrates and fats.<SEP>A low-protein diet is characterized by a lower proportion of protein intake compared to other macronutrients.<SEP>A low-protein diet (1.5 g/kg/day of natural protein intake) was used to manage patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 80}]", "id": "LOW-PROTEIN DIET"}, {"entity_type": "NUTRIENT", "description": "The total amount of fat mass in the body.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 85}]", "id": "TOTAL FAT"}, {"entity_type": "NUTRIENT", "description": "The mass of the body excluding fat.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FAT FREE MASS (FFM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure representing the proportion of body weight that is fat mass.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FAT MASS PERCENTAGE (FM%)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of the proportion of body fat located in the trunk region.<SEP>Trunk fat percentage is a physiological measure reflecting the proportion of body fat stored in the trunk area.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "TRUNK FAT PERCENTAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adipose tissue located around the abdominal organs.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "VISCERAL ADIPOSE TISSUE (VAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adipose tissue located beneath the skin.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "SUBCUTANEOUS ADIPOSE TISSUE (SAT)"}, {"entity_type": "GENOMIC VARIANT", "description": "The AA genotype is associated with changes in fat distribution in response to dietary interventions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 80}]", "id": "AA GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAT is a physiological process representing trunk adipose tissue.<SEP>TAT is a physiological process that represents trunk adipose tissue.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SAT is a physiological process representing subcutaneous adipose tissue.<SEP>SAT is a physiological process that represents subcutaneous adipose tissue.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "SAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FM% refers to fat mass percentage, a physiological indicator of body composition.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "FM%"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "description": "The FTO rs1558902 genotype is associated with changes in weight, particularly greater weight loss in individuals consuming a high-protein diet.)<SEP>Weight refers to the mass of an individual.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "WEIGHT"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The FTO rs1558902 genotype influences body composition, leading to greater loss of fat mass and lean mass in those on a high-protein diet.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "BODY COMPOSITION"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The FTO rs1558902 genotype interacts with protein intake, affecting changes in visceral fat (VAT), subcutaneous fat (SAT), and total abdominal fat (TAT).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 80}]", "id": "FAT DISTRIBUTION"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The FTO rs1558902 genotype is associated with changes in Fat Free Mass,  with greater loss observed in those on a high-protein diet.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "FFM"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The FTO rs1558902 genotype interacts with protein intake, leading to greater loss of visceral fat (VAT) in high-protein diet groups.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 81}]", "id": "VAT"}, {"source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "description": "There were genotype-time interactions on changes in total fat, FM%, and percentage of trunk fat in response to the low-fat diet.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 85}]", "id": "LOW-FAT DIET"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO rs9939609 polymorphism is a genetic variation associated with anthropometric variables.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 138}]", "id": "FTO RS9939609"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Level of education attained by an individual.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 138}]", "id": "EDUCATION LEVEL"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Level of physical activity engaged in by an individual.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "PHYSICAL ACTIVITY (PA)"}, {"entity_type": "GENOMIC VARIANT", "description": "Refers to individuals with General Population characteristics.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "GP"}, {"entity_type": "DISEASE", "description": "Represents subjects with Obesity and Hyperphagia, characterized by high BMI and increased food intake.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "OHP"}, {"entity_type": "DISEASE", "description": "Stands for Healthy Controls and Residents, representing a group of elderly individuals with good health status.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "HCR"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (single nucleotide polymorphism) is a variation in a single nucleotide within the DNA sequence.<SEP>A SNP is a single nucleotide polymorphism, a type of genomic variant.<SEP>SNPs are single nucleotide polymorphisms, which are variations in a DNA sequence.<SEP>Single nucleotide polymorphism.<SEP>A Single Nucleotide Polymorphism (SNP) is a variation at a single position in a DNA sequence.<SEP>A single nucleotide polymorphism (SNP) is a variation at a single position in a DNA sequence.<SEP>SNP stands for single nucleotide polymorphism, a type of genetic variation.<SEP>Single nucleotide polymorphism, a variation in a single nucleotide within the DNA sequence.)  (entity<SEP>A single nucleotide polymorphism, a variation in a single nucleotide within the DNA sequence.", "source_id": "chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 79}]", "id": "SNP"}, {"source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "description": "An FTO SNP increases the risk of developing obesity.)<SEP>An FTO SNP is associated with an increased risk of obesity, particularly in individuals without university studies.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 133}]", "id": "FTO SNP"}, {"entity_type": "GENE", "description": "TCF7L2 is a gene associated with diabetes risk.<SEP>TCF7L2 is a gene frequently investigated for its interaction with dietary factors on the risk of type 2 diabetes.<SEP>TCF7L2 is a gene that has variants associated with T2D risk and modifies the effect of incretins on insulin secretion.<SEP>TCF7L2 is a gene associated with type 2 diabetes.<SEP>TCF7L2 is a gene.<SEP>TCF7L2 is a gene associated with obesity.<SEP>TCF7L2 is a gene involved in glucose homeostasis.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "TCF7L2"}, {"entity_type": "NUTRIENT", "description": "Fiber is a type of carbohydrate found in plant-based foods and plays a role in regulating blood sugar levels.<SEP>Fiber is a type of carbohydrate that is indigestible by humans and can benefit gut health.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "FIBER"}, {"entity_type": "FOOD", "description": "Whole grains are foods made from unrefined cereal grains containing the bran, germ, and endosperm.<SEP>Whole grains are unrefined grains that contain the bran, germ, and endosperm, providing fiber and other nutrients.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "WHOLE GRAIN"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes is a chronic metabolic disorder characterized by high blood sugar levels.<SEP>Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to the body\'s inability to use insulin effectively.<SEP>Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels.<SEP>Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels.<SEP>Type 2 diabetes is a metabolic disorder characterized by elevated blood glucose levels.<SEP>Type 2 diabetes is a metabolic disorder characterized by high blood sugar levels.<SEP>Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to the body\'s inability to effectively use insulin.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 76}]", "id": "TYPE 2 DIABETES"}, {"entity_type": "COHORT STUDY", "description": "The Nurses\' Health Study is a large-scale prospective cohort study of women enrolled since 1976.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "NURSES\' HEALTH STUDY (NHS)"}, {"entity_type": "COHORT STUDY", "description": "The Health Professionals Follow\u2010Up Study is a longitudinal cohort study of male health professionals.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "HEALTH PROFESSIONALS FOLLOW\u2010UP STUDY (HPFS)"}, {"entity_type": "COHORT STUDY", "description": "The Malm\u00f6 Diet and Cancer study is a prospective cohort study investigating the relationship between diet and cancer risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "MALM\u00d6 DIET AND CANCER STUDY (MDCS)"}, {"entity_type": "COHORT STUDY", "description": "EPIC-InterAct is a large European cohort study focusing on cancer incidence and prevention.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)\u2010INTERACT"}, {"entity_type": "COHORT STUDY", "description": "The Shanghai Diabetes GWAS study investigates genetic associations with type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "SHANGHAI DIABETES GWAS STUDY"}, {"entity_type": "COHORT STUDY", "description": "The DESIR study explores the epidemiology and risk factors for insulin resistance syndrome.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "EPIDEMIOLOGICAL STUDY ON THE INSULIN RESISTANCE SYNDROME (DESIR)"}, {"entity_type": "COHORT STUDY", "description": "The KOGES is a Korean cohort study examining the interplay between genetics, environment, and disease.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)"}, {"entity_type": "RANDOMIZED CONTROLLED TRIAL", "description": "The Finnish Diabetes Prevention Study investigated lifestyle interventions for preventing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "FINISH DIABETES PREVENTION STUDY (DPS)"}, {"entity_type": "RANDOMIZED CONTROLLED TRIAL", "description": "The American Diabetes Prevention Project evaluated different approaches to preventing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "AMERICAN DIABETES PREVENTION PROJECT (DPP)"}, {"entity_type": "RANDOMIZED CONTROLLED TRIAL", "description": "PREDIMED is a randomized controlled trial examining the effects of the Mediterranean diet on cardiovascular health.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)"}, {"entity_type": "RANDOMIZED CONTROLLED TRIAL", "description": "An Italian study investigated lifestyle interventions for individuals with metabolic abnormalities.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "ITALIAN STUDY"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific genomic variant associated with diabetes risk.<SEP>rs7903146 is a variant in the TCF7L2 gene strongly associated with T2D risk.<SEP>rs7903146 is a risk variant in the TCF7L2 gene.<SEP>rs7903146 is a SNP located within the TCF7L2 gene.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "RS7903146"}, {"entity_type": "DISEASE", "description": "T2D stands for Type 2 Diabetes, a metabolic disorder characterized by high blood sugar levels.<SEP>T2D stands for type 2 diabetes.<SEP>Type 2 Diabetes (T2D) is a metabolic disorder.<SEP>Type 2 Diabetes (T2D) is a metabolic disorder characterized by high blood sugar levels.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 64}]", "id": "T2D"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Incretins are hormones released after meals that stimulate insulin secretion.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "INCRETINS"}, {"entity_type": "PROTEIN", "description": "A hormone produced by pancreatic beta cells that regulates blood glucose levels.<SEP>A hormone produced by the pancreas that regulates blood sugar levels.<SEP>Insulin is a hormone produced by the pancreas that regulates blood sugar levels.<SEP>Insulin is a hormone that regulates glucose metabolism and gene expression.<SEP>Insulin is a hormone that regulates blood glucose levels by promoting glucose uptake into cells.<SEP>Insulin is a hormone that lowers blood glucose levels.<SEP>Two cases developed diabetes mellitus immediately after surgery and required insulin treatment.)<SEP>Insulin is a hormone produced by the pancreas that regulates blood sugar levels.<SEP>Insulin is a hormone produced by beta cells in the pancreas that regulates blood glucose levels.<SEP>Insulin is a hormone produced by pancreatic \u03b2 cells that regulates blood sugar levels.<SEP>Insulin is a hormone produced by the pancreas that regulates blood glucose levels.<SEP>Insulin is a hormone produced by \u03b2 cells responsible for regulating blood sugar levels.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "INSULIN"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4506565 is a variant in the TCF7L2 gene.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS4506565"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific genomic variant within the TCF7L2 gene.<SEP>rs12255372 is a variant in the TCF7L2 gene.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS12255372"}, {"entity_type": "GENE", "description": "NOTCH2 is a gene involved in cell signaling and development, particularly WNT activity.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "NOTCH2"}, {"entity_type": "METABOLIC PATHWAY", "description": "The WNT signaling pathway plays a crucial role in cell growth, differentiation, and tissue development.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "WNT SIGNALING PATHWAY"}, {"entity_type": "GENE", "description": "ZBED3 is a gene involved in the regulation of the WNT signaling pathway.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ZBED3"}, {"entity_type": "GENE", "description": "IRS1 is a gene encoding insulin receptor substrate 1, involved in insulin signaling.<SEP>IRS1 is a gene that encodes a protein involved in insulin signaling.<SEP>IRS1 is a gene involved in insulin signaling and has been linked to age at first tooth.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "IRS1"}, {"entity_type": "TRANSCRIPTION FACTOR", "description": "PPAR\u03b3 (Peroxisome proliferator-activated receptor-gamma) is a master regulator of adipogenesis and also plays a role in suppressing inflammation.<SEP>PPAR\u03b3 is a gene involved in lipid metabolism and potentially diabetes risk.<SEP>PPAR\u03b3 is a gene that encodes a nuclear receptor involved in lipid metabolism and energy homeostasis.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "PPAR\u0393"}, {"entity_type": "GENE", "description": "FFAR4 is a gene that encodes a receptor for short-chain fatty acids.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "FFAR4"}, {"entity_type": "GENE", "description": "CAV2 is a gene encoding caveolin 2, a protein involved in membrane trafficking and signal transduction.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "CAV2"}, {"entity_type": "GENE", "description": "ADH1C is a gene that encodes an alcohol dehydrogenase enzyme.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ADH1C"}, {"entity_type": "GENE", "description": "HECTD4 is a gene encoding a ubiquitin ligase involved in protein degradation.<SEP>HECTD4 is a gene located in chromosome 12q24 and associated with coffee consumption.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HECTD4"}, {"entity_type": "GENE", "description": "HFE is a gene that regulates iron metabolism.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "HFE"}, {"entity_type": "GENE", "description": "SLC40A1 is a gene that encodes an iron transporter.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "SLC40A1"}, {"entity_type": "GENE", "description": "TMPRSS6 is a gene involved in iron regulation.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TMPRSS6"}, {"entity_type": "STUDY", "description": "The Stockholm Diabetes Prevention Program is a cohort study investigating diabetes prevention.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "STOCKHOLM DIABETES PREVENTION PROGRAM (SDPP)"}, {"entity_type": "STUDY", "description": "The Multi-Ethnic Study of Atherosclerosis (MESA) and the Danish Diet, Cancer and Health Study (DCHS) combined are known as MDCS.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "MDCS"}, {"entity_type": "STUDY", "description": "The EPIC-Potsdam study is a cohort study investigating the relationship between diet and health.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "EPIC-POTSDAM"}, {"entity_type": "STUDY", "description": "EPIC-InterAct is a collaborative study of cohorts across Europe focusing on the genetic and dietary risk factors for chronic diseases.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "EPIC-INTERACT"}, {"entity_type": "STUDY", "description": "The Nurses\' Health Study is a long-term cohort study of female nurses in the United States.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "NHS"}, {"entity_type": "STUDY", "description": "The Health Professionals Follow-Up Study is a long-term cohort study of male health professionals in the United States.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "HPFS"}, {"entity_type": "STUDY", "description": "DESIR (Dietary and Exercise Studies on Insulin Resistance) is a French cohort study investigating the relationship between diet, physical activity, and insulin resistance.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "DESIR"}, {"entity_type": "STUDY", "description": "The Korean Genome and Epidemiology Study (KoGES) is a population-based cohort study in Korea.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "KOGES"}, {"entity_type": "GENE", "description": "SLC2A2 is a gene encoding glucose transporter 2 and has been associated with altered AcAc or BHB levels.<SEP>SLC2A2 is a gene that may influence the response to changes in LTPA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "SLC2A2"}, {"entity_type": "GENOMIC VARIANT", "description": "These are genomic variants within the SLC2A2 gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS5393, RS5394, RS5400, AND RS5404"}, {"entity_type": "GENE", "description": "ENPP1 is a gene that may influence the response to weight loss interventions for diabetes prevention.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "ENPP1"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant within the ENPP1 gene associated with diabetes risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS1044498"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant within the MC4R gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS17066829"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant within the PPAR\u03b3 gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS1152003"}, {"entity_type": "CYTOKINE", "description": "TNF\u03b1 is a gene involved in inflammation, which may influence diabetes risk.<SEP>Tumor necrosis factor alpha (TNF\u03b1) is a pro-inflammatory cytokine that plays a role in inflammation, cell death, and immune system regulation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "TNF\u0391"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant within the TNF\u03b1 gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS1800629"}, {"entity_type": "GENE", "description": "ADRA2B is a gene involved in adrenergic signaling, which may influence diabetes risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "ADRA2B"}, {"entity_type": "GENETIC VARIATION", "description": "Glu9 is a specific allele of the ADRA2B gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "GLU9"}, {"entity_type": "GENE", "description": "LIPC is a gene involved in lipid metabolism and potentially diabetes risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "LIPC"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant within the LIPC gene.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS2070895"}, {"entity_type": "LIFESTYLE FACTOR", "description": "LTPA refers to light-to-moderate physical activity.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "LTPA"}, {"entity_type": "THERAPY", "description": "A weight loss intervention is a program or strategy aimed at reducing body weight.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "WEIGHT LOSS INTERVENTION"}, {"source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "description": "A dietary pattern is a habitual combination of food choices, characterized by specific frequencies and proportions of different food groups.<SEP>The TCF7L2 gene has been shown to interact with dietary patterns, particularly fiber and whole grain intake, influencing the risk of type 2 diabetes.)", "entity_type": "DIETARY PATTERN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "DIETARY PATTERN"}, {"source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "description": "The NHS is a prominent example of a cohort study design.)", "entity_type": "UNKNOWN", "id": "COHORT STUDIES"}, {"source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "description": "The DPS employs a randomized controlled trial design.)", "entity_type": "UNKNOWN", "id": "RANDOMIZED CONTROLLED TRIALS"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Variants in the TCF7L2 gene have been linked to an increased risk of developing T2D.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 64}]", "id": "TCF7L2 VARIANTS"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "No interaction was observed between rs7903146 and carbohydrates.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "CARBOHYDRATES"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Women with the HFE rs1799945 variant showed an increased risk of type 2 diabetes (T2D).)", "entity_type": "UNKNOWN", "id": "HFE RS1799945"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Women with the HFE rs1799945 variant showed an increased risk of type 2 diabetes (T2D).)", "entity_type": "UNKNOWN", "id": "T2D RISK"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Women with the HFE rs1800562 variant showed an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "HFE RS1800562"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC40A1 rs744653 variant was associated with a modified risk of T2D in men within the EPIC-InterAct study.)", "entity_type": "UNKNOWN", "id": "MEN T2D RISK"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC40A1 rs744653 variant was associated with a modified risk of T2D in men within the EPIC-InterAct study.)", "entity_type": "UNKNOWN", "id": "SLC40A1 RS744653"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The TMPRSS6 rs855791 variant showed borderline significance for association with T2D risk in the total sample.)", "entity_type": "UNKNOWN", "id": "TMPRSS6 RS855791"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC30A8 variants (rs16889462, 8_118252314, and 8_118252435) showed interaction with zinc intake in DPP.)", "entity_type": "UNKNOWN", "id": "SLC30A8 VARIANTS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC30A8 variants (rs16889462, 8_118252314, and 8_118252435) showed interaction with zinc intake in DPP.)", "entity_type": "UNKNOWN", "id": "ZINC INTAKE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "High intake of red and processed meat increased the risk to develop T2D among men with a high T2D Genetic Risk Score (GRS), but not among men with a low GRS.)", "entity_type": "UNKNOWN", "id": "RED MEAT/PROCESSED MEAT"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "High intake of red and processed meat increased the risk to develop T2D among men with a high T2D Genetic Risk Score (GRS), but not among men with a low GRS.)", "entity_type": "UNKNOWN", "id": "T2D\u2010GRS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "There was a marginally nonsignificant interaction between olive oil intake and the GIPR variant rs10423928 in EPIC-InterAct.)", "entity_type": "UNKNOWN", "id": "GIPR VARIANT RS10423928"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "There was a marginally nonsignificant interaction between olive oil intake and the GIPR variant rs10423928 in EPIC-InterAct.)", "entity_type": "UNKNOWN", "id": "OLIVE OIL"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The lactase persistence LCT gene variant rs4988235 influenced the association between dairy consumption and T2D risk.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 30}]", "id": "DAIRY PRODUCTS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The lactase persistence LCT gene variant rs4988235 influenced the association between dairy consumption and T2D risk.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 30}]", "id": "LCT GENE RS4988235"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Higher coffee intake had a stronger effect on reducing T2D risk in individuals with the risk allele of the TCF7L2 variant rs12255372.)", "entity_type": "UNKNOWN", "id": "COFFEE INTAKE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Higher coffee intake had a stronger effect on reducing T2D risk in individuals with the risk allele of the TCF7L2 variant rs12255372.)", "entity_type": "UNKNOWN", "id": "TCF7L2 VARIANT RS12255372"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Reduced T2D incidence was observed among coffee consumers with specific alleles (rs4402960, rs7754840, and rs5215) in the KARE study.)", "entity_type": "UNKNOWN", "id": "IGF2BP2, CDKAL1, KCNJ11 VARIANTS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "A Western dietary pattern was associated with higher T2D risk only among individuals with a high T2D-GRS.)", "entity_type": "UNKNOWN", "id": "WESTERN DIET"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Borderline significant interaction between the CLOCK variant rs4580704 and Mediterranean diet, suggesting lower T2D incidence in individuals with the G allele.)", "entity_type": "UNKNOWN", "id": "CLOCK VARIANT RS4580704"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Borderline significant interaction between the CLOCK variant rs4580704 and Mediterranean diet, suggesting lower T2D incidence in individuals with the G allele.)<SEP>The Mediterranean diet emphasizes fruits, vegetables, whole grains, legumes, and healthy fats like olive oil.", "entity_type": "DIETARY PATTERN", "id": "MEDITERRANEAN DIET"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The protective effect of physical activity (PA) on T2D risk was weaker among individuals with a high adherence to a T2D-GRS.)", "entity_type": "UNKNOWN", "id": "PA"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The minor HNF1B rs4430796 A allele weakened or reversed the protective effect of PA on T2D risk.)", "entity_type": "UNKNOWN", "id": "HNF1B RS4430796"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Women with the IRS1 rs1522813 A allele and low levels of PA had a higher risk to develop T2D compared with women with the GG genotype.)", "entity_type": "UNKNOWN", "id": "IRS1 RS1522813"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Reduced leisure-time physical activity (LTPA) was associated with higher T2D incidence in individuals with specific PPAR\u03b3 variants.)", "entity_type": "UNKNOWN", "id": "PPAR\u0393 RS1801282, RS17036314"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Increased LTPA resulted in lower T2D incidence in individuals with certain ADRA2B, ABCC8, and SLC2A2 genetic variations.)", "entity_type": "UNKNOWN", "id": "ADRA2B GLU12, ABCC8 RS3758947, SLC2A2 VARIANTS"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The SLC2A2 genotype may influence the response to changes in LTPA (light-to-moderate physical activity).)", "entity_type": "UNKNOWN", "id": "SLC2A2 VARIANTS"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "Individuals with the TCF7L2 rs12255372 risk TT genotype showed a lower incidence of T2D in intervention groups compared to control groups.)", "entity_type": "UNKNOWN", "id": "T2D INCIDENCE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "Individuals with the TCF7L2 rs12255372 risk TT genotype showed a lower incidence of T2D in intervention groups compared to control groups.)", "entity_type": "UNKNOWN", "id": "TCF7L2 RS12255372 RISK ALLELE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "Individuals with the rs7903146 risk T allele had a reduced risk of developing T2D.)", "entity_type": "UNKNOWN", "id": "RS7903146 RISK ALLELE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The weight loss intervention was associated with a reduced incidence of T2D in individuals with the ENPP1 rs1044498 diabetogenic variant.)", "entity_type": "UNKNOWN", "id": "ENPP1 RS1044498 DIABETOGENIC VARIANT"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "There was a trend for interaction between the MC4R rs17066829 variant and weight loss interventions for T2D prevention.)", "entity_type": "UNKNOWN", "id": "MC4R RS17066829"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the PPAR\u03b3 rs1152003 CC genotype.)", "entity_type": "UNKNOWN", "id": "PPAR\u0393 RS1152003 CC GENOTYPE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the TNF\u03b1 rs1800629 GG genotype.)", "entity_type": "UNKNOWN", "id": "TNF\u0391 RS1800629 GG GENOTYPE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the ADRA2B Glu9 allele.)", "entity_type": "UNKNOWN", "id": "ADRA2B GLU9 ALLELE"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the LIPC rs2070895 A allele.)", "entity_type": "UNKNOWN", "id": "LIPC RS2070895 A ALLELE"}, {"entity_type": "GENE", "description": "WFS1 is a gene associated with type 2 diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "WFS1"}, {"entity_type": "GENE", "description": "JAZF1 is a gene associated with type 2 diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "JAZF1"}, {"entity_type": "GENE", "description": "ADAMTS9 is a gene associated with type 2 diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "ADAMTS9"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk allele refers to a specific variation in a gene sequence that increases the likelihood of developing a disease or trait.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 77}]", "id": "RISK ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Age is a demographic characteristic that can influence metabolic processes and disease risk.<SEP>Age refers to the biological process of growing and developing over time.<SEP>Age is a variable used as a covariate in statistical analyses to control for potential confounding effects.<SEP>Age is a measure of time elapsed since birth.<SEP>Represents the number of years since birth.<SEP>Age refers to the number of years a person has lived and is a factor considered in the analysis.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "AGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sex refers to biological differences between males and females, which can affect hormone levels and metabolic function.<SEP>Sex refers to the biological characteristics that distinguish males from females.<SEP>Sex refers to the biological characteristics that distinguish males and females.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SEX"}, {"entity_type": "POPULATION GROUP", "description": "African ancestry refers to genetic heritage originating from the African continent.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "AFRICAN ANCESTRY"}, {"entity_type": "STATISTICAL METHOD", "description": "Nominal analysis is a type of statistical analysis used for categorical data.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "NOMINAL ANALYSIS"}, {"entity_type": "STATISTICAL METHOD", "description": "Ordinal analysis is a type of statistical analysis used for ranked or ordered categorical data.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "ORDINAL ANALYSIS"}, {"entity_type": "STATISTICAL MEASURE", "description": "Weighted odds ratio (OR) is a measure of association that takes into account the weighting of data points.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "WEIGHTED OR"}, {"entity_type": "STATISTICAL MEASURE", "description": "Unweighted odds ratio (OR) is a measure of association that does not take into account the weighting of data points.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "UNWEIGHTED OR"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs10010131 variant in the WFS1 gene is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "RS10010131"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 134}]", "id": "RS10946398"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs864745 variant in the JAZF1 gene is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "RS864745"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs4607103 variant in the ADAMTS9 gene is associated with a decreased risk of type 2 diabetes, opposite to what has been observed in European populations.)", "entity_type": "UNKNOWN", "id": "RS4607103"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Individuals with higher cumulative risk scores (based on the number of risk alleles) are more likely to have type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "CUMULATIVE RISK SCORE"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Individuals with higher cumulative risk scores (based on the number of risk alleles) are more likely to have type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "T2D CASE"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The study samples reflect the general population of African Americans in the southeast, with an average African ancestry proportion of around 0.79.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "STUDY POPULATION"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "Age was considered as a factor in statistical analyses.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 50}]", "id": "ANALYSIS"}, {"entity_type": "DISEASE", "description": "A state of healthy blood glucose regulation.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 125}]", "id": "NORMAL GLUCOSE TOLERANCE (NGT)"}, {"entity_type": "DISEASE", "description": "A condition characterized by elevated fasting or post-meal blood glucose levels, but not yet diabetes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 125}]", "id": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)"}, {"entity_type": "DISEASE", "description": "A chronic metabolic disorder characterized by high blood sugar levels due to the body\'s inability to effectively use insulin.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 125}]", "id": "TYPE 2 DIABETES (T2D)"}, {"entity_type": "QUANTITATIVE TRAIT", "description": "A measure of body fat based on height and weight.<SEP>BMI is a measure of body fat based on height and weight.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "id": "BMI (BODY MASS INDEX)"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group primarily residing in East Asia.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "EAST ASIAN"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group primarily residing in Africa.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "AFRICAN"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group primarily residing in Europe.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "EUROPEAN"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group indigenous to the North American continent.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "NATIVE NORTH AMERICAN"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group of Latin American origin.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "LATINO AMERICAN"}, {"entity_type": "ETHNIC GROUP", "description": "An ethnic group primarily residing in South Asia.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "SOUTH ASIAN"}, {"entity_type": "GENE", "description": "TAL1 is a gene associated with obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 126}]", "id": "TAL1"}, {"entity_type": "GENE", "description": "LEPR is a gene encoding the leptin receptor, involved in appetite regulation.<SEP>LEPR is a gene that interacts with fasting plasma glucose (FPG) to influence BMI.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 39}]", "id": "LEPR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9939609 is a SNP located within the FTO gene.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 65}]", "id": "RS9939609"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2984618 is a SNP located within the TAL1 gene.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 126}]", "id": "RS2984618"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1011527 is a SNP located within the LEPR gene.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 39}]", "id": "RS1011527"}, {"entity_type": "GENOMIC VARIANT", "description": "A set of single nucleotide polymorphisms (SNPs) associated with obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "OBESITY SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure combining the effects of multiple genetic variants to predict an individual\'s risk for a particular trait, such as obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "GENOTYPE RISK SCORE (GRS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The level of glucose in the blood after fasting for a specific period.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "FASTING PLASMA GLUCOSE (FPG)"}, {"source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Ethnicity encompasses cultural and genetic similarities among populations, which can influence susceptibility to certain diseases.<SEP>The percentage of individuals with NGT varies across different ethnic groups, such as East Asian, African, European, etc.)", "entity_type": "POPULATION GROUP", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 125}]", "id": "ETHNICITY"}, {"source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "description": "FPG (Fasting Plasma Glucose) measures blood glucose levels after a period of fasting.<SEP>FPG stands for fasting plasma glucose, which measures blood sugar levels after an overnight fast.<SEP>The rs1011527 SNP interacted with FPG to influence BMI at baseline.)", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 39}]", "id": "FPG"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MTHFR gene, MTHFR 1298A>C, is associated with impairment on the DIVERGT battery.<SEP>The MTHFR 1298A>C variant is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298A>C"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MS gene, MS 2756A>G, is associated with impairment on the DIVERGT battery.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756A>G"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the MTHFR 1298A>C variant, where AC or CC alleles are present. This genotype is associated with increased risk of impairment on cognitive tests.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298AC/CC"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the MS 2756A>G variant, where two AA alleles are present. This genotype is associated with increased risk of impairment on cognitive tests.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756AA"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the TSER polymorphism, where two R alleles are present.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TSER 2R/3R"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the TSER polymorphism, where three R alleles are present.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TSER 3R/3R"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the MTRR polymorphism, where two A alleles are present.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTRR 66AA"}, {"entity_type": "GENOTYPE", "description": "A genotype resulting from the MTRR polymorphism, where either AG or GG alleles are present.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTRR 66AG/GG"}, {"entity_type": "TEST", "description": "The DIVERGT battery is a test used to assess neurocognitive function.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "DIVERGT BATTERY"}, {"entity_type": "ORGANIZATION", "description": "The Pediatric Oncology Group is a group of researchers and clinicians who develop cancer treatment protocols.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "PEDIATRIC ONCOLOGY GROUP"}, {"entity_type": "TEST", "description": "TMTA is a neurocognitive test that assesses fine motor skills.<SEP>TMTA is a neuropsychological test measuring cognitive function.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTA"}, {"entity_type": "TEST", "description": "TMTB is a neurocognitive test that assesses executive function.<SEP>TMTB is a neuropsychological test measuring cognitive function.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTB"}, {"entity_type": "TEST", "description": "PEGNDH is a neurocognitive test that assesses fine motor skills.<SEP>PEGNDH refers to the physiological process of   PEnte-glutamate N-dehydrogenase activity.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PEGNDH"}, {"entity_type": "TEST", "description": "CFL is a neurocognitive test that assesses executive function.<SEP>CFL likely refers to a physiological process related to cognition or motor function, as it is used in neuropsychological assessments.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "CFL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Methotrexate (MTX) is a drug used in the treatment of certain diseases.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "MTX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "PEGDH refers to the physiological process of  PErGine dehydrolase activity.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PEGDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DIG likely refers to a physiological process related to cognition or motor function, as it is used in neuropsychological assessments.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "DIG"}, {"entity_type": "GENE", "description": "A gene is a unit of heredity that carries genetic information.<SEP>A gene is a unit of heredity which is transferred from a parent to offspring and is held to determine some characteristic of the offspring.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the GCK gene can cause MODY.<SEP>A genomic variant is a difference in DNA sequence compared to a reference sequence.<SEP>rs142786317 is a genomic variant in the SULT1A1 gene.<SEP>20<SEP>Variations in the OPRM1 gene sequence can affect its function.<SEP>Mutations in the LPL gene cause LPL deficiency.<SEP>A genomic variant in the UBE2T gene was identified in the proband, causing Fanconi Anemia-T subtype.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-607feda7df4db8151b99560074c91eea<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 144}]", "id": "GENOMIC VARIANT"}, {"entity_type": "TRANSCRIPT", "description": "A transcript is a molecule of RNA that is created from a DNA template.<SEP>The transcript of the GCK gene encodes for the Glucokinase protein.<SEP>Wild type UBE2T transcript was introduced into RA2627 fibroblasts to rescue cellular defects.<SEP>Transcripts of the PTPN22 gene are measured in various T cell subsets.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "TRANSCRIPT"}, {"entity_type": "BIOMOLECULE", "description": "A protein is a large biomolecule made up of chains of amino acids, responsible for many vital functions in living organisms.<SEP>Proteins are large biomolecules that perform various functions in cells.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PROTEIN"}, {"entity_type": "NUTRIENT", "description": "A nutrient is a substance that provides nourishment essential for the maintenance of life and growth.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "NUTRIENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process refers to a series of biochemical reactions occurring within an organism.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PHYSIOLOGICAL PROCESS"}, {"entity_type": "METABOLIC PATHWAY", "description": "A metabolic pathway is a series of interconnected chemical reactions that convert one molecule into another.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "METABOLIC PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular interaction is the binding or association between two or more molecules.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "MOLECULAR INTERACTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor is an external agent or condition that can influence living organisms.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "ENVIRONMENTAL FACTOR"}, {"entity_type": "DISEASE", "description": "A disease is a disorder of structure or function in a human, animal, or plant, especially one that produces specific symptoms.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "DISEASE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The MTHFR 1298AC/CC genotypes were associated with a 3.0-fold increased risk of impairment on the DIVERGT battery.)", "entity_type": "UNKNOWN", "id": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MTHFR 1298AC/CC genotypes had a 3.0-fold increased risk of impairment compared to those with the MTHFR 1298AA genotype.)", "entity_type": "UNKNOWN", "id": "MTHFR 1299AA"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MS 2756AA genotype were 3.8 times as likely to meet criteria for impairment on the battery compared to those with the MS 2756AG/GG genotypes.)", "entity_type": "UNKNOWN", "id": "MS 2756AG/GG"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 10 points lower on TMTA and 11.4 points lower on TMTB than those with the TSER 2R/2R genotype.)", "entity_type": "UNKNOWN", "id": "TSER 2R/2R"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Early MTX-related neurotoxicity was predictive of long-term neurocognitive impairment (p=0.03).)", "entity_type": "UNKNOWN", "id": "EARLY MTX-RELATED NEUROTOXICITY"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Early MTX-related neurotoxicity was predictive of long-term neurocognitive impairment (p=0.03).)", "entity_type": "UNKNOWN", "id": "LONG-TERM NEUROCOGNITIVE IMPAIRMENT"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "POG 9005 is a protocol developed by the Pediatric Oncology Group.)", "entity_type": "UNKNOWN", "id": "POG 9005"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "POG 9005 is a protocol developed by the Pediatric Oncology Group.)", "entity_type": "UNKNOWN", "id": "PROTOCOL"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "POG 9006 is a protocol developed by the Pediatric Oncology Group.)", "entity_type": "UNKNOWN", "id": "POG 9006"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The study involved treatment protocols POG 9005 and POG 9006, both developed by the Pediatric Oncology Group.)", "entity_type": "UNKNOWN", "id": "PEDIATRIC ONCOLOGY GROUP PROTOCOLS"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The study involved treatment protocols POG 9005 and POG 9006, both developed by the Pediatric Oncology Group.)", "entity_type": "UNKNOWN", "id": "POG 9005 & POG 9006"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MS 2756AA genotype scored on average 12.2 points lower on TMTA compared to survivors with the MS 2756AG/GG genotypes.)", "entity_type": "UNKNOWN", "id": "TMTA SCORE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MS 2756AA genotype scored on average 5.3 points lower on TMTB compared to survivors with the MS 2756AG/GG genotypes.)", "entity_type": "UNKNOWN", "id": "TMTB SCORE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MS 2756AA genotype had a mean PEGNDH score that was 11.7 points lower than those with the MS 2756AG/GG genotypes.)", "entity_type": "UNKNOWN", "id": "PEGNDH SCORE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MTRR 66AA genotype scored 10.5 points lower on CFL compared to those with the MTRR 66AG/GG genotypes.)", "entity_type": "UNKNOWN", "id": "CFL SCORE"}, {"source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "description": "A higher GRS was associated with lower scores on TMTA, suggesting a possible relationship between genetic predisposition and cognitive performance.)", "entity_type": "UNKNOWN", "id": "GRS"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC30A8 rs13266634 is a risk allele associated with higher fasting proinsulin levels.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "SLC30A8 RS13266634"}, {"entity_type": "PROTEIN", "description": "Proinsulin is a precursor to insulin and is measured as a marker of pancreatic beta-cell function.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "PROINSULIN"}, {"entity_type": "DIETARY PATTERN", "description": "The Diabetes Prevention Program (DPP) is an intervention program aimed at preventing type 2 diabetes.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "DIABETES PREVENTION PROGRAM (DPP)"}, {"entity_type": "DRUG", "description": "Metformin is a drug commonly used to treat type 2 diabetes.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "METFORMIN"}, {"entity_type": "DRUG", "description": "Troglitazone is a drug formerly used to treat type 2 diabetes.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "TROGLITAZONE"}, {"entity_type": "GENE", "description": "SLC30A8 is a gene associated with insulin secretion and glucose metabolism.<SEP>SLC30A8 is a gene that encodes a zinc transporter.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "SLC30A8"}, {"entity_type": "GENOMIC VARIANT", "description": "rs13266634 is a specific genomic variant within the SLC30A8 gene.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "RS13266634"}, {"entity_type": "PROTEIN", "description": "Fasting insulin is a measure of the amount of insulin in the blood after a period of fasting.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING INSULIN"}, {"entity_type": "NUTRIENT", "description": "Fasting glucose refers to the level of glucose in the blood after an overnight fast.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING GLUCOSE"}, {"entity_type": "GENE", "description": "PNPLA3 is a gene that encodes a protein involved in lipid metabolism.<SEP>The PNPLA3 gene encodes a protein involved in lipid metabolism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "PNPLA3"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet increases the expression of PNPLA3 in mouse liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH CARBOHYDRATE DIET"}, {"entity_type": "NUTRIENT", "description": "Lipid emulsion attenuates the expression of PNPLA3 in mouse liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "LIPID EMULSION"}, {"entity_type": "DIETARY PATTERN", "description": "A stock diet is a normal chow diet that serves as a control for comparison.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "STOCK DIET (NORMAL CHOW, NC)"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet increases the expression of PNPLA3 in mouse liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH CARBOHYDRATE DIET (HC DIET)"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet with 4% lipid emulsion, which reduces PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HC-4% LE DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet with 13.5% lipid emulsion, which reduces PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HC-13.5% LE DIET"}, {"entity_type": "PROTEIN", "description": "SREBP1c is a transcription factor involved in lipid metabolism.<SEP>Sterol regulatory element binding protein (SREBP1c) is a transcriptional factor that regulates genes involved in lipid metabolism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 31}]", "id": "SREBP1C"}, {"entity_type": "PROTEIN", "description": "Acetyl-CoA carboxylase (ACC-1) is responsible for the formation of malonyl-CoA in fatty acid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "ACC-1"}, {"entity_type": "PROTEIN", "description": "Fatty acid synthase (FAS) is involved in de novo fatty acid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "FATTY ACID SYNTHASE (FAS)"}, {"entity_type": "DIETARY PATTERN", "description": "A high-fat diet leads to fatty liver and increases hepatic triglyceride levels.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH-FAT DIET (HF DIET)"}, {"entity_type": "DIETARY PATTERN", "description": "A low-fat diet serves as a control for comparison with the HF diet.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "LOW-FAT DIET (LF DIET)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Physical activity can reduce hepatic triglyceride levels and suppress PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "EXERCISE"}, {"entity_type": "PROTEIN", "description": "ChREBP is a transcription factor that regulates glucose metabolism and its expression correlates with PNPLA3.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN (CHREBP)"}, {"entity_type": "NUTRIENT", "description": "2-Deoxy-D-glucose is a metabolic inhibitor that blocks glucose metabolism.<SEP>A non-metabolizable glucose analog that does not induce PNPLA3 or SREBP1c expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 31}]", "id": "2-DEOXY-D-GLUCOSE"}, {"entity_type": "METABOLITE", "description": "Citrate is a Krebs cycle intermediate that can increase PNPLA3 levels.<SEP>Citrate is a Krebs cycle intermediate that increases PNPLA3 levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "CITRATE"}, {"entity_type": "METABOLITE", "description": "Pyruvate is a glycolytic intermediate that does not regulate PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "PYRUVATE"}, {"entity_type": "METABOLITE", "description": "Acetate is a metabolite that does not regulate PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "ACETATE"}, {"entity_type": "TISSUE", "description": "The liver is an organ in mice that plays a role in lipid metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "MOUSE LIVER"}, {"entity_type": "TISSUE", "description": "The epididymis is a tissue in mice that stores and transports sperm.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "EPIDIDYMAL TISSUE"}, {"entity_type": "TISSUE", "description": "Adipose tissue is a type of connective tissue that stores fat.<SEP>Adipose tissue is a type of fatty tissue found in mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "ADIPOSE TISSUE"}, {"entity_type": "CELL LINE", "description": "HepG2 cells are a human hepatocellular carcinoma cell line.<SEP>HepG2 cells are a human liver cell line used for research.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "HEPG2 CELLS"}, {"entity_type": "BIOMARKER", "description": "Triglyceride (TG) content is a measure of lipid storage in the liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "TG CONTENT"}, {"entity_type": "RNA", "description": "Messenger RNA (mRNA) carries genetic information from DNA to ribosomes for protein synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "MRNA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Glucagon is a hormone that regulates glucose metabolism and gene expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "GLUCAGON"}, {"entity_type": "NUTRIENT", "description": "Linoleic acid is an unsaturated fatty acid found in Intralipid\u00ae and other dietary sources.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LINOLEIC ACID (LA)"}, {"entity_type": "NUTRIENT", "description": "Oleic acid is an unsaturated fatty acid found in Intralipid\u00ae and other dietary sources.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OLEIC ACID (OA)"}, {"entity_type": "NUTRIENT", "description": "\u03b1-Linolenic acid is an unsaturated fatty acid found in Intralipid\u00ae and other dietary sources.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "\u0391-LINOLENIC ACID (ALA)"}, {"entity_type": "NUTRIENT", "description": "Eicosapentaenoic acid is a long-chain polyunsaturated fatty acid.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "EICOSAPENTAENOIC ACID (EPA)"}, {"entity_type": "NUTRIENT", "description": "Docosahexaenoic acid is a long-chain polyunsaturated fatty acid.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "DOCOSAHEXAENOIC ACID (DHA)"}, {"entity_type": "DISEASE", "description": "FAS (Fetal Alcohol Spectrum Disorder) is a disorder caused by prenatal alcohol exposure.<SEP>FAS is a gene involved in fatty acid synthesis.<SEP>Fatty acid synthase (FAS) is an enzyme involved in fatty acid synthesis.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-d594d57f0043cce2b3d29c80323b1a11", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "FAS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "PNPLA3 siRNA is a tool used to knock down the expression of the PNPLA3 gene.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "PNPLA3 SIRNA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oil Red O staining is a method used to visualize lipid accumulation in cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OIL RED O STAINING"}, {"entity_type": "CELL TYPE", "description": "3T3-L1 adipocytes are a cell line derived from mouse fat cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "3T3-L1 ADIPOCYTES"}, {"entity_type": "CELL TYPE", "description": "Chinese hamster ovary (CHO) cells are a common cell line used in research.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "CHINESE HAMSTER OVARY CELLS"}, {"entity_type": "TISSUE", "description": "Human adipose tissue is the body\'s fat tissue.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "HUMAN ADIPOSE TISSUE"}, {"entity_type": "GENE", "description": "Acetyl-CoA carboxylase (ACC) is a key enzyme in fatty acid synthesis.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 31}]", "id": "ACC"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "A high-fat diet leads to increased hepatic triglyceride levels.)", "entity_type": "UNKNOWN", "id": "HEPATIC TRIGLYCERIDES"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "A high-fat diet leads to increased hepatic triglyceride levels.)", "entity_type": "UNKNOWN", "id": "HIGH-FAT DIET"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "The expression of ChREBP and PNPLA3 are highly correlated.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "CHREBP"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "High glucose increases PNPLA3 gene expression in HepG2 cells.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 31}]", "id": "HIGH GLUCOSE"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "High glucose promotes lipid accumulation in HepG2 cells.)<SEP>High glucose resulted in increased lipid accumulation, whereas 2-deoxy-D-glucose led to reduction of lipid content in cells.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 31}]", "id": "LIPID ACCUMULATION"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "High glucose increases PNPLA3 expression, while 2-deoxy-D-glucose suppresses it.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "GLUCOSE METABOLISM"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "PNPLA3 was not regulated by isocitrate, suggesting specificity to citrate.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "ISOCITRATE"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Treatment with LA suppressed PNPLA3 gene expression in both low and high glucose conditions.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "LA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Treatment with OA suppressed PNPLA3 gene expression in both low and high glucose conditions.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "OA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "ALA had no effect on PNPLA3 gene expression under either condition.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "ALA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions.)<SEP>EPA (eicosapentaenoic acid) is an omega-3 fatty acid.", "entity_type": "NUTRIENT", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "EPA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions.)<SEP>DHA (docosahexaenoic acid) is an omega-3 fatty acid.", "entity_type": "NUTRIENT", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 32}]", "id": "DHA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "The combination of OA, LA, and ALA significantly suppressed gene expression of SREBP1c.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "OA, LA, AND ALA"}, {"entity_type": "PHENOMENON/PROCESS", "description": "PNS refers to Prenatal Stress exposure, a significant environmental factor influencing the development and function of the nervous system.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 61}]", "id": "PNS"}, {"entity_type": "BRAIN REGION", "description": "The hippocampus is a brain region crucial for memory and learning that shows significant changes following PNS exposure.<SEP>The hippocampus is a brain region involved in learning and memory.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98<SEP>chunk-37088dc7c337929125b7fb31c9bf64cf", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 61}]", "id": "HIPPOCAMPUS"}, {"entity_type": "ANIMAL MODEL", "description": "Adult male rats are used as an animal model to study the effects of PNS on neurodevelopment.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "ADULT MALE RATS"}, {"entity_type": "STATISTICAL MEASURE", "description": "Fold Change (FC) is used to quantify the magnitude of gene expression changes between control and PNS-exposed groups.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "FC"}, {"entity_type": "STATISTICAL MEASURE", "description": "The q-value is a measure of statistical significance used to determine if observed changes in gene expression are due to chance.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "Q-VALUE"}, {"entity_type": "NON-CODING RNA", "description": "microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by binding to target mRNAs.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "MIRNAS"}, {"entity_type": "COMPUTATIONAL METHOD", "description": "This method identifies genes that are both modulated by PNS exposure and targeted by miRNAs also affected by PNS.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "MRNA-MIRNA COMBINING ANALYSIS"}, {"entity_type": "GENE", "description": "A2M is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 59}]", "id": "A2M"}, {"entity_type": "GENE", "description": "ARID5B is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARID5B"}, {"entity_type": "GENE", "description": "ARRDC4 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARRDC4"}, {"entity_type": "GENE", "description": "EPHA4 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "EPHA4"}, {"entity_type": "GENE", "description": "FBXO32 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "FBXO32"}, {"entity_type": "GENE", "description": "FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis.<SEP>FoxO1 is a gene that was modulated in both animals and humans in the same direction, and it mediates the negative effect of stress on neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98<SEP>chunk-01cd90d27130aab1a096ad616e05f182", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 59}]", "id": "FOXO1"}, {"entity_type": "GENE", "description": "HSF2 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "HSF2"}, {"entity_type": "GENE", "description": "ISOC1 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ISOC1"}, {"entity_type": "GENE", "description": "LDLRAP1 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LDLRAP1"}, {"entity_type": "GENE", "description": "LRRN3 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LRRN3"}, {"entity_type": "GENE", "description": "MYO1D is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "MYO1D"}, {"entity_type": "GENE", "description": "PIK3C2B is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PIK3C2B"}, {"entity_type": "GENE", "description": "PPAP2A is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PPAP2A"}, {"entity_type": "GENE", "description": "SAMD12 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SAMD12"}, {"entity_type": "GENE", "description": "SERINC5 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SERINC5"}, {"entity_type": "GENE", "description": "TGF-\u03b21 is a gene that was modulated in both animals and humans in the same direction, and it interacts with A2M and FoxO1.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 59}]", "id": "TGF-\u03921"}, {"entity_type": "GENE", "description": "BCL2 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "B-CELL CLL/LYMPHOMA 2 (BCL2)"}, {"entity_type": "GENE", "description": "BCL9 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "B-CELL CLL/LYMPHOMA 9 (BCL9)"}, {"entity_type": "GENE", "description": "LIN54 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LIN-54 DREAM MUVB CORE COMPLEX COMPONENT (LIN54)"}, {"entity_type": "GENE", "description": "PGAP1 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "POST-GPI ATTACHMENT TO PROTEINS 1 (PGAP1)"}, {"entity_type": "GENE", "description": "SLC6A4 is a gene that was modulated in both animals and humans in the same direction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SLC6A4"}, {"entity_type": "MOLECULAR INTERACTION", "description": "AS1842856 is a cell-permeable inhibitor of FoxO1.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 60}]", "id": "AS1842856"}, {"entity_type": "GENE", "description": "SGK-1 is a stress- and cortisol-induced gene that mediates some glucocorticoid effects on brain function, including negative effects on neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 60}]", "id": "SGK-1"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Exposure to PNS causes significant modulation of 916 genes in the hippocampus.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "GENE EXPRESSION"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Prenatal stress (PNS) disrupts various neurodevelopmental processes, including axonal guidance, protein kinase signaling, and synaptic plasticity.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 61}]", "id": "NEURODEVELOPMENT"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Changes in gene expression within the hippocampus are assessed through transcriptomic analysis following PNS exposure.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 61}]", "id": "TRANSCRIPTOMICS ANALYSIS"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Exposure to PNS leads to changes in miRNA levels, including both downregulation and upregulation.)", "entity_type": "UNKNOWN", "id": "MIRNOME CHANGES"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Exposure to PNS leads to changes in miRNA levels, including both downregulation and upregulation.)", "entity_type": "UNKNOWN", "id": "PNS EXPOSURE"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "The analysis reveals 528 significant genes involved in neurodevelopment and inflammation.)", "entity_type": "UNKNOWN", "id": "SIGNIFICANT GENES"}, {"source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "Cortisol exposure activates FoxO1 in hippocampal progenitor stem cells.)<SEP>Cortisol is a hormone involved in stress response and various physiological functions.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 60}]", "id": "CORTISOL"}, {"source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "description": "Cortisol reduces neuronal proliferation in a dose-dependent manner.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 60}]", "id": "NEURONAL PROLIFERATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (SNP) associated with long-term weight loss after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "RS4771122"}, {"entity_type": "MEDICAL PROCEDURE", "description": "A type of surgical procedure for weight loss.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "BARIATRIC SURGERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The reduction in body weight achieved over an extended period following bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "LONG TERM WEIGHT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The weight of an individual prior to undergoing bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "PRE-SURGICAL WEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The lowest percentage of body weight achieved after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "NADIR PERCENT WEIGHT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The percentage of body weight lost after bariatric surgery at two years post-surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "2 YEAR PERCENT WEIGHT LOSS"}, {"entity_type": "DISEASE", "description": "A grouping based on the pattern of weight loss after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "TRAJECTORY GROUP MEMBERSHIP"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "Additional copies of the minor (G) allele were associated with a larger percentage weight lost, after adjustment for several variables including pre-surgical BMI.)", "entity_type": "UNKNOWN", "id": "PRE-SURGICAL BMI"}, {"entity_type": "GENE", "description": "The GCK gene is a gene associated with Maturity Onset Diabetes of the Young (MODY) type 2.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 147}]", "id": "GCK"}, {"entity_type": "PROTEIN", "description": "Glucokinase is a protein that regulates glucose metabolism in pancreatic beta cells.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "GLUCOKINASE"}, {"entity_type": "DISEASE", "description": "Diabetes phenotype refers to clinical manifestations of diabetes, including elevated blood glucose levels.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "DIABETES PHENOTYPE"}, {"entity_type": "DISEASE", "description": "Maturity Onset Diabetes of the Young (MODY) is a group of inherited disorders characterized by impaired glucose tolerance and/or elevated fasting glucose levels.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 147}]", "id": "MODY"}, {"entity_type": "CELL", "description": "Cells within the pancreas responsible for producing and releasing insulin.<SEP>Pancreatic beta cells are endocrine cells in the pancreas responsible for producing and releasing insulin.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-f921f48a406901d82ec2e32af99485bf", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "PANCREATIC BETA CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fasting hyperglycemia refers to elevated blood glucose levels measured after an overnight fast.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "FASTING HYPERGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HbA1c (glycated hemoglobin) is a measure of average blood glucose levels over the past 2-3 months.<SEP>HbA1c (glycated hemoglobin) reflects average blood sugar levels over the past 2-3 months.<SEP>Hemoglobin A1c (HbA1C) is a measure of long-term blood sugar control.<SEP>HbA1c is a measure of long-term blood sugar control.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "HBA1C"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Sanger sequencing is a method for determining the nucleotide sequence of DNA.<SEP>Sanger sequencing is a method used to determine the nucleotide sequence of DNA.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 144}]", "id": "SANGER SEQUENCING"}, {"entity_type": "TEST", "description": "A MODY gene panel is a genetic test that screens for mutations in genes associated with MODY.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 144}]", "id": "MODY GENE PANEL"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean diet adherence is a dietary pattern characterized by high intake of fruits, vegetables, whole grains, legumes, and olive oil.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "MEDITERRANEAN DIET ADHERENCE"}, {"entity_type": "NUTRIENT", "description": "TAG (triacylglycerols) are a type of fat found in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}]", "id": "TAG"}, {"entity_type": "NUTRIENT", "description": "HDL-C (high-density lipoprotein cholesterol) is a type of cholesterol that helps remove LDL cholesterol from the arteries.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "HDL-C"}, {"entity_type": "NUTRIENT", "description": "LDL-C (low-density lipoprotein cholesterol) is a type of cholesterol that can build up in the arteries.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "LDL-C"}, {"entity_type": "METABOLIC PATHWAY", "description": "The apoB:apoA-1 ratio is a marker of cardiovascular health.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "APOB:APOA-1 RATIO"}, {"entity_type": "DISEASE", "description": "Hypertriacylglycerolaemia is a condition characterized by elevated levels of TAG in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 29}]", "id": "HYPERTRIACYLGLYCEROLAEMIA"}, {"entity_type": "GENOMIC VARIANT", "description": "GCKR rs780094 SNP is a single nucleotide polymorphism in the glucokinase regulatory protein gene.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}]", "id": "GCKR RS780094 SNP"}, {"entity_type": "PROTEIN", "description": "Glucokinase regulatory protein is an enzyme involved in glucose metabolism.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "GLUCOKINASE REGULATORY PROTEIN"}, {"entity_type": "GENOMIC VARIANT", "description": "TC (total cholesterol) is a type of fat found in the blood.<SEP>TC genotype refers to having one copy of the reference allele and one copy of the alternative allele for a particular SNP.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}]", "id": "TC"}, {"entity_type": "PROTEIN", "description": "ApoB is a lipoprotein that transports cholesterol and other lipids in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}]", "id": "APOB"}, {"entity_type": "PROTEIN", "description": "ApoA-1 is a lipoprotein that helps remove cholesterol from the arteries.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "APOA-1"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Smoking status is categorized as smoker or non-smoker and was analyzed in relation to gene-diet interactions.<SEP>Whether or not an individual smokes tobacco products.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "SMOKING STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAG levels are measured physiological markers potentially influenced by genetic factors and diet.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "TAG LEVELS"}, {"entity_type": "DIETARY PATTERN", "description": "Diet refers to the types and amounts of food consumed regularly.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "DIET"}, {"entity_type": "GENETIC VARIATION", "description": "Genotype refers to an individual\'s specific genetic makeup at a particular locus.)<SEP>Genotype refers to the specific genetic makeup of an individual.<SEP>The combination of alleles an individual possesses for a particular gene.", "source_id": "chunk-0c7ab28db433187759e760725a105836<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "GENOTYPE"}, {"source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "description": "The study aimed to examine whether there was an interaction between genes and diet, represented by the analysis of  smoking status (smoker vs. non-smoker) for various outcomes.)<SEP>The study investigated potential interactions between genes and diet, analyzing smoking status (smoker vs. non-smoker) for various outcomes.)", "entity_type": "UNKNOWN", "id": "DIET INTERACTION"}, {"entity_type": "DISEASE", "description": "Congenital hyperinsulinism (CHI) is a rare disorder characterized by persistently low blood sugar.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 109}]", "id": "CHI"}, {"entity_type": "DRUG", "description": "Diazoxide is a medication used to treat congenital hyperinsulinism (CHI).<SEP>Diazoxide is a medication used to treat hyperinsulinemia.<SEP>Diazoxide treatment was used to manage patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-f921f48a406901d82ec2e32af99485bf", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "DIAZOXIDE"}, {"entity_type": "THERAPY", "description": "A dietary treatment approach involves frequent feedings and uncooked cornstarch administration for managing CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 109}]", "id": "DIETARY TREATMENT"}, {"entity_type": "GENE", "description": "The ABCC8 gene plays a crucial role in regulating insulin secretion in pancreatic beta cells. Mutations in this gene can lead to congenital hyperinsulinism.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "ABCC8"}, {"entity_type": "GENE", "description": "The KCNJ11 gene encodes the Kir6.2 subunit of the ATP-sensitive potassium channel, which is involved in insulin secretion regulation.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "KCNJ11"}, {"entity_type": "GENE", "description": "The GLUD1 gene encodes glutamate dehydrogenase, an enzyme involved in glutamine metabolism. Mutations in this gene can cause hyperinsulinism.<SEP>The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1"}, {"entity_type": "DISEASE", "description": "A condition characterized by abnormally low blood sugar levels.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 109}]", "id": "HYPOGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition where the pancreas produces excessive insulin.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPERINSULINISM"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Arg322 His mutation was found in patients 54, 55 and 56.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "P.ARG322HIS MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Ser498Leu mutation was found in patient 52.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "P.SER498LEU MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Asn463Asp mutation was found in patient 53.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "P.ASN463ASP MUTATION"}, {"entity_type": "DRUG", "description": "Octreotide is a medication that suppresses insulin secretion.<SEP>Octreotide was administered to three children who were unresponsive to diazoxide.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "OCTREOTIDE"}, {"entity_type": "PROCEDURE", "description": "Pancreatectomy was performed in 10 patients who were unresponsive to drugs.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "PANCREATECTOMY"}, {"entity_type": "DISEASE", "description": "Hypoglycemia is a condition characterized by low blood glucose levels.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "HYPOGLYCAEMIA"}, {"entity_type": "DISEASE", "description": "HI, or Hyperinsulinism, is a condition characterized by excessive insulin production.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HI (HYPERINSULINISM)"}, {"entity_type": "DISEASE", "description": "HA, or Hypoglycemia, is a condition characterized by low blood glucose levels.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HA (HYPOGLYCEMIA)"}, {"entity_type": "ORGAN", "description": "The pancreas is an organ responsible for producing insulin and digestive enzymes.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "PANCREAS"}, {"entity_type": "PROCEDURE", "description": "Subtotal pancreatectomy is a surgical procedure that removes a portion of the pancreas.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 82}]", "id": "SUBTOTAL PANCREATECTOMY"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Mutations in the ABCC8 gene are a common cause of congenital hyperinsulinism (CHI).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "ABCC8 MUTATIONS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Although not identified in this study, mutations in the KCNJ11 gene can also contribute to CHI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 109}]", "id": "KCNJ11 MUTATIONS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Mutations in the GLUD1 gene are associated with hypoglycemia, hyperinsulinism (HI), and mild hyperammonemia (HA).)", "entity_type": "UNKNOWN", "id": "GLUD1 MUTATIONS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Mutations in the GLUD1 gene are associated with hypoglycemia, hyperinsulinism (HI), and mild hyperammonemia (HA).)", "entity_type": "UNKNOWN", "id": "HI AND MILD HA"}, {"source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "description": "Mutations in the GLUD1 gene are associated with hypoglycemia.)<SEP>The GLUD1 gene is associated with hypoglycaemia, HI and mild HA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 84}]", "id": "GLUD1 GENE"}, {"source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "description": "Insulin is used to treat diabetes mellitus.)<SEP>Insulin therapy is essential for managing diabetes mellitus, as it helps regulate blood sugar.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "DIABETES MELLITUS"}, {"source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "description": "Mutations in the GLUD1 gene are associated with hyperinsulinism.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 84}]", "id": "HI"}, {"source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "description": "Mutations in the GLUD1 gene are associated with hypoglycemia.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 84}]", "id": "HA"}, {"entity_type": "NUTRIENT", "description": "AcAc (acetoacetate) is a ketone body produced during ketogenesis.<SEP>AcAc is a ketone body.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "ACAC"}, {"entity_type": "NUTRIENT", "description": "BHB (beta-hydroxybutyrate) is a ketone body produced during ketogenesis.<SEP>BHB is a ketone body.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 38}]", "id": "BHB"}, {"entity_type": "DISEASE", "description": "IFG stands for Impaired Fasting Glucose, a condition characterized by elevated blood glucose levels during fasting.<SEP>IFG stands for impaired fasting glucose, a condition where blood sugar levels are higher than normal but not high enough to be diagnosed as type 2 diabetes.<SEP>Impaired Fasting Glucose (IFG) is a condition characterized by elevated blood glucose levels after an overnight fast.<SEP>Impaired Fasting Glucose (IFG) indicates elevated blood sugar levels after fasting.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 36}]", "id": "IFG"}, {"entity_type": "DISEASE", "description": "Newly diagnosed diabetes refers to individuals who have recently been diagnosed with type 2 diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 38}]", "id": "NEWLY DIAGNOSED DIABETES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG stands for 2-hour post-glucose plasma glucose, measured two hours after consuming a sugary drink.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 38}]", "id": "2HPG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose tolerance refers to the body\'s ability to process and regulate blood sugar levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "GLUCOSE TOLERANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose AUC stands for Area Under the Curve of Glucose, a measure used to assess blood glucose control over time.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "GLUCOSE AUC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Insulin sensitivity refers to the body\'s ability to respond effectively to insulin, regulating blood sugar levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "INSULIN SENSITIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Insulin secretion refers to the release of insulin from the pancreas in response to elevated blood sugar.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 38}]", "id": "INSULIN SECRETION"}, {"entity_type": "GENE", "description": "GCKR is a gene associated with cardiometabolic phenotypes.<SEP>GCKR is a gene that plays a role in glucose metabolism and has been associated with altered BHB levels.<SEP>GCKR is a gene that regulates glucose uptake and metabolism.<SEP>GCKR is a gene associated with eGFR.<SEP>GCKR is a gene that encodes glucokinase regulator and influences glucose homeostasis.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "GCKR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs780094 is a genetic variant within the GCKR gene.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 105}]", "id": "RS780094"}, {"entity_type": "GENE", "description": "FADS1 is a gene involved in fatty acid metabolism and has been associated with altered AcAc or BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "FADS1"}, {"entity_type": "GENE", "description": "ANK1 is a gene that has been associated with altered AcAc or BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "ANK1"}, {"entity_type": "GENE", "description": "HMGA2 is a gene associated with \'age at first tooth\', craniofacial development, and number of teeth.<SEP>HMGA2 is a gene associated with height.<SEP>HMGA2 is a gene involved in chromatin regulation and has been linked to number of teeth.<SEP>HMGA2 is a gene that has been associated with altered AcAc or BHB levels.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "HMGA2"}, {"entity_type": "GENE", "description": "CPT1A encodes carnitine palmitoyltransferase 1A, an enzyme that regulates fatty acid transport into mitochondria.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 41}]", "id": "CPT1A"}, {"entity_type": "GENE", "description": "HMGCS1 encodes 3-hydroxy-3-methylglutaryl-CoA synthase 1, involved in ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "HMGCS1"}, {"entity_type": "GENE", "description": "HMGCS2 encodes 3-hydroxy-3-methylglutaryl-CoA synthase 2, involved in mitochondrial ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "HMGCS2"}, {"entity_type": "GENE", "description": "ACAT1 encodes acetyl-CoA acetyltransferase 1, an enzyme involved in KB breakdown.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 41}]", "id": "ACAT1"}, {"entity_type": "GENE", "description": "BDH1 encodes BHB dehydrogenase, type 1, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "BDH1"}, {"entity_type": "GENE", "description": "OXCT1 encodes 3-oxoacid CoA transferase 1, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "OXCT1"}, {"entity_type": "GENE", "description": "ACSS2 encodes acyl-CoA synthetase short-chain family member 2, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 40}]", "id": "ACSS2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High blood glucose level.<SEP>Hyperglycemia refers to elevated blood glucose levels.<SEP>Hyperglycemia refers to high blood sugar levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 105}]", "id": "HYPERGLYCEMIA"}, {"source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "description": "Higher levels of AcAc predicted an increased risk of developing type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 38}]", "id": "INCIDENT DIABETES"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336", "description": "Expression of CPT1A is inversely correlated with Matsuda ISI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 41}]", "id": "MATSUDA ISI"}, {"entity_type": "GENE", "description": "APOC1 is a gene associated with lipid metabolism and cardiovascular health.<SEP>APOC1 is a gene involved in lipoprotein metabolism and associated with type 2 diabetes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 64}]", "id": "APOC1"}, {"entity_type": "GENE", "description": "HNF1A is a gene involved in glucose homeostasis and associated with coronary artery disease.<SEP>HNF1A is a gene involved in glucose homeostasis and insulin secretion.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 68}]", "id": "HNF1A"}, {"entity_type": "GENE", "description": "IL6R encodes the interleukin 6 receptor, involved in various inflammatory processes.<SEP>IL6R is a gene encoding the interleukin-6 receptor, involved in inflammation.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "IL6R"}, {"entity_type": "GENE", "description": "PPP1R3B is a gene associated with cardiometabolic phenotypes.<SEP>PPP1R3B is a gene associated with protein phosphatase regulation.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "PPP1R3B"}, {"entity_type": "GENE", "description": "HNF4A is a gene involved in glucose and lipid metabolism and associated with cardiometabolic phenotypes.<SEP>HNF4A is a gene involved in glucose metabolism and lipid homeostasis.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "HNF4A"}, {"entity_type": "GENE", "description": "PABPC4 is a gene encoding poly(A)-binding protein cytoplasmic 4, involved in mRNA processing.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "PABPC4"}, {"entity_type": "GENE", "description": "BCL7B is a gene involved in immune regulation and associated with cardiometabolic phenotypes.<SEP>BCL7B is a gene involved in lymphocyte development and immune function.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "BCL7B"}, {"entity_type": "GENE", "description": "TMEM18 is a gene of unknown function, potentially involved in lipid metabolism.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 131}]", "id": "TMEM18"}, {"entity_type": "GENE", "description": "PLTP is a gene encoding phospholipid transfer protein, involved in lipoprotein metabolism.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 132}]", "id": "PLTP"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the first intron of the FTO gene.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 65}]", "id": "RS1558902"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located near TMEM18 gene.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 131}]", "id": "RS2867125"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located near PLTP and PCIF1 genes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 132}]", "id": "RS6065906"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located upstream of the MC4R gene.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 69}]", "id": "RS571312"}, {"entity_type": "GENOMIC VARIANT", "description": "An APOC1 locus SNP associated with increased CRP levels and decreased cholesterol levels.<SEP>rs4420638 is a SNP located nearby the APOC1 gene on chromosome 19.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 64}]", "id": "RS4420638"}, {"entity_type": "GENOMIC VARIANT", "description": "An HNF1A locus SNP associated with increased CRP levels and decreased cholesterol levels.<SEP>rs1183910 is a SNP located in the first intron of the HNF1A gene.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 68}]", "id": "RS1183910"}, {"entity_type": "GENE", "description": "PTPN1 is a gene involved in insulin signaling.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PTPN1"}, {"entity_type": "GENE", "description": "PPARG is a gene involved in lipid metabolism and glucose homeostasis.<SEP>PPARG is a gene involved in lipid metabolism and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "PPARG"}, {"entity_type": "GENE", "description": "CDKN2B is a gene involved in cell cycle regulation.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CDKN2B"}, {"entity_type": "GENE", "description": "KLF13 is a gene involved in lipid metabolism and insulin sensitivity.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "KLF13"}, {"entity_type": "GENE", "description": "MAPKAPK5 is a gene involved in inflammatory responses.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "MAPKAPK5"}, {"entity_type": "GENE", "description": "CD36 is a gene involved in fatty acid uptake and metabolism.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CD36"}, {"entity_type": "GENE", "description": "ADRB2 is a gene encoding the beta-2 adrenergic receptor, involved in metabolic regulation.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "ADRB2"}, {"entity_type": "GENE", "description": "IL1F10 is a gene involved in inflammation and associated with cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "IL1F10"}, {"entity_type": "GENE", "description": "PABPC is a gene involved in mRNA processing and associated with cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PABPC"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6734238 is a SNP located on chromosome 2, nearby the IL1F10 gene and other interleukin 1 family genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "RS6734238"}, {"entity_type": "DISEASE", "description": "CAD stands for coronary artery disease, a cardiovascular condition.<SEP>Coronary Artery Disease (CAD) is a heart condition.<SEP>Coronary Artery Disease.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-54c4fede216a6c4183b95ee1a2edcb17<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 68}]", "id": "CAD"}, {"entity_type": "GENE", "description": "C-reactive protein (CRP) is an inflammatory marker.<SEP>CRP is a gene involved in the inflammatory response and potentially related to ovarian cancer risk.<SEP>CRP stands for C-reactive protein, an acute phase protein involved in inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 66}, {level: 2, cluster: 130}]", "id": "CRP"}, {"entity_type": "NUTRIENT", "description": "A type of fat found in the blood that is essential for cell function.<SEP>Cholesterol is a type of lipid found in the blood.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-372184452f1f9156514992455057f843", "id": "CHOLESTEROL"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the miR-34b/c gene associated with a decreased risk of intracranial aneurysm.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "MIR-34B/C RS4938723"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the TP53 gene that was not significantly associated with the risk of intracranial aneurysm.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "TP53 ARG72PRO"}, {"entity_type": "DISEASE", "description": "A cerebrovascular condition characterized by a ballooning or weakening of a blood vessel in the brain.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "INTRACRANIAL ANEURYSM"}, {"entity_type": "GENE", "description": "microRNA gene associated with various cellular processes, including cell cycle regulation and apoptosis.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "MIR-34B/C"}, {"entity_type": "GENE", "description": "Tumor suppressor gene involved in regulating cell growth, DNA repair, and apoptosis.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "TP53"}, {"entity_type": "DISEASE", "description": "Abbreviation for intracranial aneurysm, a cerebrovascular condition characterized by a ballooning or weakening of a blood vessel in the brain.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "IA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "OR stands for Odds Ratio, a measure used to quantify the strength of association between two variables.<SEP>Odds Ratio (OR) is a statistical measure indicating the strength of association between an exposure and an outcome.<SEP>Odds Ratio, used to quantify the association between an exposure and an outcome.<SEP>Odds ratio (OR) is a measure of association between an exposure and an outcome in observational studies.<SEP>Odds ratio, used to calculate the association between a genetic variant and a disease.<SEP>Odds Ratio (OR) used to measure the association between variables.<SEP>Odds ratio, a measure of association between an exposure and an outcome.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-7091ed039203b69ad83d281b22c89579<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-055177812e320344d131432b292111b0", "id": "OR"}, {"entity_type": "CONFIDENCE INTERVAL", "description": "Range of values within which the true population parameter is likely to fall.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "95% CI"}, {"entity_type": "GENE", "description": "INADL is a gene located on chromosome 1. A nonsynonymous SNP (rs1056513; G1178S (NP_005790.2)) in INADL was associated with weight, BMI, FFM, FM, trunk FM, and hip circumference.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "INADL"}, {"entity_type": "GENE", "description": "COL4A1 is a gene located on chromosome 13. An intronic variant in COL4A1 was associated with weight z-score change.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "COL4A1"}, {"entity_type": "GENE", "description": "TSEN34 is a gene located on chromosome 19. A variant in the 5\u2032UTR region of TSEN34 was associated with linear growth (height change).", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TSEN34"}, {"entity_type": "GENE", "description": "MTNR1B is a gene located on chromosome 11. An intronic variant in MTNR1B was strongly associated with fasting glucose.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MTNR1B"}, {"entity_type": "GENE", "description": "APOA5-ZNF259 is a region on chromosome 11 containing the APOA5 and ZNF259 genes. Intronic and 3\u2032UTR variants in this region were associated with triglycerides.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "APOA5-ZNF259"}, {"entity_type": "GENE", "description": "PCSK2 is a gene located on chromosome 20. An intronic variant in PCSK2 was associated with total antioxidants.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "PCSK2"}, {"entity_type": "GENE", "description": "RNASE1 is a gene located on chromosome 14. A variant in the flanking 3\u2032UTR region of RNASE1 was associated with 24-h urinary nitrogen excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RNASE1"}, {"entity_type": "GENE", "description": "ASS1P11 is a gene located on chromosome 7. A variant in the flanking 3\u2032UTR region of ASS1P11 was associated with creatinine excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ASS1P11"}, {"entity_type": "GENE", "description": "GCH1 is a gene located on chromosome 14. An intronic SNP in GCH1 was associated with 24-h urinary dopamine: creatinine ratio.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GCH1"}, {"entity_type": "GENE", "description": "KLKB1 is a gene located on chromosome 4. A nonsynonymous SNP (rs3733402; S143T (NP_000883.2)) in KLKB1 was associated with serum free IGF-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "KLKB1"}, {"entity_type": "GENE", "description": "MPRIP is a gene located on chromosome 17. An intronic SNP in MPRIP was associated with serum IGFBP-3.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MPRIP"}, {"entity_type": "GENE", "description": "XPA/FOXE1 (TTF-2) is a region on chromosome 9 containing the XPA and FOXE1 genes. A block of twenty-three SNPs in this region was highly associated with serum TSH.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "XPA/FOXE1 (TTF-2)"}, {"entity_type": "GENE", "description": "DARC is a gene located on chromosome 1.  A nonsynonymous SNP (rs12075; G42D (NP_002027.2)) and an intronic SNP in DARC were associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DARC"}, {"entity_type": "GENE", "description": "GREB1 is a gene located on chromosome 2. A coding variant in GREB1 was associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GREB1"}, {"entity_type": "GENE", "description": "DFNB31 is a gene located on chromosome 9. A coding variant in DFNB31 was associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DFNB31"}, {"entity_type": "GENE", "description": "CCR3 is a gene. Variants in the 3\u2032UTR for CCR3 were highly associated with MCP1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "CCR3"}, {"entity_type": "GENE", "description": "RASGEF1A is a gene located on chromosome 10. An intronic SNP in RASGEF1A was associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RASGEF1A"}, {"entity_type": "GENE", "description": "ABO is a gene. A variant in the intronic region of ABO was strongly associated with IL-6.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ABO"}, {"entity_type": "GENE", "description": "TMEM229B is a gene located on chromosome 14. An intronic variant in TMEM229B was associated with ad libitum energy intake at dinner.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TMEM229B"}, {"entity_type": "GENE", "description": "ARHGAP11A is a gene associated with sleep duration.<SEP>ARHGAP11A is a gene located on chromosome 15. An intronic variant in ARHGAP11A was associated with sleep duration.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "id": "ARHGAP11A"}, {"entity_type": "GENE", "description": "C21orf34 is a gene associated with respiratory quotient during sleep.<SEP>C21orf34 is a gene. A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "id": "C21ORF34"}, {"entity_type": "GENE", "description": "RPL is a gene. A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RPL"}, {"entity_type": "GENE", "description": "RPL7P3 is a gene associated with light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RPL7P3"}, {"entity_type": "GENE", "description": "CTCFL is a gene associated with sedentary-light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CTCFL"}, {"entity_type": "GENE", "description": "MATK is a gene associated with total energy expenditure.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "MATK"}, {"entity_type": "GENE", "description": "CHRNA3 is a gene associated with sleeping energy expenditure.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CHRNA3"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sleep duration is a physiological process that was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SLEEP DURATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Respiratory quotient (RQ) is a physiological process measured during sleep and was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RESPIRATORY QUOTIENT (RQ)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Light activity is a physiological process that was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "LIGHT ACTIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sedentary-light activity is a physiological process that was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SEDENTARY-LIGHT ACTIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total energy expenditure is a physiological process that was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "TOTAL ENERGY EXPENDITURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sleeping energy expenditure is a physiological process that was found to be associated with genetic variants.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SLEEPING ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "entity_type": "UNKNOWN", "id": "RESPIRATORY QUOTIENT"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A variant was identified for sedentary-light activity in 3\u2032UTR of CTCFL on chromosome 20.)", "entity_type": "UNKNOWN", "id": "SEDENTARY LIGHT ACTIVITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A non-synonymous, non-conservative SNP rs180743: p.Pro428Ala is located closely to the deletion rs3833080 which is in high LD with the variant (r2 = 0.98).", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "RS180743"}, {"entity_type": "GENOMIC VARIANT", "description": "A common deletion rs3833080 (c.1036_1062del27; S1 Data) was present in each individual of the initial screen either hetero- or homozygously.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "RS3833080"}, {"entity_type": "GENOMIC VARIANT", "description": "The deletion rs368546180 with a length of 27bp (c.933_934insdel27; p.Ala328_Gly329) results in an in frame shortened amino acid sequence of the repeat region of APOBR.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 73}, {level: 2, cluster: 139}]", "id": "RS368546180"}, {"entity_type": "GENE", "description": "SULT1A1 is a gene involved in sulfotransferase activity.<SEP>The SULT1A1 gene encodes for sulfotransferase 1A1, which plays a role in detoxification processes. Variants in this gene have been investigated for potential associations with obesity and other health conditions.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5<SEP>chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A1"}, {"entity_type": "GENE", "description": "SULT1A2 is a gene involved in sulfotransferase activity.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A2"}, {"entity_type": "GENE", "description": "TUFM is a gene involved in protein synthesis.<SEP>TUFM is a gene that may be affected by several variants.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455<SEP>chunk-607feda7df4db8151b99560074c91eea", "id": "TUFM"}, {"entity_type": "GENOMIC VARIANT", "description": "rs142786317 is a genomic variant in the SULT1A1 gene.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS142786317"}, {"entity_type": "PROTEIN", "description": "Met1Val is a protein variant within the SULT1A1 gene.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "MET1VAL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Splicing enhancers are regulatory elements involved in splicing regulation.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SPLICING ENHANCER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Splicing silencers are regulatory elements that repress splicing.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SPLICING SILENCER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A transcription factor binding site is a DNA sequence that allows transcription factors to bind and regulate gene expression.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "TRANSCRIPTION FACTOR BINDING SITE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs61737565 is located at c.922+29C>G in the TUFM gene.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "RS61737565"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs8061877 is located in the TUFM gene and affects transcription factor binding sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "RS8061877"}, {"entity_type": "GENOMIC VARIANT", "description": "The specific change in the genomic variant rs61737565 is c.922+29C>G.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "C.922+29C>G"}, {"entity_type": "PROTEIN", "description": "SRY is a transcription factor predicted to be affected by rs8061877.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SRY"}, {"entity_type": "PROTEIN", "description": "HFH 2 is a transcription factor predicted to be affected by rs8061877.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "HFH 2"}, {"entity_type": "PROTEIN", "description": "HMG-IY is a transcription factor predicted to be affected by rs8061877.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "HMG-IY"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs1136703: p.Ile7Thr is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS1136703: P.ILE7THR"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs10797300: p.Pro19Leu is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS10797300: P.PRO19LEU"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs145008170: p.Ser44Asn is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS145008170: P.SER44ASN"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs4987024: p.Tyr62Phe is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS4987024: P.TYR62PHE"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs142241142: p.Ala164Val is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS142241142: P.ALA164VAL"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs1059491: p.Asn235Thr is located within the SULT1A2 gene.)", "entity_type": "UNKNOWN", "id": "RS1059491: P.ASN235THR"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant c.3536C>G is located within the TUFM gene.)", "entity_type": "UNKNOWN", "id": "C.3536C>G"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs7187776: c.-55T>C is located within the TUFM gene.)", "entity_type": "UNKNOWN", "id": "RS7187776: C.-55T>C"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs4788099: c.817+13T>C is located within the TUFM gene.)", "entity_type": "UNKNOWN", "id": "RS4788099: C.817+13T>C"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs8061877: c.248\u221218G>A is located within the TUFM gene.)", "entity_type": "UNKNOWN", "id": "RS8061877: C.248\u221218G>A"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant rs61737565: c.922+29C>G is located within the TUFM gene.)", "entity_type": "UNKNOWN", "id": "RS61737565: C.922+29C>G"}, {"source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "description": "The genomic variant g.28854194C/G is located in the non-coding 3\u2019 UTR of the TUFM gene.)", "entity_type": "UNKNOWN", "id": "G.28854194C/G"}, {"source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "description": "Disruption of a transcription factor binding site can affect splice enhancer binding sites.)", "entity_type": "UNKNOWN", "id": "SPLICE ENHANCER BINDING SITE"}, {"entity_type": "GENE", "description": "ALOX15 is a gene associated with ovarian cancer risk.<SEP>ALOX15 is a gene that encodes arachidonate 15-lipoxygenase, an enzyme involved in lipid metabolism.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX15"}, {"entity_type": "GENE", "description": "ALOX5 is a gene involved in arachidonic acid metabolism and associated with decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX5"}, {"entity_type": "GENE", "description": "CCL2 is a chemokine that attracts monocytes and macrophages, playing a role in inflammation.<SEP>CCL2 is a gene associated with inflammation and potentially ovarian cancer risk.<SEP>CCL2 is a gene that encodes chemokine (C-C motif) ligand 2, a protein involved in immune cell recruitment.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CCL2"}, {"entity_type": "GENE", "description": "IL18 is a cytokine involved in inflammation and potentially associated with ovarian cancer risk.<SEP>IL18 is a cytokine involved in inflammatory responses and promoting Th1 cell differentiation.<SEP>IL18 is a gene that encodes interleukin 18, a cytokine involved in inflammation and immune response.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL18"}, {"entity_type": "GENE", "description": "IL1A encodes interleukin 1 alpha, a pro-inflammatory cytokine. It\'s associated with decreased risk of ovarian cancer.<SEP>IL1A is a pro-inflammatory cytokine that induces fever, promotes inflammation, and activates immune cells.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A"}, {"entity_type": "GENE", "description": "IL1B encodes interleukin 1 beta, another pro-inflammatory cytokine potentially linked to ovarian cancer risk.<SEP>IL1B is another potent pro-inflammatory cytokine that acts synergistically with IL1A.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1B"}, {"entity_type": "GENE", "description": "IL6 is a gene encoding an interleukin that promotes inflammation and may be involved in ovarian cancer development.<SEP>IL6 is a gene that encodes interleukin 6, a cytokine involved in inflammation and various cellular processes.<SEP>IL6 is a pleiotropic cytokine involved in inflammation, immune regulation, and cell growth.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL6"}, {"entity_type": "GENE", "description": "NOS3 encodes nitric oxide synthase 3, an enzyme involved in nitric oxide production. It\'s associated with decreased risk of ovarian cancer.<SEP>NOS3 is a gene associated with childhood ALL risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3"}, {"entity_type": "GENE", "description": "PTGS1 encodes cyclooxygenase-2, an enzyme involved in prostaglandin synthesis and potentially related to ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS1"}, {"entity_type": "GENE", "description": "IL10 is a cytokine with anti-inflammatory properties. It was not associated with ovarian cancer risk in this study.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL10"}, {"entity_type": "GENE", "description": "IL15RA encodes the interleukin 15 receptor alpha chain, involved in immune response regulation.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL15RA"}, {"entity_type": "GENE", "description": "IL1RN encodes interleukin 1 receptor antagonist. It\'s a natural inhibitor of IL-1 signaling.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1RN"}, {"entity_type": "GENE", "description": "IL4R encodes the interleukin 4 receptor, involved in allergic response and immune regulation.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL4R"}, {"entity_type": "GENE", "description": "IL7R encodes the interleukin 7 receptor, crucial for T cell development and immune response.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL7R"}, {"entity_type": "GENE", "description": "IL1B is a gene that encodes the interleukin 1, beta protein, which plays a role in inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL1B (INTERLEUKIN 1, BETA)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7596684 is a genomic variant located within the IL1B gene and has been associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "RS7596684"}, {"entity_type": "GENE", "description": "PTGS1 is a gene that encodes prostaglandin-endoperoxide synthase 1, an enzyme involved in prostaglandin synthesis.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2282169 is a genomic variant located within the PTGS1 gene and has been associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "RS2282169"}, {"entity_type": "DISEASE", "description": "A type of cancer that originates in the ovaries.<SEP>Ovarian cancer is a type of cancer that affects the ovaries.<SEP>Ovarian cancer is a type of cancer that originates in the ovaries.<SEP>Ovarian cancer is a type of malignancy affecting the ovaries.<SEP>Ovarian cancer is the type of cancer being studied in this research.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "OVARIAN CANCER"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The ALOX5 rs1864414 SNP is associated with a decreased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "ALOX5 RS1864414"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The ALOX5 rs1864414 SNP is associated with a decreased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "OVARIAN CANCER RISK"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The NOS3 rs743507 SNP is associated with a decreased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "NOS3 RS743507"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The IL1A rs17561 SNP is associated with a decreased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "IL1A RS17561"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The IL1B rs7596684 SNP is potentially associated with an increased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "IL1B RS7596684"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "The PTGS1 rs2282169 SNP is potentially associated with an increased risk of ovarian cancer.)", "entity_type": "UNKNOWN", "id": "PTGS1 RS2282169"}, {"source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "description": "Age was considered as a covariate in combined analyses to control for potential confounding effects.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "COMBINED ANALYSES"}, {"entity_type": "GENE", "description": "MTHFD2 is a gene involved in folate metabolism.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "MTHFD2"}, {"entity_type": "GENE", "description": "BHMT2 is a gene involved in folate metabolism.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BHMT2"}, {"entity_type": "GENE", "description": "SLC19A1 is a gene associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3918186 is a SNP in the NOS3 gene associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "RS3918186"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1051266 is a SNP in the SLC19A1 gene associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "RS1051266"}, {"entity_type": "DISEASE", "description": "Acute lymphoblastic leukemia (ALL) is a type of cancer affecting the blood and bone marrow.<SEP>Acute lymphoblastic leukemia (ALL) is a type of cancer that affects blood-forming cells.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2<SEP>chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "ALL"}, {"entity_type": "HEALTHCARE ORGANIZATION", "description": "A pediatric cancer center where ALL cases were recruited for the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "TEXAS CHILDREN\u2019S CANCER CENTER"}, {"entity_type": "TIME PERIOD", "description": "The period during which the ALL cases were recruited for the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "2003 TO 2010"}, {"entity_type": "PERCENTAGE", "description": "The participation rate of families in the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "85%"}, {"entity_type": "PERCENTAGE", "description": "The percentage of families that formed complete triads (three generations) in the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "36%"}, {"entity_type": "POPULATION GROUP", "description": "A racial/ethnic group represented in the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NON-HISPANIC WHITES"}, {"entity_type": "POPULATION GROUP", "description": "A racial/ethnic group represented in the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NON-HISPANIC BLACKS"}, {"entity_type": "POPULATION GROUP", "description": "A racial/ethnic group represented in the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "HISPANICS"}, {"entity_type": "POPULATION GROUP", "description": "A category for individuals from racial/ethnic groups not listed separately.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "OTHER RACIAL/ETHNIC GROUPS"}, {"entity_type": "AGE LIMIT", "description": "The maximum age of participants recruited for the study.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "14 YEARS OLD"}, {"entity_type": "NUMBER", "description": "The number of SNPs analyzed from 16 folate metabolic genes.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "128 TAGGING SNPS"}, {"entity_type": "GENE SET", "description": "A group of genes involved in folate metabolism.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "16 FOLATE METABOLIC GENES"}, {"source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "description": "MTHFD2 is a folate metabolic gene analyzed for association with childhood ALL.)", "entity_type": "UNKNOWN", "id": "CHILDHOOD ALL"}, {"source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "description": "The NOS3 rs3918186 SNP was associated with an increased risk of ALL.)", "entity_type": "UNKNOWN", "id": "NOS3 RS3918186"}, {"source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "description": "The SLC19A1 rs1051266 SNP was associated with a slightly increased risk of ALL.)", "entity_type": "UNKNOWN", "id": "SLC19A1 RS1051266"}, {"entity_type": "GENE", "description": "FADS1/2 is a gene cluster.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "FADS1/2"}, {"entity_type": "DIETARY PATTERN", "description": "The Healthy Eating diet emphasizes reduced saturated fat intake and increased long chain n-3 PUFA.<SEP>The Healthy Eating diet is a general term for a diet that promotes good health.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "HEALTHY EATING"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean diet emphasizes reduced saturated fat intake, increased monounsaturated fat, and increased long chain n-3 PUFA.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "MEDITERRANEAN"}, {"entity_type": "GENOMIC VARIANT", "description": "AA (arachidonic acid) is an omega-6 fatty acid.<SEP>AA refers to arachidonic acid, a polyunsaturated fatty acid.<SEP>AA genotype refers to having two copies of the reference allele for a particular SNP.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-2fb95100a1290b27baae869c6560419a<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "id": "AA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Relating to blood serum, the liquid component of blood.<SEP>Serum refers to the liquid portion of blood, which carries various nutrients and other substances.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "SERUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Colonic mucosa is the lining of the colon.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "COLONIC MUCOSA"}, {"entity_type": "GENE", "description": "The FADS1/2 gene cluster is involved in the metabolism of fatty acids.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "FADS1/2 GENE CLUSTER"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "The Healthy Eating diet significantly reduced SFA intake.)", "entity_type": "UNKNOWN", "id": "SATURATED FAT"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "The Healthy Eating diet significantly increased long chain n-3 PUFA intake.)", "entity_type": "UNKNOWN", "id": "LONG CHAIN N-3 PUFA"}, {"entity_type": "DISEASE", "description": "A sleep disorder characterized by repeated pauses in breathing during sleep.<SEP>Sleep apnoea is a sleep disorder characterized by repeated pauses in breathing during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SLEEP APNOEA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The amount of cigarettes smoked per day or week.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SMOKING FREQUENCY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The amount of alcohol consumed per day or week.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "ALCOHOL CONSUMPTION FREQUENCY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The total amount of fat in the body.<SEP>Whole-body fat mass refers to the total amount of fat in the body.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "WHOLE-BODY FAT MASS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Socioeconomic status, a measure of an individual\'s or household\'s economic and social position.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Minimum SpO2 refers to the lowest oxygen saturation level recorded during sleep.<SEP>The lowest oxygen saturation level recorded during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "MINIMUM SPO2"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The percentage of time spent sleeping with oxygen saturation under 90%.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "PERC90"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Average SpO2 is the average oxygen saturation level recorded during sleep.<SEP>The average oxygen saturation level recorded during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "AVERAGE SPO2"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The square of the BMI.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "BMI2"}, {"entity_type": "GENE", "description": "DLEU7 is a gene identified through positional and eQTL mapping as potentially associated with snoring.<SEP>DLEU7 is a gene involved in transcription regulation and has been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "DLEU7"}, {"entity_type": "GENE", "description": "MSRB3 is a gene identified through positional and eQTL mapping as potentially associated with snoring.<SEP>MSRB3 is a gene involved in redox regulation and has been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MSRB3"}, {"entity_type": "GENE", "description": "BCL11B is a gene previously associated with smoking, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BCL11B"}, {"entity_type": "GENE", "description": "SMG6 is a gene previously associated with smoking and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SMG6"}, {"entity_type": "GENE", "description": "ROBO2 is a gene previously associated with chronotype and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ROBO2"}, {"entity_type": "GENE", "description": "NSUN3 is a gene previously associated with smoking, alcohol consumption, and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "NSUN3"}, {"entity_type": "GENE", "description": "SNAP91 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SNAP91"}, {"entity_type": "GENE", "description": "BCL2 is a gene previously associated with smoking and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BCL2"}, {"entity_type": "GENE", "description": "BLC11B is a gene previously associated with smoking, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BLC11B"}, {"entity_type": "GENE", "description": "RNA5SP471 is a gene previously associated with narcolepsy and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "RNA5SP471"}, {"entity_type": "GENE", "description": "SND1 is a gene previously associated with alcohol consumption, FTO, and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SND1"}, {"entity_type": "GENE", "description": "LMO4 is a gene previously associated with insomnia and prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "LMO4"}, {"entity_type": "GENE", "description": "ANAPC4 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ANAPC4"}, {"entity_type": "GENE", "description": "SIM1 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SIM1"}, {"entity_type": "GENE", "description": "KCNQ5 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "KCNQ5"}, {"entity_type": "GENE", "description": "CEP120 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "CEP120"}, {"entity_type": "GENE", "description": "MACF1 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, and was prioritized for further investigation in relation to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MACF1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Excessive daytime sleepiness is a symptom of various conditions, including sleep disorders and narcolepsy.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "EXCESSIVE DAYTIME SLEEPINESS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Pulse rate refers to the number of heartbeats per minute.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "PULSE RATE"}, {"entity_type": "DISEASE", "description": "Major coronary heart disease refers to severe blockage or narrowing of the coronary arteries.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MAJOR CORONARY HEART DISEASE"}, {"entity_type": "DISEASE", "description": "A heart attack occurs when blood flow to the heart muscle is severely reduced or blocked.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "HEART ATTACK"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood pressure is the force exerted by blood against the walls of arteries.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BLOOD PRESSURE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs199797821 was associated with snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "RS199797821"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs200391180 was associated with snoring.<SEP>The SNP rs200391180 is associated with snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "RS200391180"}, {"entity_type": "SEX", "description": "Males have a higher prevalence of snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "MALE"}, {"entity_type": "SEX", "description": "Females have a lower prevalence of snoring compared to males.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "FEMALE"}, {"entity_type": "STUDY", "description": "The Australian Genetics of Depression Study (AGDS) provided an independent sample for testing PGS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "AUSTRALIAN GENETICS OF DEPRESSION STUDY"}, {"entity_type": "DISEASE", "description": "Snoring is a common sleep disorder characterized by noisy breathing during sleep.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SNORING"}, {"entity_type": "STUDY TYPE", "description": "Genome-Wide Association Study (GWAS) used to identify genetic variants associated with B12 and folate levels.<SEP>Genome-wide association studies (GWAS) were conducted to identify SNPs associated with snoring.<SEP>Genome-wide association study.<SEP>Genome-wide association study (GWAS) is a method used to identify genetic variants associated with specific traits or diseases.<SEP>Genome-wide association studies (GWAS) are used to identify genetic variants associated with complex traits.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-b05610f4a9a1033449b92655bfb67b28<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "clusters": "[{level: 0, cluster: 23}]", "id": "GWAS"}, {"entity_type": "STATISTICAL MEASURE", "description": "SNP heritability (h2SNP) represents the proportion of phenotypic variance explained by genetic variation.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "SNP HERITABILITY"}, {"entity_type": "STATISTICAL MEASURE", "description": "Polygenic risk score (PGS) is a measure of an individual\'s genetic predisposition to a trait.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "PGS"}, {"entity_type": "DISEASE", "description": "Obstructive Sleep Apnea (OSA) is a sleep disorder characterized by repeated pauses in breathing during sleep.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 52}]", "id": "OSA"}, {"entity_type": "GENE", "description": "Vitamin D Binding Protein (VDBP) is a gene that encodes the protein responsible for transporting vitamin D in the blood.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VDBP"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2298850 is a single nucleotide polymorphism (SNP) within the VDBP gene.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "RS2298850"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4588 is a single nucleotide polymorphism (SNP) within the VDBP gene.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "RS4588"}, {"entity_type": "PROTEIN", "description": "Vitamin D Binding Protein is a protein that binds and transports vitamin D in the blood.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D BINDING PROTEIN"}, {"entity_type": "NUTRIENT", "description": "25-hydroxyvitamin D (25(OH)D) is a major circulating form of vitamin D and an indicator of vitamin D status.<SEP>25-hydroxyvitamin D [25(OH)D] is a metabolite of vitamin D that circulates in the blood.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a<SEP>chunk-617cab4d8c10048a1335bf565693bf97", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "25(OH)D"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Vitamin D status refers to the level of vitamin D in the body and its impact on various physiological functions.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D STATUS"}, {"entity_type": "GENE", "description": "VEGFA is a gene that encodes vascular endothelial growth factor, which plays a role in angiogenesis and other physiological processes.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGFA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3025020 is a specific genetic variant within the VEGFA gene located at position -583 in the promoter region.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS3025020"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2010963 is a specific genetic variant within the VEGFA gene located at position -634 in the promoter region.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS2010963"}, {"entity_type": "METABOLIC PATHWAY", "description": "The waist-hip ratio is a measure of abdominal obesity, calculated by dividing the waist circumference by the hip circumference.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "WAIST-HIP RATIO"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A lipid profile is a blood test that measures various types of fats, including cholesterol and triglycerides.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LIPID PROFILE"}, {"entity_type": "NUTRIENT", "description": "Total testosterone is a hormone produced primarily in the testes that plays a role in male sexual development and function.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TOTAL TESTOSTERONE"}, {"entity_type": "HORMONE", "description": "Luteinizing hormone (LH) is a hormone produced by the pituitary gland that stimulates ovulation in women and testosterone production in men.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LH"}, {"entity_type": "HORMONE", "description": "Follicle-stimulating hormone (FSH) is a hormone produced by the pituitary gland that stimulates the growth of ovarian follicles in women and sperm production in men.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FSH"}, {"entity_type": "PROTEIN", "description": "Sex hormone-binding globulin (SHBG) is a protein that binds to testosterone and estrogen, regulating their levels in the blood.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "SHBG"}, {"entity_type": "HORMONE", "description": "Thyroid-stimulating hormone (TSH) is a hormone produced by the pituitary gland that stimulates the thyroid gland to produce thyroid hormones.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TSH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The homeostasis model assessment of insulin resistance (HOMA-IR) is a formula used to estimate insulin resistance.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "HOMA-IR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Erythrocyte sedimentation rate (ESR) measures how quickly red blood cells settle to the bottom of a test tube, indicating the level of inflammation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "ESR"}, {"entity_type": "CYTOKINE", "description": "IL-10 is a cytokine produced by T cells and other immune cells.<SEP>IL-10 is a cytokine with anti-inflammatory effects.<SEP>IL-10 is an anti-inflammatory cytokine.<SEP>IL-10 is an immunosuppressive cytokine that regulates immune responses.<SEP>Interleukin 10 is a cytokine with immunomodulatory effects, often suppressing inflammation.<SEP>Interleukin-10 (IL-10) is an anti-inflammatory cytokine that helps regulate the immune response.<SEP>Interleukin-10 gene (rs1800896 A/G) polymorphism<SEP>IL-10 is interleukin-10, an immunosuppressive cytokine.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 14}]", "id": "IL-10"}, {"entity_type": "CYTOKINE", "description": "IL-6 (Interleukin 6) is a proinflammatory cytokine.<SEP>IL-6 is a cytokine known to promote inflammation and Th17 cell differentiation.<SEP>IL-6 is a pro-inflammatory cytokine involved in the pathogenesis of colitis.<SEP>Interleukin-6 (IL-6) is a pro-inflammatory cytokine involved in various immune responses and inflammatory processes.<SEP>IL-6 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>IL-6 is a proinflammatory cytokine produced by adipocytes and contributes to inflammation.<SEP>Interleukin-6 (IL-6) is a proinflammatory cytokine involved in immune responses and metabolic processes.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 120}]", "id": "IL-6"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "The minor allele of rs3025020 is associated with an increased risk of PCOS.)", "entity_type": "UNKNOWN", "id": "PCOS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Genotype variations in VEGFA are associated with different levels of VEGF protein in the blood.)", "entity_type": "UNKNOWN", "id": "VEGF SERUM LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Genotype variations in VEGFA are associated with different levels of VEGF protein in the blood.)", "entity_type": "UNKNOWN", "id": "VEGFA GENOTYPE"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Individuals carrying the rs3025020 minor allele have higher bioactive testosterone levels.)", "entity_type": "UNKNOWN", "id": "BIOACTIVE TESTOSTERONE"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Individuals carrying the rs2010963 minor allele have lower free testosterone levels.)", "entity_type": "UNKNOWN", "id": "FREE TESTOSTERONE"}, {"entity_type": "GENOTYPE", "description": "Individuals carrying a val variant of a gene.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "VAL CARRIERS"}, {"entity_type": "GENOTYPE", "description": "Individuals homozygous for the iso allele of a gene.<SEP>Individuals homozygous for the non-variant (iso homozygote) genotype.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "ISO HOMOZYGOTES"}, {"entity_type": "EXPERIMENTAL CONDITION", "description": "A specific phase or time period within an experiment.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "BLOCK"}, {"entity_type": "BEHAVIORAL MEASURE", "description": "Response bias refers to the tendency to favor certain responses over others, influenced by factors like stress.<SEP>The tendency to respond in a particular way regardless of the stimulus.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "RESPONSE BIAS"}, {"entity_type": "BEHAVIORAL MEASURE", "description": "The ability to distinguish between different stimuli or outcomes.<SEP>The ability to distinguish between stimuli.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "DISCRIMINABILITY"}, {"entity_type": "STIMULUS", "description": "The level of electric shock delivered during an experiment.<SEP>The level of unpleasantness or intensity of the punishment delivered during the probabilistic reward task.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SHOCK INTENSITY"}, {"entity_type": "PSYCHOLOGICAL SCALE", "description": "The State-Trait Anxiety Inventory, a measure of anxiety.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "STAI"}, {"entity_type": "PSYCHOLOGICAL SCALE", "description": "Positive and Negative Affect Schedule - Negative Affect, a measure of negative emotions.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "PANAS NA"}, {"entity_type": "BEHAVIORAL MEASURE", "description": "Non-specific behavioral responses to stimuli.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SC RESPONSES"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant (val allele) in a gene is associated with reduced response bias under stress.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "VAL ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A task involving rewards and punishments that measures decision-making under uncertainty.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "PROBABILISTIC REWARD TASK"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants reported higher STAI scores during the stress condition than the no-stress condition.)<SEP>Participants reported significantly higher STAI scores during the stress condition compared to the no-stress condition.)", "entity_type": "UNKNOWN", "id": "STAI SCORES"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants reported higher STAI scores during the stress condition than the no-stress condition.)<SEP>Participants reported significantly higher STAI scores during the stress condition compared to the no-stress condition.)", "entity_type": "UNKNOWN", "id": "STRESS CONDITION"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants reported lower STAI scores during the no-stress condition compared to the stress condition.)", "entity_type": "UNKNOWN", "id": "NO-STRESS CONDITION"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "STAI scores increased significantly over time within both the stress and no-stress conditions.)<SEP>STAI scores significantly increased over time for both the stress and no-stress conditions.)", "entity_type": "UNKNOWN", "id": "TIME"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants reported elevated PANAS NA scores during the stress condition compared to the no-stress condition.)", "entity_type": "UNKNOWN", "id": "PANAS NA SCORES"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants exhibited lower response bias in Block 1 compared to Blocks 2 and 3.)", "entity_type": "UNKNOWN", "id": "BLOCK 1"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants showed higher response bias in Block 2 compared to Block 1.)", "entity_type": "UNKNOWN", "id": "BLOCK 2"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "Participants exhibited the highest response bias in Block 3.)", "entity_type": "UNKNOWN", "id": "BLOCK 3"}, {"source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "description": "Participants exhibit increased response bias in response to stress conditions.)", "entity_type": "UNKNOWN", "id": "STRESS"}, {"entity_type": "SNP", "description": "rs17563 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS17563"}, {"entity_type": "GENE", "description": "BMP4 is a gene associated with \'age at first tooth\' and craniofacial development.<SEP>BMP4 is a gene associated with height.<SEP>BMP4 is a gene involved in development and has been linked to age at first tooth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 94}]", "id": "BMP4"}, {"entity_type": "SNP", "description": "rs10740993 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS10740993"}, {"entity_type": "GENE", "description": "CACNB2 is a gene involved in \'number of primary teeth\'.<SEP>CACNB2 is a gene involved in calcium signaling and has been linked to age at first tooth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "CACNB2"}, {"entity_type": "SNP", "description": "rs4937076 is a single nucleotide polymorphism associated with number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS4937076"}, {"entity_type": "GENE", "description": "CDON is a gene involved in cell signaling and has been linked to number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CDON"}, {"entity_type": "SNP", "description": "rs1799922 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS1799922"}, {"entity_type": "GENE", "description": "CALU and OPN1SW are genes involved in vision and have been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CALU/OPN1SW"}, {"entity_type": "SNP", "description": "rs997154 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS997154"}, {"entity_type": "GENE", "description": "AJUBA and C14orf93 are genes involved in cytoskeleton organization and have been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "AJUBA/C14ORF93"}, {"entity_type": "SNP", "description": "rs7924176 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS7924176"}, {"entity_type": "GENE", "description": "ADK is a gene associated with craniofacial development, specifically nose width.<SEP>ADK is a gene involved in purine metabolism and has been linked to age at first tooth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "ADK"}, {"entity_type": "SNP", "description": "rs412000 is a single nucleotide polymorphism associated with number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS412000"}, {"entity_type": "GENE", "description": "TEX14 and RAD51C are genes involved in DNA repair and have been linked to number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TEX14/RAD51C"}, {"entity_type": "SNP", "description": "rs9316505 is a single nucleotide polymorphism associated with age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RS9316505"}, {"entity_type": "GENE", "description": "KCNJ2 is a gene involved in potassium ion channels and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "KCNJ2"}, {"entity_type": "GENE", "description": "IGF2BP1 is a gene associated with \'age at first tooth\' and \'number of teeth\'.<SEP>IGF2BP1 is a gene involved in mRNA binding and translation and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "IGF2BP1"}, {"entity_type": "GENE", "description": "EDA is a gene involved in development and has been linked to number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "EDA"}, {"entity_type": "SNP", "description": "rs17101923 is a single nucleotide polymorphism associated with number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "RS17101923"}, {"entity_type": "GENOMIC REGION", "description": "2q35 is a genomic region containing several genes, some linked to number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "2Q35"}, {"entity_type": "GENOMIC REGION", "description": "6q21 is a genomic region associated with \'number of primary teeth\'.<SEP>6q21 is a genomic region containing several genes, some linked to number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "6Q21"}, {"entity_type": "GENE", "description": "RAD51L1 is a gene associated with \'age at first tooth\' and \'number of teeth\'.<SEP>RAD51L1 is a gene involved in DNA repair and has been linked to number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "RAD51L1"}, {"entity_type": "GENE", "description": "TMEM9 is a gene involved in membrane trafficking and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TMEM9"}, {"entity_type": "GENE", "description": "PAX9 is a gene involved in tooth development and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "PAX9"}, {"entity_type": "GENE", "description": "FGF2 is a gene involved in cell growth and differentiation and has been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "FGF2"}, {"entity_type": "GENE", "description": "WNT10A is a gene involved in development and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "WNT10A"}, {"entity_type": "GENE", "description": "COL1A1 is a gene involved in collagen production and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "COL1A1"}, {"entity_type": "GENE", "description": "MSX1 is a gene involved in tooth development and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "MSX1"}, {"entity_type": "GENE", "description": "IGF2 is a gene involved in growth and development and has been linked to both age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "IGF2"}, {"entity_type": "GENE", "description": "FOXP2 is a gene involved in speech and language development and has been linked to age at first tooth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "FOXP2"}, {"entity_type": "GENE", "description": "KCNJ160 is a gene associated with \'age at first tooth\' and potentially craniofacial development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ160"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2520397 (FAM155E\u2013EDA) is a genetic variant associated with \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2520397"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1951867 (BMP4) is a genetic variant associated with \'age at first tooth\' and craniofacial development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 94}]", "id": "RS1951867"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1472259 (HMGA2) is a genetic variant associated with \'age at first tooth\', craniofacial development, and number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 37}]", "id": "RS1472259"}, {"entity_type": "GENOMIC VARIANT", "description": "rs8069452 (IGF2BP1) is a genetic variant associated with \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS8069452"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9788982 (KCNJ2 KCNJ160) is a genetic variant associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9788982"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2804391 (FAM155E\u2013EDA) is a genetic variant associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2804391"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1458991 (BMP4) is a genetic variant associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 94}]", "id": "RS1458991"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9894411 (IGF2BP1) is a genetic variant associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9894411"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1976274 (MSRB3) is a genetic variant associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1976274"}, {"entity_type": "GENE", "description": "AJUBA is a gene associated with craniofacial development, specifically brow prominence.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "AJUBA"}, {"entity_type": "GENE", "description": "VCL is a gene involved in \'number of primary teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "VCL"}, {"entity_type": "GENE", "description": "AP3M1 is a gene involved in \'number of primary teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "AP3M1"}, {"entity_type": "GENE", "description": "IGF2BP3 is a gene associated with \'age at first tooth\' and \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "IGF2BP3"}, {"entity_type": "GENE", "description": "C6orf173 is a gene associated with \'age at first tooth\' and \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "C6ORF173"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs (Single Nucleotide Polymorphisms) are variations in a single nucleotide within a DNA sequence.<SEP>SNPs are single nucleotide polymorphisms that can be associated with traits like height.<SEP>SNPs are Single Nucleotide Polymorphisms, variations at a single position in the DNA sequence.<SEP>Single nucleotide polymorphisms, variations in a single nucleotide within the DNA sequence.<SEP>Single nucleotide polymorphisms are variations in a single base pair of DNA.<SEP>Single nucleotide polymorphisms are variations in a single nucleotide in the DNA sequence.<SEP>Single nucleotide polymorphisms are variations in DNA sequences.", "source_id": "chunk-72f4505e43f67f3564607392cb178656<SEP>chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "SNPS"}, {"entity_type": "PHENOTYPE", "description": "Age at first tooth refers to the age at which a child\'s first tooth erupts.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "AGE AT FIRST TOOTH"}, {"entity_type": "PHENOTYPE", "description": "Number of teeth refers to the total count of teeth in an individual.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "NUMBER OF TEETH"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs11077486 is located near the KCNJ2 and KCNJ160 genes.)", "entity_type": "UNKNOWN", "id": "KCNJ2/KCNJ160"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs11077486 is located near the KCNJ2 and KCNJ160 genes.)", "entity_type": "UNKNOWN", "id": "RS11077486"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs2520397 is located near the FAM155E and EDA genes.)", "entity_type": "UNKNOWN", "id": "FAM155E/EDA"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs17101923 in HMGA2 is associated with increased face width.)", "entity_type": "UNKNOWN", "id": "FACE WIDTH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs17101923 in HMGA2 is associated with increased face width.)", "entity_type": "UNKNOWN", "id": "RS17101923 (HMGA2)"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs7924176 in ADK is associated with nose width.)", "entity_type": "UNKNOWN", "id": "NOSE WIDTH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs7924176 in ADK is associated with nose width.)", "entity_type": "UNKNOWN", "id": "RS7924176 (ADK)"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs997154 in AJUBA is associated with an increase in height and prominence of the mid-brow.)", "entity_type": "UNKNOWN", "id": "MID-BROW PROMINENCE"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The SNP rs997154 in AJUBA is associated with an increase in height and prominence of the mid-brow.)", "entity_type": "UNKNOWN", "id": "RS997154 (AJUBA)"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Several height-associated SNPs showed evidence of association with faster tooth eruption.)", "entity_type": "UNKNOWN", "id": "HEIGHT-ASSOCIATED SNPS"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "description": "Height refers to the measurement from the ground to the top of the head.<SEP>Variants in HMGA2 were found to be associated with height.)", "entity_type": "QUANTITATIVE TRAIT", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 95}]", "id": "HEIGHT"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "description": "The PMETA score for \'Age at first tooth\' is 0.0012, indicating the strength of its association with other traits.)", "entity_type": "UNKNOWN", "id": "PMETA"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the IL-10 receptor alpha gene (IL-10R\u03b1) is selectively deleted to T cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "IL-10R\u0391TDEL"}, {"entity_type": "CELL", "description": "A type of white blood cell that plays a role in adaptive immunity.<SEP>T Cells are a type of white blood cell involved in the immune response.<SEP>T cells are immune cells that can contribute to autoimmune diseases like colitis.<SEP>T cells are a type of white blood cell involved in immune responses.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-614333487e4b92705503909d34155179<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "T CELL"}, {"entity_type": "GENOMIC VARIANT", "description": "These are a subset of T cells transferred into Rag1\u2212/\u2212 recipients.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD4+CD25\u2212CD45RBHI T CELLS"}, {"entity_type": "DISEASE", "description": "Mice lacking the RAG1 gene develop no functional immune system.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "RAG1\u2212/\u2212 MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "These mice have a deletion of IL-10 receptor alpha specifically in dendritic cells and Rag1 deficient background.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "IL-10R\u0391DCDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "These mice have a deletion of IL-10 receptor alpha specifically in macrophages and Rag1 deficient background.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 91}]", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease characterized by chronic inflammation of the colon.<SEP>Colitis is an inflammatory bowel disease characterized by chronic inflammation of the colon.<SEP>An inflammatory bowel disease characterized by inflammation of the colon.<SEP>Inflammation of the colon.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "COLITIS"}, {"entity_type": "DISEASE", "description": "A specific type of colitis induced by dextran sulfate sodium, a chemical toxin.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "DSS COLITIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Macrophage response to IL-10 is important for restraining inflammation in colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "M\u03a6 RESPONSE TO IL-10"}, {"entity_type": "DISEASE", "description": "A type of colitis driven by the activity of T cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "T CELL-MEDIATED COLITIS"}, {"entity_type": "GENE", "description": "IL-10 receptor alpha chain is a receptor for the cytokine IL-10.<SEP>IL-10 receptor alpha is a protein component of the IL-10 receptor complex.<SEP>Interleukin 10 receptor alpha, involved in immune regulation.<SEP>The IL-10 receptor alpha (IL-10R\u03b1) is a protein that binds to IL-10.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "IL-10R\u0391"}, {"entity_type": "DISEASE", "description": "This refers to mice with a normal, non-modified genome.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "WILD-TYPE (WT)"}, {"entity_type": "GENE", "description": "RAG1 gene, involved in lymphocyte development and immune function.<SEP>Rag1 is a gene that encodes a recombinase enzyme essential for T cell and B cell development.<SEP>The RAG1 gene is essential for V(D)J recombination, a process required for lymphocyte development.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "RAG1"}, {"entity_type": "PROTEIN", "description": "A cell surface marker indicating T helper cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD4+"}, {"entity_type": "PROTEIN", "description": "A cell surface marker associated with regulatory T cells.<SEP>CD25 is a gene that encodes the alpha chain of the IL-2 receptor.<SEP>IL-2 receptor alpha chain, expressed on activated T cells.<SEP>CD25 is a marker expressed on activated T cells, particularly regulatory T cells (Tregs).", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "CD25"}, {"entity_type": "PROTEIN", "description": "A cell surface glycoprotein involved in immune cell activation.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD45RB"}, {"entity_type": "DISEASE", "description": "A subset of T helper cells that produce IFN-\u03b3 and contribute to inflammatory responses.<SEP>Th1 are a subset of T helper cells characterized by their production of IFN-\u03b3 and involvement in cell-mediated immunity.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "TH1"}, {"entity_type": "DISEASE", "description": "A subset of T helper cells that produce IL-17 and are involved in autoimmune inflammation.<SEP>Th17 are a subset of T helper cells characterized by their production of IL-17.<SEP>Th17 cells are a subset of T helper cells that produce IL-17 and contribute to inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 120}]", "id": "TH17"}, {"entity_type": "PROTEIN", "description": "T regulatory cells expressing the Foxp3 transcription factor, known for their suppressive function.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "FOXP3+"}, {"entity_type": "CELL TYPE", "description": "M\u03d5 refers to macrophages.<SEP>M\u03d5 stands for macrophage, a type of immune cell involved in phagocytosis and antigen presentation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "M\u03a6"}, {"entity_type": "CELL TYPE", "description": "Neutrophils are immune cells that help fight infection.<SEP>Neutrophils are phagocytic white blood cells involved in the early response to infection and inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "NEUTROPHILS"}, {"entity_type": "CELL TYPE", "description": "LPM\u03d5s (Ly6ChiCD11b+ cells) are a subset of monocyte-derived macrophages found in the lamina propria of the intestine.<SEP>LPM\u03d5s refers to lamina propria macrophages, which reside in the tissue lining the intestines.<SEP>Lamina propria macrophages, immune cells found in the gut.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 14}]", "id": "LPM\u03a6S"}, {"entity_type": "CELL SUBTYPE", "description": "This describes a specific population of LPM\u03d5s based on their surface markers.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD11BHICD11C\u2212/LO/MODF4/80+LY6G\u2212/LOSIGLECF\u2212"}, {"entity_type": "CELL MARKER", "description": "CD64 is a marker expressed by macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD64+"}, {"entity_type": "CELL MARKER", "description": "CX3CR1 is a chemokine receptor found on certain immune cells, including LPM\u03d5s.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CX3CR1+"}, {"entity_type": "GENE", "description": "CD40 is a cell surface receptor that plays a role in immune responses and is a MS risk locus.<SEP>CD40 is a gene involved in T cell activation and B cell differentiation.<SEP>CD40 is an activation marker expressed on macrophages and other immune cells.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD40"}, {"entity_type": "CELL MARKER", "description": "CD80 is an immune checkpoint molecule found on antigen-presenting cells, including macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD80"}, {"entity_type": "CELL MARKER", "description": "CD86 is another immune checkpoint molecule found on antigen-presenting cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD86"}, {"entity_type": "CELL SUBTYPE", "description": "This describes a population of macrophages with high expression of the Ly6C marker, often associated with pro-inflammatory activity.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6CHI"}, {"entity_type": "CELL SUBTYPE", "description": "This describes a population of macrophages with low expression of the Ly6C marker, often associated with anti-inflammatory activity.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6CLO"}, {"entity_type": "CELL LINE/MODEL", "description": "Rag1\u2212/\u2212 is a genetically modified mouse model lacking functional RAG1, leading to a lack of mature T cells.<SEP>Rag1\u2212/\u2212 mice are a model of immunodeficiency due to the deletion of the RAG1 gene, which is required for V(D)J recombination.<SEP>Rag1\u2212/\u2212 mice are genetically modified to lack Rag1, a gene essential for lymphocyte development.<SEP>This refers to a specific cell line or model deficient in the Rag1 gene, which is essential for lymphocyte development.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 103}]", "id": "RAG1\u2212/\u2212"}, {"entity_type": "CELL LINE/MODEL", "description": "IL-10R\u03b1MdelRag1\u2212/\u2212 is a genetically modified mouse model characterized by the deletion of the IL-10 receptor alpha subunit gene (Il10ra) and Rag1.<SEP>These mice have a deletion of the IL-10 receptor alpha chain specifically in macrophages (M\u03d5), in addition to lacking Rag1.<SEP>This refers to a specific cell line or model lacking the IL-10 receptor alpha chain and derived from Rag1 knockout mice.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "FOXP3 is a transcription factor crucial for the development and function of regulatory T cells (Tregs).<SEP>Foxp3 is a transcription factor essential for the development and function of regulatory T cells (Tregs).<SEP>Foxp3 is a transcription factor expressed by regulatory T cells (Tregs).", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "FOXP3"}, {"entity_type": "CELL SUBTYPE", "description": "Induced Tregs, or iTregs, are regulatory T cells that develop in the periphery.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "ITREG"}, {"entity_type": "CELLULAR PROCESS", "description": "Regulatory T cells (Tregs) are a subset of T lymphocytes that suppress immune responses.<SEP>Regulatory T cells (Tregs) are a subtype of immune cell that suppress immune responses.<SEP>Treg refers to regulatory T cells, a subset of lymphocytes that suppress immune responses.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "TREG"}, {"entity_type": "CELL TYPE", "description": "Na\u00efve T cells are T cells that have not yet encountered their specific antigen.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "NA\u00cfVE T CELLS"}, {"entity_type": "GENETIC MODEL", "description": "Rag2\u2212/\u2212 mice lack Rag2, a gene essential for lymphocyte development.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "RAG2\u2212/\u2212"}, {"entity_type": "REAGENT", "description": "BrdU is a nucleotide analog used to measure cell proliferation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "BRDU"}, {"entity_type": "DISEASE", "description": "IL-10R\u03b1MdelRag1\u2212/\u2212 mice are a model of colitis with increased disease severity due to the deletion of IL-10 receptor alpha on macrophages.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10R\u0391MDEL RAG1\u2212/\u2212"}, {"entity_type": "CYTOKINE", "description": "IL-1\u03b2 is a pro-inflammatory cytokine involved in the pathogenesis of colitis.<SEP>IL-1\u03b2 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>IL-1\u03b2 is a proinflammatory cytokine produced by adipocytes and contributes to inflammation.<SEP>Interleukin-1 beta (IL-1\u03b2) is a proinflammatory cytokine involved in immune responses and tissue damage.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 90}]", "id": "IL-1\u0392"}, {"entity_type": "CYTOKINE", "description": "TNF-\u03b1 (Tumor necrosis factor alpha) is a proinflammatory cytokine.<SEP>TNF-\u03b1 is a pro-inflammatory cytokine involved in the pathogenesis of colitis.<SEP>TNF-\u03b1 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>Tumor necrosis factor alpha (TNF-\u03b1) is a proinflammatory cytokine associated with inflammation and insulin resistance.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "TNF-\u0391"}, {"entity_type": "CYTOKINE", "description": "MCP-1 (CCL2) is a chemokine that attracts monocytes and macrophages to sites of inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "MCP-1"}, {"entity_type": "CYTOKINE", "description": "IL-17 is a pro-inflammatory cytokine involved in immune responses.<SEP>IL-17 is a pro-inflammatory cytokine produced by Th17 cells that contributes to inflammatory responses.<SEP>IL-17 is a pro-inflammatory cytokine produced by Th17 cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "IL-17"}, {"entity_type": "GENE", "description": "IFN-\u03b3 (Interferon gamma) is a cytokine involved in immune responses.<SEP>IFN-\u03b3 is a pro-inflammatory cytokine produced by T helper 1 cells and natural killer cells.<SEP>IFN-\u03b3 is a pro-inflammatory cytokine produced by Th1 cells.<SEP>IFN-\u03b3 was not significantly elevated in SENP1-deficient mice.<SEP>Interferon gamma (IFN-\u03b3) is a cytokine involved in immune responses, particularly in cell-mediated immunity.<SEP>IFN-\u03b3 is a gene that encodes for the interferon gamma protein.<SEP>Interferon gamma (IFN-\u03b3) is a cytokine with roles in immune responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 143}]", "id": "IFN-\u0393"}, {"entity_type": "CELL TYPE", "description": "T cells are a type of immune cell that plays a crucial role in adaptive immunity, including recognizing and destroying infected cells and regulating the immune response.<SEP>T cells are a type of lymphocyte involved in adaptive immunity.<SEP>T cells are lymphocytes involved in cell-mediated immunity.<SEP>T cells are lymphocytes that play a crucial role in adaptive immunity.<SEP>T cells are a type of white blood cell involved in the immune response.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 103}]", "id": "T CELLS"}, {"entity_type": "GENE MUTATION", "description": "IL-10R\u03b1Mdel is a deletion of the IL-10 receptor alpha gene.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10R\u0391MDEL"}, {"entity_type": "TISSUE AREA", "description": "The colonic infiltrate refers to the immune cells present within the lining of the colon.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "COLONIC INFILTRATE"}, {"entity_type": "CELL TYPE", "description": "CD4+IL-17A+ T cells are Th17 cells, a subset of T helper cells that produce IL-17A.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+IL-17A+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "CD4+IFN-\u03b3+ T cells are Th1 cells, a subset of T helper cells that produce IFN-\u03b3.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+IFN-\u0393+ T CELLS"}, {"entity_type": "CELL SURFACE MARKERS", "description": "CD4+CD25\u2212CD45RBhi is a marker profile used to identify naive T cells with the potential for differentiation into effector T cells.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+CD25\u2212CD45RBHI"}, {"entity_type": "GENETICALLY MODIFIED CELL TYPE", "description": "ROR\u03b3T-GFP reporter T cells are T cells expressing GFP under the control of the ROR\u03b3T gene, allowing visualization and tracking of Th17 cells.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ROR\u0393T-GFP REPORTER T CELLS"}, {"entity_type": "CELL TYPE", "description": "CD11bhiCD11c\u2212/lo/modF4/80+Ly6G\u2212/loSiglecF\u2212 are a specific subset of macrophages found in the lamina propria.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD11BHICD11C\u2212/LO/MODF4/80+LY6G\u2212/LOSIGLECF\u2212 LPM\u03a6S"}, {"entity_type": "CELL TYPE", "description": "Dendritic cells (DCs) are antigen-presenting cells that play a crucial role in initiating immune responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "DCS"}, {"entity_type": "CELL TYPE", "description": "Epithelial cells form the lining of organs and tissues.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "EPITHELIAL CELLS"}, {"entity_type": "GENE", "description": "ROR\u03b3T is a gene that encodes a transcription factor essential for the differentiation of Th17 cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "ROR\u0393T"}, {"entity_type": "GENOMIC VARIANT", "description": "WT refers to wild-type mice with a normal genotype.<SEP>WT refers to wild-type mice, with normal genotypes.<SEP>WT represents wild-type mice, which serve as a control group.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 3}]", "id": "WT"}, {"entity_type": "GENE", "description": "IL-6R\u03b1 is the interleukin 6 receptor, and IL-6R\u03b1\u2212/\u2212 mice lack functional IL-6 receptors.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 120}]", "id": "IL-6R\u0391\u2212/\u2212"}, {"entity_type": "DISEASE", "description": "T cell transfer colitis is a model of colitis induced by transferring activated T cells into recipient mice.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "T CELL TRANSFER COLITIS"}, {"entity_type": "CELLULAR PROCESS", "description": "Foxp3+ CD4+ T cells are regulatory T cells that suppress immune responses.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "FOXP3+ CD4+ T CELLS"}, {"entity_type": "CELLULAR PROCESS", "description": "The Th17 response refers to the activation and function of Th17 cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "TH17 RESPONSE"}, {"entity_type": "CELLULAR PROCESS", "description": "CD4+TCR+ T cells are a subset of T lymphocytes characterized by the expression of CD4 and TCR.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "CD4+TCR+ T CELLS"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "MLNs stands for mesenteric lymph nodes, which are lymphoid organs in the abdomen that drain lymph from the intestines.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "MLNS"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "Splanchnic lymph nodes are a type of lymph node located near internal organs.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "SPLANCHNIC LYMPH NODES"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "The colon is the final part of the large intestine responsible for absorbing water and forming feces.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "COLON"}, {"entity_type": "GENE", "description": "IL-6 receptor alpha is a protein component of the IL-6 receptor complex.<SEP>IL-6 receptor alpha, a protein involved in immune response.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "IL-6R\u0391"}, {"entity_type": "GENE", "description": "Interleukin 1 receptor alpha, a protein involved in immune response.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 98}]", "id": "IL-1R\u0391"}, {"entity_type": "IMMUNE CELL SUBSET", "description": "Th17 cells are a type of T helper cell involved in inflammation.<SEP>Th17 cells are pro-inflammatory T helper cells that produce IL-17.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 98}]", "id": "TH17 CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "Foxp3+ regulatory T cells are involved in immune suppression.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 98}]", "id": "FOXP3+ TREG CELLS"}, {"entity_type": "PROTEIN", "description": "Cluster of differentiation 11b, a protein marker for macrophages.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 90}]", "id": "CD11B"}, {"entity_type": "PROTEIN", "description": "Pro-interleukin 1 beta, an inactive precursor to IL-1\u03b2.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 14}]", "id": "PRO-IL-1\u0392"}, {"entity_type": "PROTEIN", "description": "Caspase 1, an enzyme involved in the activation of IL-1\u03b2.<SEP>Caspase-1 is an enzyme involved in the activation of inflammatory cytokines.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 14}]", "id": "CASPASE-1"}, {"entity_type": "COMPLEX", "description": "A multiprotein complex that activates caspase-1.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 14}]", "id": "INFLAMMASOME"}, {"entity_type": "PROTEIN", "description": "Pro-interleukin-1 beta is the precursor to IL-1 beta, an inflammatory cytokine.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "clusters": "[{level: 0, cluster: 14}]", "id": "PRO-IL-\u0392"}, {"entity_type": "PROTEIN", "description": "Mature interleukin-1 beta is a potent pro-inflammatory cytokine.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "MATURE IL-1\u0392"}, {"entity_type": "CELL TYPE", "description": "Macrophages are phagocytic immune cells involved in both innate and adaptive immunity.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "M\u03a6S"}, {"entity_type": "STIMULUS/AGENT", "description": "Lipopolysaccharide (LPS) is a bacterial component that can activate immune cells.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPS"}, {"entity_type": "STIMULUS/AGENT", "description": "Adenosine triphosphate (ATP) is a cellular energy molecule that, when released extracellularly, can act as a danger signal.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "ATP"}, {"entity_type": "PROTEIN FRAGMENT", "description": "p20 is the activated fragment of caspase-1, indicating its cleavage and activation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "P20"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Transfer of specific T cells into Rag1\u2212/\u2212 mice induces colitis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "T CELL TRANSFER"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Mice lacking IL-10 receptor alpha specifically in macrophages exhibit accelerated weight loss compared to controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 91}]", "id": "INCREASED WEIGHT LOSS"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Mice lacking IL-10 receptor alpha specifically in macrophages show increased inflammation and tissue damage in the colon.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 91}]", "id": "INCREASED HISTOPATHOLOGY"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "LPM\u03d5s from IL-10R\u03b1MdelRag1\u2212/\u2212 mice exhibited elevated surface expression of activation markers such as CD40, CD80, and CD86.)", "entity_type": "UNKNOWN", "id": "ACTIVATION"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "LPM\u03d5s from IL-10R\u03b1MdelRag1\u2212/\u2212 mice exhibited elevated surface expression of activation markers such as CD40, CD80, and CD86.)", "entity_type": "UNKNOWN", "id": "CD40, CD80, AND CD86"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Most LPM\u03d5s were phenotypically pro-inflammatory (Ly6Chi), but the proportions did not differ between IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "DISEASE SEVERITY"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Most LPM\u03d5s were phenotypically pro-inflammatory (Ly6Chi), but the proportions did not differ between IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "LY6CHI MACROPHAGES"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Increased numbers of LPM\u03d5s in IL-10R\u03b1MdelRag1\u2212/\u2212 mice were associated with increased proliferation rates.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "LPM\u03a6 PROLIFERATION"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Transferred Foxp3+ iTregs suppressed disease development in both IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 recipients.)", "entity_type": "UNKNOWN", "id": "DISEASE SUPPRESION"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Transferred Foxp3+ iTregs suppressed disease development in both IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 recipients.)", "entity_type": "UNKNOWN", "id": "FOXP3+ ITREG "}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "Actions of IL-10 on M\u03d5s generate a dependency for IL-6 in disease pathogenesis.)", "entity_type": "UNKNOWN", "id": "IL-6 REQUIREMENT"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "Transferring IL-1R\u2212/\u2212 T cells into IL-10R\u03b1MdelRag1\u2212/\u2212 mice results in milder colitis compared to WT T cell transfers.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "IL-1R\u2212/\u2212"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Blocking IL-10R signaling with an antibody elevated pro-IL-\u03b2 levels in Rag1\u2212/\u2212 M\u03d5s, suggesting that IL-10 normally restrains IL-1\u03b2 production.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}]", "id": "ANTI-IL-10R ANTIBODY"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPM\u03d5s from Rag1\u2212/\u2212 mice supported Th17 cell differentiation to a lesser extent compared to those from IL-10R\u03b1MdelRag1\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 119}]", "id": "RAG1\u2212/\u2212 LPM\u03a6S"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPM\u03d5s from Rag1\u2212/\u2212 mice supported Th17 cell differentiation to a lesser extent compared to those from IL-10R\u03b1MdelRag1\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 119}]", "id": "TH17 CELL DIFFERENTIATION"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPM\u03d5s from IL-10R\u03b1MdelRag1\u2212/\u2212 mice strongly supported Th17 cell differentiation, suggesting an enhanced capacity to promote this process.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 119}]", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 LPM\u03a6S"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Blocking IL-1 signaling significantly inhibited Th17 development in cultures with IL-10R\u03b1MdelRag1\u2212/\u2212-derived LPM\u03d5s, highlighting the importance of IL-1 in supporting Th17 cell maturation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 119}]", "id": "IL-1"}, {"entity_type": "GENUS", "description": "A genus of bacteria found in the gut microbiome.<SEP>A genus of bacteria.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINICLOSTRIDIUM 9"}, {"entity_type": "FAMILY", "description": "A bacterial family found in the gut microbiome.<SEP>A family of bacteria.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "PEPTOSTREPTOCOCCAEAE"}, {"entity_type": "GENUS", "description": "A genus of bacteria often found in the human gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BLAUTIA"}, {"entity_type": "GENUS", "description": "A genus of bacteria commonly present in the human gut microbiome.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ALISTIPES"}, {"entity_type": "GENUS", "description": "A genus of bacteria that produces short-chain fatty acids in the gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINOCOCCUS"}, {"entity_type": "GENUS", "description": "A genus of bacteria commonly found in the human gut microbiome.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FUSICATENIBACTER"}, {"entity_type": "GENUS", "description": "A genus of bacteria that produces butyrate, a beneficial short-chain fatty acid.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BUTYRICICOCCUS"}, {"entity_type": "GENUS", "description": "A genus of bacteria commonly found in the human gut microbiome.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EUBACTERIUM"}, {"entity_type": "COHORT", "description": "A cohort study involving twins.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "TWINSUK"}, {"entity_type": "COHORT", "description": "A cohort study involving twins from the Netherlands.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "NETHERLANDS TWIN REGISTRY (NTR)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The method used to extract DNA can influence microbiome composition.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "DNA EXTRACTION METHOD"}, {"entity_type": "GENE", "description": "LCT encodes the lactase enzyme, which breaks down lactose.<SEP>LCT gene encodes lactase, an enzyme involved in lactose digestion.<SEP>LCT gene is associated with lactose intolerance and has pleiotropic effects on dietary and metabolic phenotypes.<SEP>The Lactose-tolerance gene.<SEP>LCT is the gene encoding lactase, an enzyme responsible for lactose digestion.<SEP>LCT is the gene that codes for lactase enzyme.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT"}, {"entity_type": "BACTERIA", "description": "A genus of bacteria.<SEP>Bifidobacterium is a bacterial genus within Actinobacteria, potentially protective against ulcerative colitis.<SEP>Bifidobacterium is a genus of bacteria associated with gut health.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 71}]", "id": "BIFIDOBACTERIUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of the diversity of microbial species present in a sample.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "ALPHA DIVERSITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A metric used to quantify alpha diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SIMPSON INDEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A metric used to quantify alpha diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "INVERSE SIMPSON INDEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A metric used to quantify alpha diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SHANNON DIVERSITY INDICES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Mapping of microbial abundance quantitative trait loci, indicating genetic influence on bacterial abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBQTL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Mapping of microbial binary traits loci, indicating genetic influence on presence/absence of bacteria.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBBTL"}, {"entity_type": "STATISTICAL METHOD", "description": "A method used to assess the relationship between genetic variants and complex traits.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "LD SCORE REGRESSION"}, {"entity_type": "QUANTITATIVE TRAIT", "description": "The proportion of variation in a trait that is attributable to genetic factors.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "HERITABILITY"}, {"entity_type": "POPULATION GROUP", "description": "A cohort of twins studied for genetic research.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "TWINSUK COHORT"}, {"entity_type": "POPULATION GROUP", "description": "A multi-ethnic cohort studied for microbial genetics.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "GEM COHORT"}, {"entity_type": "STUDY COHORT", "description": "A specific study cohort within the GEM project.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "COPSAC2010"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs182549 showed a higher abundance of the genus Bifidobacterium in adults compared to younger individuals.<SEP>A single nucleotide polymorphism (SNP) located on chromosome 2.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "RS182549"}, {"entity_type": "GENOMIC VARIANT", "description": "A functional variant within the LCT gene.<SEP>rs4988235 is a genomic variant associated with milk intake and other dietary patterns.<SEP>rs4988235 is a genomic variant associated with lactase persistence.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "RS4988235"}, {"entity_type": "COHORT", "description": "GEM_v12 is a cohort comprising mostly European individuals.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "GEM_V12"}, {"entity_type": "COHORT", "description": "GEM_ICHIP is a cohort comprising mostly European individuals.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "GEM_ICHIP"}, {"entity_type": "COHORT", "description": "GEM_v24 is a cohort mainly composed of individuals of different Israeli subethnicities.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "GEM_V24"}, {"entity_type": "COHORT", "description": "The Personalized Nutrition Project (PNP) is a cohort of 481 adults.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "PERSONALIZED NUTRITION PROJECT (PNP)"}, {"entity_type": "COHORT", "description": "The Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) is a child cohort.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "COPENHAGEN PROSPECTIVE STUDIES ON ASTHMA IN CHILDHOOD (COPSAC)"}, {"entity_type": "GENOMIC LOCUS", "description": "The FUT2-FUT1 locus is associated with the abundance of the Ruminococcus torques genus group.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 93}]", "id": "FUT2-FUT1 LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35866622 is a proxy for the functional variant rs601338 in the FUT2 gene.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 95}]", "id": "RS35866622"}, {"entity_type": "GENOMIC VARIANT", "description": "rs601338 introduces a stop-codon in the FUT2 gene.<SEP>rs601338 is a functional variant in the FUT2 gene.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RS601338"}, {"entity_type": "GENE", "description": "The FUT2 gene encodes the enzyme alpha-1,2-fucosyltransferase.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "FUT2 GENE"}, {"entity_type": "PROTEIN", "description": "Alpha-1,2-fucosyltransferase is responsible for the secretion of fucosylated mucus glycans in the gastrointestinal mucosa.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "ALPHA-1,2-FUCOSYLTRANSFERASE"}, {"entity_type": "BACTERIAL GENUS", "description": "Ruminococcus torques is a genus of bacteria specialized in degrading complex carbohydrates.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 93}]", "id": "RUMINOCOCCUS TORQUES"}, {"entity_type": "COHORT", "description": "LifeLines-DEEP (LLD) is a cohort of individuals with genetic and phenotypic data.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "LIFELINES-DEEP (LLD)"}, {"entity_type": "COHORT", "description": "The Flemish Gut Flora Project (FGFP) is a cohort with gut microbiome data.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FLEMISH GUT FLORA PROJECT (FGFP)"}, {"entity_type": "GENE", "description": "The PCSK5 gene encodes a protein involved in cellular signaling and processing.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PCSKS5 GENE"}, {"entity_type": "GENE", "description": "The RFK gene encodes an enzyme that phosphorylates riboflavin (vitamin B2).", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RFK GENE"}, {"entity_type": "GENE", "description": "The GCNT1 gene encodes a glycosyltransferase involved in mucin biosynthesis.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GCNT1 GENE"}, {"entity_type": "GENE", "description": "The CUBN gene encodes the receptor for cobalamin complexes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "CUBN GENE"}, {"entity_type": "BACTERIAL FAMILY", "description": "Peptostreptococcaceae is a bacterial family that may be affected by genetic variants regulating vitamin B12 metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOSTREPTOCOCCACEAE"}, {"entity_type": "GENE", "description": "The LCT gene encodes lactase, an enzyme that breaks down lactose.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 136}]", "id": "LCT GENE"}, {"entity_type": "PHENOTYPE", "description": "Non-secretor status refers to individuals who cannot secrete fucosylated glycans.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "NON-SECRETOR STATUS"}, {"entity_type": "PHENOTYPE", "description": "Lactose intolerance (LI) is the inability to digest lactose due to lactase deficiency.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 136}]", "id": "LACTOSE INTOLERANCE (LI)"}, {"entity_type": "PROTEIN", "description": "Alpha-1,3 fucosyltransferase is an enzyme involved in glycosylation.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "ALPHA-1,3 FUCOSYLTRANSFERASE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7574352 is a genomic variant associated with Peptococcaceae and stool levels of chromogranin A and calprotectin.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 70}]", "id": "RS7574352"}, {"entity_type": "GENUS", "description": "Peptococcaceae is a taxon negatively associated with stool levels of chromogranin A and calprotectin and with ulcerative colitis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 70}]", "id": "PEPTOCOCCACEAE"}, {"entity_type": "PROTEIN", "description": "Chromogranin A is a marker of gut inflammation.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 70}]", "id": "CHROMOGRANIN A"}, {"entity_type": "PROTEIN", "description": "Calprotectin is a marker of gut inflammation.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 70}]", "id": "CALPROTECTIN"}, {"entity_type": "DISEASE", "description": "A type of IBD characterized by inflammation and ulcers in the colon and rectum.<SEP>Ulcerative colitis is a disease potentially protected against by higher abundance of Actinobacteria and Bifidobacterium.<SEP>Ulcerative colitis is an inflammatory bowel disease.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 70}]", "id": "ULCERATIVE COLITIS"}, {"entity_type": "GENE", "description": "IRF1 gene is involved in insulin resistance and susceptibility to type 2 diabetes.<SEP>The IRF1 gene is involved in insulin resistance, suggesting a role in regulating glucose metabolism and susceptibility to type 2 diabetes.)<SEP>IRF1 is a gene involved in immune response and inflammation.<SEP>IRF1 is a gene that encodes for a protein involved in immune response.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IRF1"}, {"entity_type": "METABOLIC DYSFUNCTION", "description": "A condition in which cells do not respond properly to insulin.<SEP>Insulin resistance is a condition where cells do not respond properly to insulin, leading to elevated blood sugar levels.<SEP>Insulin resistance is a condition where the body\'s cells do not respond properly to insulin.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 104}]", "id": "INSULIN RESISTANCE"}, {"entity_type": "GENE", "description": "FUT1/FUT2 genes are involved in the synthesis of blood group antigens and are associated with fish intake, height, cholelithiasis, Crohn\u2019s disease, alcohol intake frequency, high cholesterol and waist-to-hip ratio.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "FUT1/FUT2"}, {"entity_type": "DISEASE", "description": "Lactose intolerance is the inability to digest lactose.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "LACTOSE INTOLERANCE"}, {"entity_type": "DISEASE", "description": "T2DM is a metabolic disorder characterized by high blood sugar levels.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"entity_type": "NUTRIENT", "description": "1,5-anhydroglucitol is an indicator of glycemic variability.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "1,5-ANHYDROGLUCITOL"}, {"entity_type": "DISEASE", "description": "Cholelithiasis is the formation of gallstones.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 95}]", "id": "CHOLELITHIASIS"}, {"entity_type": "DISEASE", "description": "Crohn\'s disease is a chronic inflammatory bowel disease.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 95}]", "id": "CROHN\u2019S DISEASE"}, {"entity_type": "DIETARY PATTERN", "description": "Fish intake refers to the amount of fish consumed in a diet.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 95}]", "id": "FISH INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Alcohol intake frequency refers to how often a person consumes alcohol.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "ALCOHOL INTAKE FREQUENCY"}, {"entity_type": "DISEASE", "description": "High cholesterol is a condition characterized by elevated levels of cholesterol in the blood.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "HIGH CHOLESTEROL"}, {"entity_type": "QUANTITATIVE TRAIT", "description": "Waist-to-hip ratio is a measure of body fat distribution.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "WAIST-TO-HIP RATIO"}, {"entity_type": "PHYLUM (BACTERIA)", "description": "Actinobacteria is a bacterial class that may have a protective effect on ulcerative colitis.<SEP>Actinobacteria is a phylum of bacteria known for their ability to produce antibiotics.<SEP>Actinobacteria is a phylum of bacteria, some of which are beneficial to gut health.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 3}]", "id": "ACTINOBACTERIA"}, {"entity_type": "BACTERIAL FAMILY", "description": "Oxalobacteraceae is a bacterial family associated with a protective effect against rheumatoid arthritis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "OXALOBACTERACEAE"}, {"entity_type": "DISEASE", "description": "An autoimmune disorder characterized by joint inflammation.<SEP>Rheumatoid arthritis is a disease potentially protected against by higher abundance of Oxalobacteraceae family.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "RHEUMATOID ARTHRITIS"}, {"entity_type": "SOFTWARE TOOL", "description": "The TwoSampleMR package is a software tool used for performing Mendelian Randomization analyses.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "TWOSAMPLEMR PACKAGE"}, {"entity_type": "STATISTICAL METHOD", "description": "Mendelian Randomization is a statistical method used to assess causal relationships between exposures and outcomes.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "MENDELIAN RANDOMIZATION"}, {"entity_type": "GENETIC FACTOR", "description": "Host genetics refers to the genetic makeup of an individual that influences various biological traits.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "HOST GENETICS"}, {"entity_type": "BIOLOGICAL FEATURE", "description": "Microbiome composition refers to the relative abundance and diversity of microorganisms in a particular environment, such as the human gut.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "MICROBIOME COMPOSITION"}, {"entity_type": "BEHAVIORAL TRAIT", "description": "Dietary preferences describe an individual\'s inclinations towards specific types of food.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "DIETARY PREFERENCES"}, {"entity_type": "OBSERVABLE TRAITS", "description": "Phenotypes encompass observable characteristics and traits in an organism.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PHENOTYPES"}, {"entity_type": "DISEASE CATEGORY", "description": "Autoimmune diseases are a group of conditions characterized by the immune system attacking the body\'s own tissues.<SEP>Autoimmune diseases are a group of conditions where the immune system attacks the body\'s own tissues.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-159d4c797dae6eb825c74067af703228", "id": "AUTOIMMUNE DISEASES"}, {"entity_type": "DISEASE CATEGORY", "description": "Cardiovascular diseases encompass disorders affecting the heart and blood vessels.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "CARDIOVASCULAR DISEASES"}, {"entity_type": "DISEASE CATEGORY", "description": "Metabolic diseases involve disruptions in metabolic processes within the body.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "METABOLIC DISEASES"}, {"entity_type": "DISEASE CATEGORY", "description": "Psychiatric disorders affect mental health and behavior.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PSYCHIATRIC DISORDERS"}, {"entity_type": "OBSERVABLE TRAITS", "description": "Nutritional phenotypes represent measurable characteristics related to an individual\'s nutritional status.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 71}]", "id": "NUTRITIONAL PHENOTYPES"}, {"entity_type": "GENETIC PHENOMENON", "description": "Pleiotropy occurs when a single gene influences multiple phenotypic traits.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PLEIOTROPY"}, {"entity_type": "METHODOLOGICAL APPROACH", "description": "Sensitivity analyses are statistical methods used to assess the robustness of research findings by examining the impact of varying assumptions.<SEP>Supplemental analyses performed to assess robustness of IVW findings.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-159d4c797dae6eb825c74067af703228", "id": "SENSITIVITY ANALYSES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "95% Confidence Interval represents a range within which the true population parameter is estimated to lie with 95% probability.<SEP>A range of values within which the true value of a parameter is likely to fall.<SEP>Confidence interval, a range of values within which the true population parameter is likely to fall.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-159d4c797dae6eb825c74067af703228", "id": "95%CI"}, {"entity_type": "P-VALUE ADJUSTMENT", "description": "P-value adjustment (PBHadj) corrects for multiple comparisons.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PBHADJ"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Bacteroides are a common component of the human gut microbiome.)", "entity_type": "UNKNOWN", "id": "BACTEROIDES"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Bacteroides are a common component of the human gut microbiome.)", "entity_type": "UNKNOWN", "id": "GUT MICROBIOME"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Ruminococcus species are known to produce short-chain fatty acids, beneficial metabolites for gut health.)", "entity_type": "UNKNOWN", "id": "SHORT-CHAIN FATTY ACIDS"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Sequencing the 16S rRNA gene allows for analysis of bacterial diversity in a sample.)", "entity_type": "UNKNOWN", "id": "16S RRNA GENE"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "Peptostreptococcaeae", "entity_type": "UNKNOWN", "id": "BACTERIAL FAMILY"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "The results of the SNP-based heritability showed significant correlation across the tested taxa.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 79}]", "id": "GUT MICROBES"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The functional variant rs601338 causes a stop-codon in the FUT2 gene, leading to non-secretor status.)", "entity_type": "UNKNOWN", "id": "FUT2 PROTEIN"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "Ruminococcus torques species are involved in the degradation of complex carbohydrates.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 93}]", "id": "CARBOHYDRATE METABOLISM"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The abundance of Ruminococcus torques group was correlated with fruit intake in the Flemish Gut Flora Project.)<SEP>The abundance of Ruminococcus torques group was correlated with fruit intake in the LifeLines-DEEP cohort.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 93}]", "id": "FRUIT INTAKE"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The PCSK5 gene is located within the 9q21 locus, associated with the abundance of Allisonella.)", "entity_type": "UNKNOWN", "id": "9Q21 LOCUS"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The CUBN gene is located within the 10p13 locus, associated with Peptostreptococcaceae abundance.)", "entity_type": "UNKNOWN", "id": "10P13 LOCUS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs182549 variant is positively associated with Type 2 diabetes mellitus diagnosis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "TYPE 2 DIABETES MELLITUS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs182549 variant increases the risk of having a family history of Type 2 diabetes mellitus.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 72}, {level: 2, cluster: 137}]", "id": "FAMILY HISTORY OF T2DM"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The FUT1/FUT2 locus is mapped to several nutritional phenotypes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 71}]", "id": "FUT1/FUT2 LOCUS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The FUT1/FUT2 locus maps to immune-related signals.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 71}]", "id": "IMMUNE-RELATED SIGNALS"}, {"entity_type": "DIETARY PATTERN", "description": "Milk intake is a dietary pattern associated with rs4988235.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "MILK INTAKE"}, {"entity_type": "NUTRIENT", "description": "C15:0 is a type of fatty acid.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "C15:0"}, {"entity_type": "NUTRIENT", "description": "C17:0 is a type of fatty acid.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "C17:0"}, {"entity_type": "FOOD", "description": "Potatoes are a type of starchy vegetable.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "POTATOES"}, {"entity_type": "FOOD", "description": "Cereal products are a staple food.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "CEREAL"}, {"entity_type": "FOOD", "description": "Fruits are a source of vitamins, minerals and antioxidants.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "FRUITS"}, {"entity_type": "FOOD", "description": "Poultry is a source of protein.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "POULTRY"}, {"entity_type": "FOOD", "description": "Non-alcoholic beverages are a type of drink.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "NON-ALCOHOLIC BEVERAGES"}, {"entity_type": "FOOD", "description": "Wine is an alcoholic beverage.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "WINE"}, {"entity_type": "DISEASE", "description": "Diabetes is a chronic disease that affects blood sugar levels.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "DIABETES RISK"}, {"entity_type": "NUTRIENT", "description": "Choline is an essential nutrient involved in fetal development.<SEP>Choline is an essential nutrient involved in various bodily functions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Alcohol consumption during pregnancy can have adverse effects on fetal development.<SEP>Alcohol consumption is a significant environmental factor that can impact fetal development.<SEP>The amount of alcohol consumed regularly.<SEP>Alcohol consumption refers to the intake of alcoholic beverages.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "ALCOHOL CONSUMPTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Methamphetamine use during pregnancy can have adverse effects on fetal development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "METHAMPHETAMINE USE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "EBC is a physiological process that involves learning through associations and is used to assess infants\' cognitive development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "EYE BLINK CONDITIONING (EBC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GA is a physiological measure that indicates the stage of pregnancy at a given time.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "GESTATIONAL AGE (GA)"}, {"entity_type": "DISEASE", "description": "LBW is a condition where a baby weighs less than 2500 grams at birth.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "LOW BIRTH WEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Somatic growth refers to the physical development of the body, including weight gain, length increase, and head circumference growth.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SOMATIC GROWTH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The FTII is a test used to assess infants\' cognitive development, including visual recognition memory and processing speed.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAGAN TEST OF INFANT INTELLIGENCE (FTII)"}, {"entity_type": "DISEASE", "description": "FAS is a range of birth defects caused by alcohol exposure during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAS (FETAL ALCOHOL SPECTRUM DISORDER)"}, {"entity_type": "SOCIAL FACTOR", "description": "The level of education attained by mothers was considered a characteristic.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "MATERNAL EDUCATION"}, {"entity_type": "COGNITIVE ABILITY", "description": "These measures assess a child\'s cognitive abilities in language and non-language skills.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE"}, {"entity_type": "PSYCHOLOGICAL STATE", "description": "The level of stress experienced by mothers was assessed.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCEIVED STRESS"}, {"entity_type": "MENTAL HEALTH CONDITION", "description": "A measure of depressive symptoms was used to assess psychological well-being.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DEPRESSION"}, {"entity_type": "HEALTH STATUS", "description": "Overall nutritional health and adequacy were considered.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NUTRITIONAL STATUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cigarette smoking during pregnancy is associated with potential risks for infants.<SEP>Smoking involves the inhalation of tobacco smoke, which contains numerous harmful chemicals.<SEP>Smoking cigarettes carries significant health risks.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "SMOKING"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The use of illegal substances other than marijuana was rare, but some mothers reported using methamphetamine later in pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "ILLICIT DRUG USE"}, {"entity_type": "PHYSIOLOGICAL MEASURE", "description": "The weight of the infant at birth.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "BIRTH WEIGHT"}, {"entity_type": "DISEASE", "description": "PFAS (Prenatal Fatty Acid Spectrum Disorder) is a disorder associated with maternal fatty acid deficiency during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "PFAS"}, {"entity_type": "GENE", "description": "PEMT (Phosphatidylethanolamine N-methyltransferase) is an enzyme that plays a role in choline metabolism.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PEMT"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12325817 is a variant of the PEMT gene that reduces endogenous choline synthesis.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "RS12325817"}, {"entity_type": "HUMAN", "description": "The study focused on infants as subjects.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "INFANTS"}, {"entity_type": "HUMAN", "description": "The mothers of the infants were assessed for dietary choline intake and PEMT genotype.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "MOTHERS"}, {"entity_type": "EXPERIMENTAL GROUP", "description": "Infants in this arm received a placebo instead of choline supplementation.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PLACEBO ARM"}, {"entity_type": "EXPERIMENTAL GROUP", "description": "Infants in this arm received choline supplementation during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE ARM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Dietary intake refers to the amount of nutrients consumed, including choline, by individuals.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "DIETARY INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Pregnancy is a period of fetal development and requires adequate nutrient intake.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PREGNANCY"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Heavy alcohol consumption during pregnancy is associated with an increased risk of FASDs.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The study mentions that some mothers in both groups used methamphetamine during pregnancy.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "PREGNANCY OUTCOMES"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Infants in the choline group showed greater improvement in EBC compared to the placebo group, suggesting potential benefits of choline for cognitive development.)", "entity_type": "UNKNOWN", "id": "CHOLINE SUPPLEMENTATION"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Infants in the choline group showed greater improvement in EBC compared to the placebo group, suggesting potential benefits of choline for cognitive development.)", "entity_type": "UNKNOWN", "id": "EBC"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The majority of women had full-term pregnancies, and GA did not differ significantly between groups.)", "entity_type": "UNKNOWN", "id": "BIRTH OUTCOMES"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The majority of women had full-term pregnancies, and GA did not differ significantly between groups.)", "entity_type": "UNKNOWN", "id": "GA"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The incidence of LBW was similar between the choline and placebo groups.)", "entity_type": "UNKNOWN", "id": "LBW"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Infants in the choline group performed better on the FTII compared to the placebo group, suggesting potential benefits of choline for cognitive function.)", "entity_type": "UNKNOWN", "id": "FTII"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Maternal education levels were similar between the treatment and placebo groups.)", "entity_type": "UNKNOWN", "id": "SAMPLE CHARACTERISTICS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "There were no significant differences in gestational age at randomization between groups.)", "entity_type": "UNKNOWN", "id": "WEEKS GESTATION AT RANDOMIZATION"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The incidence of LBW was similar between the choline and placebo groups.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 35}]", "id": "LOW BIRTHWEIGHT"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "Maternal PEMT genotype influences offspring choline status.)", "entity_type": "UNKNOWN", "id": "CHOLINE STATUS"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "Adequate maternal dietary choline intake during pregnancy may impact the risk of FAS and PFAS.)", "entity_type": "UNKNOWN", "id": "DIETARY CHOLINE"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "Adequate maternal dietary choline intake during pregnancy may impact the risk of FAS and PFAS.)", "entity_type": "UNKNOWN", "id": "FAS/PFAS RISK"}, {"entity_type": "GENOMIC VARIANT", "description": "rs10886471 is a single nucleotide polymorphism (SNP) located in an intronic region of the GRK5 gene.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "RS10886471"}, {"entity_type": "GENE", "description": "GRK5 is a gene that encodes the G protein-coupled receptor kinase 5, involved in signal transduction pathways.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "GRK5"}, {"entity_type": "GENOMIC VARIANT", "description": "CA repeat sequences are tandem repeats of cytosine and adenine nucleotides found in the human genome. ", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "CA REPEAT SEQUENCES"}, {"entity_type": "DISEASE", "description": "IGT stands for Impaired Glucose Tolerance, a condition characterized by elevated blood glucose levels after a glucose challenge.<SEP>Impaired Glucose Tolerance (IGT) is a condition characterized by elevated blood glucose levels during an oral glucose tolerance test.<SEP>Impaired Glucose Tolerance (IGT) indicates the body\'s inability to properly regulate blood sugar levels after consuming glucose.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 36}]", "id": "IGT"}, {"entity_type": "DISEASE", "description": "T2DM stands for Type 2 Diabetes Mellitus, a chronic metabolic disorder characterized by high blood sugar levels.<SEP>Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by high blood sugar levels.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 36}]", "id": "T2DM"}, {"entity_type": "DISEASE", "description": "NFG stands for Non-Fasting Glucose, a group of individuals without abnormal glucose tolerance or diabetes.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "NFG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SBP (Systolic Blood Pressure) is the pressure in your arteries when your heart beats.<SEP>SBP stands for Systolic Blood Pressure, the higher number in a blood pressure reading.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "SBP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DBP (Diastolic Blood Pressure) is the pressure in your arteries between heartbeats.<SEP>DBP stands for Diastolic Blood Pressure, the lower number in a blood pressure reading.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "DBP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2 h PG (2-hour Postglucose Plasma Glucose) measures blood glucose levels 2 hours after consuming a sugary drink.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "2 H PG"}, {"entity_type": "GROUP", "description": "The NGF group was designated as the control group in this study.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "NGF GROUP"}, {"entity_type": "GROUP", "description": "Three groups were designated as case groups based on their genetic variations.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "CASE GROUPS"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele variation represents a specific genetic change within the (CA) repeat region.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)15"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele variation represents a specific genetic change within the (CA) repeat region.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)17"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele variation represents a specific genetic change within the (CA) repeat region.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)18"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele variation represents a specific genetic change within the (CA) repeat region.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)19"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Individuals with IFG, IGT, and T2DM exhibit elevated blood glucose levels.)", "entity_type": "UNKNOWN", "id": "BLOOD GLUCOSE"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Individuals with IFG, IGT, and T2DM exhibit elevated blood glucose levels.)", "entity_type": "UNKNOWN", "id": "IFG, IGT, T2DM"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "The NFG group demonstrates normal blood glucose levels.)", "entity_type": "UNKNOWN", "id": "NORMAL BLOOD GLUCOSE"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Increased waist circumference is associated with poorer metabolic health.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 83}]", "id": "METABOLIC HEALTH"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The (CA)16 allele was not significantly associated with T2DM. )", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 36}]", "id": "(CA)16 ALLELE"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "These include (CA)15, (CA)17, (CA)18, and (CA)19.)", "entity_type": "UNKNOWN", "id": "MULTIPLE ALLELES"}, {"entity_type": "NUTRIENT", "description": "Selenium is an essential trace element that plays a role in various biological processes.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "SELENIUM"}, {"entity_type": "DISEASE", "description": "Colorectal cancer is a type of cancer that affects the colon or rectum.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "COLORECTAL CANCER"}, {"entity_type": "GENE", "description": "The GPX4 gene encodes an enzyme involved in selenium metabolism.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "GPX4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs8178974 is a specific genetic variant within the GPX4 gene.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "RS8178974"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The concentration of selenium in serum is an environmental factor that can influence health.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "SERUM SELENIUM CONCENTRATION"}, {"entity_type": "NUTRIENT", "description": "Dietary fiber is a type of carbohydrate that is not digested by the human body.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "DIETARY FIBER"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engaging in physical exercise and movement.<SEP>Physical activity refers to any bodily movement that requires energy expenditure.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "PHYSICAL ACTIVITY"}, {"entity_type": "DRUG", "description": "Hormone therapy used after menopause to manage symptoms and potential health risks.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "POSTMENOPAUSAL HORMONE"}, {"entity_type": "DRUG", "description": "Nonsteroidal anti-inflammatory drugs are used to relieve pain and reduce inflammation.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "NSAIDS"}, {"entity_type": "NUTRIENT", "description": "Calcium is a mineral essential for bone health, muscle function, and other bodily processes.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "CALCIUM"}, {"entity_type": "GENE", "description": "A gene whose absence leads to impaired IL-22 signaling pathway and increased colitis susceptibility.<SEP>CARD9 is a gene involved in immune responses.<SEP>Card9 is a gene involved in shaping the bacterial and fungal gut microbiota.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 12}]", "id": "CARD9"}, {"entity_type": "DISEASE", "description": "DSS-induced colitis is a type of inflammatory bowel disease induced by dextran sulfate sodium.<SEP>DSS-induced colitis refers to a mouse model of inflammatory bowel disease induced by dextran sulfate sodium.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 88}]", "id": "DSS-INDUCED COLITIS"}, {"entity_type": "GENOMIC VARIANT", "description": "WT mice are wild-type mice, serving as a control group in experiments.<SEP>WT mice refer to wild-type mice, with normal genotypes.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 88}]", "id": "WT MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "Card9\u2212/\u2212 mice are genetically modified mice lacking the Card9 gene.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 88}]", "id": "CARD9\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "Ki67 is a protein that acts as a marker for cell proliferation.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 117}]", "id": "KI67"}, {"entity_type": "PROTEIN", "description": "Cleaved caspase 3 is a protein marker for apoptosis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CLEAVED CASPASE 3"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DSS (Dextran Sulfate Sodium) is used to induce colitis in mice.<SEP>DSS (dextran sulfate sodium) is a chemical used to induce colitis in mice.<SEP>Dextran sulfate sodium (DSS) is an environmental factor that induces colitis.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 141}]", "id": "DSS"}, {"entity_type": "TRANSCRIPTOMIC DATA", "description": "The colonic transcriptome refers to the complete set of RNA transcripts expressed in the colon.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "COLONIC TRANSCRIPTOME"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway analyses are used to identify overrepresented biological pathways in a set of genes.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "PATHWAY ANALYSES"}, {"entity_type": "PROTEIN", "description": "REGIII-\u03b3 is an antimicrobial protein produced by intestinal epithelial cells.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REGENERATING ISLET-DERIVED 3 GAMMA (REG3G)"}, {"entity_type": "PROTEIN", "description": "REGIII-\u03b2 is an antimicrobial protein produced by intestinal epithelial cells.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REGENERATING ISLET-DERIVED 3 BETA (REG3B)"}, {"entity_type": "PROTEIN", "description": "IL-1\u03b2 is a proinflammatory cytokine involved in inflammatory responses.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "INTERLEUKIN 1BETA (IL1B)"}, {"entity_type": "GENE", "description": "A protein that can normalize AHR ligand production and colitis susceptibility.<SEP>IL-22 is a cytokine involved in immune responses, particularly in mucosal immunity.<SEP>IL-22 is a cytokine that promotes tissue repair and immune response against pathogens.<SEP>Interleukin-22 gene (rs1179251 C/G and rs2227485 C/T) polymorphisms", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "IL-22"}, {"entity_type": "CYTOKINE", "description": "IL-17A is a cytokine involved in immune responses.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-17A"}, {"entity_type": "IMMUNE CELL SUBSET", "description": "CD3\u2212CD4\u2212NKp46\u2212 cells are a subset of immune cells involved in various immune responses.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CD3\u2212CD4\u2212NKP46\u2212"}, {"entity_type": "MICROBIOTA", "description": "The fungal microbiota refers to the community of fungi residing in a particular environment.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "FUNGAL MICROBIOTA"}, {"entity_type": "MICROBIOTA", "description": "The bacterial microbiota refers to the community of bacteria residing in a particular environment.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "BACTERIAL MICROBIOTA"}, {"entity_type": "PHYLUM (FUNGI)", "description": "Ascomycota is a phylum of fungi encompassing a wide range of species.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ASCOMYCOTA"}, {"entity_type": "PHYLUM (FUNGI)", "description": "Basidiomycota is a phylum of fungi known for their characteristic fruiting bodies.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "BASIDIOMYCOTA"}, {"entity_type": "PHYLUM (FUNGI)", "description": "Zygomycota is a phylum of fungi characterized by their zygospores.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ZYGOMYCOTA"}, {"entity_type": "GENUS (BACTERIA)", "description": "Adlercreutzia is a genus of bacteria commonly found in the human gut.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ADLERCREUTZIA (GENUS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Card9 is a gene involved in the immune response.<SEP>Card9\u2212/\u2212 refers to mice with a knockout mutation in the Card9 gene.<SEP>Card9\u2212/\u2212 represents mice lacking the Card9 gene.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 3}]", "id": "CARD9\u2212/\u2212"}, {"entity_type": "MICROBE", "description": "Adlercreutzia is a genus of bacteria found in the gut microbiota.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 3}]", "id": "ADLERCREUTZIA"}, {"entity_type": "MICROBE", "description": "Lactobacillus reuteri is a species of bacteria known for its probiotic properties.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 3}]", "id": "LACTOBACILLUS REUTERI"}, {"entity_type": "GENETIC MODIFIER", "description": "GF refers to germ-free mice, raised in a sterile environment without any microbiota.<SEP>GF refers to germ-free mice, which lack any microbiota.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "GF"}, {"entity_type": "MICROBIOTA", "description": "Mice colonized with the microbiota of WT mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 140}]", "id": "WT\u2192GF"}, {"entity_type": "MICROBIOTA", "description": "Mice colonized with the microbiota of Card9\u2212/\u2212 mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 89}]", "id": "CARD9\u2212/\u2212\u2192GF"}, {"entity_type": "IMMUNE CELL TYPE", "description": "\u03b3\u03b4 T cells are a subset of T lymphocytes that play roles in both innate and adaptive immunity.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "\u0393\u0394 T CELLS"}, {"entity_type": "IMMUNE CELL TYPE", "description": "Dendritic cells reside in the intestinal tissue and are involved in antigen presentation and immune regulation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INTESTINAL DENDRITIC CELLS"}, {"entity_type": "CELL TYPE", "description": "Immune cells that engulf and destroy pathogens.<SEP>Macrophages are immune cells involved in inflammation and phagocytosis.<SEP>Macrophages are phagocytic cells that play roles in inflammation and tissue repair.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-29025895ac187b8e88dec5cea9478842<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "MACROPHAGES"}, {"entity_type": "CYTOKINE", "description": "IL-23 is a cytokine involved in the differentiation of Th17 cells.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-23"}, {"entity_type": "NUTRIENT", "description": "An essential amino acid that is metabolized by the gut microbiota and required for AHR activation.<SEP>Tryptophan is an essential amino acid involved in various metabolic processes.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "TRYPTOPHAN"}, {"entity_type": "METABOLITES", "description": "Indole derivatives are metabolites produced from tryptophan metabolism, including indole-3-acetic acid (IAA).", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 12}]", "id": "INDOLE DERIVATIVES"}, {"entity_type": "METABOLITE", "description": "IAA is an indole derivative and a ligand for the aryl hydrocarbon receptor (AHR).", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INDOLE-3-ACETIC ACID (IAA)"}, {"entity_type": "METABOLITE", "description": "A metabolite produced from tryptophan by IDO1, often elevated in IBD patients.<SEP>Kynurenine is a metabolite produced from tryptophan via the enzyme indoleamine 2,3-dioxygenase 1 (IDO1).", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "KYNURENINE (KYN)"}, {"entity_type": "ENZYME", "description": "An enzyme involved in tryptophan metabolism and Kyn production.<SEP>IDO1 is an enzyme involved in the metabolism of tryptophan.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1)"}, {"entity_type": "TRANSCRIPTION FACTOR", "description": "AHR (aryl hydrocarbon receptor) is a transcription factor that regulates gene expression in response to ligands like indole derivatives.<SEP>An aryl hydrocarbon receptor that regulates cellular responses to ligands such as tryptophan metabolites.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "AHR"}, {"entity_type": "BACTERIA", "description": "L. reuteri is a probiotic bacterium known to activate AHR.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "L. REUTERI"}, {"entity_type": "BACTERIA", "description": "Allobaculum sp. is a genus of bacteria found in the gut and capable of activating AHR.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "ALLOBACULUM SP."}, {"entity_type": "MOUSE MODEL", "description": "GF mice refers to germ-free mice, raised in a sterile environment without any microbiota.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "GF MICE"}, {"entity_type": "MOUSE MODEL", "description": "Card9\u2212/\u2212\u2192GF mice are germ-free mice with a knockout mutation in the Card9 gene.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "CARD9\u2212/\u2212\u2192GF MICE"}, {"entity_type": "MOUSE MODEL", "description": "WT\u2192GF mice are germ-free mice with normal genotypes.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "WT\u2192GF MICE"}, {"entity_type": "IMMUNE CELL TYPE", "description": "ILCs are innate lymphoid cells involved in immune responses.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "ILC\'S"}, {"entity_type": "CYTOKINE", "description": "IL-22 is a cytokine involved in immune responses, particularly in mucosal immunity.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 117}]", "id": "IL22"}, {"entity_type": "PROTEIN", "description": "Reg3g is a protein that plays a role in antimicrobial defense.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "REG3G"}, {"entity_type": "PROTEIN", "description": "Reg3b is a protein that plays a role in antimicrobial defense.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "REG3B"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The collection of microorganisms inhabiting the gut, which influence AHR activation and colitis susceptibility.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 12}]", "id": "GUT MICROBIOTA"}, {"entity_type": "DISEASE", "description": "A chronic condition involving inflammation of the gastrointestinal tract, encompassing Crohn\u2019s disease and ulcerative colitis.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IBD (INFLAMMATORY BOWEL DISEASE)"}, {"entity_type": "DISEASE", "description": "A type of IBD characterized by inflammation that affects any part of the digestive tract.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CROHN\'S DISEASE"}, {"entity_type": "METABOLITES", "description": "Molecules produced by the microbiota that bind to and activate AHR.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "AHR LIGANDS"}, {"entity_type": "METABOLITES", "description": "Products of microbial metabolism extracted from fecal samples.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "MICROBIOTA-DERIVED METABOLITES"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism within the CARD9 gene associated with IBD risk and reduced AHR activation.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CARD9 SNP (RS10781499)"}, {"entity_type": "GENE", "description": "A gene associated with IBD, whose variants were not found to be related to AHR activation in this study.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "NOD2"}, {"entity_type": "GENE", "description": "A gene associated with IBD, whose variants were not found to be related to AHR activation in this study.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "ATG16L1"}, {"entity_type": "GENE", "description": "A gene associated with IBD, whose variants were not found to be related to AHR activation in this study.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "LRRK2"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The CARD9 gene plays a role in mediating immune responses, particularly against pathogens.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 114}]", "id": "CARD9 GENE"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The CARD9 gene plays a role in mediating immune responses, particularly against pathogens.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 115}]", "id": "IMMUNE RESPONSE"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "REGIII-\u03b3 is an antimicrobial protein induced by IL-22, playing a role in immune defense.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 115}]", "id": "REG3G (ENCODING REGIII-\u0393)"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "REGIII-\u03b2 is an antimicrobial protein induced by IL-22, contributing to immune defense.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 115}]", "id": "REG3B (ENCODING REGIII-\u0392)"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "IL-1\u03b2 is a proinflammatory cytokine involved in inflammatory responses.)<SEP>Increased Il1b expression suggests enhanced inflammation in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "INFLAMMATION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Card9\u2212/\u2212 mice exhibit decreased expression of Il22, Reg3g, Reg3b, and Il17a.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 88}]", "id": "REDUCED IL-22 PRODUCTION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "IL-22+ cells are immune cells that produce IL-22.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 115}]", "id": "IL-22+ CELLS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The CD3\u2212CD4\u2212NKp46\u2212 subset is a type of immune cell that is reduced in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 115}]", "id": "CD3\u2212CD4\u2212NKP46\u2212 SUBSET"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The gut microbiota composition is altered in Card9\u2212/\u2212 mice, suggesting a role for CARD9 in shaping the microbiota.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 114}]", "id": "MICROBIOTA"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Decreased Ki67 staining indicates reduced epithelial cell proliferation in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 117}]", "id": "EPITHELIAL CELL PROLIFERATION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Increased cleaved caspase 3 staining indicates increased apoptosis in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "APOPTOSIS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "DSS administration induces colitis in mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 87}, {level: 2, cluster: 141}]", "id": "COLITIS INDUCTION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Comparing transcriptomes between WT and Card9\u2212/\u2212 mice revealed differentially expressed genes.)", "entity_type": "UNKNOWN", "id": "DIFFERENTIAL GENE EXPRESSION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Comparing transcriptomes between WT and Card9\u2212/\u2212 mice revealed differentially expressed genes.)", "entity_type": "UNKNOWN", "id": "TRANSCRIPTOMIC DATA ANALYSIS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Card9\u2212/\u2212 mice showed a dominance of immune-related pathways, indicating stronger immune activation.)", "entity_type": "UNKNOWN", "id": "IMMUNE-RELATED PATHWAYS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Expression of Reg3g is induced by IL-22, contributing to antimicrobial defense.)", "entity_type": "UNKNOWN", "id": "ANTIMICROBIAL DEFENSE"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "IL-22 has a protective role in colitis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 117}]", "id": "PROTECTIVE ROLE"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "IL-17A plays a protective role in colitis, working in concert with IL-22.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 117}]", "id": "IL17A"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The population of CD3\u2212CD4\u2212NKp46\u2212 cells is reduced in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "CD3\u2212CD4\u2212NKP46\u2212 CELLS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The population of CD3\u2212CD4\u2212NKp46\u2212 cells is reduced in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "REDUCED POPULATION"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Card9\u2212/\u2212 mice exhibit altered fungal microbiota composition and increased susceptibility to fungal infection.)", "entity_type": "UNKNOWN", "id": "DYSBIOSIS"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Ascomycota is one of the dominant phyla in the gut fungal microbiota of both WT and Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "DOMINANT FUNGAL PHYLA"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Card9\u2212/\u2212 mice show decreased abundance of Actinobacteria compared to WT mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 3}]", "id": "BACTERIAL DIVERSITY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "There is a negative correlation between bacterial and fungal biodiversity in WT mice, suggesting competition.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 3}]", "id": "BACTERIAL BIODIVERSITY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "Mice colonized with Card9\u2212/\u2212 microbiota show impaired recovery from DSS-induced epithelial damage.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 89}]", "id": "IMPAIRED RECOVERY FROM DSS-INDUCED INJURY"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "The gut microbiota modulates IL-22 production by T cells and ILCs in the colon.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 12}]", "id": "IL-22 PRODUCTION"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "The gut microbiota of Card9\u2212/\u2212 mice exhibits impaired tryptophan metabolism, leading to decreased AHR ligand production.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 88}]", "id": "TRYPTOPHAN METABOLISM"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "The gut microbiota influences AHR activation through the production of ligands like IAA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 12}]", "id": "AHR ACTIVATION"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of Ficz, an AHR agonist, reduces colitis severity in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "COLITIS SEVERITY"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of Ficz, an AHR agonist, reduces colitis severity in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "FICZ"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Supplementation with specific Lactobacillus strains rescues colitis susceptibility in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 12}]", "id": "COLITIS SUSCEPTIBILITY"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Supplementation with specific Lactobacillus strains rescues colitis susceptibility in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 12}]", "id": "LACTOBACILLUS STRAINS"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of exogenous IL-22 normalizes AHR ligand production and colitis susceptibility in Card9\u2212/\u2212 mice.)<SEP>IL-22 is involved in regulating the production of AHR ligands by the gut microbiota.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "AHR LIGAND PRODUCTION"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Mice lacking IL-22 exhibit alterations in their gut microbiota composition.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 114}]", "id": "IL22\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "\u03b22 microglobulin (\u03b22m) is a protein that associates with MHC class I molecules.<SEP>\u03b22M is a gene that plays a role in hypertension.<SEP>\u03b22m is a protein that associates with MHC molecules.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 19}]", "id": "\u03922M"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3184504 is a genetic variant associated with plasma \u03b22M levels and SH2B3 expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "RS3184504"}, {"entity_type": "GENE", "description": "SH2B3 is a gene whose expression influences \u03b22M levels.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3"}, {"entity_type": "DISEASE", "description": "High blood pressure, a cardiovascular condition.<SEP>Hypertension is a condition characterized by high blood pressure.<SEP>Hypertension is a cardiovascular risk factor associated with increased sUA levels and HUA risk in individuals carrying the ABCG2 rs2231142 T allele.<SEP>Hypertension is high blood pressure.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "HYPERTENSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Angiotensin II is a hormone that regulates blood pressure and fluid balance.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ANGIOTENSIN II"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Albuminuria refers to the presence of albumin in the urine, often indicating kidney damage.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ALBUMINURIA"}, {"entity_type": "NUTRIENT", "description": "LDL-cholesterol is a type of cholesterol associated with an increased risk of heart disease.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "LDL-CHOLESTEROL"}, {"entity_type": "NUTRIENT", "description": "HDL-cholesterol is a type of cholesterol associated with a decreased risk of heart disease.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "HDL-CHOLESTEROL"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "The rs3184504 polymorphism influences both SH2B3 expression and \u03b22M levels.)", "entity_type": "UNKNOWN", "id": "SH2B3 EXPRESSION"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Decreased SH2B3 expression is causally linked to higher \u03b22M levels.)", "entity_type": "UNKNOWN", "id": "\u03922M LEVELS"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Sh2b3\u2212/\u2212 mice exhibit increased \u03b22M expression in response to angiotensin II, suggesting SH2B3 normally constrains \u03b22M expression.)", "entity_type": "UNKNOWN", "id": "SH2B3 DEFICIENCY"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Sh2b3\u2212/\u2212 mice exhibit increased \u03b22M expression in response to angiotensin II, suggesting SH2B3 normally constrains \u03b22M expression.)", "entity_type": "UNKNOWN", "id": "\u03922M EXPRESSION"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "A metabolic disorder characterized by high blood glucose levels.<SEP>Diabetes is a metabolic disorder characterized by high blood sugar levels.<SEP>Diabetes is a risk factor for hypertension.)<SEP>A metabolic disorder characterized by high blood sugar levels.<SEP>Diabetes is a chronic condition characterized by high blood sugar levels.", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "DIABETES"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Smoking is a risk factor for hypertension.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "CIGARETTE SMOKING"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Statins may help lower blood pressure and reduce the risk of hypertension.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "STATIN USE"}, {"entity_type": "GENE", "description": "DHFR is a gene involved in folate metabolism.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "DHFR"}, {"entity_type": "GENE", "description": "MTHFD1 is a gene involved in folate metabolism.<SEP>The MTHFD1 gene encodes a protein with three enzyme activities: 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methylenetetrahydrofolate cyclohydrolase, and 10-formyltetrahydrofolate-synthetase.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1"}, {"entity_type": "GENE", "description": "MTHFR is a gene involved in folate metabolism.<SEP>The MTHFR gene contains the SNP rs1801133, which potentially influences folate levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR"}, {"entity_type": "GENE", "description": "SHMT1 is a gene involved in folate metabolism.<SEP>The SHMT1 gene encodes an enzyme that catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF).", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1"}, {"entity_type": "GENE", "description": "TYMS is a gene involved in DNA synthesis.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS"}, {"entity_type": "NUTRIENT", "description": "Folate is a nutrient involved in metabolism and is associated with male infertility.<SEP>Folate is a nutrient involved in various biological processes.<SEP>Folate is a nutrient measured in maternal serum and associated with birthweight.<SEP>Folate is an essential nutrient for cell growth and development.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "FOLATE"}, {"entity_type": "DISEASE", "description": "NTDs are birth defects of the brain and spinal cord.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "NTDS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFD1 gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS2236224"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFD1 gene.<SEP>The polymorphism rs2236225 in the MTHFD1 gene results in an ARG-653-GLN amino acid change and is associated with susceptibility to neural tube defects.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS2236225"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFD1 gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS11627387"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFR gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS1476413"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFR gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS1801131"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the MTHFR gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS1801133"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the SHMT1 gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS669340"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the SHMT1 gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS12939757"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the TYMS gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS502396"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the TYMS gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS699517"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) located in the TYMS gene.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "RS2847153"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Infants with CT genotype in MTHFD1 SNPs rs2236224 and rs2236225 had a 1.5-fold increased risk of NTDs when folate intake was low.)", "entity_type": "UNKNOWN", "id": "LOW FOLATE INTAKE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Infants with CT genotype in MTHFD1 SNPs rs2236224 and rs2236225 had a 1.5-fold increased risk of NTDs when folate intake was low.)", "entity_type": "UNKNOWN", "id": "MTHFD1 SNPS RS2236224, RS2236225"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The AG genotype in MTHFD1 SNP rs11627387 was associated with a four-fold increase in NTD risk when maternal folate intake was low.)", "entity_type": "UNKNOWN", "id": "LOW MATERNAL FOLATE INTAKE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The AG genotype in MTHFD1 SNP rs11627387 was associated with a four-fold increase in NTD risk when maternal folate intake was low.)", "entity_type": "UNKNOWN", "id": "MTHFD1 SNP RS11627387 AG GENOTYPE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Mothers with heterozygous MTHFR SNPs had a decreased risk of NTD-affected pregnancies compared to those with common homozygous genotypes when folate intake was low.)", "entity_type": "UNKNOWN", "id": "MTHFR SNPS RS1476413, RS1801131, AND RS1801133 IN HETEROZYGOUS MOTHERS"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "A maternal gene-only effect for SHMT1 SNP rs669340 CG genotype appeared to be associated with a reduced risk of NTDs.)", "entity_type": "UNKNOWN", "id": "REDUCED RISK OF NTDS"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "A maternal gene-only effect for SHMT1 SNP rs669340 CG genotype appeared to be associated with a reduced risk of NTDs.)", "entity_type": "UNKNOWN", "id": "SHMT1 SNP RS669340 CG GENOTYPE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "An interaction effect was observed for risk of NTDs in infants with the SHMT1 SNP rs12939757 AG genotype that were in the low folate intake group compared to those with the AA genotype that were in the high folate intake group.)", "entity_type": "UNKNOWN", "id": "SHMT1 SNP RS12939757 AG GENOTYPE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The gene-folate interaction was associated with a reduced risk of NTDs for mothers in the low folate intake group with TYMS SNP rs502396 or rs699517 heterozygous genotype compared to the high folate intake group.)", "entity_type": "UNKNOWN", "id": "TYMS SNPS RS502396 OR RS699517 HETEROZYGOUS GENOTYPE"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The interaction effect in infants was also protective for risk for SNP rs2847153 (OR[int GG vs. AG] = 0.73, 80% CI: 0.37, 1.45 (LRT P = 0.14)).)", "entity_type": "UNKNOWN", "id": "TYMS SNP RS2847153 AG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS10399931"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS4950928"}, {"entity_type": "GENE", "description": "The CHI3LI gene is associated with Type 2 Diabetes.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "CHI3LI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "C-peptide is a hormone released by the pancreas in response to insulin secretion.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "SERUM C-PEPTIDE CONCENTRATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS12123883"}, {"entity_type": "DATASET", "description": "The Inter99 cohort is a dataset of individuals with and without T2D.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "INTER99"}, {"entity_type": "ORGANIZATION", "description": "The Steno Diabetes Center is a medical institution specializing in diabetes research.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "STENO DIABETES CENTER"}, {"entity_type": "PATIENT GROUP", "description": "Individuals diagnosed with Type 2 Diabetes.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "T2D PATIENTS"}, {"entity_type": "DIAGNOSTIC TEST", "description": "A test to assess blood sugar regulation.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "NORMAL GLUCOSE TOLERANCE TEST"}, {"entity_type": "DISEASE", "description": "Elevated blood glucose levels after a period of fasting.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED FASTING GLUCOSE (IFG)"}, {"entity_type": "DISEASE", "description": "Difficulty regulating blood glucose levels after consuming glucose.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"entity_type": "STATISTICAL ANALYSIS", "description": "A statistical method that adjusts for multiple factors.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "MULTIADJUSTED ASSOCIATION"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "Measurable characteristics related to health, such as BMI and C-peptide levels.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "QUANTITATIVE TRAITS"}, {"entity_type": "GENETIC VARIATION", "description": "Regions of DNA linked together during inheritance.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "HAPLOTYPE BLOCKS"}, {"entity_type": "GENE", "description": "CFH is a gene associated with AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFH"}, {"entity_type": "GENOMIC VARIANT", "description": "The Y402H CFH genomic variant is a risk factor for AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "Y402H CFH"}, {"entity_type": "GENOMIC VARIANT", "description": "The A69S genomic variant is a risk factor for AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "A69S"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs641153 (CFB/C2) genomic variant is associated with increased odds of AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS641153 (CFB/C2)"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs10033900 (CFI) genomic variant did not show a main effect on AMD in the CAREDS study.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS10033900 (CFI)"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2230199 (C3) genomic variant did not show a main effect on AMD in the CAREDS study.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS2230199 (C3)"}, {"entity_type": "DISEASE", "description": "AMD (Age-related Macular Degeneration) is a disease affecting the macula, a part of the retina responsible for central vision.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "AMD"}, {"entity_type": "DIETARY PATTERN", "description": "The Healthy Lifestyle Score (HLS) is a measure of dietary and lifestyle factors.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"entity_type": "DIETARY PATTERN", "description": "Stable diets are defined as those with consistent eating habits over time.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "STABLE DIETS"}, {"entity_type": "NUTRIENT", "description": "Omega-3 fatty acids are essential fatty acids known to have various health benefits.<SEP>Omega-3 fatty acids are supplements that can help reduce triglycerides.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "OMEGA-3 FATTY ACIDS"}, {"entity_type": "GENE", "description": "ARMS2 is a gene associated with AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "ARMS2"}, {"entity_type": "METABOLIC PATHWAY", "description": "LZ refers to levels of lutein, zeaxanthin, and other carotenoids in the macula and serum. It\'s involved in ocular health.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "LZ"}, {"entity_type": "GENE", "description": "ARMS2 is a gene involved in AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "ARMS2 GENE"}, {"entity_type": "DIETARY PATTERN", "description": "A healthy lifestyle score is a measure that considers dietary habits and other lifestyle factors.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "HEALTHY LIFESTYLE SCORE"}, {"entity_type": "DISEASE", "description": "Age-related macular degeneration (AMD) is a common eye disease that can lead to vision loss.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "AMD RISK"}, {"entity_type": "GENOMIC VARIANT", "description": "C3 rs2230199 is a specific genetic variant within the C3 gene.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "C3 RS2230199"}, {"entity_type": "GENOMIC VARIANT", "description": "CFI rs10033900 is a specific genetic variant within the CFI gene.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "CFI RS10033900"}, {"entity_type": "STATISTICAL MEASURE", "description": "The synergy index is a statistical measure used to assess the interaction between two risk factors.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "SYNERGY INDEX"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Women with two copies of the Y402H CFH risk allele had 2.4 times greater odds of AMD compared to those with zero copies.)", "entity_type": "UNKNOWN", "id": "CFH GENOTYPE (Y402H)"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Women with two copies of the A69S CFH risk allele had 2.2 times greater odds of AMD compared to those with zero copies.)", "entity_type": "UNKNOWN", "id": "A69S CFH GENOTYPE"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Women with low HLS scores had higher odds of AMD compared to those with high scores.)", "entity_type": "UNKNOWN", "id": "LOW HLS"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "The joint effect of both a high-risk CFH genotype and low HLS was more than additive, increasing the odds of AMD.)", "entity_type": "UNKNOWN", "id": "HIGH-RISK CFH GENOTYPE (CC)"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Better status for LZ partially explained the association between HLS and AMD in women with the high risk CC genotype.)", "entity_type": "UNKNOWN", "id": "CFH GENOTYPE (CC)"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Women with at least one ARMS2 risk allele and low HLS had higher odds of AMD compared to those with zero risk alleles and high HLS.)", "entity_type": "UNKNOWN", "id": "ARMS2 RISK ALLELES"}, {"source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "description": "Variants in the complement pathway genes CFB and C2 have been associated with AMD risk, although the main effects were not significant in this study.)", "entity_type": "UNKNOWN", "id": "CFB/C2"}, {"source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "description": "CFB and C2 are genes involved in the complement pathway.)", "entity_type": "UNKNOWN", "id": "COMPLEMENT PATHWAY GENES"}, {"entity_type": "GENE", "description": "ACAD10 is a gene located in chromosome 12q24 and associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "ACAD10"}, {"entity_type": "GENE", "description": "CUX2 is a gene located in chromosome 12q24 and associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "CUX2"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2074356 is a SNP located in the HECTD4 gene and associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS2074356"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11066015 is a SNP located in the ACAD10 gene and associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS11066015"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12229654 is a SNP located in the MYL2 gene and associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 67}, {level: 2, cluster: 135}]", "id": "RS12229654"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11065828 is an imputed SNP associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 43}]", "id": "RS11065828"}, {"entity_type": "GENOMIC VARIANT", "description": "rs79105258 is an imputed SNP associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 43}]", "id": "RS79105258"}, {"entity_type": "DIETARY PATTERN", "description": "Black coffee refers to coffee without added sugar and is associated with a lower risk of prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 76}]", "id": "BLACK COFFEE"}, {"entity_type": "DIETARY PATTERN", "description": "Sugared coffee refers to coffee with added sugar and is associated with a lower risk of prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 76}]", "id": "SUGARED COFFEE"}, {"entity_type": "DISEASE", "description": "Prediabetes is a condition characterized by elevated blood sugar levels but not high enough to be diagnosed as type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 76}]", "id": "PREDIABETES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Alcohol consumption can have both positive and negative health effects.<SEP>Alcohol consumption can influence health outcomes.<SEP>Alcohol is an addictive substance that can cause craving, sedation, and stimulation.<SEP>Alcohol is an intoxicating substance consumed as a beverage and metabolized by the body.<SEP>The consumption of alcoholic beverages can have various health effects, including increased risk of certain diseases.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6<SEP>chunk-2c91cdebb36ef064eb01a7021a961302<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "ALCOHOL"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant form of a gene that is less common.<SEP>The minor allele refers to the less frequent variant of a genetic marker, such as an SNP.", "source_id": "chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-f05ecc979eea31a1ab844c2c7de12432", "id": "MINOR ALLELE"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "rs11065828 is an imputed SNP associated with coffee consumption.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 43}]", "id": "COFFEE CONSUMPTION"}, {"entity_type": "GENE", "description": "SENP1 gene is deficient in SENP1-aP2KO mice.<SEP>SENP1 is a gene involved in SUMOylation and its deletion affects adipocyte differentiation and cytokine production.<SEP>SENP1 is a gene involved in diabetes pathogenesis.<SEP>SENP1 is a gene involved in various cellular functions.<SEP>SENP1 is a gene involved in various cellular processes, including immune regulation and inflammation. It plays a role in the development of type 1 diabetes (T1DM).<SEP>SENP1 is a gene that encodes for a protein involved in ubiquitination processes.<SEP>SENP1 is a gene that plays a role in regulating NF-\u03baB activation and cytokine production in adipocytes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 107}]", "id": "SENP1"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Adipoq-Cre is a genetic tool used to drive gene expression in mature adipocytes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOQ-CRE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "PdgfR\u03b1-Cre is a genetic tool used to drive gene expression in bipotent progenitor adipocytes (white and beige adipocytes).", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PDGFR\u0391-CRE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "aP2-Cre is a genetic tool used to drive gene expression in adipocytes, with variable efficiency in macrophages or capillary endothelium.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "AP2-CRE"}, {"entity_type": "DISEASE", "description": "SENP1-AdipoqKO is a genetically modified mouse model with deletion of SENP1 specifically in adipocytes.<SEP>SENP1-AdipoqKO mice exhibit type-1-like diabetes mellitus.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "SENP1-ADIPOQKO"}, {"entity_type": "DISEASE", "description": "SENP1-PdgfRKO mice exhibit type-1-like diabetes mellitus.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "SENP1-PDGFRKO"}, {"entity_type": "DISEASE", "description": "SENP1-aP2KO is a genetically modified mouse model lacking expression of SENP1 in adipocyte-specific tissues.<SEP>SENP1-aP2KO is a genetically modified mouse model with deletion of SENP1 specifically in adipocytes.<SEP>SENP1-aP2KO mice exhibit type-1-like diabetes mellitus.<SEP>SENP1-aP2KO mice have a deletion of the SENP1 gene specifically in adipocytes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "SENP1-AP2KO"}, {"entity_type": "DISEASE", "description": "Ctrl mice are the control group in these experiments.<SEP>Ctrl refers to control group mice that are not genetically modified or treated with any experimental interventions.<SEP>Ctrl refers to control group mice that lack the SENP1-aP2KO genetic modification.<SEP>Ctrl represents a control group where no siRNA was transfected.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "CTRL"}, {"entity_type": "DISEASE", "description": "T1DM is type 1 diabetes mellitus, an autoimmune disease characterized by insulin deficiency.<SEP>Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by destruction of insulin-producing pancreatic beta cells.<SEP>Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas.<SEP>Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by insulin deficiency.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "T1DM"}, {"entity_type": "TISSUE", "description": "A type of fat tissue found between the shoulder blades.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INTERSCAPULAR BROWN ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "A type of fat tissue located around the reproductive organs.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERIGONADAL WHITE ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "A type of fat tissue surrounding the pancreas.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERI-PANCREATIC ADIPOSE TISSUE (PAT)"}, {"entity_type": "TISSUE STRUCTURE", "description": "Clusters of hormone-producing cells in the pancreas.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PANCREATIC ISLETS"}, {"entity_type": "TISSUE STRUCTURE", "description": "Clusters of hormone-producing cells in the pancreas.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ISLETS"}, {"entity_type": "NUTRIENT", "description": "Glucose is a primary energy source for cells.<SEP>The primary source of energy for the body.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The concentration of glucose in the bloodstream.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "BLOOD GLUCOSE LEVEL"}, {"entity_type": "CELL TYPE", "description": "Cells that surround and support blood vessels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SMOOTH MUSCLE CELLS/PERICYTES"}, {"entity_type": "CELL TYPE", "description": "Cells that line the inner surface of blood vessels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "VASCULAR ENDOTHELIAL CELLS"}, {"entity_type": "PROTEIN", "description": "A cell adhesion molecule expressed in vascular endothelial cells.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "VE-CADHERIN"}, {"entity_type": "PROTEIN", "description": "A marker protein for smooth muscle cells.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SM22\u0391"}, {"entity_type": "DISEASE", "description": "Insulin-dependent diabetes mellitus is an autoimmune disease characterized by T-cell-mediated destruction of insulin-producing pancreatic islet \u03b2 cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "INSULIN-DEPENDENT DIABETES MELLITUS"}, {"entity_type": "CELL TYPE", "description": "\u03b2 cells are the insulin-producing cells in pancreatic islets.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "PANCREATIC ISLET \u0392 CELLS"}, {"entity_type": "CELL TYPE", "description": "A subtype of T lymphocytes involved in cytotoxic immunity.<SEP>A type of immune cell that plays a role in the adaptive immune response.<SEP>CD8+ T cells are immune cells that target islet-specific glucose-6-phosphatase catalytic subunit-related protein.<SEP>Cytotoxic CD8+ T cells attack and destroy pancreatic islet \u03b2 cells.<SEP>CD8+ T cells are a type of immune cell that recognize antigens presented by MHC molecules.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 58}]", "id": "CD8+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "A subtype of T lymphocytes involved in cell-mediated immunity.<SEP>A type of immune cell that plays a role in the adaptive immune response.<SEP>Helper CD4+ T cells play a role in coordinating immune responses.<SEP>T helper cells that express the CD4 surface marker.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "CD4+ T CELLS"}, {"entity_type": "ANTIBODY", "description": "Autoantibodies, such as IAA, are directed against \u03b2 cells in autoimmune diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN AUTOANTIBODY (IAA)"}, {"entity_type": "BIOMARKER", "description": "Elevated CRP levels are associated with inflammation and diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "CRP (C-REACTIVE PROTEIN)"}, {"entity_type": "METABOLIC PRODUCT", "description": "\u03b2-hydroxybutyrate is a ketone body produced during diabetic ketoacidosis.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "\u0392-HYDROXYBUTYRATE"}, {"entity_type": "IMMUNE CELL SUBSET", "description": "Th1 cells are pro-inflammatory T helper cells that produce IFN-\u03b3.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "TH1 CELLS"}, {"entity_type": "CELL TYPE", "description": "Tregs are a subset of T cells that suppress immune responses and maintain self-tolerance.<SEP>Tregs suppress immune responses and maintain tolerance.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "REGULATORY T CELLS (TREGS)"}, {"entity_type": "IMMUNE CELL", "description": "Dendritic cells present antigens to T cells and initiate immune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "DENDRITIC CELLS"}, {"entity_type": "PROTEIN", "description": "NRP-V7 is an autoantigen targeted by CD8+ T cells in type 1 diabetes.<SEP>NRP-V7 is an autoantigen targeted by CD8+ T cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "NRP-V7"}, {"entity_type": "CONTROL GROUP", "description": "Ctrl mice serve as a control group for comparison with SENP1-deficient mice.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "CTRL MICE"}, {"entity_type": "STRAIN OF MICE", "description": "BALB/C mice were used as the source for skin transplantation.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "BALB/C MICE"}, {"entity_type": "LYMPHOID TISSUE", "description": "Pancreatic lymph nodes are involved in immune responses within the pancreas.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "PANCREATIC LYMPH NODES"}, {"entity_type": "LYMPHOID ORGAN", "description": "The spleen is a major lymphoid organ involved in immune function.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "SPLEEN"}, {"entity_type": "IMMUNE CELL SUBSET", "description": "Macrophages expressing MHCII, CD11b, and lacking CD11c are involved in immune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "MHCII+CD11B+CD11C\u2212 MACROPHAGES"}, {"entity_type": "PROTEIN", "description": "Islet-specific glucose-6-phosphatase catalytic subunit-related protein is a peptide target for CD8+ T cells.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN"}, {"entity_type": "SIGNAL MOLECULE", "description": "Cytokines are signaling molecules involved in inflammation and immune responses.<SEP>Small proteins secreted by immune cells that mediate communication between cells.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CYTOKINES"}, {"entity_type": "CELLULAR COMPONENT", "description": "Pancreatic \u03b2 cells are insulin-producing cells in the pancreas.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC \u0392 CELLS"}, {"entity_type": "DISEASE", "description": "Cardiac myocarditis is inflammation of the heart muscle.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CARDIAC MYOCARDITIS"}, {"entity_type": "TISSUE", "description": "PATs are a specific type of adipose tissue located around the pancreas.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)"}, {"entity_type": "TISSUE", "description": "Subcutaneous adipose tissue is adipose tissue located beneath the skin.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SUBCUTANEOUS ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Inguinal adipose tissue is a type of subcutaneous adipose tissue located in the groin area.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "INGUINAL ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Gonadal adipose tissue is adipose tissue located in the gonads.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "GONADAL ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Peri-renal adipose tissue is adipose tissue located around the kidneys.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PERI-RENAL ADIPOSE TISSUE"}, {"entity_type": "CYTOKINE", "description": "CCL5 is a chemokine that attracts immune cells to sites of inflammation.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CCL5 (RANTES)"}, {"entity_type": "RECEPTOR", "description": "CCR5 is a receptor for CCL5.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CCR5"}, {"entity_type": "CELLULAR COMPONENT", "description": "Islet \u03b2 cells are pancreatic cells responsible for insulin production.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLET \u0392 CELLS"}, {"entity_type": "GENETIC MODEL", "description": "SENP1-aP2KO mice are a genetic model with a deletion in the SENP1 gene.<SEP>SENP1-aP2KO mice are a genetically modified mouse model with deletion of SENP1 specifically in adipocytes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP1-AP2KO MICE"}, {"entity_type": "PROCESS", "description": "Immune cell expansion refers to the proliferation and increase in numbers of immune cells.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IMMUNE CELL EXPANSION"}, {"entity_type": "PROCESS", "description": "Immunological destruction is the damage to tissues or cells by the immune system.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IMMUNOLOGICAL DESTRUCTION"}, {"entity_type": "PROCESS", "description": "Systemic autoimmune responses involve the immune system attacking various parts of the body.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SYSTEMIC AUTOIMMUNE RESPONSES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Insulin deficiency is a lack of sufficient insulin production, leading to high blood sugar levels.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "INSULIN DEFICIENCY"}, {"entity_type": "PROCESS", "description": "Cytokine overproduction refers to the excessive release of cytokines by immune cells.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CYTOKINE OVERPRODUCTION"}, {"entity_type": "PROCESS", "description": "Immune tolerance break is the failure of the immune system to distinguish self from non-self, leading to autoimmune responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IMMUNE TOLERANCE BREAK"}, {"entity_type": "CYTOKINE", "description": "TNF (Tumor Necrosis Factor) is a proinflammatory cytokine produced by adipocytes and contributes to inflammation.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "TNF"}, {"entity_type": "CHEMOKINE", "description": "CCL5 (chemokine ligand 5) is a chemokine that attracts immune cells to the pancreas.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "CCL5"}, {"entity_type": "CELL TYPE", "description": "\u03b2 cells are pancreatic cells responsible for insulin production.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "\u0392 CELL"}, {"entity_type": "CELL TYPE", "description": "Adipocytes are fat cells.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "ADIPOCYTE"}, {"entity_type": "ENZYME", "description": "Fatty acid synthase is an enzyme involved in fatty acid synthesis, a key process in adipocyte differentiation.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "FATTY ACID SYNTHASE"}, {"entity_type": "ENZYME", "description": "Adipose triglyceride lipase is an enzyme that breaks down triglycerides stored in adipose tissue.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "ADIPOSE TRIGLYCERIDE LIPASE"}, {"entity_type": "ENZYME", "description": "Lipoprotein lipase is an enzyme involved in the hydrolysis of triglycerides from lipoproteins, delivering fatty acids to tissues.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "LIPOPROTEIN LIPASE"}, {"entity_type": "PROTEIN", "description": "IKK (I\u03baB kinase) is a protein involved in the NF-\u03baB signaling pathway.<SEP>IKK (I\u03baB kinase) is a protein kinase that phosphorylates I\u03baB\u03b1, leading to NF-\u03baB activation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "IKK"}, {"entity_type": "PROTEIN", "description": "I\u03baB\u03b1 (Inhibitor of \u03baB alpha) is a protein that binds to and inhibits NF-\u03baB.<SEP>I\u03baB\u03b1 (inhibitor of \u03baB alpha) is a protein that inhibits NF-\u03baB activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "I\u039aB\u0391"}, {"entity_type": "PROTEIN", "description": "ERK1/2 (Extracellular signal-regulated kinases 1 and 2) are proteins involved in various cellular signaling pathways, including those regulating cell growth and differentiation.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "ERK1/2"}, {"entity_type": "TRANSCRIPTION FACTOR", "description": "NF-\u03baB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor that regulates the expression of genes involved in inflammation and immune responses.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "NF-\u039aB"}, {"entity_type": "GENOMIC VARIANT", "description": "siRNA is a short interfering RNA molecule used to knockdown gene expression.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SIRNA"}, {"entity_type": "PROTEIN", "description": "NF-\u03baB p65/RelA is a subunit of the NF-\u03baB transcription factor.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NF-\u039aB P65/RELA"}, {"entity_type": "PROTEIN", "description": "IL-1\u03b2 (Interleukin 1 beta) is a proinflammatory cytokine.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "IL-1 \u0392"}, {"entity_type": "GENE", "description": "SENP2 is a gene encoding for an enzyme involved in SUMOylation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP2"}, {"entity_type": "PROTEIN", "description": "NEMO (NF-\u03baB essential modulator) is a subunit of the IKK complex and involved in NF-\u03baB activation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO"}, {"entity_type": "PROTEIN", "description": "SUMO1 (Small ubiquitin-like modifier 1) is a protein that can be conjugated to other proteins, influencing their activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SUMO1"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Etoposide VP16 is a chemotherapy drug that induces DNA damage.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "ETOPOSIDE VP16"}, {"entity_type": "DISEASE", "description": "NOD mice are a genetically susceptible mouse strain used as a model for type 1 diabetes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NON-OBESE DIABETIC (NOD) MICE"}, {"entity_type": "PROTEIN", "description": "Flag-NEMO is a fusion protein of NEMO tagged with the Flag epitope for purification and detection.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "FLAG-NEMO"}, {"entity_type": "PROTEIN", "description": "WT NEMO refers to the normal, unmodified form of the NEMO protein.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "WILD TYPE (WT) NEMO"}, {"entity_type": "PROTEIN", "description": "NEMO K277R is a mutant form of NEMO where lysine at position 277 is replaced with arginine, preventing SUMOylation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO K277R"}, {"entity_type": "PROTEIN", "description": "NEMO K309R is a mutant form of NEMO where lysine at position 309 is replaced with arginine, preventing SUMOylation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO K309R"}, {"entity_type": "PROTEIN", "description": "NEMO DM refers to a mutant form of NEMO with both lysine 277 and 309 replaced with arginine, resulting in inability to be SUMOylated.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO DOUBLE MUTANT (DM)"}, {"entity_type": "DISEASE", "description": "NOD mouse is a genetic strain of mice susceptible to developing type 1 diabetes, used as a model for studying the disease.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "NOD MOUSE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Proinflammatory cytokines are signaling molecules involved in inflammation and immune responses. Their levels are elevated in T1DM.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 107}]", "id": "PROINFLAMMATORY CYTOKINES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "\u03b2-cell apoptosis is the programmed death of beta cells in the pancreas, a hallmark of T1DM.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "\u0392-CELL APOPTOSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Islet disruption refers to damage or dysfunction of the pancreatic islets, where insulin is produced.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ISLET DISRUPTION"}, {"entity_type": "DRUG", "description": "JSH-23 is an inhibitor of NF-\u03baB activation used in research studies.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 107}]", "id": "JSH-23"}, {"entity_type": "DIETARY PATTERN", "description": "High Fat Diet (HFD) is a dietary intervention used in the study.<SEP>High-Fat Diet (HFD) is a dietary pattern characterized by high intake of fat, often associated with obesity and metabolic disorders.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 104}]", "id": "HFD"}, {"entity_type": "CELL TYPE", "description": "Adipocytes are cells specialized in storing fat.<SEP>Adipocytes are fat cells that store energy.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ADIPOCYTES"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "Perigonadal Adipose Tissue (PATs) is a type of adipose tissue studied in the context of metabolic health.<SEP>Perigonadal adipose tissue (PAT) is a type of fat found around the gonads.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 42}]", "id": "PATS"}, {"entity_type": "CELL TYPE", "description": "Islet-reactive T cells are immune cells that target and destroy insulin-producing beta cells in the pancreas.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 143}]", "id": "ISLET-REACTIVE T CELLS"}, {"entity_type": "PROTEIN", "description": "Preproinsulin is the precursor molecule to insulin, synthesized and processed by beta cells.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "PREPROINSULIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune tolerance refers to the body\'s ability to recognize and not attack its own tissues.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "IMMUNE TOLERANCE"}, {"entity_type": "PHYSIOLOGICAL STATE", "description": "\u03b2-cell rest is a state of reduced activity and stress in beta cells, potentially induced by insulin administration.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "\u0392-CELL REST"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Metabolic stress refers to cellular dysfunction caused by imbalances in nutrient metabolism.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "METABOLIC STRESS"}, {"entity_type": "TISSUE", "description": "Epididymal fat is a type of adipose tissue located near the epididymis.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "EPIDIDYMAL FAT"}, {"entity_type": "PROTEIN", "description": "Adipose Tissue-Specific Protein 2 (aP2) is a marker for adipocytes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "AP2"}, {"entity_type": "ASSAY", "description": "Insulin Tolerance Test (ITT) is used to assess insulin sensitivity in animals.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "INSULIN RESISTANCE TEST (ITT)"}, {"entity_type": "TISSUE", "description": "The liver is an organ responsible for many metabolic functions, including glucose regulation.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "LIVER"}, {"source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "The GTT measures the ability of an individual to clear glucose from their bloodstream. Elevated blood glucose levels after a glucose challenge indicate hyperglycemia.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 105}]", "id": "GLUCOSE TOLERANCE TEST (GTT)"}, {"source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "The ITT measures the sensitivity to insulin. Impaired response to insulin indicates insulin resistance.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 104}]", "id": "INSULIN TOLERANCE TEST (ITT)"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "SENP1 deficient mice develop type-1-like diabetic phenotypes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 107}]", "id": "TYPE-1-LIKE DIABETIC PHENOTYPES"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "SENP1 deficient mice show autoimmune mediated damages and develop insulin-dependent diabetes mellitus.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "SENP1-DEFICIENT MICE"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Immune cell invasion, indicative of insulitis, damages pancreatic islet \u03b2 cells.)", "entity_type": "UNKNOWN", "id": "IMMUNE CELL INVASION"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Loss of function in the \u03b2 cell, indicated by decreased insulin staining, contributes to diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 108}]", "id": "\u0392 CELL DEATH"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "SENP1-aP2KO mice exhibited elevated levels of IAA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "IAA"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "In SENP1-aP2KO mice, Tregs populations decreased in the pancreatic lymph nodes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "TREGS"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "In SENP1-aP2KO mice, NRP-V7-positive CD8+ T cells were detected targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 97}, {level: 2, cluster: 142}]", "id": "NRP-V7-POSITIVE CD8+ T CELLS"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Both Ctrl and SENP1-aP2KO mice exhibited similar skin rejection responses, indicating SENP1-aP2KO mice are not immunodeficient.)", "entity_type": "UNKNOWN", "id": "SKIN TRANSPLANTATION"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Analysis of immune cell populations in pancreatic lymph nodes revealed changes associated with autoimmune responses in SENP1-deficient mice.)", "entity_type": "UNKNOWN", "id": "IMMUNE CELL ANALYSIS"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "SENP1 deletion in adipocytes increases the secretion of IL-6, contributing to inflammation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}, {level: 1, cluster: 118}]", "id": "SENP1-AP2KO ADIPOCYTES"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "CCL5 expression induced by SENP1-aP2KO adipocytes attracts immune cells to the pancreas.)", "entity_type": "UNKNOWN", "id": "IMMUNE CELL RECRUITMENT"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SENP1 knockdown in adipocytes led to significantly higher expression of proinflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2.)", "entity_type": "UNKNOWN", "id": "PROINFLAMMATORY CYTOKINE EXPRESSION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SENP1 knockdown in adipocytes led to significantly higher expression of proinflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2.)", "entity_type": "UNKNOWN", "id": "SENP1 KNOCKDOWN"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Overexpression of SENP1 decreased phospho-p65/RelA and cytokine production in adipocytes.)", "entity_type": "UNKNOWN", "id": "PHOSPHO-P65/RELA AND CYTOKINE PRODUCTIONS"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Overexpression of SENP1 decreased phospho-p65/RelA and cytokine production in adipocytes.)", "entity_type": "UNKNOWN", "id": "SENP1 OVEREXPRESSION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Deletion of SENP1 resulted in increased NEMO SUMOylation in adipocytes.)", "entity_type": "UNKNOWN", "id": "NEMO SUMOYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Deletion of SENP1 resulted in increased NEMO SUMOylation in adipocytes.)", "entity_type": "UNKNOWN", "id": "SENP1 DELETION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Etoposide VP16 induced phosphorylation of IKK and p65/RelA in adipocytes.)", "entity_type": "UNKNOWN", "id": "DNA DAMAGE AGENT ETOPOSIDE VP16"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Etoposide VP16 induced phosphorylation of IKK and p65/RelA in adipocytes.)", "entity_type": "UNKNOWN", "id": "IKK AND P65/RELA ACTIVATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Deletion of SENP1 enhanced both basal and stress-induced IKK and p65/RelA activation in adipocytes.)", "entity_type": "UNKNOWN", "id": "STRESS-INDUCED IKK AND P65/RELA ACTIVATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Deletion of SENP1 also enhanced both basal and stress-induced NEMO SUMOylation in adipocytes.)", "entity_type": "UNKNOWN", "id": "STRESS-INDUCED NEMO SUMOYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SUMO-deficient NEMO mutants (K277R, K309R, and DM) decreased NF-\u03baB p65/RelA phosphorylation.)", "entity_type": "UNKNOWN", "id": "NEMO K309R OR NEMO DM MUTANTS"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SUMO-deficient NEMO mutants (K277R, K309R, and DM) decreased NF-\u03baB p65/RelA phosphorylation.)", "entity_type": "UNKNOWN", "id": "NF-\u039aB P65/RELA PHOSPHORYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "NEMO SUMOylation mutants affected the protein expression of proinflammatory cytokines in adipocytes.)", "entity_type": "UNKNOWN", "id": "NEMO MUTATIONS"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Knockdown of SENP1 increased the phosphorylation of I\u03baB\u03b1.)", "entity_type": "UNKNOWN", "id": "I\u039aB\u0391 PHOSPHORYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Expression of WT NEMO slightly increased NF-\u03baB p65/RelA phosphorylation.)", "entity_type": "UNKNOWN", "id": "NEMO-WT"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Deletion of SENP1 enhances both basal and stress-induced IKK and p65/RelA activation in adipocytes, suggesting a role in inflammatory responses.)", "entity_type": "UNKNOWN", "id": "INFLAMMATORY STIMULI"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "High Fat Diet (HFD) significantly increased cytokine production, particularly IL-6, TNF-\u03b1 and IL-1\u03b2 in PATs of SENP1-aP2KO mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 104}]", "id": "CYTOKINE PRODUCTION"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "SENP1-aP2KO mice exhibited significantly reduced basal and glucose-stimulated insulin levels compared to Ctrl mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 106}]", "id": "INSULIN LEVELS"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "High Fat Diet (HFD) increased body weight in SENP1-aP2KO mice compared to their counterparts on a standard chow diet.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 104}]", "id": "BODY WEIGHT"}, {"entity_type": "GENOMIC VARIANT", "description": "FokI is a genomic variant (rs2228570 or rs10735810) that has been associated with an increased risk of ovarian cancer.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "FOKI"}, {"entity_type": "GENOMIC VARIANT", "description": "ApaI (rs7975232) is a genomic variant that was evaluated for its association with ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "APAI"}, {"entity_type": "GENOMIC VARIANT", "description": "BsmI (rs1544410) is a genomic variant that was investigated for its association with ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "BSMI"}, {"entity_type": "GENOTYPE", "description": "CC carriers refer to individuals homozygous for the C allele of the FokI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "CC CARRIERS"}, {"entity_type": "GENOTYPE", "description": "CT carriers refer to individuals heterozygous for the T and C alleles of the FokI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "CT CARRIERS"}, {"entity_type": "GENOTYPE", "description": "TT carriers refer to individuals homozygous for the T allele of the FokI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "TT CARRIERS"}, {"entity_type": "GENOTYPE", "description": "TG carriers refer to individuals heterozygous for the G and T alleles of the ApaI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "TG CARRIERS"}, {"entity_type": "GENOTYPE", "description": "GG carriers refer to individuals homozygous for the G allele of the ApaI variant.<SEP>GG carriers refer to individuals homozygous for the G allele of the BsmI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "GG CARRIERS"}, {"entity_type": "GENOTYPE", "description": "GA carriers refer to individuals heterozygous for the A and G alleles of the BsmI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "GA CARRIERS"}, {"entity_type": "GENOTYPE", "description": "AA carriers refer to individuals homozygous for the A allele of the BsmI variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "AA CARRIERS"}, {"entity_type": "GENE", "description": "CDX-2 is a gene studied for its potential association with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "CDX-2"}, {"entity_type": "GENOMIC VARIANT", "description": "The TaqI variant (rs731236) has been investigated for its potential role in ovarian cancer susceptibility.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "TAQI"}, {"entity_type": "GENOMIC VARIANT", "description": "AA/GA genotype refers to carriers of either the A allele or two copies of it.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "AA/GA"}, {"entity_type": "GENOMIC VARIANT", "description": "GG genotype refers to having two copies of the alternative allele for a particular SNP.<SEP>GG genotype refers to individuals carrying two copies of the G allele.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "GG"}, {"entity_type": "STATISTICAL MEASURE", "description": "CI stands for Confidence Interval, a range of values within which the true population parameter is likely to fall.<SEP>Confidence Interval (CI) represents a range within which the true value of the population parameter likely falls.<SEP>Confidence Interval (CI) indicates the range of values within which the true population parameter likely falls.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-7091ed039203b69ad83d281b22c89579<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "CI"}, {"entity_type": "GROUP", "description": "A case refers to an individual diagnosed with a specific disease or condition, in this context, ovarian cancer.<SEP>Individuals diagnosed with breast cancer.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CASE"}, {"entity_type": "GROUP", "description": "A control is an individual without the disease or condition being studied, used for comparison.<SEP>Individuals without breast cancer, used for comparison.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CONTROL"}, {"source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "description": "Individuals with the AA/GA genotype have a potentially increased risk of ovarian cancer compared to those with the GG genotype.)", "entity_type": "UNKNOWN", "id": "AA/GA VS. GG"}, {"source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "description": "The Odds Ratio (OR) quantifies the strength of association between genetic variants and the risk of developing ovarian cancer.)", "entity_type": "UNKNOWN", "id": "RISK"}, {"entity_type": "GENE", "description": "VDR is a gene encoding the Vitamin D Receptor, involved in regulating calcium homeostasis and immune function.<SEP>VDR is a gene that codes for the vitamin D receptor.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "id": "VDR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs731236 is a single nucleotide polymorphism (SNP) in the VDR gene.<SEP>rs731236 is a specific SNP within the VDR gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS731236"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7975232 is a single nucleotide polymorphism (SNP) in the VDR gene.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS7975232"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1544410 is a single nucleotide polymorphism (SNP) in the VDR gene.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS1544410"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2228570 is a single nucleotide polymorphism (SNP) in the VDR gene.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS2228570"}, {"entity_type": "DISEASE", "description": "T. cruzi is a parasite that causes Chagas disease.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "T. CRUZI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Seronegative refers to individuals who lack antibodies against T. cruzi.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "SERONEGATIVE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Seropositive refers to individuals who have antibodies against T. cruzi.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "SEROPOSITIVE"}, {"entity_type": "DISEASE", "description": "CCC (Chagas Cardiomyopathy) is a heart condition caused by chronic infection with T. cruzi.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "CCC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Asymptomatic refers to individuals who show no symptoms of disease.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "ASYMPTOMATIC"}, {"source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "description": "The allele frequency of rs2228570 differed significantly between seronegative and seropositive individuals, suggesting a possible protective effect against infection.)", "entity_type": "UNKNOWN", "id": "INFECTION BY T. CRUZI"}, {"entity_type": "GENOMIC VARIANT", "description": "IL-1A -889C>T is a genomic variant associated with Herniated Nucleus Pulposus (HNP) risk.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A -889C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "TNF-A 238G>A is a genomic variant studied for its association with Herniated Nucleus Pulposus (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A 238G>A"}, {"entity_type": "GENOMIC VARIANT", "description": "VDR TaqI is a genomic variant investigated for its potential role in Herniated Nucleus Pulposus (HNP) susceptibility.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "VDR TAQI"}, {"entity_type": "DISEASE", "description": "Herniated Nucleus Pulposus (HNP) is a condition involving the protrusion of the nucleus pulposus, often resulting in pain and neurological symptoms.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "HERNIATED NUCLEUS PULPOSUS (HNP)"}, {"entity_type": "GENE", "description": "IL-1A is a gene encoding for Interleukin 1 Alpha, a pro-inflammatory cytokine.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A"}, {"entity_type": "GENE", "description": "TNF-A is a gene encoding Tumor Necrosis Factor Alpha, a pro-inflammatory cytokine.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800587 is a specific SNP within the IL-1A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "RS1800587"}, {"entity_type": "GENOMIC VARIANT", "description": "rs361525 is a specific SNP within the TNF-A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "RS361525"}, {"entity_type": "GENOMIC VARIANT", "description": "The \'C\' allele at rs4988235 is associated with non-persistence of lactase.<SEP>The C allele refers to one variant of the IL-1A -889C>T polymorphism.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "C ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "The \'T\' allele at rs4988235 is associated with lactase persistence.<SEP>The T allele refers to another variant of the IL-1A -889C>T polymorphism.<SEP>The T allele was slightly lower in CRC patients compared to the control group.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "T ALLELE"}, {"entity_type": "ALLELE", "description": "The G allele refers to one variant of the TNF-A 238G>A polymorphism.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "G ALLELE"}, {"entity_type": "ALLELE", "description": "The A allele refers to another variant of the TNF-A 238G>A polymorphism.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "A ALLELE"}, {"entity_type": "DISEASE", "description": "A group of individuals who are not infected with HIV.)<SEP>A group of individuals who do not have CD and are used as a comparison to CD subjects.<SEP>Healthy controls are individuals who do not have Herniated Nucleus Pulposus (HNP).<SEP>Individuals without Crohn\'s disease used as a comparison group.<SEP>Healthy controls are individuals without a diagnosed medical condition who serve as a comparison group.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-3c66ee37333cba1e51a2bdc729038b68<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "HEALTHY CONTROLS"}, {"entity_type": "GROUP", "description": "HNP patients are individuals diagnosed with Herniated Nucleus Pulposus.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "HNP PATIENTS"}, {"entity_type": "PROFESSION", "description": "Orthonpaedic surgeons specialize in the diagnosis and treatment of musculoskeletal disorders, including HNP.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "ORTHONPAEDIC SURGEONS"}, {"entity_type": "NUTRIENT", "description": "B12 is a nutrient measured in maternal serum and associated with birthweight.<SEP>Vitamin B12 is a nutrient essential for cellular function and metabolism.<SEP>Vitamin B12 is a nutrient involved in metabolism and is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-22216738ccbae0a6276bb4499018c434", "id": "B12"}, {"entity_type": "GENE", "description": "The FUT2 gene, also known as rs602662, has an association with B12 levels and birthweight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FUT2"}, {"entity_type": "GENE", "description": "The MMACHC gene, represented by rs12272669 and a proxy rs11234541, is associated with B12 levels during pregnancy.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MMACHC"}, {"entity_type": "STATISTICAL METHOD", "description": "Inverse Variance Weighted (IVW) analysis used to estimate causal effects of B12 and folate levels on birthweight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "IVW ANALYSIS"}, {"entity_type": "STUDY TYPE", "description": "EFSOCH study provided data on B12 and folate levels in pregnant women.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "EFSOCH STUDY"}, {"entity_type": "PHENOTYPE", "description": "Birthweight is a measured outcome variable, influenced by maternal and fetal factors.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "BIRTHWEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gestational duration refers to the length of pregnancy.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "GESTATIONAL DURATION"}, {"entity_type": "STATISTICAL METHOD", "description": "MR Egger is a statistical method used in Mendelian Randomization to estimate causal effects.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "MR EGGER"}, {"entity_type": "STATISTICAL METHOD", "description": "Inverse Variance Weighted (IVW) analysis is a statistical method used in Mendelian Randomization to estimate causal effects.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "IVW"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Maternal B12 levels were not causally associated with offspring birthweight.)", "entity_type": "UNKNOWN", "id": "B12 LEVELS (MATERNAL)"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Maternal folate levels had a positive causal effect on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "FOLATE LEVELS (MATERNAL)"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Fetal folate levels had a negative causal effect on their own birthweight, although smaller than the maternal folate effect.)", "entity_type": "UNKNOWN", "id": "FOLATE LEVELS (FETAL)"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The GWAS identified 10 variants associated with serum B12 levels and 4 variants associated with serum folate levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 23}]", "id": "VARIANTS (SNPS)"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The GWAS investigated the association between genetic variants and maternal serum B12 levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 23}]", "id": "SERUM B12 LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The GWAS investigated the association between genetic variants and maternal serum folate levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 23}]", "id": "SERUM FOLATE LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The identified SNPs explained a proportion of variance in serum B12 concentrations.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 23}]", "id": "B12 LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The identified SNPs explained a portion of the variation in serum folate concentration.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 23}]", "id": "FOLATE LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The IVW analysis assessed the causal effect of maternal B12 levels on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "MATERNAL B12 LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The IVW analysis assessed the causal effect of fetal B12 levels on their own birthweight.)", "entity_type": "UNKNOWN", "id": "FETAL B12 LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The IVW analysis assessed the causal effect of maternal folate levels on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "MATERNAL FOLATE LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The IVW analysis assessed the causal effect of fetal folate levels on their own birthweight.)", "entity_type": "UNKNOWN", "id": "FETAL FOLATE LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Supplemental analyses were conducted to validate and strengthen the findings from the IVW analysis.)", "entity_type": "UNKNOWN", "id": "IVW RESULTS"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "There is no evidence of a causal effect of maternal folate levels on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "MATERNAL FOLATE"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "There is no evidence of a causal effect of maternal folate levels on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "OFFSPRING BIRTHWEIGHT"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "There is no evidence of a causal effect of maternal B12 levels on offspring birthweight.)", "entity_type": "UNKNOWN", "id": "MATERNAL B12"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "There is no evidence of a causal effect of fetal B12 levels on gestational duration.)", "entity_type": "UNKNOWN", "id": "FETAL B12"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "There is no evidence of a causal effect of fetal folate levels on gestational duration.)", "entity_type": "UNKNOWN", "id": "FETAL FOLATE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MTHFR gene associated with cardiovascular disease risk.<SEP>MTHFR C677T is a genomic variant associated with increased risk of venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR C677T"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MTHFR gene associated with cardiovascular disease risk.<SEP>MTHFR A1298C is a genomic variant associated with increased risk of venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR A1298C"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the PAI\u20101 gene associated with cardiovascular disease risk.<SEP>PAI\u20101 \u2010675 4G/5G is a genomic variant associated with increased risk of venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI\u20101 \u2010675 4G/5G"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the PAI\u20101 gene associated with cardiovascular disease risk.<SEP>PAI\u20101 A844G is a genomic variant.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI\u20101 A844G"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the Prothrombin gene associated with cardiovascular disease risk.<SEP>Prothrombin G20210A is a genomic variant associated with increased risk of venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PROTHROMBIN G20210A"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the Factor V gene associated with cardiovascular disease risk.<SEP>Factor V G1691A is a genomic variant associated with increased risk of venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "FACTOR V G1691A"}, {"entity_type": "DISEASE", "description": "Left Ventricular (LV) patients is a group of individuals with cardiovascular issues.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "LV PATIENTS"}, {"entity_type": "DISEASE", "description": "A patient diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE), collectively known as venous thromboembolism (VTE).", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "id": "LV PATIENT"}, {"source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "description": "25 out of 129 LV patients tested positive for the homozygous TT genotype.)", "entity_type": "UNKNOWN", "id": "HOMOZYGOUS CARRIER"}, {"source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "description": "29 out of 82 LV patients tested positive for the AC genotype.)", "entity_type": "UNKNOWN", "id": "HETEROZYGOUS CARRIER"}, {"entity_type": "GENOMIC VARIANT", "description": "The PEMT M175V variant is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "PEMT M175V"}, {"entity_type": "GENOMIC VARIANT", "description": "The TCblR rs173665 variant is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "TCBLR RS173665"}, {"entity_type": "GENOMIC VARIANT", "description": "The MTHFR 677C>T variant was not associated with male infertility in this study population.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MTHFR 677C>T"}, {"entity_type": "METABOLIC PROCESS", "description": "Homocysteine (tHcy) is a metabolite involved in metabolism and is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "THCY"}, {"entity_type": "DISEASE", "description": "Infertile men are characterized by poorer semen quality compared to fertile men.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "INFERTILE MEN"}, {"entity_type": "POPULATION", "description": "Fertile controls are a comparison group with good semen quality.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "FERTILE CONTROLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Semen concentration refers to the number of sperm cells per unit volume of semen.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SEMEN CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sperm number refers to the total count of sperm cells in a semen sample.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SPERM NUMBER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total progressive sperm refers to the percentage of sperm cells that are actively moving forward in a straight line.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "TOTAL PROGRESSIVE SPERM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Normal sperm morphology refers to the structural integrity and shape of sperm cells.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "NORMAL SPERM MORPHOLOGY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Non-motile sperm are sperm cells that lack the ability to move.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "NON-MOTILE SPERM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Semen volume refers to the total amount of semen produced in a ejaculation.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SEMEN VOLUME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DNA fragmentation refers to damage to the DNA within sperm cells.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "DNA FRAGMENTATION"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "Homozygosity for the PEMT M175V minor V allele was positively associated with male infertility.)", "entity_type": "UNKNOWN", "id": "MALE INFERTILITY"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "Infertile men exhibit significantly lower semen quality compared to fertile controls.)", "entity_type": "UNKNOWN", "id": "POORER SEMEN QUALITY"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "Infertile subjects had a lower mean semen concentration compared to fertile controls.)", "entity_type": "UNKNOWN", "id": "INFERTILE SUBJECTS"}, {"entity_type": "GENOMIC VARIANT", "description": "The polymorphism rs1979277 in the SHMT1 gene is associated with an increased risk of TMD.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1979277"}, {"entity_type": "PROTEIN", "description": "The Leu435Phe amino acid change, caused by the rs1979277 polymorphism, may affect the function of the SHMT1 enzyme.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "LEU435PHE"}, {"entity_type": "GENOMIC VARIANT", "description": "The polymorphism rs638416 in the promoter region (5\'-UTR) of the SHMT1 gene is associated with an increased risk of TMD.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS638416"}, {"entity_type": "GENE", "description": "The GSTM1 gene encodes mu-class glutathione S-transferase, which detoxifies electrophilic compounds.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1"}, {"entity_type": "GENOMIC VARIANT", "description": "The GSTM1-null polymorphism is a deletion of the GSTM1 gene and is associated with an increased risk of cancer and male infertility.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1-NULL"}, {"entity_type": "GENE", "description": "The MTRR gene encodes an enzyme responsible for the regeneration of Methionine Synthase (MTR).", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "MTRR"}, {"entity_type": "GENOMIC VARIANT", "description": "The polymorphism rs1801394 in the MTRR gene results in an Ile22Met amino acid change and is associated with a reduced enzyme affinity for its substrate.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1801394"}, {"entity_type": "GENE", "description": "The DRD4 gene encodes the dopamine D4 receptor.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4"}, {"entity_type": "GENOMIC VARIANT", "description": "The DRD4-48bptr polymorphism is a 48-bp VNTR in exon 3 of the DRD4 gene and can be characterized as S-DRD4 (2 to 5 repetitions) or L-DRD4 (6 or more repetitions).", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4-48BPTR"}, {"entity_type": "NUTRIENT", "description": "Tetrahydrofolate (THF) is a coenzyme involved in one-carbon metabolism.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "TETRAHYDROFOLATE (THF)"}, {"entity_type": "NUTRIENT", "description": "5,10-methylenetetrahydrofolate (5,10-CH2-THF) is a form of THF involved in pyrimidine synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pyrimidine synthesis is the pathway for creating pyrimidine nucleotides, essential components of DNA and RNA.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "PYRIMIDINE"}, {"entity_type": "PROTEIN", "description": "Methionine Synthase (MTR) is an enzyme that catalyzes the conversion of homocysteine to methionine.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "METHIONINE SYNTHASE (MTR)"}, {"entity_type": "MOLECULE", "description": "SAM (S-adenosylmethionine) is a methyl donor used by MTR in the conversion of homocysteine to methionine.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "SAM (S-ADENOSYLMETHIONINE)"}, {"entity_type": "METABOLIC PRODUCT", "description": "Thymidylate is a nucleotide involved in DNA synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "THYMIDYLATE"}, {"entity_type": "METABOLIC PRODUCT", "description": "Purines are nucleotides essential for both DNA and RNA synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "PURINES"}, {"entity_type": "MOLECULE", "description": "Glutathione is a tripeptide that plays a critical role in antioxidant defense.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GLUTAATHIONE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Electrophilic compounds can be harmful to cells, requiring detoxification by enzymes like GSTM1.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "ELECTROPHILIC COMPOUNDS"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The SHMT1 enzyme catalyzes the conversion of serine to glycine.)", "entity_type": "UNKNOWN", "id": "SERINE"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The SHMT1 enzyme catalyzes the conversion of serine to glycine.)", "entity_type": "UNKNOWN", "id": "GLYCINE"}, {"entity_type": "METHODOLOGY", "description": "The CDC MBA is a method for measuring serum folate.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC MBA"}, {"entity_type": "METHODOLOGY", "description": "The CDC HPLC-MS/MS method measures serum folate with high precision.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC HPLC-MS/MS"}, {"entity_type": "NUTRIENT", "description": "5-methylTHF is a form of folate used as a calibrator in some laboratories.<SEP>5-methyltetrahydrofolate (5-methylTHF) is a biologically active form of folate.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "5-METHYLTHF"}, {"entity_type": "NUTRIENT", "description": "Folic acid is a common dietary form of folate and can be converted into 5-methylTHF.<SEP>Folic acid is a form of folate used as a calibrator in some laboratories.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "FOLIC ACID"}, {"entity_type": "MICROORGANISM", "description": "L. rhamnosus is a type of bacteria used in some laboratory assays.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "L. RHAMNOSUS"}, {"entity_type": "CULTURE MEDIA", "description": "This medium was used by all laboratories for culturing microorganisms.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "FOLIC ACID CASEI MEDIUM"}, {"entity_type": "STATISTICAL MEASURE", "description": "The Pearson correlation coefficient measures the strength and direction of a linear relationship between two variables.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "PEARSON CORRELATION"}, {"entity_type": "SAMPLE TYPE", "description": "Serum samples were analyzed to determine folate concentrations.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "SERUM SAMPLES"}, {"entity_type": "MEASUREMENT ERROR", "description": "Imprecision refers to the variation in results obtained from repeated measurements of the same sample.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "IMPRECISION"}, {"entity_type": "ANALYTICAL TOOL", "description": "A calibration curve is used to quantify the relationship between signal intensity and analyte concentration.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CALIBRATION CURVE"}, {"entity_type": "ANALYTICAL TECHNIQUE", "description": "Spectrophotometry measures the absorption or transmission of light through a sample.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "SPECTROPHOTOMETRY"}, {"entity_type": "MICROORGANISM VARIANT", "description": "Laboratory #3 used the wild-type strain of L. rhamnosus for their assay.)<SEP>The wild-type strain is the natural form of an organism.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "WILD-TYPE STRAIN"}, {"entity_type": "MICROORGANISM VARIANT", "description": "A chloramphenicol-resistant strain can grow in the presence of the antibiotic chloramphenicol.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CHLORAMPHENICOL-RESISTANT STRAIN"}, {"entity_type": "ORGANIZATION", "description": "The ATCC is a biological resource center that provides microorganisms and cell lines.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "AMERICAN TYPE CULTURE COLLECTION (ATCC)"}, {"entity_type": "ORGANIZATION", "description": "The NCIMB is a culture collection for industrial, food, and agricultural microorganisms.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "NATIONAL COLLECTION OF INDUSTRIAL, FOOD AND AGRICULTURAL MICROORGANISMS (NCIMB)"}, {"entity_type": "NUTRIENT", "description": "S-FOL is a form of folate.<SEP>S-FOL is a form of folic acid.<SEP>S-FOL refers to serum folate, a measure of the amount of folate in the blood.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "S-FOL"}, {"entity_type": "NUTRIENT", "description": "WB-FOL is a form of folate.<SEP>WB-FOL refers to whole-blood folate, a measure of the amount of folate in the blood.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "WB-FOL"}, {"entity_type": "METABOLIC PATHWAY", "description": "The CDC MBA target value is a reference standard for folate measurement.<SEP>The CDC MBA target value represents a standard reference point for serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC MBA TARGET VALUE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The day of the week potentially influenced serum and whole-blood folate measurements, with Day 1 showing lower results compared to Day 2.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "DAY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Different microorganisms used in laboratory assays may have influenced serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "MICROORGANISM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #2 exhibited a clear microorganism effect on serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #2"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #3 showed a microorganism effect on whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #3"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #4 exhibited a microorganism effect on serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #4"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #6 showed a significant deviation from the CDC MBA target value for both S-FOL and WB-FOL.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #6"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #7 exhibited minimal variation in serum and whole-blood folate measurements across different conditions.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #7"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #8 showed a clear calibrator effect on serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #8"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Laboratory #9 exhibited a clear calibrator effect on serum and whole-blood folate measurements.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY #9"}, {"entity_type": "DISEASE", "description": "Group 1 laboratories are those using CDC reagents and are compared to the CDC MBA target value.<SEP>Group 1 laboratories used the 5-methylTHF calibrator.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "GROUP 1 LABORATORIES"}, {"entity_type": "DISEASE", "description": "Group 2 laboratories are those using folic acid calibrator and are compared to the CDC MBA target value.<SEP>Group 2 laboratories used the folic acid calibrator.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "GROUP 2 LABORATORIES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "CDC reagents are used in laboratories for folate analysis.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC REAGENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "IH reagents are used in laboratories for folate analysis.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "IH REAGENTS"}, {"source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "description": "Different laboratories showed varying levels of imprecision when measuring serum folate.)", "entity_type": "UNKNOWN", "id": "LABORATORIES"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "The use of IH reagents (IH-CAL) compared to CDC reagents (CDC-CAL) resulted in significant differences in serum and whole-blood folate measurements.)", "entity_type": "UNKNOWN", "id": "CDC-CAL"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "The use of IH reagents (IH-CAL) compared to CDC reagents (CDC-CAL) resulted in significant differences in serum and whole-blood folate measurements.)", "entity_type": "UNKNOWN", "id": "IH-CAL"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "Comparison of laboratories using IH reagents (IH-MO) versus those using CDC reagents (CDC-MO) revealed varying effects on serum and whole-blood folate.)", "entity_type": "UNKNOWN", "id": "CDC-MO"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "Comparison of laboratories using IH reagents (IH-MO) versus those using CDC reagents (CDC-MO) revealed varying effects on serum and whole-blood folate.)", "entity_type": "UNKNOWN", "id": "IH-MO"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "Group 2 laboratories use a folic acid calibrator for folate analysis.)", "entity_type": "UNKNOWN", "id": "FOLIC ACID CALIBRATOR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1695 is a polymorphism associated with an increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1695"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1138272 is a polymorphism not associated with an increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1138272"}, {"entity_type": "GENOMIC VARIANT", "description": "The Ile105Val SNP is a single nucleotide polymorphism affecting the GSTP1 protein.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL"}, {"entity_type": "DISEASE", "description": "Breast cancer is a malignant tumor originating in the breast tissue.<SEP>Breast cancer is a type of cancer affecting the breast tissue.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "BREAST CANCER"}, {"entity_type": "STATISTICAL CONCEPT", "description": "A principle describing the expected distribution of alleles in a population.<SEP>A principle describing the expected genotype frequencies in a population that is not evolving.<SEP>A principle stating that allele and genotype frequencies in a population will remain constant from generation to generation if certain evolutionary influences are not working on them.<SEP>A principle in population genetics stating that allele and genotype frequencies remain constant from generation to generation.<SEP>Hardy-Weinberg equilibrium is a principle describing the genetic makeup of a population that is not evolving.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-54c4fede216a6c4183b95ee1a2edcb17<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "HARDY-WEINBERG EQUILIBRIUM"}, {"entity_type": "DNA SEQUENCE", "description": "A variant form of a gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE"}, {"entity_type": "STATISTIC", "description": "The p-value represents the statistical significance of an observation, indicating the probability of obtaining the observed results by chance.<SEP>The probability of observing the results obtained if there were no association between the genetic variant and the disease.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "P-VALUE"}, {"source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "description": "The GSTP1 gene encodes glutathione S-transferase pi, an enzyme involved in detoxification.<SEP>The Ile105Val SNP affects the function of the GSTP1 protein.)", "entity_type": "GENE", "id": "GSTP1"}, {"entity_type": "GENOMIC VARIANT", "description": "p.R778L is a pathogenic variant associated with three haplogroups (A, B, C).<SEP>p.R778L is a pathogenic variant in the WD gene.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.R778L"}, {"entity_type": "GENOMIC VARIANT", "description": "p.P992L is a pathogenic variant in the WD gene.<SEP>p.P992L is another pathogenic variant, associated with six haplogroups (D, E, F, G, H, I).", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.P992L"}, {"entity_type": "GENOMIC VARIANT", "description": "p.T935M is a pathogenic variant in the WD gene.<SEP>p.T935M presented a uniform state, with only one kind of haplogroup (J) found on WD chromosomes.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.T935M"}, {"entity_type": "GENE", "description": "WD is a gene associated with Wilson disease (a genetic disorder).", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "WD"}, {"entity_type": "DISEASE", "description": "Wilson disease is a genetic disorder characterized by copper accumulation.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "WILSON DISEASE"}, {"entity_type": "GENOMIC VARIANT", "description": "Haplogroup A was found to be the most common haplogroup associated with p.R778L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP A"}, {"entity_type": "GENOMIC VARIANT", "description": "Haplogroup E was more common on WD chromosomes for the p.P992L variant.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP E"}, {"entity_type": "GENOMIC VARIANT", "description": "Haplogroup J consists of two variants (J1 and J2) and is associated with p.T935M.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP J"}, {"entity_type": "GENOMIC VARIANT", "description": "WD chromosomes are a specific type of chromosome associated with a particular genetic condition.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "WD CHROMOSOMES"}, {"entity_type": "GENOMIC VARIANT", "description": "Control chromosomes serve as a comparison group to analyze the distribution of pathogenic variants.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "CONTROL CHROMOSOMES"}, {"entity_type": "GENOMIC VARIANT", "description": "Haplotype variant A1 (10-7-7) is a specific subvariant within Haplogroup A.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOTYPE VARIANT A1"}, {"entity_type": "GENOMIC VARIANT", "description": "A group of genomic variants, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, and CYP2C9*11, reduce CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*2, *3, *5, *8, AND *11"}, {"entity_type": "GENE", "description": "CYP2C9 is a gene that encodes for an enzyme involved in warfarin metabolism.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9"}, {"entity_type": "DRUG", "description": "Warfarin is a medication used to prevent blood clots.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "WARFARIN"}, {"entity_type": "DISEASE", "description": "Deep vein thrombosis (DVT) and pulmonary embolism (PE) are conditions characterized by blood clots.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "DVT/PE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs1799853) associated with CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1799853"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs1057910) associated with CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1057910"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs28371686) associated with CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371686"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs7900194) associated with CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS7900194"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs28371685) associated with CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371685"}, {"entity_type": "ALGORITHM", "description": "An algorithm that utilizes CYP2C9 genotype to predict warfarin dose.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9 PHARMACOGENOMICS ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "An algorithm that uses clinical variables to predict warfarin dose.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "IWPC CLINICAL ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "A novel algorithm designed to predict warfarin dose based on both genetic and clinical factors.<SEP>A novel algorithm for predicting drug doses, specifically designed to improve accuracy in African American populations.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1<SEP>chunk-b2730f3087aee6d9cff6e4939b229323", "id": "AA ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "Algorithms developed by the Institute for Work and Personal Care (IWPC), used for pharmacogenomics and clinical dose prediction.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC ALGORITHMS"}, {"entity_type": "PATIENT GROUP", "description": "Patients who received high doses of medication, serving as a test group for algorithm performance.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "HIGH DOSE GROUP"}, {"entity_type": "FIELD", "description": "The study of how genes affect an individual\'s response to medications.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PHARMACOGENOMICS"}, {"entity_type": "ALGORITHM", "description": "An algorithm used in clinical practice for dose prediction, based on factors like patient history and medical conditions.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "CLINICAL ALGORITHM"}, {"entity_type": "MEASUREMENT", "description": "Actual doses of medication administered to patients.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "OBSERVED DOSES"}, {"entity_type": "PREDICTION", "description": "Estimated doses of medication calculated by algorithms.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PREDICTED DOSES"}, {"entity_type": "METRIC", "description": "A measure of the average difference between predicted and observed doses, indicating algorithm accuracy.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "MAE (MEAN ABSOLUTE ERROR)"}, {"entity_type": "METRIC", "description": "The number of patients who need to be genotyped to prevent one incorrect dose prediction.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "NNG (NUMBER NEEDED TO GENOTYPE)"}, {"entity_type": "RANGE", "description": "A specific range within which medication doses are considered safe and effective.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "THERAPEUTIC DOSE RANGE"}, {"entity_type": "GENETIC ANCESTRY", "description": "The proportion of an individual\'s genetic heritage originating from West Africa.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "WAA (WEST AFRICAN ANCESTRY)"}, {"entity_type": "GENE", "description": "CYP24A1 is a gene that encodes an enzyme involved in vitamin D metabolism.<SEP>The CYP24A1 gene is involved in vitamin D metabolism.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a<SEP>chunk-1327975b50e4a0aac1792cb595041ee5", "id": "CYP24A1"}, {"entity_type": "GENE", "description": "CYP27B1 is a gene that encodes an enzyme involved in vitamin D synthesis.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs927650 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "RS927650"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35051736 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS35051736"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2296241 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "RS2296241"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2762939 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS2762939"}, {"entity_type": "NUTRIENT", "description": "1,25-dihydroxyvitamin D [1,25(OH)2D] is the active form of vitamin D.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "1,25(OH)2D"}, {"entity_type": "DISEASE", "description": "Adenoma recurrence refers to the reappearance of colorectal adenomas after initial removal.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADENOMA RECURRENCE"}, {"entity_type": "DISEASE", "description": "Advanced adenoma recurrence refers to the reappearance of advanced colorectal adenomas, which have a higher risk of progressing to cancer.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADVANCED ADENOMA RECURRENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "CC genotype refers to having two copies of the reference allele for a particular SNP.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "CC"}, {"entity_type": "GENOMIC VARIANT", "description": "TT genotype refers to having two copies of the alternative allele for a particular SNP.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "TT"}, {"entity_type": "GENOMIC VARIANT", "description": "AG genotype refers to having one copy of the reference allele and one copy of the alternative allele for a particular SNP.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "AG"}, {"entity_type": "DISEASE", "description": "Villous histology refers to a type of colorectal adenoma characterized by finger-like projections lining the colon wall.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "VILLOUS HISTOLOGY"}, {"entity_type": "GENOMIC VARIANT", "description": "The c.428_430delAAG variant is a deletion mutation in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.428_430DELAAG"}, {"entity_type": "GENOMIC VARIANT", "description": "The c.1186C\u2009>\u2009T variant is a substitution mutation in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.1186C\u2009>\u2009T"}, {"entity_type": "MOLECULAR INTERACTION", "description": "HRMA (High-Resolution Melting Analysis) is a molecular technique used to detect and genotype genetic variations.<SEP>High-Resolution Melting Analysis (HRMA) is a technique used to detect and genotype genetic variations.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 145}]", "id": "HRMA"}, {"entity_type": "ASSAY", "description": "A duplex assay allows for the simultaneous amplification and analysis of two different target sequences in one reaction.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "DUPLEX ASSAY"}, {"entity_type": "DATA", "description": "A melting profile represents the change in fluorescence or absorbance of a DNA sample as temperature increases.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 144}]", "id": "MELTING PROFILE"}, {"entity_type": "DATA", "description": "Tm (melting temperature) is the temperature at which half of the DNA molecules are melted.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "TM"}, {"entity_type": "DATA", "description": "A Temperature-shifted and Different Plot visualizes melting curves at different temperatures.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "TEMPERATURE-SHIFTED AND DIFFERENT PLOT"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "description": "HRMA is performed on DNA samples to analyze their genetic variations.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 145}]", "id": "DNA"}, {"entity_type": "GENOMIC VARIANT", "description": "A novel mutation in the ATP7A gene, P1001L, was found in the patient.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "P1001L"}, {"entity_type": "GENE", "description": "The ATP7A gene is involved in copper transport and metabolism.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATP7A"}, {"entity_type": "DISEASE", "description": "Menkes disease is a genetic disorder characterized by copper deficiency.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MENKES DISEASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Copper levels in the cerebrospinal fluid are elevated in Menkes disease.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CEREBROSPINAL FLUID COPPER"}, {"entity_type": "PROTEIN", "description": "Dopamine-b-hydroxylase is a copper-dependent enzyme involved in catecholamine synthesis.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DOPAMINE-B-HYDROXYLASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Catecholamine ratios are affected in Menkes disease due to deficient dopamine-b-hydroxylase activity.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CATECHOLAMINE RATIOS"}, {"entity_type": "PROTEIN", "description": "b2-microglobulin is a marker of renal tubular injury.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "B2-MICROGLOBULIN"}, {"entity_type": "DIAGNOSTIC TOOL", "description": "A test used to assess developmental skills in children.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DENVER DEVELOPMENTAL SCREENING TEST II"}, {"entity_type": "DIAGNOSTIC IMAGING", "description": "Magnetic Resonance Imaging of the brain was performed to visualize atrophy and delayed myelination.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BRAIN MRI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reduction in size of brain tissue.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATROPHY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Formation of a myelin sheath around nerve fibers.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MYELINATION"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "Measures the strength of electrical signals transmitted by the median nerve.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIAL"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "Measures the speed at which electrical signals travel along the median nerve.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE CONDUCTION VELOCITY"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "Measures the electrical activity of sensory nerves.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "SENSORY ACTION POTENTIAL"}, {"entity_type": "BIOCHEMICAL MEASUREMENT", "description": "Blood test measuring the amount of copper in the blood.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "SERUM COPPER LEVEL"}, {"entity_type": "BIOCHEMICAL MEASUREMENT", "description": "Urine test measuring levels of b2-microglobulin, a marker of renal tubular injury.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "URINE B2-MICROGLOBULIN"}, {"entity_type": "BIOCHEMICAL MEASUREMENT", "description": "Measures the relative amounts of different catecholamines in the blood.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "PLASMA CATECHOLAMINE RATIOS"}, {"entity_type": "DIAGNOSTIC PROCEDURE", "description": "Analysis of DNA to identify genetic mutations.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MOLECULAR ANALYSIS"}, {"entity_type": "MOLECULAR TECHNIQUE", "description": "Polymerase Chain Reaction, used to amplify specific DNA sequences.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "PCR"}, {"entity_type": "GENETIC FEATURE", "description": "A site recognized by the BsmAI restriction enzyme.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BSMAI RESTRICTION SITE"}, {"entity_type": "TISSUE SAMPLE", "description": "Cells taken from skin biopsy and grown in culture.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "FIBROBLAST CULTURE"}, {"entity_type": "MOLECULAR TECHNIQUE", "description": "Used to measure gene expression levels.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "QUANTITATIVE REAL-TIME PCR (Q-RT-PCR)"}, {"entity_type": "CELL LINE", "description": "Caco-2 cells are a human colorectal adenocarcinoma cell line.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "CACO-2 CELLS"}, {"entity_type": "GENE", "description": "ID1 is a gene that encodes for the deiodinase enzyme.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "ID1"}, {"entity_type": "TRANSCRIPT", "description": "IDI-T is a transcript variant of the ID1 gene with a T allele in its 3\u2032UTR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI-T"}, {"entity_type": "TRANSCRIPT", "description": "IDI-C is a transcript variant of the ID1 gene with a C allele in its 3\u2032UTR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI-C"}, {"entity_type": "PROTEIN", "description": "GPX4 encodes for the glutathione peroxidase 4 protein, which plays a role in antioxidant defense.<SEP>GPx4 is a selenoprotein involved in cellular antioxidant defense.<SEP>GPx4 is a selenoprotein that acts as an antioxidant enzyme.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX4"}, {"entity_type": "PROTEIN", "description": "The ID1 protein is a deiodinase enzyme involved in thyroid hormone metabolism.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "ID1 PROTEIN"}, {"entity_type": "PROTEIN", "description": "Deiodinase is an enzyme involved in thyroid hormone metabolism.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "DEIODINASE"}, {"entity_type": "NUTRIENT", "description": "Selenium is an essential trace element required for various biological processes.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENIUM (SE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "tert-butylhydroperoxide is a chemical used to induce oxidative stress.<SEP>tert-butylhydroperoxide is an oxidizing agent used to induce oxidative stress in cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TERT-BUTYLHYDROPEROXIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress is a state of imbalance between reactive oxygen species (ROS) production and antioxidant defense.<SEP>Oxidative stress refers to an imbalance between reactive oxygen species production and antioxidant defenses.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OXIDATIVE STRESS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutathione peroxidase (GPx) activity is an indicator of antioxidant capacity.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX ACTIVITY"}, {"entity_type": "PROTEIN", "description": "TR1 is a selenoprotein involved in thyroid hormone metabolism.<SEP>TR1 is a transcript that encodes for an unknown protein.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TR1"}, {"entity_type": "AMINO ACID", "description": "Selenocysteine is a unique amino acid incorporated into selenoproteins.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENOCYSTEINE"}, {"entity_type": "CELL LINE", "description": "IDI-C cells are human cell lines with an inserted copy of the IDI gene.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-C CELLS"}, {"entity_type": "CELL LINE", "description": "IDI-T cells are human cell lines without the insertion of the IDI gene.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-T CELLS"}, {"entity_type": "PROTEIN", "description": "GPx1 is a selenoprotein involved in cellular antioxidant defense.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX1"}, {"entity_type": "PROTEIN", "description": "Selenoprotein H is a selenoprotein with unknown function.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENOPROTEIN H"}, {"entity_type": "NUTRIENT", "description": "Se is the chemical symbol for selenium, an essential trace element.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE"}, {"entity_type": "CULTURE MEDIUM", "description": "Serum-free medium is a culture media lacking serum.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SERUM-FREE MEDIUM"}, {"entity_type": "CELLULAR PROCESS", "description": "ROS refers to reactive oxygen species, which are highly reactive molecules produced as byproducts of cellular metabolism.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "ROS"}, {"entity_type": "GENE", "description": "IDI is a gene involved in selenium metabolism and selenoprotein biosynthesis.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "The IDI transcript variants are linked to the GPX4 3\u2032UTR for expression.)", "entity_type": "UNKNOWN", "id": "GPX4 3\u2032UTR"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Deiodinase (ID1) may influence the production of selenoproteins like GPx and TR1.)", "entity_type": "UNKNOWN", "id": "SELENOPROTEINS"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Caco-2 cells grown in Se depleted medium are more sensitive to tert-butylhydroperoxide.)", "entity_type": "UNKNOWN", "id": "SE DEPLETED MEDIUM"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "IDI-C cells exhibit greater increases in reactive oxygen species (ROS) compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "INCREASED ROS"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "IDI-C cells display significantly lower glutathione peroxidase (GPx) activity compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "LOWER GPX ACTIVITY"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "In Se-supplemented conditions, IDI-C cells show a higher content of GPx4 protein compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "INCREASED GPX4 PROTEIN"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "In Se-supplemented conditions, IDI-C cells show a higher content of GPx4 protein compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "SE SUPPLEMENTED MEDIUM"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Selenoprotein levels are influenced by selenium (Se) availability.)", "entity_type": "UNKNOWN", "id": "SE STATUS"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "The ID1 gene encodes for the deiodinase enzyme, responsible for converting thyroid hormones.)", "entity_type": "UNKNOWN", "id": "DEIODINASE ACTIVITY"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Different 3\u2032UTR variants of ID1 may compete for selenium incorporation machinery.)", "entity_type": "UNKNOWN", "id": "IDI-T/C VARIANTS"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Different 3\u2032UTR variants of ID1 may compete for selenium incorporation machinery.)", "entity_type": "UNKNOWN", "id": "SE INCORPORATION"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "GPx4 plays a crucial role in protecting cells from oxidative damage.)", "entity_type": "UNKNOWN", "id": "ANTIOXIDANT DEFENSE"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Selenium deficiency leads to decreased activity of selenoproteins like GPx.)", "entity_type": "UNKNOWN", "id": "REDUCED GPX ACTIVITY"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Selenium deficiency leads to decreased activity of selenoproteins like GPx.)", "entity_type": "UNKNOWN", "id": "SE DEPLETION"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "Real-time PCR showed similar levels of TR1, GPx1, and GPx4 mRNA in both IDI-T and IDI-C cells grown in either Se-depleted or supplemented medium.)", "entity_type": "UNKNOWN", "id": "IDI-T AND IDI-C CELLS"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "Real-time PCR showed similar levels of TR1, GPx1, and GPx4 mRNA in both IDI-T and IDI-C cells grown in either Se-depleted or supplemented medium.)", "entity_type": "UNKNOWN", "id": "TR1, GPX1, AND GPX4 MRNAS"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "Selenoprotein H mRNA levels were significantly lower in IDI-C cells compared to IDI-T cells, regardless of selenium supply.)", "entity_type": "UNKNOWN", "id": "SELENOPROTEIN H MRNA"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "In Se-depleted medium, IDI-C cells showed less viability than IDI-T cells. As Se concentration increased, IDI-C cells demonstrated greater viability compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "CELL VIABILITY"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "In Se-depleted medium, IDI-C cells showed less viability than IDI-T cells. As Se concentration increased, IDI-C cells demonstrated greater viability compared to IDI-T cells.)", "entity_type": "UNKNOWN", "id": "SE CONTENT"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "When grown in Se-depleted medium, IDI-C cells exhibited greater oxidative stress than IDI-T cells after tert-butylhydroperoxide challenge.)", "entity_type": "UNKNOWN", "id": "IDI-C AND IDI-T CELLS"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "IDI-C clones showed a greater increase in ROS levels compared to IDI-T clones after tert-butylhydroperoxide exposure.)", "entity_type": "UNKNOWN", "id": "IDI-C CLONES"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "IDI-C clones showed a greater increase in ROS levels compared to IDI-T clones after tert-butylhydroperoxide exposure.)", "entity_type": "UNKNOWN", "id": "ROS LEVELS"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "IDI-C and IDI-T clones expressing similar IDI transgene levels showed significant differences in GPx activity, with higher activity observed in the IDI-C clones.)", "entity_type": "UNKNOWN", "id": "IDI-C AND IDI-T CLONES"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "IDI-C cells express the IDI gene.)", "entity_type": "UNKNOWN", "id": "IDI GENE"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "The level of IDI transcript varied between different IDI-C and IDI-T clones.)", "entity_type": "UNKNOWN", "id": "IDI TRANSCRIPT"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "GAPDH is used as a reference for normalizing mRNA expression levels.)", "entity_type": "UNKNOWN", "id": "GAPDH"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "GAPDH is used as a reference for normalizing mRNA expression levels.)", "entity_type": "UNKNOWN", "id": "HOUSEKEEPING GENE"}, {"entity_type": "GENE", "description": "CHAT is a gene that encodes for the enzyme cholinergic acetyltransferase (ChAT). Mutations in this gene can lead to various neurological disorders.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation results in a change of a single amino acid in the protein sequence.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "MISSENSE MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A nonsense mutation results in a premature stop codon, leading to a truncated protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "NONSENSE MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific missense mutation where valine at position 136 is replaced by methionine.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.VAL136MET"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific missense mutation where alanine at position 557 is replaced by threonine.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.ALA557THR"}, {"entity_type": "PROTEIN", "description": "ChAT protein is the product of the CHAT gene and catalyzes acetylcholine synthesis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT PROTEIN"}, {"entity_type": "CELL LINE", "description": "Bosc 23 cells are used in genetic engineering experiments.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "BOSC 23 CELLS"}, {"entity_type": "BACTERIA", "description": "E. coli is a bacterium commonly used in genetic engineering.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "E. COLI"}, {"entity_type": "AMINO ACID", "description": "Methionine at position 202 within the CHAT protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "MET202"}, {"entity_type": "AMINO ACID", "description": "Tryptophan at position 421 within the CHAT protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "TRP421"}, {"entity_type": "AMINO ACID", "description": "Threonine at position 553 within the CHAT protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "THR553"}, {"entity_type": "AMINO ACID", "description": "Alanine at position 557 within the CHAT protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "ALA557"}, {"entity_type": "SPECIES", "description": "Fruit fly, a model organism in genetics research.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "DROSOPHILA"}, {"entity_type": "SPECIES", "description": "A nematode commonly used as a model organism in biological research.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "C. ELEGANS"}, {"entity_type": "TRANSCRIPT", "description": "A transcript variant of the CHAT gene that encodes for a specific type of ChAT protein expressed in the spinal cord.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "SPINAL CORD CHAT TRANSCRIPT"}, {"entity_type": "TECHNIQUE", "description": "A method used to detect specific proteins in cell lysates.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "IMMUNOBLOT"}, {"entity_type": "CHROMATOGRAPHY MATERIAL", "description": "A type of chromatography column used to purify histidine-tagged proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "NI-NTA COLUMN"}, {"entity_type": "CHROMATOGRAPHY TECHNIQUE", "description": "A method used to further purify proteins after initial purification steps.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "FAST PROTEIN LIQUID CHROMATOGRAPHY"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The text focuses on analyzing mutations within the CHAT gene.)", "entity_type": "UNKNOWN", "id": "MUTATION ANALYSIS"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "This mutation was observed in three patients.)", "entity_type": "UNKNOWN", "id": "PATIENT"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The CHAT gene encodes for the ChAT protein.)", "entity_type": "UNKNOWN", "id": "CHAT GENE"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "Mutant and wild-type CHAT cDNAs were engineered into Bosc 23 cells to analyze protein expression.)", "entity_type": "UNKNOWN", "id": "CHAT PROTEIN EXPRESSION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "Wild-type and mutant ChAT cDNAs were transformed into E. coli to purify the enzymes for kinetic analysis.)", "entity_type": "UNKNOWN", "id": "CHAT PROTEIN PURIFICATION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The study evaluated the kinetic parameters of wild-type and mutant ChATs to understand their functional differences.)", "entity_type": "UNKNOWN", "id": "CHAT FUNCTION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The study evaluated the kinetic parameters of wild-type and mutant ChATs to understand their functional differences.)", "entity_type": "UNKNOWN", "id": "KINETIC PROPERTIES"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "Thermal stability is an important factor for protein function, and this study analyzed the impact of mutations on ChAT thermal stability.)", "entity_type": "UNKNOWN", "id": "THERMAL STABILITY"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "This amino acid residue is conserved across various species and mutated in some patients.)", "entity_type": "UNKNOWN", "id": "MUTATION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The CHAT protein structure is conserved between humans and Drosophila.)", "entity_type": "UNKNOWN", "id": "DROSOPHILA CONSERVATION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The CHAT protein structure is conserved between humans and C. elegans.)", "entity_type": "UNKNOWN", "id": "C. ELEGANS CONSERVATION"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "E. coli expressing ChAT was purified using a Ni-NTA column.)", "entity_type": "UNKNOWN", "id": "CHAT PURIFICATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TGSH is a marker for measuring the levels of reduced glutathione.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TGSH"}, {"entity_type": "NUTRIENT", "description": "GSH is a reduced form of glutathione, an antioxidant.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GSH"}, {"entity_type": "NUTRIENT", "description": "GSSG is an oxidized form of glutathione.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GSSG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The GSSG/GSH ratio reflects the balance between oxidized and reduced glutathione, indicating the oxidative state.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GSSG/GSH RATIO"}, {"entity_type": "NUTRIENT", "description": "HCY is homocysteine, an amino acid.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "HCY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "oxLDL is oxidized low-density lipoprotein cholesterol, a marker of cardiovascular disease.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OXLDL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "OLAB is a marker of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OLAB"}, {"entity_type": "DISEASE", "description": "CD measures products of lipid peroxidation.<SEP>Crohn\'s disease, a chronic inflammatory bowel disease.<SEP>CD refers to Crohn\'s Disease, an inflammatory bowel disease.<SEP>Crohn\'s Disease (CD) is a chronic inflammatory bowel disease characterized by abnormal immune responses.<SEP>Crohn\'s Disease, a chronic inflammatory bowel disease.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "CD"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "BCD-LDL measures products of lipid peroxidation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "BCD-LDL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAOC is total antioxidant capacity, a measure of the body\'s ability to neutralize free radicals.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TAOC"}, {"entity_type": "GENE", "description": "BCL2L11 is a gene.<SEP>BCL2L11 is involved in apoptosis.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7<SEP>chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "BCL2L11"}, {"entity_type": "GENE", "description": "NDUFS7 is part of complex I of the mitochondrial respiratory chain.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "NDUFS7"}, {"entity_type": "GENE", "description": "EIF3J is a component of the eukaryotic translation initiation factor 3 complex.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "EIF3J"}, {"entity_type": "GENE", "description": "ZNF761 encodes a zinc finger protein.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ZNF761"}, {"entity_type": "GENE", "description": "PSMG3 is involved in proteasome assembly.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "PSMG3"}, {"entity_type": "GENE", "description": "ENTHD1 participates in purine metabolism and signal transduction.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ENTHD1"}, {"entity_type": "GENE", "description": "LRIG1 is a receptor tyrosine kinase.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "LRIG1"}, {"entity_type": "GENE", "description": "RIPK3 plays a role in programmed cell death.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RIPK3"}, {"entity_type": "GENE", "description": "RPS6KC1 is involved in ribosomal biogenesis and protein synthesis.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RPS6KC1"}, {"entity_type": "GENE", "description": "ATP2B4 encodes a calcium ATPase pump.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ATP2B4"}, {"entity_type": "GENE", "description": "SEMA6A encodes a semaphorin protein with anti-angiogenic function.<SEP>SEMA6A is a gene associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "SEMA6A"}, {"entity_type": "GENE", "description": "TAPBP is involved in protein trafficking.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TAPBP"}, {"entity_type": "GENE", "description": "RGL2 plays a role in cell signaling and proliferation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RGL2"}, {"entity_type": "GENE", "description": "CKAP5 interacts with actin filaments and regulates cytoskeletal dynamics.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CKAP5"}, {"entity_type": "GENE", "description": "FOSL2 is involved in the cellular response to stress and growth factors.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FOSL2"}, {"entity_type": "GENE", "description": "FAM20C encodes a protein involved in phosphorylation.<SEP>FAM20C is a gene associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FAM20C"}, {"entity_type": "GENE", "description": "FRMD6 contains FERM domain and interacts with membrane proteins.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FRMD6"}, {"entity_type": "GENOMIC FEATURE", "description": "CpGs are cytosine-phosphate-guanine dinucleotides in DNA that can be methylated.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CPG"}, {"entity_type": "GENETIC MATERIAL", "description": "The genome is the complete set of genetic information.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GENOME"}, {"entity_type": "GENE", "description": "E2F1 is a gene/protein with a potential role in atherosclerosis and coronary heart disease (CHD).", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "E2F1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress markers are measured as indicators of oxidative stress.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "OXIDATIVE STRESS MARKERS"}, {"entity_type": "GENOMIC REGION", "description": "CpG islands are regions of the genome with a high concentration of CpG dinucleotides.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CPG ISLANDS"}, {"entity_type": "GENOMIC REGION", "description": "Promoters are regions of DNA upstream of a gene that regulate transcription.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PROMOTER"}, {"entity_type": "DATABASE", "description": "RegulomeDB is a database that identifies functional regulatory elements across different cell types.<SEP>RegulomeDB is a database that provides information about regulatory elements in the genome.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b<SEP>chunk-b05610f4a9a1033449b92655bfb67b28", "id": "REGULOMEDB"}, {"entity_type": "PROTEIN", "description": "Transcription factors are proteins that bind to DNA and regulate gene expression.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "TRANSCRIPTION FACTORS (TFS)"}, {"entity_type": "BIOINFORMATIC TOOL", "description": "Gene set enrichment analysis is a method used to identify functional groups of genes that are enriched in a particular dataset.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "GENE SET ENRICHMENT ANALYSIS"}, {"entity_type": "GENETIC VARIANT", "description": "cis-meQTLs are genetic variants that influence the methylation of nearby CpG sites.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CIS-MEQTLS"}, {"entity_type": "GENE", "description": "AMDHD1 is a gene associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "AMDHD1"}, {"entity_type": "GENE", "description": "HSP90AB1 is a gene associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "HSP90AB1"}, {"entity_type": "GENE", "description": "WNK2 is a gene associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "WNK2"}, {"entity_type": "GENE", "description": "CEP55 is a gene.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CEP55"}, {"entity_type": "GENE", "description": "CPB1 is a gene.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPB1"}, {"entity_type": "GENE", "description": "HIST1H4D is a gene.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HIST1H4D"}, {"entity_type": "GENE", "description": "DVL1 is a gene.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DVL1"}, {"entity_type": "GENE", "description": "ZNF341 is a gene.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG site cg07547695 is a genomic location.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPG SITE CG07547695"}, {"entity_type": "GENOMIC VARIANT", "description": "rs726430 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS726430"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG site cg24371383 is a genomic location.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPG SITE CG24371383"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12782691 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS12782691"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG site cg04072156 is a genomic location.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPG SITE CG04072156"}, {"entity_type": "GENOMIC VARIANT", "description": "rs16861015 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS16861015"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG site cg14532755 is a genomic location.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPG SITE CG14532755"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1665364 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS1665364"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2236786 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS2236786"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3752749 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS3752749"}, {"entity_type": "GENOMIC VARIANT", "description": "rs732754 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS732754"}, {"entity_type": "GENOMIC VARIANT", "description": "rs744658 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS744658"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798719 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798719"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798726 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798726"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798727 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798727"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798741 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798741"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798744 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798744"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798751 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798751"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798754 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798754"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798755 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798755"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798756 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798756"}, {"entity_type": "GENOMIC VARIANT", "description": "rs798766 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS798766"}, {"entity_type": "GENOMIC VARIANT", "description": "rs811316 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS811316"}, {"entity_type": "GENOMIC VARIANT", "description": "rs8389 is a genomic variant.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS8389"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG site cg08170869 is a genomic location.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPG SITE CG08170869"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "Homocysteine (HCY) is involved in lipid metabolism and signaling pathways.)", "entity_type": "UNKNOWN", "id": "LIPID-RELATED PROCESSES"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "Oxidation of LDL cholesterol is a risk factor for cardiovascular disease.)", "entity_type": "UNKNOWN", "id": "CARDIOVASCULAR DISEASE"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "CD measures products of lipid peroxidation, indicating oxidative damage.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "LIPID PEROXIDATION"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The study found an association between methylation at the BCL2L11 gene and oxidative stress markers.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG07547695, RS726430"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The study found an association between methylation at the CEP55 gene and oxidative stress markers.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG24371383, RS12782691"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The study found an association between methylation at the CPB1 gene and oxidative stress markers.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG04072156, RS16861015"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "Hypomethylation in HIST1H4D was associated with a higher risk of T2D.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG08170869"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "Hypomethylation in DVL1 was associated with a higher risk of T2D.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG03465880"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The methylation levels at the ZNF341 gene were associated with heart failure.)", "entity_type": "UNKNOWN", "id": "METHYLATION AT CPG SITE CG11842944"}, {"entity_type": "GENE", "description": "The MT-ATP6 gene encodes a subunit of ATP synthase, which is essential for mitochondrial function and energy production.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MT-ATP6"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant 8993T>G in the MT-ATP6 gene leads to an amino acid substitution p.Leu156Arg.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "8993T>G"}, {"entity_type": "PROTEIN", "description": "The protein change p.Leu156Arg is a known disease-causing variant responsible for Leigh syndrome due to deficient activity of complex V (ATP synthase).", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "P.LEU156ARG"}, {"entity_type": "DISEASE", "description": "Leigh syndrome is a genetic mitochondrial disorder.<SEP>Leigh syndrome is a mitochondrial disorder characterized by deficient activity of complex V (ATP synthase) in the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "LEIGH SYNDROME"}, {"entity_type": "INDIVIDUAL", "description": "CMH000067 is a proband (patient) being studied.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000067"}, {"entity_type": "INDIVIDUAL", "description": "CMH000068 is the father of CMH000067.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000068"}, {"entity_type": "INDIVIDUAL", "description": "CMH000069 is the mother of CMH000067.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000069"}, {"entity_type": "SEQUENCING TECHNOLOGY", "description": "Illumina HiSeq 2000 is the sequencing technology used in this study.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ILLUMINA HISEQ 2000"}, {"entity_type": "ALIGNMENT SOFTWARE", "description": "GSNAP is a software used for aligning sequencing reads.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "GSNAP"}, {"entity_type": "PROCEDURE", "description": "Exome enrichment is a technique to specifically target and sequence protein-coding regions of the genome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "EXOME ENRICHMENT"}, {"entity_type": "GENOME TYPE", "description": "The mitochondrial genome is a separate DNA molecule from nuclear DNA, inherited maternally.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MITOCHONDRIAL GENOME"}, {"entity_type": "PROTEIN", "description": "ATP synthase 6 is an essential subunit of complex V in the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ATP SYNTHASE 6 (MT-ATP6)"}, {"entity_type": "GENE", "description": "Mitochondrial gene encoding a subunit of respiratory complex I.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH DEHYDROGENASE SUBUNIT 1"}, {"entity_type": "GENE", "description": "Gene that encodes coenzyme Q2 homolog, prenyltransferase, involved in the biosynthesis of coenzyme Q.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation occurring in the FMN binding site of Complex I.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "GLU246LYS"}, {"entity_type": "PROTEIN", "description": "Multi-subunit protein complex that functions in the electron transport chain, catalyzing the transfer of electrons from NADH to ubiquinone.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COMPLEX I"}, {"entity_type": "MOLECULE", "description": "Flavin mononucleotide, a prosthetic group found in some enzymes, including Complex I.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "FMN"}, {"entity_type": "MOLECULE", "description": "Nicotinamide adenine dinucleotide, an electron carrier molecule involved in cellular respiration.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH"}, {"entity_type": "MOLECULE", "description": "A lipid-soluble electron carrier that participates in the electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "UBIQUINONE"}, {"entity_type": "MOLECULAR STRUCTURE", "description": "A type of prosthetic group found in proteins, often involved in redox reactions.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "IRON\u2013SULFUR CLUSTER"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "MT-ATP6 encodes a subunit of complex V (ATP synthase), which is essential for mitochondrial function.)", "entity_type": "UNKNOWN", "id": "COMPLEX V"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "NDUFV1 encodes a protein that functions in the electron transport chain by releasing electrons from NADH.)", "entity_type": "UNKNOWN", "id": "ELECTRON TRANSPORT CHAIN"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "NDUFV1 encodes a protein that functions in the electron transport chain by releasing electrons from NADH.)", "entity_type": "UNKNOWN", "id": "NDUFV1"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "The c.736G>A variant leads to an amino acid change Glu246Lys in the NDUFV1 protein.)", "entity_type": "UNKNOWN", "id": "C.736G>A"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "The c.349G>A variant results in the amino acid substitution Ala117Thr in the NDUFV1 protein.)", "entity_type": "UNKNOWN", "id": "ALA117THR"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "The c.349G>A variant results in the amino acid substitution Ala117Thr in the NDUFV1 protein.)", "entity_type": "UNKNOWN", "id": "C.349G>A"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "Exome sequencing was performed to discover genetic variants in CMH000067.)", "entity_type": "UNKNOWN", "id": "EXOME SEQUENCING"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "Exome sequencing was performed to discover genetic variants in CMH000067.)", "entity_type": "UNKNOWN", "id": "VARIANT DISCOVERY"}, {"entity_type": "GENE", "description": "OPRM1 is a gene involved in opioid receptor function and may influence alcohol craving.<SEP>OPRM1 is a gene that encodes the mu-opioid receptor.<SEP>OPRM1 is an opioid receptor gene.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "OPRM1"}, {"entity_type": "GENETIC VARIANT", "description": "Individuals homozygous for the Asn40 allele of the OPRM1 gene.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ASN40 HOMOZYGOTES"}, {"entity_type": "GENE", "description": "ALDH2 is a gene involved in alcohol metabolism.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ALDH2"}, {"entity_type": "GENOMIC VARIANT", "description": "Asp40 refers to a specific variant within the OPRM1 gene.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASP40"}, {"entity_type": "GENOMIC VARIANT", "description": "Asn40 refers to a specific variant within the OPRM1 gene.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASN40"}, {"entity_type": "DRUG", "description": "Naltrexone is a medication used to reduce alcohol consumption.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NALTREXONE"}, {"entity_type": "DRUG", "description": "A placebo is a inactive substance used as a control in clinical trials.<SEP>Placebo is a control substance with no therapeutic effect.", "source_id": "chunk-0c7ab28db433187759e760725a105836<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "PLACEBO"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Variations in the OPRM1 gene have been associated with differences in alcohol craving.)", "entity_type": "UNKNOWN", "id": "ALCOHOL CRAVING"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The ALDH2 gene encodes an enzyme involved in alcohol metabolism.)", "entity_type": "UNKNOWN", "id": "ALCOHOL METABOLISM"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The ADH1B gene encodes an enzyme involved in alcohol metabolism.)", "entity_type": "UNKNOWN", "id": "ADH1B"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Naltrexone is a medication used to treat alcohol use disorder.)", "entity_type": "UNKNOWN", "id": "MEDICATION"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "BrAC (blood alcohol concentration) refers to the amount of alcohol present in the bloodstream.)", "entity_type": "UNKNOWN", "id": "BRAC"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The AUDIT questionnaire is a tool for assessing alcohol use disorders.)<SEP>The Alcohol Use Disorders Identification Test (AUDIT) is a screening tool for alcohol use disorders.", "entity_type": "SCALE", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "AUDIT"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "ALDH2 genotype was a significant covariate in the analysis of alcohol self-administration, indicating its potential influence on drinking behavior.)", "entity_type": "UNKNOWN", "id": "ALCOHOL SELF-ADMINISTRATION"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "ALDH2 genotype was a significant covariate in the analysis of alcohol self-administration, indicating its potential influence on drinking behavior.)", "entity_type": "UNKNOWN", "id": "ALDH2 GENOTYPE"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "Asp40 carriers consumed significantly fewer drinks compared to Asn40 homozygotes, suggesting an association between OPRM1 genotype and alcohol consumption.)", "entity_type": "UNKNOWN", "id": "OPRM1 GENOTYPE"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "Asn40 homozygotes had a significantly shorter latency to first drink compared to other genotypes.)", "entity_type": "UNKNOWN", "id": "LATENCY TO FIRST DRINK"}, {"entity_type": "GENOMIC VARIANT", "description": "The ALDH2 rs671 polymorphism is a genetic variant associated with alcohol metabolism.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 124}]", "id": "ALDH2 RS671"}, {"entity_type": "GENOMIC VARIANT", "description": "These are the genotypes resulting from the ALDH2 rs671 polymorphism.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "GG, GA, AA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The level of cortisol present in the blood.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "BLOOD CORTISOL LEVEL"}, {"entity_type": "SOCIAL FACTOR", "description": "An individual\'s level of formal education.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "EDUCATION STATUS"}, {"entity_type": "SOCIAL GROUP", "description": "Males of the study population.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MEN"}, {"entity_type": "SOCIAL GROUP", "description": "Females of the study population.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 124}]", "id": "WOMEN"}, {"entity_type": "SOCIAL GROUP", "description": "Individuals who formerly consumed alcohol.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 34}]", "id": "EX-DRINKERS"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "The ALDH2 rs671 polymorphism influences blood cortisol levels, particularly in men.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 124}]", "id": "CORTISOL LEVEL"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "These factors were considered in multivariate models to assess their influence on the relationship between alcohol consumption and blood cortisol levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 33}]", "id": "SMOKING STATUS, HYPERTENSION, DIABETES, EDUCATION STATUS"}, {"entity_type": "GENE", "description": "ABCG2 is a gene that plays a role in uric acid transport.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "ABCG2"}, {"entity_type": "GENE", "description": "SLC2A9 is a gene involved in glucose transport and metabolism.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC2A9"}, {"entity_type": "GENE", "description": "SLC22A12 is a gene that encodes a transporter protein.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC22A12"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3733591 is a single nucleotide polymorphism (SNP) in the SLC2A9 gene.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS3733591"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2231142 is a genomic variant associated with elevated serum uric acid (sUA) levels and hyperuricemia (HUA) risk.<SEP>rs2231142 is a single nucleotide polymorphism (SNP) in the ABCG2 gene.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS2231142"}, {"entity_type": "GENOMIC VARIANT", "description": "rs893006 is a single nucleotide polymorphism (SNP) in the SLC22A12 gene.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS893006"}, {"entity_type": "DISEASE", "description": "HUA stands for hyperuricemia, a condition characterized by elevated levels of uric acid in the blood.<SEP>Hyperuricemia (HUA) is a condition characterized by elevated serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "HUA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum creatinine is a measure of kidney function.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SERUM CREATININE"}, {"entity_type": "NUTRIENT", "description": "TG stands for triglycerides, a type of fat found in the blood.<SEP>Triglycerides (TG) are a type of lipid, a nutrient that provides energy.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "TG"}, {"entity_type": "LIPID", "description": "LDL stands for low-density lipoprotein, often referred to as \'bad\' cholesterol.<SEP>Low-density lipoprotein (LDL) is a type of lipid, often referred to as \'bad cholesterol\'.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "LDL"}, {"entity_type": "LIPID", "description": "HDL stands for high-density lipoprotein, often referred to as \'good\' cholesterol.<SEP>High-density lipoprotein (HDL) is a type of lipid, often referred to as \'good cholesterol\'.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "HDL"}, {"entity_type": "DRUG", "description": "Diuretics are medications that help remove excess fluid from the body by increasing urine production.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "DIURETICS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FBG stands for Fasting Blood Glucose, a measure of blood sugar level after an overnight fast.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "FBG"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Tobacco smoking involves inhaling and exhaling smoke from tobacco products.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "TOBACCO SMOKING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum Uric Acid (sUA) level refers to the amount of uric acid present in the blood.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SUA LEVEL"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC2A9 rs3733951 variant is a genetic marker associated with serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 74}]", "id": "SLC2A9 RS3733951"}, {"entity_type": "GENOMIC VARIANT", "description": "The ABCG2 rs2231142 variant is a genetic marker associated with serum uric acid (sUA) levels and hyperuricemia (HUA).", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "ABCG2 RS2231142"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC22A12 rs893006 variant is a genetic marker associated with serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 74}]", "id": "SLC22A12 RS893006"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "High TG levels are a cardiovascular risk factor associated with increased sUA levels and HUA risk in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "HIGH TRIGLYCERIDES (TG)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Low HDL cholesterol is a cardiovascular risk factor associated with increased HUA risk in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "LOW HDL CHOLESTEROL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum uric acid (sUA) is a physiological marker of purine metabolism.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SUA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum uric acid (sUA) is a physiological process measured in the blood as a marker of purine metabolism.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "SERUM URIC ACID"}, {"entity_type": "DISEASE", "description": "Hyperuricemia (HUA) is a disease characterized by elevated serum uric acid levels.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "HYPERURICEMIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A risk factor is an environmental or lifestyle characteristic that increases the likelihood of developing a disease.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "RISK FACTOR"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cardiovascular risk factors are environmental influences that contribute to the development of cardiovascular diseases.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "CARDIOVASCULAR RISK FACTORS"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "The C risk allele in SLC2A9 rs3733591 was associated with an increased risk of HUA.)", "entity_type": "UNKNOWN", "id": "SLC2A9 RS3733591"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "description": "Individuals carrying the C allele of the SLC2A9 rs3733951 polymorphism have higher sUA levels compared to those with the T allele.)<SEP>The SLC2A9 rs3733951 C allele is associated with higher sUA levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 74}]", "id": "SUA LEVELS"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "description": "Each copy of the T allele in the ABCG2 rs2231142 polymorphism increases the risk of HUA.)<SEP>The ABCG2 rs2231142 T allele increases the risk of HUA.)", "entity_type": "UNKNOWN", "id": "HUA RISK"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "description": "Elevated TG levels are associated with higher sUA levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 74}]", "id": "HIGH TG"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "description": "Individuals with low HDL levels have an increased risk of HUA.)", "entity_type": "UNKNOWN", "id": "LOW HDL"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "description": "Individuals with high LDL levels have an increased risk of HUA.)", "entity_type": "UNKNOWN", "id": "HIGH LDL"}, {"entity_type": "GENE", "description": "LRP2 is a gene associated with kidney function.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "LRP2"}, {"entity_type": "GENE", "description": "Gene involved in kidney function, downregulated by salt exposure and CKD.<SEP>NFATC1 is a gene associated with kidney function.<SEP>NFATC1 is a gene that plays a central role in inducible gene transcription during immune response.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf<SEP>chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 116}]", "id": "NFATC1"}, {"entity_type": "GENE", "description": "UNCX is a gene associated with kidney function and CKD risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 46}]", "id": "UNCX"}, {"entity_type": "GENE", "description": "ALMS1 is a gene associated with kidney function and CKD risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 46}]", "id": "ALMS1"}, {"entity_type": "GENE", "description": "PDILT-UMOD is a gene complex associated with kidney function and CKD risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 46}]", "id": "PDILT-UMOD"}, {"entity_type": "GENE", "description": "PRKAG2 is a gene associated with kidney function in individuals with diabetes.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "PRKAG2"}, {"entity_type": "GENE", "description": "SLC34A1 is a gene associated with eGFR.<SEP>SLC34A1 is a gene involved in renal phosphate reabsorption.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "SLC34A1"}, {"entity_type": "GENE", "description": "DCDC5-MPPED2 is a gene complex associated with eGFR.<SEP>DCDC5-MPPED2 is a gene with multiple variants potentially affecting kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 49}]", "id": "DCDC5-MPPED2"}, {"entity_type": "GENE", "description": "PIP5K1B encodes phosphatidylinositol phosphate kinase type 1 beta and has roles in cell signaling.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "PIP5K1B"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1260326 is a missense variant in the GCKR gene, resulting in altered glucose metabolism.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RS1260326"}, {"entity_type": "DISEASE", "description": "Chronic Kidney Disease is a progressive decline in kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "CHRONIC KIDNEY DISEASE (CKD)"}, {"entity_type": "ORGANISM", "description": "Drosophila melanogaster is the common fruit fly, frequently used as a model organism.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "DROSOPHILA MELANOGASTER"}, {"entity_type": "GENE", "description": "loco gene involved in salt stress resistance.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCO"}, {"entity_type": "GENOMIC VARIANT", "description": "y1w1 genetic background used in the study.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "Y1W1"}, {"entity_type": "GENOMIC VARIANT", "description": "locoEY-P283 genomic variant used in the study.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCOEY-P283"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Sodium chloride (NaCl) used to induce salt stress.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NACL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Stress response triggered by high NaCl concentrations.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "SALT STRESS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Ability of organisms to persist in challenging conditions.<SEP>The ability of a cell or organism to maintain life and resist death.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf<SEP>chunk-614333487e4b92705503909d34155179", "id": "SURVIVAL"}, {"entity_type": "DISEASE", "description": "Reduced fitness in individuals due to reduced genetic diversity.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "INBREEDING DEPRESSION"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetically diverse strains with mixed ancestry.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "HYBRID HETEROGENIC STRAINS"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetically identical strains used for comparison.<SEP>Genetically identical strains.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "ISOGENIC STRAINS"}, {"entity_type": "GENE", "description": "Gene involved in kidney function, downregulated by salt exposure and CKD.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RGS14"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutant organisms with variations in the loco gene.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCO MUTANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Control organisms with the y1w1 genetic background.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "Y1W1 CONTROLS"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic background with mixed ancestry.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "HETEROGENIC BACKGROUND"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Process of measuring gene expression in kidney tissue.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RENAL MRNA EXPRESSION"}, {"entity_type": "DISEASE", "description": "Kidney disease characterized by scarring and hardening.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "GLOMERULOSCLEROSIS"}, {"entity_type": "MEDICAL INTERVENTION", "description": "Surgical procedure to remove part of the kidneys.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "SUB-TOTAL NEPHRECTOMY"}, {"entity_type": "DISEASE", "description": "Chronic kidney disease, a progressive decline in kidney function.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 46}]", "id": "CKD"}, {"source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "description": "Lead SNPs at the 20 eGFR loci are associated with increased risk of CKD.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 46}]", "id": "LEAD EGFR SNPS"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This variant has been functionally linked to increased risk of CKD by altering triglyceride and cholesterol synthesis and export.)", "entity_type": "UNKNOWN", "id": "GCKR P.PRO446LEU (RS1260326)"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This lead SNP overlaps DHSs in RPTECs, indicating its potential regulatory effect on these cells.)", "entity_type": "UNKNOWN", "id": "RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This lead SNP overlaps DHSs in RPTECs, indicating its potential regulatory effect on these cells.)", "entity_type": "UNKNOWN", "id": "RS35716097"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This lead SNP overlaps DHSs in fetal kidney cells, suggesting a role in kidney development.)", "entity_type": "UNKNOWN", "id": "FETAL KIDNEY CELL DHSS"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This lead SNP overlaps DHSs in fetal kidney cells, suggesting a role in kidney development.)", "entity_type": "UNKNOWN", "id": "RS8096658"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "NFATC1 is a downstream target of the immunosuppression drug cyclosporine A.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}, {level: 1, cluster: 116}]", "id": "CYCLOSPORINE A"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Reduced expression of RGS14 ortholog \'loco\' in Drosophila melanogaster is associated with increased lifespan and stress resistance.)", "entity_type": "UNKNOWN", "id": "STRESS RESISTANCE"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "RGS14 encodes a member of the regulator of G protein signaling family.)", "entity_type": "UNKNOWN", "id": "G PROTEIN SIGNALING"}, {"entity_type": "DISEASE", "description": "An infection caused by the bacterium Campylobacter.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CAMPYLOBACTER INFECTION"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation in the genes that confer resistance to quinolone antibiotics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE-RESISTANT CAMPYLOBACTER"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation in the genes that confer resistance to erythromycin antibiotics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "ERYTHROMYCIN-RESISTANT CAMPYLOBACTER"}, {"entity_type": "BACTERIA", "description": "A species of Campylobacter bacteria.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. COLI"}, {"entity_type": "BACTERIA", "description": "A species of Campylobacter bacteria.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. JEJUNI"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Traveling to other countries, which may increase exposure to Campylobacter.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "FOREIGN TRAVEL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Geographic region associated with high prevalence of quinolone-resistant Campylobacter.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SOUTHERN EUROPE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Geographic region associated with high prevalence of quinolone-resistant Campylobacter.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SOUTHEAST ASIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Geographic region with low prevalence of quinolone-resistant Campylobacter.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SCANDINAVIAN COUNTRIES"}, {"entity_type": "FOOD", "description": "Poultry sources that are associated with an increased risk of quinolone-resistant Campylobacter infection.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "FRESH POULTRY (OTHER THAN CHICKEN AND TURKEY)"}, {"entity_type": "FOOD", "description": "Poultry source associated with a decreased risk of quinolone-resistant Campylobacter infection.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CHICKEN (DANISH ORIGIN)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Activity associated with an increased risk of quinolone-resistant Campylobacter infection.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SWIMMING"}, {"entity_type": "DISEASE", "description": "A disease caused by bacteria resistant to quinolone antibiotics.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "QUINOLONE-RESISTANT INFECTION"}, {"entity_type": "GENOMIC VARIANT", "description": "C. jejuni is a bacterial species commonly associated with foodborne illness.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTER JEJUNI"}, {"entity_type": "GENOMIC VARIANT", "description": "C. coli is a bacterial species commonly associated with foodborne illness.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTER COLI"}, {"entity_type": "DISEASE", "description": "A disease caused by bacteria acquired within a specific geographic area.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "DOMESTICALLY ACQUIRED INFECTION"}, {"entity_type": "FOOD", "description": "A type of poultry commonly consumed.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CHICKEN"}, {"entity_type": "FOOD", "description": "A type of poultry commonly consumed.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "TURKEY"}, {"entity_type": "FOOD", "description": "A type of meat commonly consumed.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "PORK"}, {"entity_type": "COUNTRY", "description": "A country known for exporting food products.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "FRANCE"}, {"entity_type": "COUNTRY", "description": "A country known for exporting food products.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "ITALY"}, {"entity_type": "COUNTRY", "description": "A country known for exporting food products.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "UNITED KINGDOM"}, {"entity_type": "ANIMAL MODEL", "description": "Chickens raised specifically for meat production.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "BROILER CHICKENS"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Thirteen (8.5%) of 153 C. jejuni isolates and 8 (29.6%) of 27 C. coli isolates were resistant to nalidixic acid.)", "entity_type": "UNKNOWN", "id": "NALIDIXIC ACID RESISTANCE"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Three (2.0%) of 153 C. jejuni isolates and 5 (18.5%) of 27 C. coli isolates were resistant to erythromycin.)", "entity_type": "UNKNOWN", "id": "ERYTHROMYCIN RESISTANCE"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "entity_type": "UNKNOWN", "id": "RETAIL FOOD PRODUCTS"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "In 10 (11.9%) of 84 domestically acquired infections, patients reported eating fresh poultry other than chicken and turkey compared with 4 (9.5%) of 42 infections in persons with travel-related infections.)", "entity_type": "UNKNOWN", "id": "POULTRY CONSUMPTION"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Patients with domestically acquired quinolone-sensitive C. jejuni infections were more likely to have a C. jejuni subtype that was also identified among retail food products and broiler chickens than were patients with domestically acquired quinolone-resistant infections.)", "entity_type": "UNKNOWN", "id": "QUINOLONE-SENSITIVE INFECTION"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Forty patients (32.8%) were treated with antimicrobial agents for their campylobacteriosis; of these, 33 patients (27%) received a fluoroquinolone.)", "entity_type": "UNKNOWN", "id": "CAMPYLOBACTERIOSIS TREATMENT"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Forty patients (32.8%) were treated with antimicrobial agents for their campylobacteriosis; of these, 33 patients (27%) received a fluoroquinolone.)", "entity_type": "UNKNOWN", "id": "FLUOROQUINOLONES"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Of these, 6 patients (4.9%) received a macrolide for the C. jejuni infection.)", "entity_type": "UNKNOWN", "id": "MACROLIDE"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "entity_type": "UNKNOWN", "id": "CAMPYLOBACTER JEJUNI INFECTION"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with increased social disinhibition score.<SEP>SNP rs9534511 is located on the HTR2A gene.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS9534511"}, {"entity_type": "GENE", "description": "HTR2A is a serotonin receptor gene.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR2A"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with increased social disinhibition score.<SEP>SNP rs4938056 is located on the HTR3B gene.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS4938056"}, {"entity_type": "GENE", "description": "HTR3B is a gene, but variation at rs45460698 was not associated with CINV.<SEP>HTR3B is a serotonin receptor gene.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR3B"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with increased social disinhibition score.<SEP>SNP rs1998220 is located in an intronic region of the OPRM1 gene.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS1998220"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with a decreased social disinhibition score.<SEP>SNP rs1003921 resides in an intronic region of the KCNC1 gene.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS1003921"}, {"entity_type": "GENE", "description": "KCNC1 is a potassium channel gene.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "KCNC1"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with a decreased social disinhibition score.<SEP>SNP rs16116 is located in an intergenic region downstream of the NPY gene.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS16116"}, {"entity_type": "GENE", "description": "NPY is a neuropeptide gene.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "NPY"}, {"entity_type": "SNP", "description": "A genomic variant (SNP) associated with a decreased social disinhibition score.<SEP>SNP rs16870286 is part of LINC00518, a miscellaneous RNA gene that codes for an uncharacterized protein.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS16870286"}, {"entity_type": "GENE", "description": "LINC00518 is a miscellaneous RNA gene.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINC00518"}, {"entity_type": "PHENOTYPE", "description": "A personality trait characterized by impulsive, risk-taking behaviors and a lack of restraint.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "SOCIAL DISINHIBITION"}, {"entity_type": "CATEGORICAL VARIABLE", "description": "Refers to the biological sex of an individual, typically categorized as male or female.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "GENDER"}, {"entity_type": "CONTINUOUS VARIABLE", "description": "Measures the degree to which an individual has adapted to a new language and culture.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINGUISTIC ACCULTURATION"}, {"entity_type": "MEASURE", "description": "The Toronto Alexithymia Scale (TAS) is a questionnaire used to assess the ability to identify and describe one\'s emotions.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "TAS"}, {"entity_type": "MEASURE", "description": "The Difficulties in Emotion Regulation Scale (DAS) measures difficulties with regulating emotions.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "DAS"}, {"entity_type": "MEASURE", "description": "A measure reflecting a tendency to engage in impulsive or risky behavior.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "SOCIAL DISINHIBITION SCORE"}, {"entity_type": "GENE", "description": "CNR1 is a gene that encodes the CB1 receptor.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CNR1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2023239 is a genetic variant that interacts with medication and alcohol consumption.<SEP>rs2023239 is a genomic variant found upstream of exon 3 of the CNR1 gene, acting as an alternative promoter.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "RS2023239"}, {"entity_type": "BRAIN REGION", "description": "The Nucleus Accumbens (NAcc) is a brain region involved in reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "NACC"}, {"entity_type": "BRAIN REGION", "description": "The Ventromedial Prefrontal Cortex (VMPFC) is a brain region involved in emotional regulation and decision-making.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VMPFC"}, {"entity_type": "BRAIN REGION", "description": "The Ventral Tegmental Area (VTA) is a brain region involved in reward and motivation.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VTA"}, {"entity_type": "BRAIN REGION", "description": "The Orbitofrontal Cortex (OFC) is a brain region involved in reward processing and decision-making.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "OFC"}, {"entity_type": "SCALE", "description": "The Alcohol Urge Questionnaire (AUQ) measures cravings for alcohol.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "AUQ"}, {"entity_type": "SCALE", "description": "The Profile of Mood States (POMS) is a questionnaire measuring mood states.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "PROFILE OF MOOD STATES"}, {"entity_type": "STUDY", "description": "Zhang et al conducted a study on the CNR1 gene.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "ZHANG ET AL"}, {"entity_type": "BRAIN REGION", "description": "Brodmann areas 9 and 10 are regions within the prefrontal cortex.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "BRODMANN AREAS 9 AND 10"}, {"entity_type": "TISSUE TYPE", "description": "Postmortem prefrontal cortex tissue was analyzed for CB1 receptor levels.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "POSTMORTEM PFC"}, {"entity_type": "POPULATION", "description": "The study included 34 participants who were heavy drinkers.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "HEAVY DRINKERS"}, {"entity_type": "CONTROL CONDITION", "description": "Litchi juice served as an active control condition in the fMRI study.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "LITCHI JUICE"}, {"entity_type": "DRUG", "description": "Olanzapine is a medication that targets the dopamine system.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "OLANZAPINE"}, {"entity_type": "DRUG", "description": "Cyproheptadine hydrochloride is a control medication used in comparison to olanzapine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CYPROHEPTADINE HYDROCHLORIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The dopamine system is a neurotransmitter system involved in reward and motivation.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "DOPAMINE SYSTEM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reward is a positive reinforcement experienced after engaging in pleasurable activities.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "REWARD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Positive affect refers to feelings of happiness, contentment, and well-being.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "POSITIVE AFFECT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A subjective experience of euphoria or intoxication.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "SELF-REPORTED HIGH"}, {"entity_type": "SUBSTANCE", "description": "Beverages containing ethanol, which can produce intoxicating effects.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "ALCOHOLIC BEVERAGES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Stimuli that trigger cravings or memories associated with alcohol.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CUE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An intense desire for a substance, in this case, alcohol.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CRAVING"}, {"entity_type": "PHYSIOLOGICAL MEASURE", "description": "A measure of the quantity of alcoholic beverages consumed daily.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "DRINKS PER DRINKING DAY"}, {"entity_type": "DISEASE", "description": "A chronic condition characterized by compulsive alcohol seeking and use despite negative consequences.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "ALCOHOL DEPENDENCE"}, {"entity_type": "THERAPY", "description": "Administration of olanzapine to treat mental health conditions.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "OLANZAPINE TREATMENT"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The rs2023239 genotype influences CB1 receptor binding levels in postmortem human prefrontal cortex.)", "entity_type": "UNKNOWN", "id": "CB1 BINDING"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "CT genotype refers to a heterozygous variant at the C-13910 locus.<SEP>Individuals with the CT genotype for rs2023239 demonstrate significantly greater CB1 binding compared to those with the TT genotype.)", "entity_type": "GENOMIC VARIANT", "id": "CT GENOTYPE"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with the CT genotype for rs2023239 demonstrate significantly greater CB1 binding compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "GREATER CB1 BINDING"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the NAcc when exposed to alcohol cues compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "INCREASED NACC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the VMPFC when exposed to alcohol cues compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "INCREASED VMPFC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the VTA when exposed to alcohol cues compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "INCREASED VTA ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the OFC when exposed to alcohol cues compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "INCREASED OFC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, the AUDIT score was significantly correlated with activation of the VMPFC.)", "entity_type": "UNKNOWN", "id": "ALCOHOL USE DISORDER SCORE"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, the AUDIT score was significantly correlated with activation of the VMPFC.)", "entity_type": "UNKNOWN", "id": "VMPFC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, the AUQ score was significantly correlated with activation of the VMPFC and OFC.)", "entity_type": "UNKNOWN", "id": "URGE TO CONSUME ALCOHOL"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, the AUQ score was significantly correlated with activation of the VMPFC and OFC.)", "entity_type": "UNKNOWN", "id": "VMPFC AND OFC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with the CT genotype reported significantly greater reward and positive affect after drinking alcohol compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "REWARD AND POSITIVE AFFECT"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The National Center for Biotechnology Information provided data used in the analysis of the CNR1 gene.)", "entity_type": "UNKNOWN", "id": "DATA SOURCE"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The National Center for Biotechnology Information provided data used in the analysis of the CNR1 gene.)", "entity_type": "UNKNOWN", "id": "NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with the CT genotype for rs2023239 demonstrated significantly greater CB1 binding in Brodmann areas 9 and 10 compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "INCREASED CB1 BINDING IN BRODMANN AREAS 9 AND 10"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The rs2023239 genotype was associated with differences in CB1 binding levels within postmortem PFC tissue.)", "entity_type": "UNKNOWN", "id": "CB1 BINDING IN POSTMORTEM PFC"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Individuals with at least one copy of the C allele in rs2023239 demonstrated greater activation in brain regions associated with reward and motivation during exposure to alcohol cues compared to those with the TT genotype.)", "entity_type": "UNKNOWN", "id": "GREATER ACTIVATION DURING ALCOHOL CUE EXPOSURE"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, greater activation was observed in brain regions during the alcohol vs. litchi juice comparison compared to the TT group.)", "entity_type": "UNKNOWN", "id": "INCREASED ACTIVATION DURING ALCOHOL VS. LITCHI COMPARISON"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "There were no significant differences in self-reported ancestry between the TT and CT genotype groups.)", "entity_type": "UNKNOWN", "id": "NO DIFFERENCE IN ANCESTRY DISTRIBUTION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, higher AUDIT scores were significantly correlated with activation in the VMPFC.)", "entity_type": "UNKNOWN", "id": "CORRELATION WITH VMPFC ACTIVATION"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "In the CT group, higher AUQ scores were significantly correlated with activation in both the VMPFC and OFC.)", "entity_type": "UNKNOWN", "id": "CORRELATION WITH OFC AND VMPFC ACTIVATION"}, {"source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "description": "Individuals with the CT genotype reported greater cue-elicited craving when treated with placebo vs olanzapine.)", "entity_type": "UNKNOWN", "id": "CUE-ELICITED CRAVING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving the packaging and transport of dietary fat in the form of chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "EXOGENOUS LIPID METABOLISM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving the breakdown of chylomicrons by lipoprotein lipase.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "ENDOGENOUS LIPID METABOLISM"}, {"entity_type": "PROTEIN", "description": "An enzyme involved in the breakdown of chylomicrons.<SEP>Lipoprotein lipase (LPL) is an enzyme that breaks down triglycerides in lipoproteins.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPOPROTEIN LIPASE (LPL)"}, {"entity_type": "DISEASE", "description": "A rare autosomal recessive disorder characterized by decreased lipoprotein lipase activity due to mutations in the LPL gene.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "LPL DEFICIENCY"}, {"entity_type": "MOLECULE", "description": "A lipoprotein particle that transports dietary fat absorbed from the intestines to the bloodstream.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CHYLOMICRON"}, {"entity_type": "DISEASE", "description": "A condition characterized by elevated levels of triglycerides in the blood.<SEP>Hypertriglyceridemia is a condition characterized by high levels of triglycerides in the blood.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HYPERTRIGLYCERIDEMIA"}, {"entity_type": "DISEASE", "description": "Eruptive xanthomas are skin lesions that can appear when triglyceride levels exceed 2000 mg/dl.<SEP>Skin lesions characterized by yellow papules, commonly associated with hyperlipidemia.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ERUPTIVE XANTHOMAS"}, {"entity_type": "DISEASE", "description": "Enlargement of the liver and spleen, which can be a complication of LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "HEPATO-SPLENOMEGALY"}, {"entity_type": "DISEASE", "description": "A condition characterized by fat deposits in the retina, often associated with hypertriglyceridemia.<SEP>Lipemia retinalis is a condition where triglycerides accumulate in the blood vessels of the retina.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPEMIA RETINALIS"}, {"entity_type": "DISEASE", "description": "Inflammation of the pancreas, which can be a complication of hypertriglyceridemia.<SEP>Pancreatitis is an inflammation of the pancreas that can be triggered by high triglyceride levels.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "PANCREATITIS"}, {"entity_type": "DIETARY PATTERN", "description": "Dietary fat restriction is a cornerstone treatment for LPL deficiency.<SEP>The cornerstone of treatment for LPL deficiency, involving limiting the intake of dietary fat.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "DIETARY FAT RESTRICTION"}, {"entity_type": "THERAPY", "description": "An experimental treatment approach for LPL deficiency that aims to correct the underlying genetic defect.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "GENE THERAPY"}, {"entity_type": "SYMPTOM", "description": "A condition characterized by vomiting of dark-colored material resembling coffee grounds.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "COFFEE-GROUND EMESIS"}, {"entity_type": "SYMPTOM", "description": "A condition characterized by the passage of black, tarry stools due to bleeding in the digestive tract.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MELENA"}, {"entity_type": "SYMPTOM", "description": "A skin eruption characterized by small, raised bumps.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "PAPULAR RASH"}, {"entity_type": "TEST", "description": "Complete Blood Count, a test that measures various blood components.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CBC"}, {"entity_type": "NUTRIENT", "description": "Lipids found in the blood that are used for energy storage.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "TRIGLYCERIDES (TG)"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "Genetic material extracted from a blood sample.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "BLOOD DNA"}, {"entity_type": "GENE", "description": "The LPL gene provides instructions for making lipoprotein lipase (LPL) enzyme which breaks down triglycerides.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LPL GENE"}, {"entity_type": "NUTRIENT", "description": "Medium-chain triglycerides (MCT) supplements are absorbed directly into the portal vein and can be helpful in managing triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "MCT SUPPLEMENTS"}, {"entity_type": "DRUG", "description": "Gemfibrozil is a medication that can lower triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GEMFIBROZIL"}, {"entity_type": "DRUG", "description": "Orlistat is a medication used to treat obesity and can also lower triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ORLISTAT"}, {"entity_type": "GENOMIC VARIANT", "description": "A gain-of-function variant of the LPL gene can be introduced intramuscularly to increase lipoprotein lipase activity.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GAIN-OF-FUNCTION VARIANT OF THE LPL GENE"}, {"entity_type": "DRUG", "description": "Diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors are a promising new treatment for LPL deficiency.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "DGAT1 INHIBITORS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Amino acid residue 240 is crucial for the functional importance of the local domain in lipolysis of triglyceride-rich lipoproteins.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "AMINO ACID RESIDUE 240"}, {"source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "description": "The patient presented with episodes of coffee-ground emesis.)", "entity_type": "UNKNOWN", "id": "CASE REPORT PATIENT"}, {"source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "description": "Genomic DNA was isolated from whole blood for analysis.)", "entity_type": "UNKNOWN", "id": "GENOMIC ANALYSIS"}, {"entity_type": "DRUG", "description": "Topiramate is a medication used to treat alcohol use disorder.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "TOPIRAMATE"}, {"entity_type": "EFFICACY METRIC", "description": "NNT (Number Needed to Treat) is a measure of treatment effectiveness, indicating how many patients need to be treated to prevent one additional HDD.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "NNT"}, {"entity_type": "EVENT", "description": "An adverse event is any unintended or harmful effect that occurs as a result of taking medication.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ADVERSE EVENT"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2832407 is a specific genetic variant that influences the effectiveness of topiramate.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "RS2832407"}, {"entity_type": "POPULATION GROUP", "description": "European-Americans are a distinct population group.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "EUROPEAN-AMERICAN (EA)"}, {"entity_type": "ABBREVIATION/ACRONYM", "description": "HDDs stand for Heavy Drinking Days, a measure of alcohol consumption.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "HDDS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The severity of adverse events is assessed on a scale.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ADVERSE EVENT SEVERITY"}, {"entity_type": "DISEASE", "description": "Alcohol use disorder is a chronic, relapsing disease characterized by an inability to control alcohol consumption.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ALCOHOL USE DISORDER"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "Patients receiving topiramate reported more adverse events than those receiving placebo.)", "entity_type": "UNKNOWN", "id": "ADVERSE EVENTS"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "Patients homozygous for the rs2832407*C allele experienced greater benefit from topiramate treatment in terms of HDD reduction.)", "entity_type": "UNKNOWN", "id": "RS2832407*C-HOMOZYGOTES"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "The effect of topiramate was not observed in patients carrying the rs2832407*A allele.)", "entity_type": "UNKNOWN", "id": "RS2832407*A-ALLELE CARRIERS"}, {"entity_type": "GENE", "description": "ABCB1 is a gene associated with CINV severity.<SEP>The ABCB1 gene encodes the P-glycoprotein, a transporter involved in drug resistance.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCB1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1045642 is a variant in the ABCB1 gene associated with acute nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "RS1045642"}, {"entity_type": "GENOMIC VARIANT", "description": "A/G genotype refers to heterozygotes at rs1045642.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "A/G"}, {"entity_type": "GENOMIC VARIANT", "description": "G/G genotype refers to homozygous wild type at rs1045642.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "G/G"}, {"entity_type": "GENOMIC VARIANT", "description": "A/A genotype refers to homozygous variant at rs1045642.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "A/A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs45460698 is a genomic variant in the HTR3B gene not associated with CINV.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "RS45460698"}, {"entity_type": "DRUG", "description": "Palonosetron is an anti-emetic medication commonly used to prevent nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PALONOSETRON"}, {"entity_type": "DRUG", "description": "Dexamethasone is a corticosteroid commonly used as an anti-emetic medication.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DEXAMETHASONE"}, {"entity_type": "DRUG", "description": "Prochlorperazine is an anti-emetic medication used to prevent nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PROCHLORPERAZINE"}, {"entity_type": "DRUG", "description": "Ondansetron is an anti-emetic medication used to prevent nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ONDANSETRON"}, {"entity_type": "DRUG", "description": "Fosaprepitant is an anti-emetic medication used to prevent nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "FOSAPREPITANT"}, {"entity_type": "DISEASE", "description": "CINV stands for Chemotherapy-Induced Nausea and Vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CINV"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Acute nausea refers to the feeling of sickness immediately after chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ACUTE NAUSEA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Delayed nausea refers to the feeling of sickness that occurs days or weeks after chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DELAYED NAUSEA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Vomiting is the forceful expulsion of stomach contents.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "VOMITING"}, {"entity_type": "DISEASE", "description": "Gastrointestinal cancer encompasses cancers of the digestive tract.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "GASTROINTESTINAL CANCER"}, {"entity_type": "DISEASE", "description": "Thoracic cancer refers to cancers located in the chest.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "THORACIC CANCER"}, {"entity_type": "DISEASE", "description": "Advanced stage disease refers to cancer that has spread beyond its original location.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ADVANCED STAGE DISEASE"}, {"entity_type": "GENE", "description": "MCM6 gene encodes a protein involved in DNA replication.<SEP>MCM6 is a gene involved in DNA replication and cell cycle progression.<SEP>MCM6 is a gene involved in DNA replication and repair.<SEP>MCM6 is a gene located near LCT.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-ea45644d73f260cf365527dcc3af86e1", "id": "MCM6"}, {"entity_type": "LONG NON-CODING RNA", "description": "LOC100507600 is a long non-coding RNA (lncRNA) that regulates LCT mRNA expression.<SEP>LOC100507600 is a long non-coding RNA whose promoter is located within the LCT intron 5.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 55}]", "id": "LOC100507600"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Changes in DNA methylation patterns influencing gene expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA MODIFICATION"}, {"entity_type": "CELL TYPE", "description": "Specialized cells lining the small intestine responsible for nutrient absorption.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "ENTEROCYTES"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "Part of the small intestine where LCT expression is investigated.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "JEJUNUM"}, {"entity_type": "CELL TYPE", "description": "Immune cells found in blood and other tissues.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "WHITE BLOOD CELLS"}, {"entity_type": "BIOLOGICAL FEATURE", "description": "Patterns of DNA methylation changes associated with specific cell types or conditions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA MODIFICATION PROFILES"}, {"entity_type": "GENOMIC FEATURE", "description": "Sites in the genome where a cytosine nucleotide is followed by a guanine nucleotide.<SEP>Specific locations within the genome where cytosine (C) is followed by guanine (G) nucleotides.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "CPG SITES"}, {"entity_type": "GENOMIC REGION", "description": "Non-coding regions within a gene that are transcribed but removed during RNA splicing.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON"}, {"entity_type": "GENOMIC REGION", "description": "Coding regions within a gene that are translated into proteins.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EXON"}, {"entity_type": "GENOMIC REGION", "description": "Untranslated region at the 3\' end of messenger RNA (mRNA) involved in mRNA stability and translation.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "3\u2032-UTR"}, {"entity_type": "GENOMIC VARIANT", "description": "C-13910 is a genomic variant that influences LCT activity.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "C-13910"}, {"entity_type": "GENOMIC VARIANT", "description": "T-13910 is a genomic variant that influences LCT activity.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "T-13910"}, {"entity_type": "GENOMIC VARIANT", "description": "Exon 16 of MCM6 shows significant differences between C-13910 and T-13910 carrying haplotypes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "MCM6 EXON 16"}, {"entity_type": "TRANSCRIPT", "description": "LCT mRNA is the messenger RNA transcript of the LCT gene.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "LCT MRNA"}, {"entity_type": "TRANSCRIPT", "description": "lncRNA LOC100507600 is a non-coding RNA transcribed from the opposite strand of LCT and regulates its expression.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "LNCRNA LOC100507600"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Sperm samples are environmental factors used to investigate DNA modification differences.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "SPERM SAMPLES"}, {"entity_type": "GENOMIC VARIANT", "description": "CC genotype refers to a homozygous variant at the C-13910 locus.<SEP>The CC genotype is associated with an increased risk of CRC.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-5b0cc96debf110f3544685d3b227ff27", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "CC GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "TT genotype refers to a homozygous variant at the C-13910 locus.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "TT GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Embryogenesis is the developmental process from fertilized egg to embryo.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 54}]", "id": "EMBRYOGENESIS"}, {"entity_type": "CELL LINE", "description": "Caco-2 is a human intestinal epithelial cell line.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CACO-2"}, {"entity_type": "PROTEIN", "description": "CTCF is a protein that binds to insulator sites and regulates gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CTCF"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located at position -13910 in the genome.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SNP -13910"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Small interfering RNAs are used to silence gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SMALL-INTERFERING RNAS"}, {"entity_type": "DATABASE", "description": "ENCODE datasets provide information about genomic features and regulatory elements.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ENCODE DATASETS"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The promoter of the long non-coding RNA LOC100507600 is located within the LCT intron 5.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 55}]", "id": "LCT INTRON 5"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Differential DNA modifications were observed at the MCM6 intron 13 region between individuals with different LCT-MCM6 haplotypes.)", "entity_type": "UNKNOWN", "id": "MCM6 INTRON 13"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The LCT exon 1 region has characteristics of an active promoter, indicated by histone marks like H3K4me3 and H3K27ac.)", "entity_type": "UNKNOWN", "id": "ACTIVE PROMOTER"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The LCT exon 1 region has characteristics of an active promoter, indicated by histone marks like H3K4me3 and H3K27ac.)", "entity_type": "UNKNOWN", "id": "LCT EXON 1"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers (H3K4me1 and H3K27ac) were detected at the LCT introns 2 and 3.)", "entity_type": "UNKNOWN", "id": "ACTIVE ENHANCER"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers (H3K4me1 and H3K27ac) were detected at the LCT introns 2 and 3.)", "entity_type": "UNKNOWN", "id": "LCT INTRON 2 & 3"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers (H3K4me1 and H3K27ac) were detected at the MCM6 intron 13 and exon 16.)", "entity_type": "UNKNOWN", "id": "MCM6 INTRON 13 & EXON 16"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The MCM6 3\'-UTR region displays histone marks characteristic of active enhancers.)", "entity_type": "UNKNOWN", "id": "MCM6 3\'-UTR"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The jejunum is a tissue where LCT expression is investigated.)", "entity_type": "UNKNOWN", "id": "LCT EXPRESSION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modifications at MCM6 intron 13 differ between individuals with different C-13910/T-13910 genotypes.)", "entity_type": "UNKNOWN", "id": "C-13910/T-13910 GENOTYPES"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "LCT mRNA levels are highest in lactase persistent individuals and lower in lactase non-persistent individuals.)<SEP>LCT mRNA levels are not significantly affected by age in lactase persistent (TT) individuals.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 51}]", "id": "LACTASE PERSISTENCE GENOTYPE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modifications at LCT and MCM6 increase with age in lactase non-persistent individuals, but decrease with age in lactase persistent individuals.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 54}]", "id": "DNA MODIFICATIONS"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "LCT intron 2 is highly conserved across mammals.)", "entity_type": "UNKNOWN", "id": "EVOLUTIONARY CONSERVATION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "LCT intron 2 is highly conserved across mammals.)", "entity_type": "UNKNOWN", "id": "LCT INTRON 2"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "LCT intron 2 is an important regulatory element for lactase non-persistence.)", "entity_type": "UNKNOWN", "id": "LACTASE NON-PERSISTENCE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modification differences between CC, CT and TT genotypes at MCM6 intron 13 are observed in sperm samples, suggesting that modifications are erased during embryogenesis.)", "entity_type": "UNKNOWN", "id": "CC GENOTYPE/TT GENOTYPE"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "CTCF binding site overlaps the lncRNA promoter.)", "entity_type": "UNKNOWN", "id": "LNCRNA PROMOTER"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Increased DNA methylation inhibits CTCF binding at insulator sites.)", "entity_type": "UNKNOWN", "id": "CTCF BINDING"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Increased DNA methylation inhibits CTCF binding at insulator sites.)", "entity_type": "UNKNOWN", "id": "DNA METHYLATION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion of Lct intron 2 caused a significant downregulation of LCT mRNA in mice.)", "entity_type": "UNKNOWN", "id": "LCT INTRON 2 DELETION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion of Lct intron 2 caused a significant downregulation of LCT mRNA in mice.)", "entity_type": "UNKNOWN", "id": "LCT MRNA REDUCTION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion of Mcm6 intron 13 resulted in less pronounced LCT mRNA reduction in mice.)", "entity_type": "UNKNOWN", "id": "MCM6 INTRON 13 DELETION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion in MCM6 intron 13 or LCT intron 2 resulted in a decrease in LCT mRNA levels in differentiated Caco-2 cells.)", "entity_type": "UNKNOWN", "id": "CACO-2 CELLS, DIFFERENTIATED STATE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lactase persistence is the ability to digest lactose in adulthood.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 28}]", "id": "LACTASE PERSISTENCE"}, {"entity_type": "FOOD", "description": "Milk is a food product consumed by humans.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 28}]", "id": "MILK"}, {"entity_type": "COUNTRY", "description": "Romania is a country in Eastern Europe.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "ROMANIA"}, {"entity_type": "COUNTRY", "description": "Poland is a country in Eastern Europe.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "POLAND"}, {"entity_type": "COUNTRY", "description": "Russia is a country in Eastern Europe.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "RUSSIA"}, {"entity_type": "COUNTRY", "description": "The Czech Republic is a country in Eastern Europe.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 27}]", "id": "CZECH REPUBLIC"}, {"entity_type": "COUNTRY", "description": "The UK (United Kingdom) is a country in Western Europe.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "UK"}, {"source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "description": "There was an elevated risk of RCC among those consuming milk compared to those who never consumed it.)", "entity_type": "UNKNOWN", "id": "MILK CONSUMPTION"}, {"source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "description": "There was an elevated risk of RCC among those consuming milk compared to those who never consumed it.)", "entity_type": "UNKNOWN", "id": "RCC"}, {"entity_type": "THERAPY", "description": "Hydroxyurea (HU) treatment is investigated in this study.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HU TREATMENT"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP had a very low allele frequency and was excluded from the study.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HBG2-XMN1-RS7482144"}, {"entity_type": "POPULATION", "description": "The study analyzed data from a Brazilian cohort.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BRAZILIAN COHORT"}, {"entity_type": "GENOMIC VARIANT", "description": "This haplotype, carrying all three BCL11A SNPs, is associated with higher baseline and MTD HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "T-A-C HAPLOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is associated with increased baseline and MTD HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HMIP-2 RS9399137"}, {"entity_type": "GENOMIC VARIANT", "description": "The C-A haplotype is a specific combination of genetic variations within the HMIP-2 gene.<SEP>This haplotype, carrying the C-A alleles of the two HMIP-2 SNPs, is associated with higher baseline HbF levels.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "C-A HAPLOTYPE"}, {"entity_type": "HEMATOLOGICAL MARKER", "description": "HbF stands for hemoglobin F and is a measure of fetal hemoglobin.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HBF"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline HbF refers to the initial level of fetal hemoglobin (HbF) present in an individual.)<SEP>Baseline HbF refers to the initial level of hemoglobin F at the start of the study.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BASELINE HBF"}, {"entity_type": "HEMATOLOGICAL MARKER", "description": "MTD HbF stands for hemoglobin F at the maximum tolerated dose (MTD) of hydroxyurea.<SEP>Mean Target Density Hemoglobin F (MTD HbF) refers to the target density of fetal hemoglobin in red blood cells.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "MTD HBF"}, {"entity_type": "HEMATOLOGICAL MARKER", "description": "Delta HbF represents the change in fetal hemoglobin levels compared to a baseline measurement.)<SEP>Delta HbF represents the change in hemoglobin F levels from baseline to MTD.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "DELTA HBF"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is located within the BCL11A gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BCL11A RS4671393"}, {"entity_type": "GENE", "description": "HMIP-2 is a gene implicated in hemoglobin levels.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "HMIP-2"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The BCL11A rs1427407 SNP is associated with increased baseline and MTD HbF levels.)", "entity_type": "UNKNOWN", "id": "BCL11A RS1427407"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The BCL11A rs11886868 SNP is associated with MTD and delta HbF.)", "entity_type": "UNKNOWN", "id": "BCL11A RS11886868"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The HMIP-2 rs9402686 SNP is associated with increased baseline and MTD HbF levels.)", "entity_type": "UNKNOWN", "id": "HMIP-2 RS9402686"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "There was an inverse correlation between delta HbF and HbF at baseline.)", "entity_type": "UNKNOWN", "id": "HBF AT BASELINE"}, {"entity_type": "PROTEIN", "description": "FANCD2 is a protein involved in DNA repair, and its monoubiquitination is crucial for the Fanconi Anemia pathway.<SEP>FANCD2 is a protein involved in the Fanconi Anemia (FA) pathway.<SEP>FANCD2 is a protein substrate for the FANCL complex.<SEP>FANCD2 is a protein that interacts with URD and FANCI.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f<SEP>chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "id": "FANCD2"}, {"entity_type": "PROTEIN", "description": "FANCI is a protein involved in the Fanconi Anemia (FA) pathway.<SEP>FANCI is another protein involved in DNA repair, working alongside FANCD2.<SEP>FANCI is a protein substrate for the FANCL complex.<SEP>FANCI is a protein that interacts with URD and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f<SEP>chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "id": "FANCI"}, {"entity_type": "PROTEIN", "description": "UBE2T is a gene involved in Fanconi Anemia.<SEP>UBE2T is a gene that encodes for a protein involved in ubiquitination and DNA repair.<SEP>Ube2T is an E2 ubiquitin-conjugating enzyme that interacts with the RING domain.<SEP>Ube2T is an E2 ubiquitin-conjugating enzyme.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8<SEP>chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "id": "UBE2T"}, {"entity_type": "PROTEIN", "description": "FANCA is a protein involved in the Fanconi Anemia (FA) pathway.<SEP>FANCA is a protein that interacts with FAAP20 through its N-terminal region.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "MMC (Mitomycin C) is a crosslinking agent that induces DNA damage.<SEP>MMC is a crosslinking agent used to study cellular sensitivity.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "MMC"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DEB (Diepoxybutane) is a crosslinking agent that induces DNA damage.<SEP>DEB is a crosslinking agent used to study cellular sensitivity.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "DEB"}, {"entity_type": "CELL TYPE", "description": "Fibroblasts are cells derived from connective tissue.<SEP>Fibroblasts are connective tissue cells that play a role in DNA repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FIBROBLAST"}, {"entity_type": "CELL TYPE", "description": "Lymphoblastoid cell lines are immortalized B-lymphocytes.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "LYMPHOBLASTOID CELL LINE (LCLS)"}, {"entity_type": "GENETIC ELEMENT", "description": "AluYa5 is a type of repetitive DNA sequence found in the human genome.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "ALUYA5 REPEAT"}, {"entity_type": "ALLELE", "description": "Wild type refers to the normal, non-mutated allele of a gene.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "WILD TYPE"}, {"entity_type": "ALLELE", "description": "A mutant allele contains a change in the DNA sequence from the wild type.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "MUTANT ALLELE"}, {"entity_type": "GENOTYPE", "description": "Compound heterozygosity refers to having two different mutant alleles of a gene.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "COMPOUND HETEROZYGOUS MUTATIONS"}, {"entity_type": "PROCESS", "description": "Protein expression is the process by which information encoded in DNA is used to synthesize proteins.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "PROTEIN EXPRESSION"}, {"entity_type": "PROTEIN", "description": "Overexpression of the UBE2T protein rescued cellular hypersensitivity to crosslinking agents and restored monoubiquitination of FANCD2 and FANCI.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "UBE2T PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cisplatin is a chemotherapy drug that also acts as a crosslinking agent.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "CISPLATIN"}, {"entity_type": "DISEASE", "description": "RA2627 fibroblasts are cells from a patient with Fanconi Anemia-T subtype.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "RA2627"}, {"entity_type": "CELL LINE", "description": "BJ cells are a normal human fibroblast cell line used as a control in experiments.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "BJ CELLS"}, {"entity_type": "DISEASE", "description": "Fanconi Anemia-T subtype is a genetic disorder characterized by defective DNA repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 146}]", "id": "FANCONI ANEMIA-T SUBTYPE"}, {"entity_type": "INDIVIDUAL", "description": "The proband is the individual with Fanconi Anemia-T subtype whose cells were studied in this research.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "PROBAND"}, {"entity_type": "GENE PRODUCT", "description": "Wild type UBE2T refers to the normal, functional version of the UBE2T gene product.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "WILD TYPE UBE2T"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Crosslinking agents like MMC, DEB, and cisplatin induce DNA damage by forming covalent bonds between DNA strands.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "CROSSLINKING AGENTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The G2 phase is a stage in the cell cycle where DNA replication is completed and cells prepare for mitosis.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "G2 PHASE"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "FANCD2 is a key protein involved in the Fanconi Anemia (FA) pathway.)", "entity_type": "UNKNOWN", "id": "FANCONI ANEMIA PATHWAY"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "UBE2T is involved in DNA repair processes.)", "entity_type": "UNKNOWN", "id": "DNA REPAIR"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Fibroblasts are hypersensitive to MMC, indicating potential FA.)", "entity_type": "UNKNOWN", "id": "CELLULAR SENSITIVITY"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Fibroblasts are used as a model system to study cell function and disease.)", "entity_type": "UNKNOWN", "id": "STUDY MODEL"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "LCLs are derived from blood cells and can be used to study hematopoiesis (blood cell formation).)", "entity_type": "UNKNOWN", "id": "HEMATOPOIESIS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "LCLs are derived from blood cells and can be used to study hematopoiesis (blood cell formation).)", "entity_type": "UNKNOWN", "id": "LCLS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "AluYa5 repeats can mediate genetic recombination events.)", "entity_type": "UNKNOWN", "id": "GENETIC RECOMBINATION"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The wild type allele usually encodes a functional protein.)", "entity_type": "UNKNOWN", "id": "FUNCTIONAL PROTEIN"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "A mutant allele may result in a non-functional or altered protein.)", "entity_type": "UNKNOWN", "id": "DISRUPTED FUNCTION"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Compound heterozygosity often leads to loss of gene function.)", "entity_type": "UNKNOWN", "id": "LOSS OF FUNCTION"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "A genomic variant in the UBE2T gene causes Fanconi Anemia-T subtype.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 146}]", "id": "UBE2T GENE"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Overexpression of UBE2T rescued cellular defects in RA2627 cells, suggesting that UBE2T deficiency is the cause of the disorder.)", "entity_type": "UNKNOWN", "id": "RA2627 CELLS"}, {"entity_type": "GENE", "description": "RPS19 is a gene that is mutated in Diamond-Blackfan anemia (DBA).", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS19"}, {"entity_type": "PROTEIN", "description": "LARS is involved in aminoacyl-tRNA biosynthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "LARS"}, {"entity_type": "PROTEIN", "description": "WARS is a gene that was found to be downregulated in DBA patients compared to controls.<SEP>WARS is involved in aminoacyl-tRNA biosynthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94<SEP>chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "WARS"}, {"entity_type": "PROTEIN", "description": "GARS is involved in aminoacyl-tRNA biosynthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "GARS"}, {"entity_type": "PROTEIN", "description": "SARS is involved in aminoacyl-tRNA biosynthesis.<SEP>SARS is involved in glycine, serine and threonine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "SARS"}, {"entity_type": "PROTEIN", "description": "QARS is involved in aminoacyl-tRNA biosynthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "QARS"}, {"entity_type": "PROTEIN", "description": "EPRS is involved in aminoacyl-tRNA biosynthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "EPRS"}, {"entity_type": "PROTEIN", "description": "PSAT1 is involved in glycine, serine and threonine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PSAT1"}, {"entity_type": "PROTEIN", "description": "PHGDH is involved in glycine, serine and threonine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PHGDH"}, {"entity_type": "PROTEIN", "description": "CTH is involved in glycine, serine and threonine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "CTH"}, {"entity_type": "PROTEIN", "description": "SHMT2 is involved in glycine, serine and threonine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "SHMT2"}, {"entity_type": "PROTEIN", "description": "CASP9 is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "CASP9"}, {"entity_type": "PROTEIN", "description": "NFKBIA is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKBIA"}, {"entity_type": "PROTEIN", "description": "NFKBIE is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKBIE"}, {"entity_type": "PROTEIN", "description": "APAF1 is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "APAF1"}, {"entity_type": "PROTEIN", "description": "NFKB2 is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKB2"}, {"entity_type": "PROTEIN", "description": "NFKB1 is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKB1"}, {"entity_type": "PROTEIN", "description": "BIRC3 is involved in death receptor signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "BIRC3"}, {"entity_type": "GENE", "description": "RPL22 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL22"}, {"entity_type": "GENE", "description": "RPL27A is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL27A"}, {"entity_type": "GENE", "description": "RPL29 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL29"}, {"entity_type": "GENE", "description": "RPL31 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL31"}, {"entity_type": "GENE", "description": "RPL14 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL14"}, {"entity_type": "GENE", "description": "RPL18A is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL18A"}, {"entity_type": "GENE", "description": "RPS3 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS3"}, {"entity_type": "GENE", "description": "RPL18 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL18"}, {"entity_type": "GENE", "description": "RPL13 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL13"}, {"entity_type": "GENE", "description": "RPL3 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL3"}, {"entity_type": "GENE", "description": "RPL34 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL34"}, {"entity_type": "GENE", "description": "RPS2 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS2"}, {"entity_type": "GENE", "description": "RPS12 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS12"}, {"entity_type": "GENE", "description": "RPL15 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL15"}, {"entity_type": "GENE", "description": "RPL28 is a gene involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL28"}, {"entity_type": "GENE", "description": "AMPD3 is a gene that was found to be upregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "AMPD3"}, {"entity_type": "GENE", "description": "CCND2 is a gene that was found to be upregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CCND2"}, {"entity_type": "GENE", "description": "SOD2 is a gene that was found to be upregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SOD2"}, {"entity_type": "GENE", "description": "TNFAIP3 is a gene that was found to be upregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "TNFAIP3"}, {"entity_type": "GENE", "description": "COMP is a gene that was found to be downregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "COMP"}, {"entity_type": "GENE", "description": "ZIC1 is a gene that was found to be downregulated in DBA patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "ZIC1"}, {"entity_type": "DISEASE", "description": "DBA refers to a specific disease, likely Dubin-Johnson Syndrome.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "DBA"}, {"entity_type": "CONTROL GROUP", "description": "Controls are individuals used as a baseline comparison in medical research.<SEP>Controls are individuals who do not have the condition being studied and serve as a comparison group.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "CONTROLS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in RPS19 affect aminoacyl-tRNA biosynthesis pathways.)", "entity_type": "UNKNOWN", "id": "AMINOACYL-TRNA BIOSYNTHESIS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in RPS19 affect glycine, serine and threonine metabolism pathways.)", "entity_type": "UNKNOWN", "id": "GLYCINE, SERINE AND THREONINE METABOLISM"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in RPS19 affect death receptor signaling pathways.)", "entity_type": "UNKNOWN", "id": "DEATH RECEPTOR SIGNALING"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "RPL22 is involved in protein synthesis.)", "entity_type": "UNKNOWN", "id": "PROTEIN SYNTHESIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located within the BDNF gene, specifically at position rs6265 with alleles G and A.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF RS6265 (G/A)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located within the BDNF gene, specifically at position rs2049046 with alleles A and T.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RS2049046 (A/T)"}, {"entity_type": "DISEASE", "description": "A neurological disorder characterized by recurring headaches often accompanied by nausea, vomiting, and sensitivity to light and sound.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "MIGRAINE"}, {"entity_type": "DATABASE", "description": "A database of biomedical literature maintained by the National Library of Medicine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "PUBMED"}, {"entity_type": "DATABASE", "description": "A multidisciplinary citation indexing service that indexes scholarly research publications.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "WEB OF SCIENCE"}, {"entity_type": "DATABASE", "description": "A collection of systematic reviews on healthcare interventions, diagnostic tests, and health care systems.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "COCHRANE DATABASES"}, {"entity_type": "POPULATION GROUP", "description": "A group of people who share common ancestry and physical characteristics, specifically those with origins in Europe.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "CAUCASIAN POPULATION GROUPS"}, {"entity_type": "COHORT STUDY", "description": "A type of observational study that follows a group of individuals over time to observe the development of health outcomes.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "AUSTRALIAN-BASED INDEPENDENT COHORTS"}, {"entity_type": "STATISTICAL CONCEPT", "description": "A principle in population genetics stating that allele and genotype frequencies in a population will remain constant from generation to generation in the absence of disturbing factors.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"entity_type": "QUALITY ASSESSMENT TOOL", "description": "A metric used to assess the methodological quality of scientific studies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "NOS SCORE"}, {"entity_type": "STATISTICAL METHOD", "description": "A statistical technique for combining data from multiple independent studies to obtain a more precise estimate of an effect.<SEP>Meta-analysis is a statistical method used to combine the results of multiple studies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-814fe155e9cb953da61f6a79d1d25784", "id": "META-ANALYSIS"}, {"entity_type": "STATISTICAL MODEL", "description": "A type of statistical model used in meta-analysis that assumes a fixed effect size across studies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "FIXED-EFFECTS MODEL"}, {"entity_type": "STATISTICAL MEASURE", "description": "A measure of association between an exposure and an outcome, calculated as the odds of the outcome occurring in the exposed group divided by the odds of the outcome occurring in the unexposed group.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "ODDS RATIO (OR)"}, {"entity_type": "STATISTICAL MEASURE", "description": "A range of values within which we are confident that the true population parameter lies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "CONFIDENCE INTERVAL (CI)"}, {"entity_type": "STATISTICAL METHOD", "description": "A technique used to assess the robustness of a meta-analysis by examining the impact of removing individual studies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "SENSITIVITY ANALYSIS"}, {"entity_type": "PUBLICATION BIAS TEST", "description": "A statistical test used to detect publication bias in meta-analyses.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BEGG\u2019S TEST"}, {"entity_type": "PUBLICATION BIAS TEST", "description": "A statistical test used to detect publication bias in meta-analyses.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "EGGER\u2019S TEST"}, {"source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "description": "The BDNF rs2049046 (A/T) polymorphism is also associated with a higher susceptibility to migraine.)", "entity_type": "UNKNOWN", "id": "BDNF RS2049046 (A/T)"}, {"entity_type": "DRUG", "description": "Adalimumab is a biologic drug used to treat autoimmune diseases.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ADALIMUMAB"}, {"entity_type": "DISEASE", "description": "HS (Hidradenitis Suppurativa) is a chronic skin condition characterized by painful nodules, abscesses and fistulas.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HS"}, {"entity_type": "DISEASE", "description": "Psoriasis is a common inflammatory skin condition that causes red, scaly patches.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PSORIASIS"}, {"entity_type": "DISEASE CLASSIFICATION SYSTEM", "description": "The Hurley classification system is used to stage HS based on the severity and extent of lesions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HURLEY III"}, {"entity_type": "DISEASE SEVERITY SCORE", "description": "The Sartorius score is a numerical scale used to assess the severity of HS.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "SARTORIUS SCORE"}, {"entity_type": "DISEASE SEVERITY SCORE", "description": "PASI (Psoriasis Area and Severity Index) is a numerical scale used to assess the severity of psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PASI"}, {"entity_type": "PATIENT", "description": "A 48-year-old Caucasian woman with HS who developed paradoxical psoriasis after adalimumab treatment.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 1"}, {"entity_type": "PATIENT", "description": "A 40-year-old Caucasian man with HS who developed paradoxical psoriasis after adalimumab treatment.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 2"}, {"entity_type": "PATIENT", "description": "A 27-year-old Caucasian man with HS who developed paradoxical psoriasis after biological therapy.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 3"}, {"entity_type": "SKIN LESION", "description": "Nodules are solid, raised bumps on the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "NODULES"}, {"entity_type": "SKIN LESION", "description": "Fistulas are abnormal tunnels connecting two organs or tissues.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "FISTULAS"}, {"entity_type": "SKIN LESION", "description": "Sinus tracts are narrow passages that lead from an abscess to the surface of the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "SINUS TRACTS"}, {"entity_type": "SKIN LESION", "description": "Erythematous-scaly lesions are red, scaly patches on the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ERYTHEMATOUS-SCALY LESIONS"}, {"entity_type": "SKIN LESION", "description": "Pustular lesions are small, pus-filled bumps on the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PUSTULAR LESIONS"}, {"entity_type": "DISEASE", "description": "Alopecia areata is an autoimmune disorder that causes hair loss in patches.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ALOPECIA AREATA"}, {"entity_type": "SKIN LESION", "description": "Eczematous-like skin lesions resemble eczema, a common inflammatory skin condition.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ECZEMATOUS-LIKE SKIN LESIONS"}, {"entity_type": "SKIN LESION", "description": "Comedones are small, black or white bumps on the skin caused by clogged hair follicles.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "COMEDONES"}, {"entity_type": "HISTOLOGICAL FEATURE", "description": "Epidermal hyperplasia is an abnormal thickening of the epidermis, the outermost layer of the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "EPIDERMAL HYPERPLASIA"}, {"entity_type": "HISTOLOGICAL FEATURE", "description": "Parakeratosis is a condition in which the stratum corneum, the outermost layer of the epidermis, does not fully keratinize.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PARAKERATOSIS"}, {"entity_type": "HISTOLOGICAL FEATURE", "description": "Papillary vessel ectasia is an abnormal widening of blood vessels in the dermis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PAPILLARY VESSEL ECTASIA"}, {"entity_type": "CYTOKINE", "description": "IL-22 is a cytokine involved in inflammatory responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 103}]", "id": "IL\u201022"}, {"entity_type": "IMMUNE CELL", "description": "CD3+ cells are a type of T cell.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD3+ CELLS"}, {"entity_type": "IMMUNE CELL", "description": "CD4+ cells are a subset of T cells that play a role in immune regulation and activation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD4+ CELLS"}, {"entity_type": "IMMUNE CELL", "description": "CD8+ cells are a subset of T cells that directly kill infected or cancerous cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD8+ CELLS"}, {"entity_type": "CELL TYPE", "description": "PBMCs (peripheral blood mononuclear cells) include lymphocytes, monocytes, and other immune cells.<SEP>Peripheral blood mononuclear cells, containing various immune cell types.<SEP>Peripheral blood mononuclear cells are a heterogeneous population of immune cells obtained from the peripheral blood.<SEP>PBMCs are peripheral blood mononuclear cells, which include various immune cell types.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "PBMCS"}, {"entity_type": "CELL TYPE", "description": "Keratinocytes are the predominant cell type in the epidermis, responsible for producing keratin.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "KERATINOCYTES"}, {"entity_type": "CELL TYPE", "description": "Endothelial cells line blood vessels and play a role in blood flow regulation and immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ENDOTHELIAL CELLS"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Innate immunity molecules are part of the body\'s first line of defense against pathogens.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "INNATE IMMUNITY MOLECULES"}, {"entity_type": "CYTOKINE", "description": "IFN-\u03b2 is a type I interferon, involved in antiviral responses and immune regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TYPE I IFN\u2010\u0392"}, {"entity_type": "CYTOKINE", "description": "IFN-\u03ba is another type of type I interferon with similar functions to IFN-\u03b2.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TYPE I IFN\u2010\u039a"}, {"entity_type": "CYTOKINE", "description": "IFN-\u03b12a is a type I interferon involved in antiviral responses and immune regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN\u2010\u03912A"}, {"entity_type": "CYTOKINE", "description": "IFN-\u03bb1 is a type III interferon with antiviral and immunomodulatory effects.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN\u2010\u039b1"}, {"entity_type": "ANTIMICROBIAL PEPTIDE", "description": "LL-37 is an antimicrobial peptide produced by keratinocytes and other cells, involved in innate immunity.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LL\u201037"}, {"entity_type": "CYTOKINE", "description": "LT-\u03b1 is a member of the TNF family of cytokines, involved in immune cell development and activation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LT\u2010\u0391"}, {"entity_type": "CYTOKINE", "description": "LT-\u03b2 is another member of the TNF family of cytokines, similar to LT-\u03b1 in function.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LT\u2010\u0392"}, {"entity_type": "CYTOKINE", "description": "TNF-\u03b1 is a proinflammatory cytokine involved in various immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNF\u2010\u0391"}, {"entity_type": "GENE", "description": "HLA-C is a gene encoding a protein involved in the immune system\'s recognition of pathogens.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA\u2010C"}, {"entity_type": "GENE", "description": "ERAP1 is a gene encoding an enzyme involved in antigen processing.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ERAP1"}, {"entity_type": "GENE", "description": "CCHCR1 is a gene that contains three SNPs (rs1576/rs130079/rs746647).", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 62}]", "id": "CCHCR1"}, {"entity_type": "GENE", "description": "IL23R is a gene that has been associated with paradoxical psoriasiform reactions to anti-TNF therapies.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11209026 is a SNP in the IL23R gene that was previously associated with paradoxical psoriasiform reactions to anti-TNFs.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS11209026"}, {"entity_type": "GENOMIC VARIANT", "description": "rs72676067 is a SNP in the IL23R gene detected in patient 2.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS72676067"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1004819 is a SNP in the IL23R gene detected in patient 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS1004819"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1576 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 62}]", "id": "RS1576"}, {"entity_type": "GENOMIC VARIANT", "description": "rs130079 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 62}]", "id": "RS130079"}, {"entity_type": "GENOMIC VARIANT", "description": "rs746647 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 62}]", "id": "RS746647"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Paradoxical psoriasis manifests as psoriasiform or eczematous skin lesions.)", "entity_type": "UNKNOWN", "id": "PARADOXICAL PSORIASIS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Paradoxical psoriasis manifests as psoriasiform or eczematous skin lesions.)", "entity_type": "UNKNOWN", "id": "SKIN LESIONS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "HS patients showed enriched CD8+, but not CD4+ cells in skin biopsies compared to PBMCs.)", "entity_type": "UNKNOWN", "id": "CD3+ CELLS FROM SKIN BIOPSIES"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "HS patients showed enriched CD8+, but not CD4+ cells in skin biopsies compared to PBMCs.)", "entity_type": "UNKNOWN", "id": "HS PATIENTS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "The epidermis of psoriasiform reactions was immunoreactive for IFN-\u03ba.)", "entity_type": "UNKNOWN", "id": "IFN\u2010\u039a"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "The inflammatory infiltrate pattern in paradoxical psoriasis strongly resembles that present in acute psoriasis.)", "entity_type": "UNKNOWN", "id": "ACUTE PSORIASIS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "The type I IFN\u2010\u03b2 was expressed at levels significantly higher than classical psoriasis (~1.9-fold increase).)", "entity_type": "UNKNOWN", "id": "CLASSICAL PSORIASIS"}, {"entity_type": "GENE", "description": "FANCL is a gene that encodes for the FANCL protein.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "FANCL"}, {"entity_type": "PROTEIN", "description": "The DRWD domain is a structural motif found in the FANCL protein.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DRWD DOMAIN"}, {"entity_type": "PROTEIN", "description": "Human FANCL is a protein involved in DNA repair.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HUMAN FANCL"}, {"entity_type": "PROTEIN", "description": "DmFANCL is a protein from Drosophila that has structural similarities to human FANCL.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DMFANCL"}, {"entity_type": "PROTEIN", "description": "Ubiquitin is a small protein that is covalently attached to other proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "UBIQUITIN"}, {"entity_type": "AMINO ACID", "description": "Cysteine is an amino acid that can form disulfide bonds.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CYSTEINE"}, {"entity_type": "SECONDARY STRUCTURE", "description": "An \u03b1-helix is a common secondary structure element in proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0391-HELIX"}, {"entity_type": "SECONDARY STRUCTURE", "description": "A \u03b2-strand is a common secondary structure element in proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0392-STRAND"}, {"entity_type": "SECONDARY STRUCTURE", "description": "A \u03b2-meander is a specific arrangement of \u03b2-strands.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0392-MEANDER"}, {"entity_type": "PROTEIN MOTIF", "description": "The YPXXXP motif is a conserved sequence found in some proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "YPXXXP MOTIF"}, {"entity_type": "PROTEIN MOTIF", "description": "The HPXXXP motif is a conserved sequence found in some proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HPXXXP MOTIF"}, {"entity_type": "PROTEIN", "description": "The URD (Ubiquitin-like domain) is a protein domain that interacts with other proteins like Ube2T and FANCI/FANCD2.<SEP>URD is a protein that interacts with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "id": "URD"}, {"entity_type": "PROTEIN", "description": "DmDRWD is the Drosophila homolog of the human DRWD, containing structural similarities but some variations.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "DMDRWD"}, {"entity_type": "PROTEIN", "description": "The RING domain binds Ube2T with a high affinity.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "RING DOMAIN"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids form a hydrophobic patch on the N-terminal lobe of the URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-149, TYR-165, PHE-166, AND VAL-167"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids form a patch on the URD between \u03b1-helix 1 and the N-terminal region of the large kinked helix.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-121, ALA-140, ILE-184, TYR-187, AND LEU-191"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These residues are in a conserved region on the N-terminal region corresponding to DmDRWD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "TYR-112, TYR-113, AND LEU-116"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These residues are in a more extensively conserved region on the N-terminal region in humans.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ILE-115, TRP-123, LEU-126, VAL-127, TYR-128, ALA-129, AND PHE-133"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids form a hydrophobic groove between the last \u03b2-strand of the four-stranded \u03b2-meander and \u03b1-helix 3 on the C-terminal domain of DmDRWD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ILE-243, MET-246, LEU-248, LEU-264, LEU-268, AND TRP-271"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids form a hydrophobic groove in the human URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "PHE-253, VAL-260, AND LEU-268"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These residues are in addition to those forming the hydrophobic groove in the human URD compared to DmFANCL.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-248, PHE-252, LEU-254, ILE-265, AND ILE-271"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids form a hydrophobic patch on the C-terminal lobe of the URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "TRP-212, VAL-213, AND LEU-214"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "This histidine residue in Ube2T is predicted to interact with the RING domain.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HIS-63"}, {"entity_type": "GENOMIC VARIANT", "description": "L248A/F252A/L254A/I265A is a mutation in the C-terminal lobe of URD that reduces binding with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "L248A/F252A/L254A/I265A"}, {"entity_type": "GENOMIC VARIANT", "description": "W212A/L214A is a mutation in the C-terminal lobe of URD that reduces binding with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "W212A/L214A"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The C-terminal lobe of URD is involved in substrate binding.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "C-TERMINAL LOBE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The N-terminal lobe of URD does not appear to be involved in substrate binding based on the results.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "N-TERMINAL LOBE"}, {"source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "description": "Mutation of residues L149 and F166 in the URD reduces binding to both FANCI and FANCD2.)", "entity_type": "UNKNOWN", "id": "FANCI,FANCD2"}, {"source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "description": "Mutation of residues L149 and F166 in the URD reduces binding to both FANCI and FANCD2.)", "entity_type": "UNKNOWN", "id": "L149A/F166A"}, {"source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "description": "The L248A/F252A/L254A/I265A mutation reduces the binding strength of URD to FANCI and FANCD2.)", "entity_type": "UNKNOWN", "id": "BINDING STRENGTH"}, {"entity_type": "GENE", "description": "FGFR4 is a gene.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4"}, {"entity_type": "GENOMIC VARIANT", "description": "rs376618 is a genomic variant in the FGFR4 gene.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "RS376618"}, {"entity_type": "GENOMIC VARIANT", "description": "rs351855 is a functional genetic variant in the FGFR4 gene, resulting in the Gly388Arg amino acid change.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "RS351855"}, {"entity_type": "PROTEIN", "description": "Gly388Arg is an amino acid change resulting from the rs351855 genomic variant.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GLY388ARG"}, {"entity_type": "DRUG", "description": "Colesevelam is a drug used to treat hypercholesterolemia.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "COLESEVELAM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "AC t1/2 represents the terminal half-life of  a drug in circulation.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "AC T1/2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GC24 represents the amount of a drug remaining in circulation after 24 hours.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GC24"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CT represents the time to reach peak drug concentration.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "CT"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4975017 is a genomic variant in the KLB gene.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "RS4975017"}, {"entity_type": "GENE", "description": "KLB is a gene.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB"}, {"entity_type": "PROTEIN", "description": "Arg728Gln is an amino acid change resulting from the rs17618244 genomic variant.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "ARG728GLN"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17618244 is a functional genetic variant in the KLB gene, resulting in the Arg728Gln amino acid change.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "RS17618244"}, {"entity_type": "POPULATION", "description": "Healthy control patients were part of a previous study.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "HEALTHY CONTROL PATIENTS"}, {"entity_type": "DOCUMENT ELEMENT", "description": "Table 1 presents data on Hardy-Weinberg equilibrium.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "TABLE 1"}, {"entity_type": "DOCUMENT ELEMENT", "description": "Table 2 shows the distribution of participant genotypes for SNPs.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "TABLE 2"}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "The FGFR4 rs376618 SNP did not satisfy Hardy-Weinberg equilibrium in this study.)", "entity_type": "UNKNOWN", "id": "FGFR4 RS376618"}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "The FGFR4 rs376618 SNP did not satisfy Hardy-Weinberg equilibrium in this study.)", "entity_type": "UNKNOWN", "id": "HWE"}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "The FGFR4 rs351855 genomic variant causes the Gly388Arg amino acid change in the FGFR4 protein.)", "entity_type": "UNKNOWN", "id": "FGFR4 RS351855"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Diarrhea.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 47}]", "id": "IBS-D"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Constipation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "IBS-C"}, {"entity_type": "DISEASE", "description": "Healthy Volunteers.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "HV"}, {"entity_type": "PROTEIN", "description": "Fibroblast growth factor 19, a hormone involved in bile acid metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 48}]", "id": "FGF19"}, {"entity_type": "METABOLIC PATHWAY", "description": "The process of creating bile acids in the liver.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "BA SYNTHESIS"}, {"entity_type": "PROTEIN", "description": "Complement component C4, a protein involved in the immune system and inflammation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "C4"}, {"entity_type": "PROCEDURE", "description": "Surgical removal of the gallbladder.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 47}]", "id": "CHOLECYSTECTOMY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of body fat based on height and weight.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "BODY MASS INDEX (BMI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The amount of weight of fecal matter produced over a specific period.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 48}]", "id": "STOOL WEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The amount of fat contained in fecal matter.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 48}]", "id": "STOOL FAT"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Patients with IBS-D had higher serum C4 levels compared to IBS-C and HV.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 48}]", "id": "SERUM C4"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Patients with IBS-D had higher stool bile acid (BA) levels compared to IBS-C, but not HV.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 47}]", "id": "STOOL BA"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "There was a strong positive correlation between total stool bile acid (BA) and serum C4 levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 48}]", "id": "TOTAL STOOL BA"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "The genetic variant FGFR4 rs1966265 was marginally associated with stool BA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 47}]", "id": "FGFR4 RS1966265"}, {"entity_type": "GENE", "description": "FAAP20 is a 20 kDa protein that binds to FANCA and contains a conserved UBZ domain in its C-terminal extremity.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20"}, {"entity_type": "MOLECULAR INTERACTION", "description": "UBZ is a conserved domain found in proteins like FAAP20 that binds to ubiquitin.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "UBZ"}, {"entity_type": "MOLECULAR INTERACTION", "description": "K63-Ub2 is a type of ubiquitin chain linked via lysine 63.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K63-UB2"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A zinc ion coordinates with residues in the FAAP20-UBZ protein.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ZINC ION"}, {"entity_type": "AMINO ACID", "description": "Leu71 is an amino acid residue found on ubiquitin molecules.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "LEU71"}, {"entity_type": "AMINO ACID", "description": "Gly76 is an amino acid residue found on ubiquitin molecules.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "GLY76"}, {"entity_type": "AMINO ACID", "description": "Cys147 is an amino acid residue in FAAP20-UBZ that coordinates with the zinc ion.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS147"}, {"entity_type": "AMINO ACID", "description": "Cys150 is an amino acid residue in FAAP20-UBZ that coordinates with the zinc ion.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS150"}, {"entity_type": "AMINO ACID", "description": "His166 is an amino acid residue in FAAP20-UBZ that coordinates with the zinc ion.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "HIS166"}, {"entity_type": "AMINO ACID", "description": "Cys170 is an amino acid residue in FAAP20-UBZ that coordinates with the zinc ion.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS170"}, {"entity_type": "AMINO ACID", "description": "Ile44 is an amino acid residue on Ubiquitin that interacts with various UBZ domains.<SEP>Ile44 is an amino acid residue on ubiquitin involved in hydrophobic interactions.<SEP>Isoleucine (Ile44) is a key amino acid involved in binding FAAP20-UBZ to ubiquitin.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ILE44"}, {"entity_type": "PROTEIN", "description": "FAAP20-UBZ is a protein domain involved in ubiquitin binding.<SEP>FAAP20-UBZ is a protein that interacts with Ubiquitin (Ub) through hydrophobic residues in its \u03b1-helix.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "FAAP20-UBZ"}, {"entity_type": "PROTEIN", "description": "Ubiquitin (Ub) is a molecule involved in various cellular processes, including protein degradation and signaling.<SEP>Ubiquitin (Ub) is a small protein that is involved in various cellular processes, including protein degradation and signal transduction.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "UB"}, {"entity_type": "AMINO ACID", "description": "Leucine (Leu8) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "LEU8"}, {"entity_type": "AMINO ACID", "description": "Valine (Val70) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "VAL70"}, {"entity_type": "AMINO ACID", "description": "Threonine (Thr66) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "THR66"}, {"entity_type": "AMINO ACID", "description": "Histidine (His68) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "HIS68"}, {"entity_type": "AMINO ACID", "description": "Alanine (Ala46) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ALA46"}, {"entity_type": "AMINO ACID", "description": "Glycine (Gly47) is an amino acid residue within the ubiquitin molecule.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "GLY47"}, {"entity_type": "AMINO ACID", "description": "Tryptophan (Trp180) is an amino acid residue within the FAAP20-UBZ domain.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "TRP180"}, {"entity_type": "AMINO ACID", "description": "Aspartic acid (Asp164) is an amino acid residue within the FAAP20-UBZ domain.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ASP164"}, {"entity_type": "AMINO ACID", "description": "Cysteine (Cys150) is an amino acid residue within the FAAP20-UBZ domain that coordinates zinc.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "C150"}, {"entity_type": "MUTATION", "description": "A168L is a site-directed mutation where Alanine (Ala168) is replaced with Leucine (Leu).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "A168L"}, {"entity_type": "MUTATION", "description": "W180A is a site-directed mutation where Tryptophan (Trp180) is replaced with Alanine.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "W180A"}, {"entity_type": "MUTATION", "description": "D164A is a site-directed mutation where Aspartic acid (Asp164) is replaced with Alanine.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "D164A"}, {"entity_type": "MUTATION", "description": "L161A is a site-directed mutation where Leucine (Leu161) is replaced with Alanine.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "L161A"}, {"entity_type": "MUTATION", "description": "A172L is a site-directed mutation where Alanine (Ala172) is replaced with Leucine.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "A172L"}, {"entity_type": "MUTATION", "description": "D177A is a site-directed mutation where Aspartic acid (Asp177) is replaced with Alanine.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "D177A"}, {"entity_type": "PROTEIN", "description": "NEMO-UBZ is a protein that interacts with Ubiquitin (Ub) in a different manner than RAD18-UBZ and WRNIP1-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "NEMO-UBZ"}, {"entity_type": "PROTEIN", "description": "Pol\u03b7-UBZ is a protein that interacts with Ubiquitin (Ub) in a similar way to FAAP20-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "POL\u0397-UBZ"}, {"entity_type": "PROTEIN", "description": "WRNIP1-UBZ is a protein that interacts with Ubiquitin (Ub) through its \u03b2-loop.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "WRNIP1-UBZ"}, {"entity_type": "PROTEIN", "description": "RAD18-UBZ is a protein that interacts with Ubiquitin (Ub) through its \u03b2-loop.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "RAD18-UBZ"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Pro21-Val22 is an amino acid sequence in the \u03b2-loop of WRNIP1 that interacts with Ile44 of Ub.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "PRO21-VAL22"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Pro398-Lys399 is an amino acid sequence in the \u03b2-loop of NEMO-UBZ that differs from WRNIP1 and interacts differently with Ile44.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "PRO398-LYS399"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Glu636-Lys637 is an amino acid sequence in the \u03b2-loop of Pol\u03b7-UBZ that differs from WRNIP1 and interacts similarly to FAAP20-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "GLU636-LYS637"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids in FAAP20-UBZ interact with Ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ASP164, LEU167, ALA168, LEU171"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids in Pol\u03b7-UBZ are functionally equivalent to those in FAAP20-UBZ and contribute to similar Ub binding.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ASP652, PHE655, ALA656, LEU659"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "These amino acids in NEMO-UBZ replace the corresponding residues in FAAP20-UBZ and result in different Ub binding.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "GLN411, VAL414, MET415, ILE418"}, {"entity_type": "AMINO ACID", "description": "Ala168 in FAAP20-UBZ is involved in Ub binding but absent or divergent in other UBZs like WRNIP1 and RAD18.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ALA168"}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "The distance between Leu71 of one ubiquitin and Lys63 of its neighboring ubiquitins is 34.0 \u00c5 and 34.8 \u00c5, indicating limited interaction.)", "entity_type": "UNKNOWN", "id": "LEU71 OF UBIQUITIN"}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "FAAP20-UBZ binds to different types of ubiquitin chains (K63, K48, and M1) with varying affinities.)", "entity_type": "UNKNOWN", "id": "K63-UB2, K48-UB2, M1-UB2"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These amino acids in Ub form a hydrophobic patch that interacts with FAAP20-UBZ.)", "entity_type": "UNKNOWN", "id": "LEU8, ILE44, VAL70, THR66, HIS68"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The Asp164 residues in FAAP20-UBZ form hydrogen bonds with Ala46 and Gly47 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "ALA46, GLY47 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The Asp164 residues in FAAP20-UBZ form hydrogen bonds with Ala46 and Gly47 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "ASP164 O\u0394 ATOMS OF FAAP20-UBZ"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The Trp180 residue in FAAP20-UBZ interacts with Ile44 of ubiquitin through hydrophobic interactions.)", "entity_type": "UNKNOWN", "id": "ILE44 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The N\u03b5 atom of Trp180 in FAAP20-UBZ forms a hydrogen bond with the Gly47 residue in ubiquitin.)", "entity_type": "UNKNOWN", "id": "GLY47 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The N\u03b5 atom of Trp180 in FAAP20-UBZ forms a hydrogen bond with the Gly47 residue in ubiquitin.)", "entity_type": "UNKNOWN", "id": "TRP180 N\u0395 ATOM"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The main-chain CO group of Leu171 in FAAP20-UBZ interacts with Arg72 in ubiquitin through a hydrogen bond.)", "entity_type": "UNKNOWN", "id": "ARG72 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The main-chain CO group of Leu171 in FAAP20-UBZ interacts with Arg72 in ubiquitin through a hydrogen bond.)", "entity_type": "UNKNOWN", "id": "LEU171"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The main-chain CO groups of Ser174 and Thr175 in FAAP20-UBZ form hydrogen bonds with the N\u03b7 atoms of Arg72 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "SER174, THR175"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The O\u03b4 atoms of Asp177 in FAAP20-UBZ interact with the N\u03b5 and N\u03b7 atoms of Arg42 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "ARG42 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The O\u03b4 atoms of Asp177 in FAAP20-UBZ interact with the N\u03b5 and N\u03b7 atoms of Arg42 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "ASP177"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The main-chain CO group of Val178 in FAAP20-UBZ forms a hydrogen bond with the N\u03b5 atom of Gln49 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "GLN49 OF UB"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The main-chain CO group of Val178 in FAAP20-UBZ forms a hydrogen bond with the N\u03b5 atom of Gln49 in ubiquitin.)", "entity_type": "UNKNOWN", "id": "VAL178"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These mutations disrupt the interaction between FAAP20-UBZ and ubiquitin.)", "entity_type": "UNKNOWN", "id": "A168L, W180A, D164A"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These mutations disrupt the interaction between FAAP20-UBZ and ubiquitin.)", "entity_type": "UNKNOWN", "id": "UB BINDING"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These mutations impair the ability of FAAP20 to localize to DNA damage sites.)", "entity_type": "UNKNOWN", "id": "FAAP20 LOCALIZATION TO ICL SITES"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These mutations impair the ability of FAAP20 to localize to DNA damage sites.)", "entity_type": "UNKNOWN", "id": "L161A, A172L, D177A"}, {"source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "description": "The \u03b1-helix of FAAP20-UBZ interacts with Ubiquitin in a similar way to the UIM domain of Vps27.)", "entity_type": "UNKNOWN", "id": "UIM"}, {"source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "description": "The \u03b1-helix of FAAP20-UBZ interacts with Ubiquitin in a manner similar to the MIU domain of Rabex5.)", "entity_type": "UNKNOWN", "id": "MIU"}, {"entity_type": "GENOMIC VARIANT", "description": "A collection of single nucleotide polymorphisms (SNPs) within the HLA gene region used as markers for specific HLA haplotypes.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-TAGSNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A high risk HLA haplotype associated with CD, predicted by tag SNPs.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DQ2.5"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific HLA-DQ haplotype.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DQ2.2"}, {"entity_type": "GENOMIC VARIANT", "description": "A designation for individuals lacking all high risk HLA alleles.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DQX"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Chronic diarrhea is a common clinical symptom of Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "CHRONIC DIARRHEA"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Abdominal pain is a common clinical symptom of Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "ABDOMINAL PAIN"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Anorexia is a common clinical symptom of Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "ANOREXIA"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Abdominal distension is a common clinical symptom of Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 111}]", "id": "ABDOMINAL DISTENSION"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Type 1 diabetes mellitus is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "TYPE 1 DIABETES MELLITUS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "An autoimmune disorder where the immune system attacks the thyroid gland.<SEP>Autoimmune thyroiditis is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "AUTOIMMUNE THYROIDITIS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Systemic lupus erythematosus is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "SYSTEMIC LUPUS ERYTHEMATOSUS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Osteomalacia is a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "OSTEOMALACIA"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Seizure disorders are a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "SEIZURE DISORDERS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Down syndrome is a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 112}]", "id": "DOWN SYNDROME"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "rs2395182 is a single nucleotide polymorphism (SNP) <SEP>rs2395182 is a specific HLA-tagSNP identified in the study.)", "entity_type": "GENOMIC VARIANT", "id": "RS2395182"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "rs7775228 is a single nucleotide polymorphism (SNP) <SEP>rs7775228 is a specific HLA-tagSNP identified in the study.)", "entity_type": "GENOMIC VARIANT", "id": "RS7775228"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "rs2187668 is a specific HLA-tagSNP identified in the study.)", "entity_type": "UNKNOWN", "id": "RS2187668"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "rs7454108 is a specific HLA-tagSNP identified in the study.)", "entity_type": "UNKNOWN", "id": "RS7454108"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "DQ2.5 is a specific HLA-DQ haplotype.)", "entity_type": "UNKNOWN", "id": "HLA-DQ HAPLOTYPE"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "DQ8 is a specific HLA-DQ haplotype.)", "entity_type": "UNKNOWN", "id": "DQ8"}, {"entity_type": "THERAPY", "description": "A chemotherapy regimen consisting of paclitaxel and carboplatin administered in cycles.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "PACLITAXEL-CARBOPLATIN COMBINATION THERAPY"}, {"entity_type": "THERAPY", "description": "A chemotherapy regimen consisting of carboplatin administered in cycles.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "CARBOPLATIN MONOTHERAPY"}, {"entity_type": "GENE", "description": "ABCC2 is a gene associated with platinum-free interval (PFI) in ovarian cancer patients.<SEP>The ABCC2 gene encodes a multidrug resistance-associated protein involved in drug transport.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC2"}, {"entity_type": "GENE", "description": "The ABCA1 gene encodes a protein involved in cholesterol efflux and lipid metabolism.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCA1"}, {"entity_type": "GENE", "description": "The ERCC1 gene encodes a protein involved in DNA repair.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC1"}, {"entity_type": "GENE", "description": "The CYP3A4 gene encodes a cytochrome P450 enzyme involved in drug metabolism.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "CYP3A4"}, {"entity_type": "GENE", "description": "The ABCC1 gene encodes a multidrug resistance-associated protein involved in drug transport.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC1"}, {"entity_type": "GENE", "description": "ERCC2 is a gene associated with platinum-free interval (PFI) in ovarian cancer patients.<SEP>The ERCC2 gene encodes a protein involved in nucleotide excision repair.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC2"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located in the ERCC2 gene.<SEP>rs1799793 is a genomic variant in the ERCC2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1799793"}, {"entity_type": "DISEASE", "description": "A condition characterized by a low number of platelets, which are essential for blood clotting.<SEP>A condition characterized by a low platelet count.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "THROMBOCYTOPENIA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12762549 is a genomic variant in the ABCC2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS12762549"}, {"entity_type": "GENE", "description": "SERPINB2 is a gene associated with platinum-free interval (PFI) in ovarian cancer patients.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "SERPINB2"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6104 is a genomic variant in the SERPINB2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS6104"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Platinum-free interval (PFI) refers to the time between surgery and the next platinum-based chemotherapy treatment.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "PLATINUM-FREE INTERVAL (PFI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FIGO stage is a system for classifying the severity of ovarian cancer based on tumor spread.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "FIGO STAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tumor grade describes the aggressiveness of an ovarian cancer based on cell appearance.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR GRADE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tumor histology refers to the microscopic examination of a tumor sample to determine its cellular characteristics.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR HISTOLOGY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Residual disease after debulking surgery refers to any remaining cancer cells after surgical removal.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RESIDUAL DISEASE AFTER DEBULKING SURGERY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cox regression analysis is a statistical method used to model the relationship between survival time and predictor variables.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "COX REGRESSION ANALYSIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Kaplan-Meier survival analysis is a graphical method for visualizing survival data over time.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "KAPLAN-MEIER SURVIVAL ANALYSIS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Paclitaxel-carboplatin combination therapy increases the risk of Grade 3\u20134 anemia.)<SEP>Paclitaxel-carboplatin combination therapy is associated with an increased risk of grade 3\u20134 anemia.)", "entity_type": "UNKNOWN", "id": "GRADE 3\u20134 ANEMIA"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC1 gene are associated with an increased need for erythropoiesis-stimulating agents during chemotherapy.)", "entity_type": "UNKNOWN", "id": "USE OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "entity_type": "UNKNOWN", "id": "USE OF COLONY-STIMULATING FACTORS (CSFS)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1799793 variant is significantly associated with a longer progression-free interval.)", "entity_type": "UNKNOWN", "id": "PROGRESSION-FREE INTERVAL (PFI)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the CYP3A4 gene are associated with an increased risk of thrombocytopenia.)", "entity_type": "UNKNOWN", "id": "CYP3A4 VARIANTS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC1 gene are associated with an increased need for erythropoiesis-stimulating agents during chemotherapy.)", "entity_type": "UNKNOWN", "id": "ABCC1 VARIANTS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC1 gene are associated with an increased need for erythropoiesis-stimulating agents during chemotherapy.)", "entity_type": "UNKNOWN", "id": "USE OF ESAS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "entity_type": "UNKNOWN", "id": "ABCC2 VARIANTS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "Variants in the ABCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "entity_type": "UNKNOWN", "id": "USE OF CSFS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1799793 variant is significantly associated with a longer progression-free interval.)", "entity_type": "UNKNOWN", "id": "PFI"}, {"entity_type": "GENE", "description": "UMPS is a gene that encodes for an enzyme involved in pyrimidine biosynthesis.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "UMPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A 6.4 Mb deletion on chromosome 3 containing the UMPS gene was identified in patient I1.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "6.4 MB DELETION"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant causes a frameshift and premature stop codon in the UMPS gene, leading to loss of protein function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.302DELA (P.LYS101ARGFS*9)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant introduces a premature stop codon in the UMPS gene, resulting in truncated protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.385G>T (P.GLY129*) "}, {"entity_type": "GENOMIC VARIANT", "description": "Similar to c.385G>T, this variant causes a premature stop codon in the UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.889G>T (P.GLU297*) "}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation alters amino acid 75 from proline to histidine in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.224C>A (P.PRO75HIS)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation replaces arginine with glycine at amino acid 96 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.286A>G (P.ARG96GLY)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation changes glycine to arginine at position 429 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.1285G>C (P.GLY429ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation replaces glycine with arginine at amino acid 104 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.310G>A (GLY104ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation changes arginine to histidine at amino acid 230 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.689G>A (P.ARG230HIS)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation substitutes arginine with cysteine at amino acid 230 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.688C>T (P.ARG230CYS)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation changes isoleucine to asparagine at amino acid 286 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.857T>A (P.ILE286ASN)"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense mutation replaces valine with methionine at amino acid 151 in the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.451G>A (P.VAL151MET)"}, {"entity_type": "GENOMIC VARIANT", "description": "This synonymous variant does not change the amino acid sequence of the UMPS protein.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.360A>G (P.LEU120LEU)"}, {"entity_type": "GENE", "description": "Transforming growth factor beta 1 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "TGF-SS1"}, {"entity_type": "GENE", "description": "Interleukin-8 gene (rs4073 T/A) polymorphism", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "INTERLEUKIN-8"}, {"entity_type": "PROTEIN", "description": "IL-27 is an interleukin with immunomodulatory functions.<SEP>Interleukin-27 gene (rs17855750T/G) polymorphism", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "IL-27"}, {"entity_type": "ASSAY", "description": "A type of allele discrimination assay used for genotyping.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TAQMAN"}, {"entity_type": "REAL-TIME PCR INSTRUMENT", "description": "A real-time polymerase chain reaction instrument used in molecular biology.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "VIIA\u2122 7"}, {"entity_type": "ASSAYS", "description": "A type of molecular assay that distinguishes between different alleles.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "ALLELE DISCRIMINATION ASSAY"}, {"entity_type": "DISEASE", "description": "Colorectal Cancer (CRC) is a disease that has an association with specific genotypes.<SEP>Colorectal cancer.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-5b0cc96debf110f3544685d3b227ff27", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 45}]", "id": "CRC"}, {"entity_type": "GROUP", "description": "A comparison group used to evaluate the frequency of T allele in individuals without CRC.<SEP>A group of individuals used as a comparison to the experimental group.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-5b0cc96debf110f3544685d3b227ff27", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 127}]", "id": "CONTROL GROUP"}, {"entity_type": "LOCATION", "description": "A city in Saudi Arabia where the patient population is from.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RIYADH CITY"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The TaqMan (ViiA\u2122 7 Real-Time PCR) method was used for genotyping.)", "entity_type": "UNKNOWN", "id": "GENOTYPING"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "Demographic and clinical characteristics of patients and control participating in this study are reported for CRC.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 44}, {level: 2, cluster: 127}]", "id": "PATIENTS AND CONTROLS"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The limited population of subjects with the study (Riyadh city only) may explain the deviation from Hardy-Weinberg Equilibrium for TGF-\u00df1.)", "entity_type": "UNKNOWN", "id": "POPULATION"}, {"entity_type": "GENE", "description": "TSLP is a gene that has been associated with asthma susceptibility.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP"}, {"entity_type": "DISEASE", "description": "Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "ASTHMA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1898671 is a single nucleotide polymorphism (SNP) in the TSLP gene.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "RS1898671"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced expiratory volume in 1 second (FEV1) is a measure of lung function.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "FEV1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced vital capacity (FVC) is a measure of the total amount of air that can be exhaled from the lungs.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "FVC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The ratio of FEV1 to FVC is a measure of lung function.<SEP>The ratio of forced expiratory volume in 1 second to forced vital capacity, a measure of lung function.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "id": "FEV1/FVC"}, {"entity_type": "PROTEIN", "description": "Immunoglobulin E (IgE) is an antibody involved in allergic reactions.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "IGE"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "The SNP rs1898671 in the TSLP gene was nominally associated with asthma susceptibility.)", "entity_type": "UNKNOWN", "id": "ASTHMA SUSCEPTIBILITY"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "The risk of asthma associated with the SNP rs1898671 was increased in ex-smokers.)", "entity_type": "UNKNOWN", "id": "EX-SMOKERS"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "The association between the SNP rs1898671 and asthma risk was not significant in never-smokers.)", "entity_type": "UNKNOWN", "id": "NEVER-SMOKERS"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "There were differences in self-reported race/ethnicity between cases and controls.)", "entity_type": "UNKNOWN", "id": "SELF-REPORTED RACE/ETHNICITY"}, {"entity_type": "GENE", "description": "PTPN2 is a gene that has been linked to susceptibility to MAPbacteremia in Crohn\'s disease (CD) patients.<SEP>PTPN2 is a gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN2"}, {"entity_type": "GENE", "description": "PTPN2/22 is a combined entity of PTPN2 and PTPN22.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2/22"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (single nucleotide polymorphism) within the PTPN2 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 79}]", "id": "RS1893217"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN2 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2542151"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN2 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS7234029"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN2 gene associated with CD.<SEP>rs478582 is a single nucleotide polymorphism (SNP) located in the PTPN2 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN22 gene.<SEP>rs2476601 is a single nucleotide polymorphism (SNP) located in the PTPN22 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "RS2476601"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN22 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2488457"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN22 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS33996649"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN22 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS34209542"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP within the PTPN22 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2476599"}, {"entity_type": "GENOMIC VARIANT", "description": "A genotype where an individual has two different alleles for a particular gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HETEROZYGOUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genotype where an individual has two identical alleles for a particular gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HOMOZYGOUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in PTPN2 gene, rs478582 has been linked to altered gene expression and a potential role in susceptibility to MAP infection.<SEP>PTPN2:rs478582 is a single nucleotide polymorphism (SNP) in the PTPN2 gene.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "clusters": "[{level: 0, cluster: 21}, {level: 1, cluster: 113}, {level: 2, cluster: 144}]", "id": "PTPN2:RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in PTPN22 gene, rs2476601 has been linked to altered gene expression and a potential role in susceptibility to MAP infection.<SEP>PTPN22:rs2476601 is a single nucleotide polymorphism (SNP) in the PTPN22 gene.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 99}]", "id": "PTPN22:RS2476601"}, {"entity_type": "PATHOGEN", "description": "Mycobacterium avium complex, a type of bacteria that can cause infection in humans.<SEP>Mycobacterium avium subspecies paratuberculosis (MAP) is a bacterium that can cause Johne\'s disease.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "MAP"}, {"entity_type": "DISEASE", "description": "MAPbacteremia is a condition characterized by the presence of MAP bacteria in the blood.<SEP>The presence of MAP bacteria in the bloodstream, indicating infection.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "MAPBACTEREMIA"}, {"entity_type": "GENETIC MARKER", "description": "A specific DNA sequence within the MAP genome used for detection and identification.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "IS900"}, {"entity_type": "GENE", "description": "TPPN22 is a gene that has been linked to susceptibility to MAPbacteremia in Crohn\'s disease (CD) patients.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "TPPN22"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory bowel disease characterized by inflammation of the digestive tract.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "CROHN\'S DISEASE (CD)"}, {"entity_type": "GENOMIC VARIANT", "description": "Having one copy of each allele for a given SNP.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "HETEROZYGOUS (TC)"}, {"entity_type": "GENOMIC VARIANT", "description": "Having two copies of the same allele for a given SNP.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "HOMOZYGOUS (TT)"}, {"entity_type": "GENOMIC VARIANT", "description": "Having two copies of the less common allele for a given SNP.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "MINOR (CC)"}, {"entity_type": "GENOMIC VARIANT", "description": "Having two copies of the more common allele for a given SNP.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "MAJOR (AA)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "MAP PPD-like is a molecule used to stimulate T-cell response.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "MAP PPD-LIKE"}, {"entity_type": "CELL", "description": "A type of white blood cell that plays a key role in the immune response.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "T-CELL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "PHA (Phytohemagglutinin) is a plant lectin that stimulates T-cell proliferation.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PHA"}, {"source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "description": "The rs2476601 variant in PTPN22 is significantly associated with various inflammatory autoimmune diseases.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 99}]", "id": "INFLAMMATORY AUTOIMMUNE DISEASES"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "The C-G haplotype, formed by the combination of heterozygous or minor/major alleles in rs478582 and rs2476601, is associated with an increased risk of MAPbacteremia in CD patients.)", "entity_type": "UNKNOWN", "id": "C-G HAPLOTYPE"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "The T-A haplotype, formed by the combination of major/heterozygous or minor alleles in rs478582 and rs2476601, is associated with an increased risk of MAPbacteremia in CD patients.)", "entity_type": "UNKNOWN", "id": "T-A HAPLOTYPE"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "The combined effects of MAPbacteremia presence and either PTPN2:rs478582 or PTPN22:rs2476601 SNPs are associated with increased IFN-\u03b3 expression in CD patients.)", "entity_type": "UNKNOWN", "id": "IFN-\u0393 EXPRESSION"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "PTPN22 is a gene that encodes a protein tyrosine phosphatase involved in T cell signaling.<SEP>PTPN22 is a gene that encodes for the protein Lymphoprotein Tyrosine Phosphatase (LYP).<SEP>PTPN22 is a gene that encodes the LYP protein.<SEP>The combined effects of MAPbacteremia presence and either PTPN2:rs478582 or PTPN22:rs2476601 SNPs are associated with increased IFN-\u03b3 expression in CD patients.)", "entity_type": "GENE", "id": "PTPN22"}, {"source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "description": "Treatment with PHA stimulated T-cell proliferation in both CD and healthy control subjects.)", "entity_type": "UNKNOWN", "id": "T-CELL PROLIFERATION"}, {"source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "description": "T-cells from healthy control subjects showed a lower fold change in response to PHA and MAP PPD-like compared to CD subjects.)", "entity_type": "UNKNOWN", "id": "HEALTHY CONTROL SUBJECTS"}, {"entity_type": "GENOMIC VARIANT", "description": "LYP-620R is a non-risk allele of the PTPN22 gene.<SEP>LYP-620R is a risk variant in the LYP gene associated with altered T cell activation.<SEP>LYP-620R is a variant of the LYP gene.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "LYP-620R"}, {"entity_type": "GENOMIC VARIANT", "description": "LYP-620W is a risk allele of the PTPN22 gene.<SEP>LYP-620W is a variant in the LYP gene that may confer a loss of function.<SEP>LYP-620W is a variant of the LYP gene.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "LYP-620W"}, {"entity_type": "PROTEIN", "description": "LYP is a protein encoded by the PTPN22 gene and plays a role in regulating T cell activation.<SEP>The LYP protein is encoded by the PTPN22 gene and functions as a Lymphoprotein Tyrosine Phosphatase.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LYP PROTEIN"}, {"entity_type": "T CELL SUBSET", "description": "Na\u00efve T helper cells that have not yet encountered their specific antigen.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "NA\u00cfVE TCONV"}, {"entity_type": "T CELL SUBSET", "description": "T helper cells that have previously encountered their specific antigen and have a memory of the encounter.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "MEMORY TCONV"}, {"entity_type": "T CELL SUBSET", "description": "A type of T helper cell that suppresses the activity of other immune cells.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "REGULATORY T CELL (TREG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Activation of T cells using a nonspecific stimulus.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "POLYCLONAL ACTIVATION"}, {"entity_type": "MOLECULE", "description": "T Cell Receptor (TCR) is a protein complex on the surface of T cells that recognizes antigens presented by MHC molecules.<SEP>The T cell receptor, responsible for recognizing specific antigens.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-830d8819004960d1d149ac70149c72a0", "clusters": "[{level: 0, cluster: 19}]", "id": "TCR"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A signaling complex assembled upon TCR activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LAT SIGNALOSOME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cellular process involving calcium ions.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "CALCIUM SIGNALING"}, {"entity_type": "METABOLIC PATHWAY", "description": "Signaling pathway involved in cell proliferation and differentiation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "MAPK/ERK PATHWAY"}, {"entity_type": "PROTEIN", "description": "Phosphorylated form of ERK, indicating activation of the MAPK/ERK pathway.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "PERK"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Enhanced green fluorescent protein used as a marker for gene expression.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "EGFP REPORTER"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A retrovirus commonly used in gene delivery studies.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LENTIVIRUS"}, {"entity_type": "CELLULAR COMPONENT", "description": "Antigen-presenting cells from the same individual as the T cells.<SEP>Autologous antigen-presenting cells (APCs) are immune cells that present antigens to T cells, originating from the same individual.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "AUTOLOGOUS APCS"}, {"entity_type": "PROTEIN", "description": "CD69 is a gene that encodes a protein expressed on activated T cells.<SEP>Early activation marker for T cells.<SEP>CD69 is an early activation marker on T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 102}]", "id": "CD69"}, {"entity_type": "PROTEIN", "description": "Co-stimulatory molecule involved in T cell activation.<SEP>ICOS is a gene that encodes a protein involved in T cell activation and differentiation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 102}]", "id": "ICOS"}, {"entity_type": "PROTEIN", "description": "Activating receptor found on various immune cells.<SEP>CD226 is a gene that encodes an activating immune receptor expressed on T cells and NK cells.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 102}]", "id": "CD226"}, {"entity_type": "PROTEIN", "description": "Immune checkpoint molecule involved in T cell exhaustion.<SEP>PD-1 is a gene that encodes a protein involved in immune checkpoint regulation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 102}]", "id": "PD-1"}, {"entity_type": "PROTEIN", "description": "CTLA-4 is a gene that encodes an inhibitory immune receptor expressed on T cells.<SEP>Immune checkpoint molecule expressed by Tregs.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CTLA-4"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The T cell receptor is a transmembrane protein complex responsible for recognizing antigens.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "T CELL RECEPTOR (TCR)"}, {"entity_type": "PROTEIN", "description": "A scaffolding protein that plays a central role in TCR signaling.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LINKER FOR ACTIVATION OF T CELLS (LAT)"}, {"entity_type": "PROTEIN", "description": "CD4 is a transmembrane domain used in CAR T cell design.<SEP>Co-receptor found on helper T cells, essential for TCR activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD4"}, {"entity_type": "CELLULAR COMPONENT", "description": "Antigen presenting cells from the same individual as the T cells being studied.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "AUTOLOGOUS ANTIGEN PRESENTING CELLS (APCS)"}, {"entity_type": "PROTEIN", "description": "Surface proteins expressed on activated T cells, such as CD69, ICOS, CD25, CD226, and PD-1.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "T CELL ACTIVATION MARKERS"}, {"entity_type": "CELLULAR PROCESS", "description": "Conventional T cells (Tconvs) are a major subtype of T lymphocytes that mediate immune responses.<SEP>Tconv refers to conventional T cells, a subset of lymphocytes involved in adaptive immunity.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "TCONV"}, {"entity_type": "CELL TYPE", "description": "APCs are antigen-presenting cells, such as dendritic cells and macrophages, that present antigens to T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "APCS"}, {"entity_type": "PROTEIN", "description": "Enhanced green fluorescent protein, used for tracking tumor cells in vivo.<SEP>eGFP is a green fluorescent protein used as a reporter gene for cell tracking.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "EGFP"}, {"entity_type": "CELLULAR PROCESS", "description": "Mock-transfected refers to cells that were transfected with a control vector lacking a gene of interest.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "MOCK-TRANSFECTED"}, {"entity_type": "CHEMICAL", "description": "PMA is phorbol 12-myristate 13-acetate, a tumor promoter used to activate T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PMA"}, {"entity_type": "CHEMICAL", "description": "Ionomycin is a calcium ionophore that activates T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IONOMYCIN"}, {"entity_type": "CYTOKINE", "description": "IL-2 is a cytokine produced by activated T cells that promotes T cell growth and proliferation.<SEP>IL-2 is interleukin-2, a cytokine important for T cell proliferation and survival.<SEP>Interleukin 2, a cytokine that promotes T cell growth and proliferation.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "IL-2"}, {"entity_type": "CYTOKINE", "description": "IL-4 is interleukin-4, a cytokine involved in Th2 immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-4"}, {"entity_type": "CYTOKINE", "description": "IL-5 is interleukin-5, a cytokine involved in eosinophil activation and antibody production.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-5"}, {"entity_type": "CYTOKINE", "description": "IL-9 is interleukin-9, a cytokine involved in mast cell and basophil activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-9"}, {"entity_type": "CYTOKINE", "description": "IL-13 is interleukin-13, a cytokine involved in Th2 immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-13"}, {"entity_type": "CYTOKINE", "description": "IFN\u03b3 is a cytokine produced by activated T cells with antiviral and antitumor effects.<SEP>IFN\u03b3 is interferon gamma, a cytokine important for Th1 immune responses.<SEP>Interferon gamma (IFN\u03b3) is a cytokine produced by activated T cells and other immune cells that plays a role in inflammation and antiviral responses.<SEP>Interferon gamma, a cytokine produced by activated immune cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "IFN\u0393"}, {"entity_type": "GENE", "description": "LYP is a gene that encodes for the protein Lymphoprotein Tyrosine Phosphatase.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP"}, {"entity_type": "PROTEIN", "description": "Effector cytokines are signaling molecules produced by immune cells that mediate various immune functions, such as inflammation and cell activation.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "EFFECTOR CYTOKINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Th1 signature refers to a specific pattern of gene expression and cytokine production characteristic of T helper 1 (Th1) cells, which play a role in cell-mediated immunity.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TH1 SIGNATURE"}, {"entity_type": "DISEASE", "description": "Autoimmune disorders are chronic diseases caused by the immune system attacking the body\'s own tissues.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "AUTOIMMUNE DISORDER"}, {"entity_type": "MODEL ORGANISM", "description": "Ptpn22 knockout mice are genetically engineered animals lacking the PTPN22 gene, used to study the function of LYP protein.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "PTPN22 KNOCKOUT MICE"}, {"entity_type": "CELL", "description": "T responder cells (Tregs) are T lymphocytes that respond to stimulation by APCs and differentiate into effector cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TRESP"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "CD69 expression is upregulated upon activation of Tconv cells.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 102}]", "id": "TCONV ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "CTLA-4 expression is upregulated upon activation of Tregs.)", "entity_type": "UNKNOWN", "id": "TREG ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "Overexpression of LYP-620R reduces T cell activation.)", "entity_type": "UNKNOWN", "id": "T CELL ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "Overexpression of LYP-620R modulates TCR signaling.)", "entity_type": "UNKNOWN", "id": "TCR SIGNALING"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "The LYP-620W variant has a weaker effect on T cell proliferation compared to LYP-620R.)", "entity_type": "UNKNOWN", "id": "T CELL PROLIFERATION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpressed LYP-620R significantly repressed Tresp proliferation.)", "entity_type": "UNKNOWN", "id": "TREG-MEDIATED SUPPRESSION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The Tconv-intrinsic susceptibility conferred by LYP-620W is due to reduced control over activation, proliferation, and effector mechanisms.)", "entity_type": "UNKNOWN", "id": "TCONV-INTRINSIC SUSCEPTIBILITY"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpression of LYP-620W slightly increased Treg suppressive capacity.)", "entity_type": "UNKNOWN", "id": "TREG SUPPRESSIVE CAPACITY"}, {"entity_type": "GENE", "description": "TAG72 is a protein expressed by ovarian cancer cells and targeted by CAR T cells in this study.<SEP>TAG72 is a protein that is expressed on the surface of certain tumor cells.<SEP>TAG72 is the target antigen for the CAR T cells used in this study.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TAG72"}, {"entity_type": "PROTEIN", "description": "4-1BB is an intracellular co-stimulatory domain used in CAR T cell design.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "4-1BB"}, {"entity_type": "PROTEIN", "description": "CC49 is a humanized scFv antibody fragment that targets TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CC49"}, {"entity_type": "PROTEIN", "description": "IgG4 Fc is an extracellular spacer lacking a CH2 domain used in CAR T cell design.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "IGG4 FC"}, {"entity_type": "PROTEIN", "description": "CD3\u03b6 is a cytolytic domain used in CAR T cell design.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD3\u0396"}, {"entity_type": "PROTEIN", "description": "CD19t is a truncated CD19 protein used for cell tracking in CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD19T"}, {"entity_type": "CELLULAR COMPONENT", "description": "TAG72-BB\u03b6 CAR T cells are an experimental cancer treatment targeting the TAG72 antigen.<SEP>TAG72-BB\u03b6 CAR T cells are genetically modified T cells that express the TAG72-BB\u03b6 chimeric antigen receptor.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72-BB\u0396 CAR T CELLS"}, {"entity_type": "CELL TYPE", "description": "Cells found in blood that include lymphocytes, monocytes, and other immune cells.<SEP>PBMCs are blood cells obtained from healthy donors used for generating CAR T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)"}, {"entity_type": "CELLULAR COMPONENT", "description": "dPBMCs are peripheral blood mononuclear cells depleted of CD14+ and CD25+ cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "DPBMC"}, {"entity_type": "CELLULAR COMPONENT", "description": "Mock T cells are control T cells that have not been genetically modified.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "MOCK (UNTRANSDUCED) T CELLS"}, {"entity_type": "VIRAL PARTICLE", "description": "TAG72-BB\u03b6 CAR lentivirus is a viral vector used to deliver the TAG72-BB\u03b6 CAR gene into T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72-BB\u0396 CAR LENTIVIRUS"}, {"entity_type": "PROTEIN", "description": "CD137 is a co-stimulatory receptor on T cells that is upregulated upon activation.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD137"}, {"entity_type": "CELLULAR COMPONENT", "description": "SKOV3 are ovarian cancer cell lines.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "SKOV3"}, {"entity_type": "CELLULAR COMPONENT", "description": "OVCAR8 are ovarian cancer cell lines.<SEP>OVCAR8 is an ovarian cancer cell line that does not express TAG72.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OVCAR8"}, {"entity_type": "CELLULAR COMPONENT", "description": "COV362.4 are ovarian cancer cell lines.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "COV362.4"}, {"entity_type": "CELLULAR COMPONENT", "description": "OVCAR3 are ovarian cancer cell lines.<SEP>OVCAR3 is an ovarian cancer cell line used in the study.<SEP>OVCAR3 is an ovarian cancer cell line used in this study.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OVCAR3"}, {"entity_type": "CELLULAR COMPONENT", "description": "OV90 are ovarian cancer cell lines.<SEP>OV90 is an aggressive ovarian cancer cell line used in this study.<SEP>OV90 is another ovarian cancer cell line used in the study.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OV90"}, {"entity_type": "CELLULAR COMPONENT", "description": "LS174T are colon cancer cell lines.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "LS174T"}, {"entity_type": "RATIO", "description": "The E:T ratio is the ratio of effector cells (CAR T cells) to target cells (tumor cells).", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "E:T RATIO"}, {"entity_type": "PROTEIN", "description": "PSCA is a protein expressed on prostate cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "PSCA"}, {"entity_type": "DISEASE", "description": "OAS3 refers to ascites from patient 3, characterized as TAG72-negative.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OAS3"}, {"entity_type": "DISEASE", "description": "OAS4 refers to ascites from patient 4, characterized as TAG72-positive.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OAS4"}, {"entity_type": "DISEASE", "description": "OAS7 refers to ascites from patient 7, characterized as TAG72-positive.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OAS7"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Chimeric antigen receptor T cells engineered to target TAG72.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "CAR T CELLS"}, {"entity_type": "PROTEIN", "description": "Firefly luciferase, used for non-invasive imaging of tumor growth.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "FFLUC"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Control T cells without the CAR construct.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "MOCK T CELLS"}, {"entity_type": "DISEASE", "description": "Immunodeficient mice strain used for in vivo studies.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "NSG MICE"}, {"entity_type": "CELL", "description": "OVCAR3 cells express all three antigens: TAG72, MUC1 and MUC16.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OVCAR3 CELLS"}, {"entity_type": "CELL", "description": "OV90 cells express low levels of MUC1 but not MUC16 and TAG72.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OV90 CELLS"}, {"entity_type": "TREATMENT", "description": "Mock treatment serves as a control for the effects of TAG72-BB\u03b6 CAR T cell therapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MOCK TREATMENT"}, {"entity_type": "PROTEIN", "description": "MUC1 is a protein expressed on some ovarian cancer cells and used as a potential target in this study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MUC1"}, {"entity_type": "PROTEIN", "description": "MUC16 is a protein expressed on some ovarian cancer cells and used as a potential target in this study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MUC16"}, {"entity_type": "PHENOMENON", "description": "Tumor recurrence is a common resistance mechanism to CAR T cell therapy, observed in this study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TUMOR RECURRENCE"}, {"entity_type": "MECHANISM", "description": "Antigen escape is a mechanism of resistance where tumors lose expression of the targeted antigen, hindering CAR T cell effectiveness.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "ANTIGEN ESCAPE"}, {"entity_type": "BODY FLUID", "description": "Ascites is a fluid accumulation in the abdominal cavity, which can harbor cancer cells.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "ASCITES"}, {"entity_type": "TISSUE", "description": "Solid tumors are a type of tumor characterized by dense, compact growth.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "SOLID TUMOR"}, {"source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "description": "Activation of TAG72-BB\u03b6 CAR T cells is measured by upregulation of CD137.)", "entity_type": "UNKNOWN", "id": "TAG72-BB\u0396 CAR T CELL ACTIVATION"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Increased anti-tumor responses compared to intravenous delivery.)<SEP>Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells resulted in more potent anti-tumor effects than intravenous delivery.)", "entity_type": "UNKNOWN", "id": "REGIONAL I.P. DELIVERY"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "OVCAR3 cells were transduced with eGFP/ffluc for tumor tracking.)", "entity_type": "UNKNOWN", "id": "EGFP/FFLUC"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Limited anti-tumor response in comparison to regional i.p. delivery.)", "entity_type": "UNKNOWN", "id": "I.V. DELIVERY"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "More durable tumor control compared to single dosing.)", "entity_type": "UNKNOWN", "id": "REPEAT TAG72-BB\u0396 CAR T CELL DOSING"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "More durable tumor control compared to single dosing.)", "entity_type": "UNKNOWN", "id": "TUMOR CONTROL"}, {"source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "description": "OVCAR8 cells do not express TAG72, MUC16, or very low levels of MUC1.)", "entity_type": "UNKNOWN", "id": "OVCAR8 CELLS"}, {"entity_type": "GENE", "description": "THSD4 is a gene located on chromosome 15q23 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "THSD4"}, {"entity_type": "GENE", "description": "UACA is a gene located on chromosome 15q23 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "UACA"}, {"entity_type": "GENE", "description": "TLE3 is a gene located on chromosome 15q23 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "TLE3"}, {"entity_type": "GENE", "description": "A gene of unknown function located on chromosome 10.<SEP>C10orf11 is a gene located on chromosome 10q22.3 and was associated with FEV1 in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "id": "C10ORF11"}, {"entity_type": "GENE", "description": "CCL23 is a gene located on chromosome 17q12 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CCL23"}, {"entity_type": "GENE", "description": "A chemokine protein that attracts immune cells.<SEP>CCL18 is a gene located on chromosome 17q12 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "id": "CCL18"}, {"entity_type": "GENE", "description": "PITPNC1 is a gene located on chromosome 17q24.2 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "PITPNC1"}, {"entity_type": "GENE", "description": "CHAF1B is a gene located on chromosome 21q22.13 and was associated with FEV1/FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CHAF1B"}, {"entity_type": "GENE", "description": "IL37 is a gene located on chromosome 2q13 and was associated with FEV1 in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "IL37"}, {"entity_type": "GENE", "description": "ASXL3 is a gene located on chromosome 18q12.1 and was associated with FVC in the GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "ASXL3"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variants associated with low FEV1/FVC ratios.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "LOW FEV1/FVC ALLELES"}, {"entity_type": "HUMAN POPULATION", "description": "A genetically isolated human population studied for their respiratory traits.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "HUTTERITES"}, {"entity_type": "ALGORITHM", "description": "An algorithm used to mine the Gene Ontology database for functional connections between genes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GRAIL ALGORITHM"}, {"entity_type": "DATABASE", "description": "A database containing information about gene functions and relationships.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GENE ONTOLOGY DATABASE"}, {"entity_type": "GENE FAMILY", "description": "A family of genes encoding antimicrobial proteins.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "\u0392-DEFENSIN GENES"}, {"entity_type": "GENE FAMILY", "description": "A family of genes encoding signaling proteins involved in immune cell recruitment.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CHEMOKINE GENES"}, {"entity_type": "CHEMOKINE", "description": "A chemokine protein involved in stem cell migration and hematopoiesis.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CXCL12"}, {"entity_type": "GENE", "description": "A gene encoding a receptor for tumor necrosis factor.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "TNFRSF13B"}, {"entity_type": "GENOMIC LOCUS", "description": "A genomic region containing the THSD4, UACA, and TLE3 genes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "THSD4-UACA-TLE3"}, {"entity_type": "GENOMIC LOCUS", "description": "A genomic region containing the CCL23 and CCL18 genes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CCL23-CCL18"}, {"entity_type": "MEASUREMENT", "description": "The difference between an individual\'s measured FEV1/FVC and the expected value based on population data.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "RESIDUAL FEV1/FVC"}, {"entity_type": "STATISTICAL METHOD", "description": "Categorizing individuals into groups based on a specific characteristic, in this case, the number of \'low FEV1/FVC alleles\'.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "BINNING"}, {"entity_type": "GENETIC MODEL", "description": "A model where multiple genes contribute to a trait additively.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "ADDITIVE GENETIC ARCHITECTURE"}, {"entity_type": "GENOMIC VARIANT", "description": "Genome-Wide Association Study Single Nucleotide Polymorphisms, specific SNPs associated with a particular trait through GWAS analysis.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GWAS SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms that have been identified as statistically associated with predicting a phenotype, such as FEV1/FVC in this case.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "PREDICTIVE SNPS"}, {"entity_type": "GENOMIC REGION", "description": "Specific genomic regions identified multiple times in independent studies to be associated with a particular trait.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "REPLICATED LOCI"}, {"entity_type": "HUMAN POPULATION", "description": "A genetically isolated population of people, often studied for their unique genetic characteristics.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "HUTTERITE"}, {"entity_type": "GENE", "description": "CTLA4 is a gene that plays a role in immune regulation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "CTLA4"}, {"entity_type": "GENOMIC VARIANT", "description": "rs231775 is a SNP in the CTLA4 gene associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231775"}, {"entity_type": "GENOMIC VARIANT", "description": "rs231725 is a SNP in the CTLA4 gene associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231725"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3087243 is a SNP in the CTLA4 gene.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243"}, {"entity_type": "GENOMIC VARIANT", "description": "rs5742909 is a SNP in the CTLA4 gene.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909"}, {"entity_type": "DISEASE", "description": "Primary Biliary Cholangitis (PBC) is a chronic liver disease.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PBC"}, {"entity_type": "POPULATION", "description": "Asians are a geographical population group.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "ASIANS"}, {"entity_type": "POPULATION", "description": "Caucasians are a geographical population group.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "CAUCASIANS"}, {"entity_type": "DATABASE", "description": "A reference panel of human genomic variation used for genotyping and imputation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "1000 GENOMES REFERENCE PANEL"}, {"entity_type": "GENE", "description": "A gene that plays an essential role in regulating inflammatory responses to viral infections.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IBKBKE GENE"}, {"entity_type": "GENE", "description": "A gene involved in T cell differentiation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STAT6"}, {"entity_type": "GENE", "description": "A gene involved in intracellular transport of vesicles.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STX2 (SYNTAXIN 2)"}, {"entity_type": "GENE", "description": "A long non-coding RNA located downstream of the IKBKE gene.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RP11\u2212534L20.5 GENE"}, {"entity_type": "GENE", "description": "An inhibitory immune checkpoint gene associated with T1D and other endocrine autoimmune diseases.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CTLA4 GENE"}, {"entity_type": "DISEASE", "description": "An autoimmune disease characterized by the destruction of insulin-producing cells in the pancreas.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "T1D (TYPE 1 DIABETES)"}, {"entity_type": "DISEASE", "description": "An autoimmune disease that affects the joints.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RA (RHEUMATOID ARTHRITIS)"}, {"entity_type": "REGULATORY ELEMENT", "description": "Expression Quantitative Trait Loci (eQTLs) are genetic variants associated with variations in gene expression.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "EQTLS"}, {"entity_type": "GENOMIC FEATURE", "description": "A probe is a short DNA sequence used to detect specific genes or genomic regions.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "PROBE"}, {"entity_type": "GENOMIC VARIANT", "description": "cg26091609 is a genomic variant associated with CTLA4 expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CG26091609"}, {"entity_type": "GENE", "description": "RPS26 is a gene involved in ribosome biogenesis, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RPS26"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1131017 is a SNP located in the 5\'UTR of the RPS26 gene and implicated in T cell regulation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS1131017"}, {"entity_type": "GENE", "description": "CDK2 is a gene involved in cell cycle regulation, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CDK2"}, {"entity_type": "GENE", "description": "RAB5B is a gene involved in endocytosis and vesicle trafficking, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RAB5B"}, {"entity_type": "GENE", "description": "SUOX is a gene involved in the metabolism of cysteine and methionine, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "SUOX"}, {"entity_type": "GENE", "description": "IKZF4 is a gene involved in transcriptional regulation, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IKZF4"}, {"entity_type": "GENE", "description": "ERBB3 is a gene involved in cell growth and survival, located at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "ERBB3"}, {"entity_type": "GENE", "description": "IL-27 is a cytokine produced by innate immune cells that binds to the IL27RA receptor.<SEP>IL27 is a gene encoding an interleukin with immunomodulatory functions.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27"}, {"entity_type": "GENE", "description": "STAT1 is a gene involved in signal transduction and immune response.<SEP>STAT1 is a gene that encodes for a protein involved in immune signaling and interferon response.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "STAT1"}, {"entity_type": "GENE", "description": "REC8 is a gene involved in chromosome segregation during cell division.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "REC8"}, {"entity_type": "RESOURCE", "description": "The GWAS Catalog is a repository of genome-wide association study results.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GWAS CATALOG"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An eQTL (expression quantitative trait locus) describes the genetic variation that influences gene expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "EQTL"}, {"entity_type": "CELL SUBTYPE", "description": "CD4+ T cells are a subtype of T cell that play a role in cell-mediated immunity.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CD4+ T CELL"}, {"entity_type": "CELL SUBTYPE", "description": "CD8+ T cells are a subtype of T cell responsible for killing infected or cancerous cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CD8+ T CELL"}, {"entity_type": "DISEASE", "description": "Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas.<SEP>Type 1 diabetes is an autoimmune disease characterized by destruction of pancreatic beta cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "T1D"}, {"entity_type": "DISEASE", "description": "Vitiligo is an autoimmune disorder causing loss of skin pigmentation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "VITILIGO"}, {"entity_type": "MUTATION", "description": "A missense SNP causes a change in amino acid sequence within a protein.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "AMINO ACID CHANGE"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense SNP (rs181206) within the IL27 gene has been associated with altered expression of IRF1 and STAT1.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "SNP RS181206"}, {"entity_type": "GENE", "description": "IL27RA is a gene encoding for a subunit of the IL-27 receptor.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27RA"}, {"entity_type": "GENE", "description": "IL6ST (also known as gp130) is a gene encoding for a protein that forms part of the receptor for various cytokines, including IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL6ST (GP130)"}, {"entity_type": "CELL TYPE", "description": "B cells are a type of immune cell that produces antibodies to fight infections.<SEP>Lymphocytes responsible for humoral immunity and antibody production.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "B CELLS"}, {"entity_type": "CELL TYPE", "description": "Phagocytic cells that can differentiate into macrophages and dendritic cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "MONOCYTES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genome-wide association study (GWAS) single nucleotide polymorphism.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "GWAS SNP"}, {"entity_type": "PROTEIN", "description": "EBI3 is a protein that forms a heterodimer with IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "EBI3"}, {"entity_type": "GENE", "description": "IL6ST (also known as gp130) is a gene encoding for a protein that forms part of the receptor for various cytokines, including IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "GP130 (IL6ST)"}, {"entity_type": "DNA SEQUENCE", "description": "Specific DNA sequences bound by STAT proteins to regulate gene transcription in response to interferon signaling.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "INTERFERON STIMULATED RESPONSE ELEMENTS (ISRE)"}, {"entity_type": "CELL LINE", "description": "A human embryonic kidney cell line commonly used in molecular biology research.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "HEK293 CELLS"}, {"entity_type": "PROTEIN VARIANT", "description": "The naturally occurring form of IL-27 protein with a leucine amino acid at position 119.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "WILD-TYPE (LEU119)"}, {"entity_type": "PROTEIN VARIANT", "description": "A mutated form of IL-27 protein with a proline amino acid substituted for leucine at position 119.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "MISSENSE (PRO119)"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The IKBKE gene plays an essential role in regulating inflammatory responses to viral infections.)", "entity_type": "UNKNOWN", "id": "INFLAMMATORY RESPONSES TO VIRAL INFECTIONS"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "STAT6 is a transcriptional activator involved in T cell differentiation.)", "entity_type": "UNKNOWN", "id": "T CELL DIFFERENTIATION"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "STX2 is involved in intracellular transport of vesicles.)", "entity_type": "UNKNOWN", "id": "INTRACELLULAR TRANSPORT OF VESICLES"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "STX2 is involved in intracellular transport of vesicles.)", "entity_type": "UNKNOWN", "id": "STX2"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The CTLA4 gene is associated with T1D and RA.)", "entity_type": "UNKNOWN", "id": "T1D AND RA"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Binding of IL-27 to its receptor (IL27RA) activates the STAT1/STAT3 pathway, which induces transcription of IRF1 and STAT1 genes.)", "entity_type": "UNKNOWN", "id": "IRF1 & STAT1"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Higher expression levels of IL27RA and IL6ST genes are observed in CD4+ T cells compared to CD8+ T cells, suggesting specific receptor expression for IL-27.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "IL27RA & IL6ST"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "The expression levels of IRF1 and STAT1 show a strong positive correlation.)", "entity_type": "UNKNOWN", "id": "POSITIVE CORRELATION"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "IL-27 binds to its receptor, IL27RA, triggering downstream signaling pathways.)", "entity_type": "UNKNOWN", "id": "IL27 & IL27RA"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "IL-27 binds to its receptor, IL27RA, triggering downstream signaling pathways.)", "entity_type": "UNKNOWN", "id": "INTERACTION"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "EBI3 associates with IL-27 to form a functional cytokine complex.)", "entity_type": "UNKNOWN", "id": "EBI3 & IL27"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "EBI3 associates with IL-27 to form a functional cytokine complex.)", "entity_type": "UNKNOWN", "id": "HETERODIMER FORMATION"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Binding of IL-27 to its receptor activates the STAT1/STAT3 pathway, leading to phosphorylation and nuclear translocation of these transcription factors.)", "entity_type": "UNKNOWN", "id": "STAT1/STAT3 PATHWAY"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Activated STAT proteins can bind to ISREs and promote the transcription of target genes, including IRF1.)", "entity_type": "UNKNOWN", "id": "STAT1 & IRF1"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Activated STAT proteins can bind to ISREs and promote the transcription of target genes, including IRF1.)", "entity_type": "UNKNOWN", "id": "TRANSCRIPTIONAL REGULATION"}, {"entity_type": "PROTEIN", "description": "IL-8 is a protein involved in inflammatory responses and plays a role in asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8"}, {"entity_type": "TRANSCRIPT", "description": "IL-8 mRNA is the messenger RNA molecule that codes for the IL-8 protein.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 MRNA"}, {"entity_type": "GENE", "description": "The IL-8 gene encodes for the IL-8 protein, which is involved in inflammatory processes.<SEP>The IL-8 gene encodes for the IL-8 protein, which is involved in inflammatory processes.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4073 is a single nucleotide polymorphism (SNP) in the IL-8 gene.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS4073"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2227306 is a single nucleotide polymorphism (SNP) in the IL-8 gene.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS2227306"}, {"entity_type": "POPULATION GROUP", "description": "Children are individuals in the developmental stage from birth to puberty.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "CHILDREN"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The IL-8 protein is encoded by the IL-8 mRNA transcript.)", "entity_type": "UNKNOWN", "id": "IL-8 PROTEIN"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Elevated IL-8 serum levels are associated with asthma in patients compared to healthy controls.)", "entity_type": "UNKNOWN", "id": "IL-8 SERUM LEVELS"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Elevated IL-8 mRNA levels are found in patients with asthma compared to healthy controls.)", "entity_type": "UNKNOWN", "id": "IL-8 MRNA LEVELS"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The homozygous TT genotype of the rs4073 polymorphism is associated with an increased risk of developing asthma.)", "entity_type": "UNKNOWN", "id": "ASTHMA RISK"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The homozygous TT genotype of the rs4073 polymorphism is associated with an increased risk of developing asthma.)", "entity_type": "UNKNOWN", "id": "RS4073 GENOTYPE"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The CC or CT genotypes of the rs2227306 polymorphism are associated with increased susceptibility to asthma.)", "entity_type": "UNKNOWN", "id": "RS2227306 GENOTYPE"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The rs4073 TT genotype is associated with a higher risk of developing atopic asthma.)", "entity_type": "UNKNOWN", "id": "ATOPIC ASTHMA"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The rs4073 TT genotype is associated with a higher risk of developing atopic asthma.)", "entity_type": "UNKNOWN", "id": "RS4073 TT GENOTYPE"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The rs2227306 CC genotype is associated with an increased risk of developing atopic asthma.)", "entity_type": "UNKNOWN", "id": "RS2227306 CC GENOTYPE"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Individuals carrying at least one copy of the rs4073 T allele have a higher risk of experiencing severe asthma.)", "entity_type": "UNKNOWN", "id": "ASTHMA SEVERITY"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Individuals carrying at least one copy of the rs4073 T allele have a higher risk of experiencing severe asthma.)", "entity_type": "UNKNOWN", "id": "RS4073 T ALLELE"}, {"entity_type": "GENE", "description": "The ASAH1 gene is located on 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array.<SEP>The ASAH1 gene is studied in the context of genetic association and power analysis.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "ASAH1"}, {"entity_type": "GENE", "description": "The NAT2 gene is located on 8p22 and has 22 HapMap SNPs and only 4 typed SNPs from the transcription start to end of the gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "NAT2"}, {"entity_type": "GENE", "description": "FGFR2 is a much larger gene. In regions of high LD, the kernel machine method outperforms the min test. In regions of weak LD, the two methods have comparable power.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "FGFR2"}, {"entity_type": "GENE", "description": "The HLA-B gene is part of the human leukocyte antigen (HLA) complex and lies on 6p21.3.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HLA-B"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method for testing associations between sets of SNPs and a phenotype.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "KERNEL MACHINE SNP-SET TEST"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method for testing associations between individual SNPs and a phenotype.<SEP>The min test is a statistical test used for detecting genetic associations.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "MIN TEST"}, {"entity_type": "METABOLIC PATHWAY", "description": "A type of kernel used in the kernel machine SNP-set test that assumes a linear relationship between SNPs and the phenotype.<SEP>The linear kernel is a type of kernel function used in statistical analysis.<SEP>The linear kernel is one type of kernel used in the analysis.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "LINEAR KERNEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method for testing associations between sets of SNPs and a time-to-event outcome.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "SURVIVAL KERNEL MACHINE SNP-SET TEST"}, {"entity_type": "METABOLIC PATHWAY", "description": "A type of kernel used in the kernel machine SNP-set test that measures the pairwise identity by state (IBS) between SNPs.<SEP>The IBS kernel is a type of kernel used in the analysis.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "IBS KERNEL"}, {"entity_type": "METABOLIC PATHWAY", "description": "A type of kernel used in the kernel machine SNP-set test that weighs the pairwise identity by state (IBS) between SNPs based on their minor allele frequency (MAF).", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "WEIGHTED IBS KERNEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A software program used to visualize and analyze linkage disequilibrium (LD) patterns.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HAPLOVIEW"}, {"entity_type": "METABOLIC PATHWAY", "description": "Linkage disequilibrium refers to the non-random association between alleles at different loci.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "LD"}, {"entity_type": "NUTRIENT", "description": "MAF stands for Minor Allele Frequency, a measure of the prevalence of an allele.<SEP>Minor allele frequency is a measure of the prevalence of an allele in a population.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "MAF"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2523608 is a specific SNP mentioned as a causal SNP in the text.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "RS2523608"}, {"entity_type": "MEASUREMENT", "description": "Power refers to the ability of a statistical test to detect an effect.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "POWER"}, {"entity_type": "STATISTICAL TEST", "description": "The SNP-set test, also known as kernel machine SNP-set test, was used to evaluate the overall effect of the gene.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "SNP-SET TEST"}, {"entity_type": "GENETIC CORRELATION", "description": "LDs stands for linkage disequilibrium, a measure of genetic correlation between variants.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LDS"}, {"source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "description": "The ASAH1 gene consists of 86 HapMap SNPs and 14 typed SNPs.)", "entity_type": "UNKNOWN", "id": "TYPED SNPS"}, {"source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "description": "The HLA-B gene has 6 HapMap SNPs.)", "entity_type": "UNKNOWN", "id": "HAPMAP SNPS"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "Simulations using imputed data were conducted to assess the performance of different kernel methods for detecting the effect of the ASAH1 gene.)", "entity_type": "UNKNOWN", "id": "IMPUTED DATA"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The power analysis was conducted both when the causal SNPs were typed and untyped but in good LDs with typed SNPs.)", "entity_type": "UNKNOWN", "id": "UNTYPED SNPS"}, {"entity_type": "THERAPY", "description": "A type of immunotherapy that blocks the CTLA-4 protein.<SEP>A type of immunotherapy treatment that blocks CTLA-4.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-CTLA-4"}, {"entity_type": "THERAPY", "description": "A type of immunotherapy that blocks the PD-1 protein.<SEP>A type of immunotherapy treatment that blocks PD-1.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-PD-1"}, {"entity_type": "THERAPY", "description": "A combination of anti-CTLA-4 and anti-PD-1 therapies.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "COMBINATION THERAPY"}, {"entity_type": "GENE", "description": "A gene associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "PTP N2 GENE"}, {"entity_type": "DISEASE", "description": "An autoimmune disorder affecting the small intestine.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "CELIAC DISEASE"}, {"entity_type": "DISEASE", "description": "A group of inflammatory conditions affecting the digestive tract.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "INFLAMMATORY BOWEL DISEASE"}, {"entity_type": "DISEASE", "description": "An autoimmune disorder characterized by insulin deficiency.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 78}]", "id": "TYPE 1 DIABETES"}, {"entity_type": "GENE", "description": "A gene that encodes interleukin-2, a cytokine involved in immune responses.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 86}]", "id": "IL2 GENE"}, {"entity_type": "DISEASE", "description": "An immune response to an otherwise harmless substance.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 86}]", "id": "ALLERGY"}, {"entity_type": "DISEASE", "description": "A type of cancer where melanoma has spread to other parts of the body.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "METASTATIC MELANOMA"}, {"entity_type": "LOCATION", "description": "New York University Langone Health, a medical center in New York City.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "NYULH"}, {"entity_type": "LOCATION", "description": "University of California, Los Angeles, a research university in Los Angeles.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "UCLA"}, {"entity_type": "THERAPY", "description": "Treatment that combines multiple therapies, in this case, anti-CTLA-4 and anti-PD-1.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "COMBINATION-THERAPY"}, {"entity_type": "PATIENT", "description": "Individuals participating in the study.<SEP>Patients are individuals receiving medical treatment for a condition.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "PATIENTS"}, {"entity_type": "DISEASE STATE", "description": "Individuals who experience a positive treatment response.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "RESPONDERS"}, {"entity_type": "DISEASE STATE", "description": "Individuals who do not experience a positive treatment response.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "NON-RESPONDERS"}, {"entity_type": "DISEASE STATE", "description": "A group of individuals who are non-responders to treatment.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "CASES"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "rs17388568 is a SNP located in the IL2 gene.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 86}]", "id": "RS17388568"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "25 autoimmune risk SNPs were tested for their association with response after passing quality control measures.)", "entity_type": "UNKNOWN", "id": "25 AUTOIMMUNE RISK SNPS"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "25 autoimmune risk SNPs were tested for their association with response after passing quality control measures.)", "entity_type": "UNKNOWN", "id": "QUALITY CONTROL (QC)"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Samples for anti-CTLA-4 treated patients were obtained from NYULH.)", "entity_type": "UNKNOWN", "id": "ANTI-CTLA-4 TREATMENT SAMPLES"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Samples for anti-PD-1 treated patients were obtained from UCLA.)", "entity_type": "UNKNOWN", "id": "ANTI-PD-1 TREATMENT SAMPLES"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Samples for combination therapy treated patients were obtained from UCLA.)", "entity_type": "UNKNOWN", "id": "COMBINATION THERAPY TREATMENT SAMPLES"}, {"source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "description": "The study investigated whether SNPs were associated with treatment response to different therapies.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 63}]", "id": "TREATMENT RESPONSE"}, {"entity_type": "GENE", "description": "EBNA2 is a protein encoded by Epstein-Barr virus (EBV) that plays a role in immune evasion and latency.<SEP>EBNA2 is a transcription factor encoded by the Epstein-Barr virus (EBV) that plays a role in regulating gene expression.<SEP>EBNA2 is a transcription factor that binds to chromatin at MS risk loci.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBNA2"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region associated with an increased risk of multiple sclerosis (MS).", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "MS RISK LOCUS"}, {"entity_type": "GENE", "description": "The TRAF3/RCOR1 locus is involved in the immune response and is a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAFA3/RCOR1"}, {"entity_type": "GENE", "description": "TNFAIP8 is a gene involved in inflammatory responses.<SEP>TNFAIP8 is involved in the regulation of inflammation and is a MS risk locus.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFAIP8"}, {"entity_type": "GENE", "description": "TNFRSF1A encodes the TNF receptor 1, which plays a role in immune responses and is a MS risk locus.<SEP>TNFRSF1A is a gene involved in TNF receptor signaling.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFRSF1A"}, {"entity_type": "GENE", "description": "TBX6 is a transcription factor involved in development and is a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TBX6"}, {"entity_type": "PROTEIN", "description": "A synthetic peptide that inhibits the function of EBNA2, a viral protein.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBNA2-TAT"}, {"entity_type": "PROTEIN", "description": "A protein encoded by the Epstein-Barr virus (EBV) that plays a role in cell proliferation and transformation.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "LMP1"}, {"entity_type": "PROTEIN", "description": "A transcription factor that interacts with EBNA2.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "RBP-J\u039a"}, {"entity_type": "DISEASE", "description": "An autoimmune disease characterized by inflammation and damage to the central nervous system.<SEP>Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "id": "MULTIPLE SCLEROSIS (MS)"}, {"entity_type": "GENE", "description": "CLECL1 encodes a C-type lectin domain family 1 member, involved in immune cell signaling and is a MS risk locus.<SEP>CLECL1 is a gene involved in immune cell activation.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "id": "CLECL1"}, {"entity_type": "GENE", "description": "TRAF3 is a gene involved in immune signaling.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TRAF3"}, {"entity_type": "GENE", "description": "RCOR1 is a gene involved in transcriptional regulation.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "RCOR1"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "Variations in the TRAF3 gene are associated with increased risk of Multiple Sclerosis (MS).)", "entity_type": "UNKNOWN", "id": "MS RISK"}, {"entity_type": "GENE", "description": "The COX-2 gene is involved in the inflammatory response and has been linked to aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-2 GENE"}, {"entity_type": "GENE", "description": "The ITGA2 gene encodes an integrin protein involved in platelet function and has been associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2 GENE"}, {"entity_type": "GENE", "description": "The COX-1 gene is involved in the production of prostaglandins, which play a role in pain and inflammation.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-1 GENE"}, {"entity_type": "GENE", "description": "The ITGA2B gene encodes an integrin protein involved in platelet function and has been linked to aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2B GENE"}, {"entity_type": "DISEASE", "description": "A condition where aspirin is ineffective in preventing or treating certain conditions, often related to platelet function.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ASPIRIN INSENSITIVITY"}, {"entity_type": "POPULATION GROUP", "description": "Individuals of Chinese ethnicity studied in the meta-analysis.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CHINESE SUBJECTS"}, {"entity_type": "POPULATION GROUP", "description": "Individuals of Caucasian ethnicity studied in the meta-analysis.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CAUCASIAN SUBJECTS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variation in the DNA sequence of the COX-1 gene.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS3842787"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variation in the DNA sequence of the ITGA2B gene.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS201184269"}, {"entity_type": "GENOMIC VARIANT", "description": "rs20417 is a genomic variant associated with coronary artery disease (CAD) and influences the percentage of CAD between patients and controls.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 68}]", "id": "RS20417"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1126643 is a genomic variant associated with platelet number and contributes to heterogeneity in studies.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "RS1126643"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Platelet number refers to the count of platelets in the blood, which is involved in blood clotting.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "PLATELET NUMBER"}, {"entity_type": "GENE", "description": "STAT5B is a gene involved in immune system function, particularly the development and maintenance of T cells and regulatory T cells.<SEP>STAT5B is a gene that encodes for the protein STAT5B, which plays a critical role in growth hormone signaling.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "STAT5B"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a genomic variant in the STAT5B gene that results in a nonsense mutation.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "C.1892G>A"}, {"entity_type": "PROTEIN", "description": "This is a protein truncation due to the c.1892G>A variant, resulting in a shortened STAT5B protein lacking parts of its SH2 and transactivation domains.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "P.W631*"}, {"entity_type": "PROTEIN", "description": "Recombinant human insulin-like growth factor 1 is used to improve growth in patients with growth hormone deficiency.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)"}, {"entity_type": "DISEASE", "description": "A condition characterized by insufficient production of growth hormone, leading to stunted growth.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE DEFICIENCY (GHI)"}, {"entity_type": "DISEASE", "description": "A chronic skin condition characterized by itchy, inflamed patches.<SEP>Eczema is a chronic skin condition characterized by inflammation, itching, and rash.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "ECZEMA"}, {"entity_type": "DISEASE", "description": "Chronic inflammation of the airways, causing symptoms like wheezing and coughing.<SEP>Reactive airway disease is a condition characterized by narrowing and inflammation of the airways, leading to symptoms like wheezing and coughing.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "REACTIVE AIRWAY DISEASE"}, {"entity_type": "DISEASE", "description": "A condition where stomach acid flows back into the esophagus.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "GASTROESOPHAGEAL REFLUX DISEASE (GERD)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Having parents who are closely related, increasing the risk of recessive genetic disorders.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "CONSANGUINEOUS"}, {"entity_type": "DISEASE", "description": "An infection of the lungs that causes inflammation and fluid buildup in the air sacs.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "PNEUMONIA"}, {"entity_type": "DISEASE", "description": "A life-threatening condition caused by an overwhelming inflammatory response to infection.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SEPSIS"}, {"entity_type": "DISEASE", "description": "A chronic lung disease that affects premature infants, causing damage to the lungs and airways.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "BRONCHOPULMONARY DYSPLASIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Challenges in consuming and processing food, leading to inadequate nutrition.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "FEEDING DIFFICULTIES"}, {"entity_type": "DISEASE", "description": "Delayed growth and development due to inadequate nutritional intake or absorption.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "FAILURE TO THRIVE"}, {"entity_type": "DISEASE", "description": "A condition characterized by abnormally short height compared to average for age and sex.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SHORT STATURE (GH DEFICIENCY)"}, {"entity_type": "DISEASE", "description": "A genetic disorder where the body cannot respond properly to growth hormone, leading to stunted growth.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE INSENSITIVITY SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A pattern of fat accumulation in the abdomen and central part of the body.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "CENTRIPETAL FAT DISTRIBUTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An enlarged forehead compared to the rest of the face.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "FOREHEAD PROMINENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A flattened bridge between the eyes, creating a concave appearance.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "DEPRESSED NASAL BRIDGE"}, {"entity_type": "DISEASE", "description": "A group of allergic conditions that involve inflammation of the skin and airways.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "ATOPIC DISEASE"}, {"entity_type": "DISEASE", "description": "Infections affecting the skin, including bacterial, fungal, or viral causes.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SKIN INFECTIONS"}, {"entity_type": "DISEASE", "description": "Infections affecting any part of the urinary system, including the kidneys, bladder, and urethra.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "URINARY TRACT INFECTIONS (UTIS)"}, {"entity_type": "DISEASE", "description": "Infections affecting the lungs, such as pneumonia or bronchitis.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "PULMONARY INFECTIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Swelling of the lymph nodes due to infection, inflammation, or other causes.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "LYMPHADENOPATHY"}, {"entity_type": "DISEASE", "description": "A condition characterized by low platelet count in the blood without a known cause.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "IDIOPATHIC THROMBOCYTOPENIA"}, {"entity_type": "GENOMIC VARIANT", "description": "A p.W631* variant in the STAT5B gene leads to a loss-of-function (LOF) effect.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "P.W631* VARIANT"}, {"entity_type": "CELL TYPE", "description": "NK cells are a type of immune cell that plays a role in recognizing and destroying infected or cancerous cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "NK CELLS"}, {"entity_type": "CELL TYPE", "description": "Memory T cells are a type of T cell that provides long-lasting immunity against previously encountered pathogens.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "MEMORY T CELLS"}, {"entity_type": "DISEASE", "description": "Atopy refers to a predisposition towards allergic reactions and sensitization to environmental allergens.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "ATOPY"}, {"entity_type": "DISEASE", "description": "Autoimmunity occurs when the immune system mistakenly attacks the body\'s own tissues.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "AUTOIMMUNITY"}, {"entity_type": "DISEASE", "description": "Thyroiditis is an inflammation of the thyroid gland.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "THYROIDITIS"}, {"entity_type": "PROTEIN", "description": "CD127 is a subunit of the IL-7 receptor, important for T cell development and survival.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "CD127"}, {"entity_type": "CELL", "description": "TCM cells are a type of immune cell.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "TCM CELLS"}, {"entity_type": "CELL SUBTYPE", "description": "CD4+ TEM cells are a subset of T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ TEM CELLS"}, {"entity_type": "CELL SUBTYPE", "description": "CD8+ TEM cells are a subset of T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 53}]", "id": "CD8+ TEM CELLS"}, {"entity_type": "CELL SUBTYPE", "description": "CD8+ TEMRA cells are a subset of T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEMRA CELLS"}, {"entity_type": "GENOMIC VARIANT", "description": "A STAT5B variant is present in the patients described.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "STAT5B VARIANT"}, {"entity_type": "CELL SUBTYPE", "description": "CD8+ memory T cells are a subset of T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ MEMORY T CELLS"}, {"entity_type": "DISEASE", "description": "STAT5B deficiency is a genetic condition affecting the STAT5B gene.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "STAT5B DEFICIENCY"}, {"entity_type": "INDIVIDUAL GROUP", "description": "The text refers to siblings being compared in this study.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 53}]", "id": "SIBLINGS"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Infancy is described as a stage of development where certain changes occur.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "INFANCY"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Age 4 years old is mentioned as a point of normalization for some cell populations.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "AGE 4"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Mutations in the STAT5B gene can lead to growth hormone deficiency, as it is involved in growth hormone signaling.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "GROWTH HORMONE DEFICIENCY"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Having consanguineous parents increases the risk of inheriting recessive genetic disorders that can cause growth failure.)", "entity_type": "UNKNOWN", "id": "CONSANGUINEOUS PARENTS"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Having consanguineous parents increases the risk of inheriting recessive genetic disorders that can cause growth failure.)", "entity_type": "UNKNOWN", "id": "SEVERE POST-NATAL GROWTH FAILURE"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "LOF STAT5B mutations result in various immune defects, including reduced NK cell function, elevated B cells with increased immunoglobulin production, and T cell lymphopenia.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "IMMUNE DEFECTS"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-614333487e4b92705503909d34155179<SEP>chunk-41c7131af28e2a745ef6b88b8601860f", "description": "The STAT5B p.W631* variant disrupts STAT5B function and leads to immune system dysregulation.)<SEP>The complex network of cells and processes that defend the body against pathogens.<SEP>The complex network of cells and tissues that protects the body from disease.", "entity_type": "BIOLOGICAL PROCESS", "id": "IMMUNE SYSTEM"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "The STAT5B p.W631* variant disrupts STAT5B function and leads to immune system dysregulation.)", "entity_type": "UNKNOWN", "id": "STAT5B P.W631* VARIANT"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "STAT5B is involved in FOXP3 induction, Treg function, and self-tolerance. Loss-of-function STAT5B variants impair the maintenance of FOXP3 expression in Tregs over time.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 101}]", "id": "REGULATORY T CELLS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "The STAT5B variant appears to play a role in dysregulating CD8+ T cell activation and homeostasis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}, {level: 1, cluster: 100}]", "id": "CD8+ T CELL ACTIVATION AND HOMEOSTASIS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "The text refers to three siblings, P1, P2, and P3.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 53}]", "id": "P1, P2, P3"}, {"entity_type": "GENE", "description": "HLA-DRB1 is a gene involved in immune response.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA\u2010DRB1"}, {"entity_type": "GENE", "description": "HLA-DQB1 is a gene involved in immune response.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA\u2010DQB1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28383172 is a single nucleotide polymorphism (SNP) located in the HLA\u2010DRB1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "RS28383172"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4713586 is a single nucleotide polymorphism (SNP) ", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "RS4713586"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Allergic reaction to aspirin.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "ASP HYPERSENSITIVITY"}, {"entity_type": "GENE", "description": "A gene that encodes a protein involved in immune response.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "HLA-DRB1*07:01"}, {"entity_type": "GENE", "description": "A gene that encodes a protein involved in immune response.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQA1*02:01"}, {"entity_type": "GENE", "description": "A gene that encodes a protein involved in immune response.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQB1*02:02"}, {"entity_type": "DISEASE", "description": "An adverse reaction to Escherichia coli lipopolysaccharide (LPS).", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "E. COLI ASP HYPERSENSITIVITY"}, {"entity_type": "GENE", "description": "A gene belonging to the major histocompatibility complex (MHC) class II, involved in antigen presentation.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "HLA-DRB1"}, {"entity_type": "GENE", "description": "A gene belonging to the major histocompatibility complex (MHC) class II, involved in antigen presentation.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQA1"}, {"entity_type": "GENE", "description": "A gene belonging to the major histocompatibility complex (MHC) class II, involved in antigen presentation.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQB1"}, {"entity_type": "ALGORITHM", "description": "An algorithm used for genetic tagging.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM II"}, {"entity_type": "ALGORITHM", "description": "An algorithm used for genetic tagging.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM III"}, {"entity_type": "ALGORITHM", "description": "An algorithm used for genetic tagging.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM IV"}, {"entity_type": "ALGORITHM", "description": "A statistical model, which outperformed other algorithms in the study.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM V"}, {"entity_type": "METHOD", "description": "A method of genetic tagging using two single nucleotide polymorphisms (SNPs).", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "2-SNP TAGGING"}, {"entity_type": "POPULATION GROUP", "description": "A specific group within a larger population, defined by geographic location and ancestry.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "EUR SUPER POPULATION"}, {"entity_type": "DATASET", "description": "A collection of genetic data from individuals across the globe.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "1000 GENOMES DATASET"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "HLA-DRB1*07:01 is part of the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "entity_type": "UNKNOWN", "id": "HLA\u2010DRB1*07:01"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "HLA-DRB1*07:01 is part of the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "entity_type": "UNKNOWN", "id": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "The HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype is associated with E. coli ASP hypersensitivity.)", "entity_type": "UNKNOWN", "id": "HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "Algorithm V is a surrogate marker for the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "entity_type": "UNKNOWN", "id": "HLA-DRB1*07:07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "Algorithm V achieved higher sensitivity compared to other algorithms.)", "entity_type": "UNKNOWN", "id": "SENSITIVITY"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "Algorithm V demonstrated a greater negative predictive value compared to algorithms III and IV.)", "entity_type": "UNKNOWN", "id": "NEGATIVE PREDICTIVE VALUE"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "Algorithm V exhibited higher specificity than algorithm II.)", "entity_type": "UNKNOWN", "id": "SPECIFICITY"}, {"source_id": "chunk-1f50436a36721971a0a256131d7fca62", "description": "Algorithm V displayed a superior positive predictive value compared to algorithm II.)", "entity_type": "UNKNOWN", "id": "POSITIVE PREDICTIVE VALUE"}, {"entity_type": "GENE", "description": "TLR7 is a gene associated with immune response.<SEP>TLR7 is a gene involved in the innate immune response to viral RNA.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179008 is a single nucleotide polymorphism (SNP) within the TLR7 gene.<SEP>rs179008 is a specific polymorphism within the TLR7 gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179008"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179009 is a single nucleotide polymorphism (SNP) within the TLR7 gene.<SEP>rs179009 is a specific polymorphism within the TLR7 gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179009"}, {"entity_type": "DISEASE", "description": "A group of individuals diagnosed with HIV infection.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "HIV-INFECTED INDIVIDUALS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The use of tobacco products can have various health effects, including increased risk of certain diseases.)<SEP>Tobacco use, including smoking cigarettes or using tobacco products, is a risk factor for various diseases.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TOBACCO"}, {"entity_type": "DISEASE", "description": "Human Immunodeficiency Virus, a retrovirus that attacks the immune system.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "HIV"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CD4 cell count is a measure of the number of CD4+ T cells in the blood, which are crucial for immune function.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "CD4 COUNTS"}, {"entity_type": "DISEASE", "description": "HIV progresses through different stages characterized by increasing severity and immune system decline.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "HIV DISEASE STAGES"}, {"entity_type": "DISEASE", "description": "The initial stage of HIV infection, often asymptomatic or with mild symptoms.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "EARLY HIV DISEASE STAGE"}, {"entity_type": "DISEASE", "description": "A stage where HIV has progressed and starts causing more noticeable immune system impairment.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "INTERMEDIATE HIV DISEASE STAGE"}, {"entity_type": "DISEASE", "description": "The final stage of HIV infection, marked by severe immune deficiency and increased susceptibility to opportunistic infections.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "ADVANCED HIV DISEASE STAGE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method used to examine the relationship between multiple variables, including demographic factors, lifestyle choices, and genetic variations.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS"}, {"entity_type": "DISEASE", "description": "HIV disease progression refers to the advancement of HIV infection in an individual.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "HIV DISEASE PROGRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CD4 counts measure the number of certain immune cells in the blood and are used to monitor HIV infection.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "BASELINE CD4 COUNTS"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "Individuals with specific TLR7 polymorphisms (rs179008 and rs179009) may be more susceptible to certain stages of HIV disease.)<SEP>Individuals with specific TLR7 polymorphisms may be more susceptible to certain stages of HIV disease.)", "entity_type": "UNKNOWN", "id": "TLR7 POLYMORPHISMS"}, {"source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "description": "This analysis was used to determine if age, sex, tobacco use, alcohol consumption, baseline CD4 counts, and TLR7 polymorphisms were independent risk factors for HIV disease progression.)", "entity_type": "UNKNOWN", "id": "AGE, SEX, TOBACCO, ALCOHOL, BASELINE CD4 COUNTS, AND TLR7 POLYMORPHISMS"}, {"entity_type": "GENOMIC VARIANT", "description": "A known hotspot mutation in the ALK gene.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 129}]", "id": "ALK R1275Q"}, {"entity_type": "GENOMIC VARIANT", "description": "A known activating mutation in the NRAS gene, commonly found in melanoma, thyroid, and colorectal cancers.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "NRAS Q61K"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations in the ALK gene, specifically at position 1174.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "ALK F1174L/I/C"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation in the ZNF717 gene.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "ZNF717 Q716"}, {"entity_type": "GENE", "description": "A gene that encodes a tyrosine kinase receptor involved in cell growth and survival.<SEP>ALK is a gene that encodes for proteins involved in cellular signaling.<SEP>ALK is a protein that can be targeted by neoepitopes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "ALK"}, {"entity_type": "GENE", "description": "A human leukocyte antigen (HLA) allele that presents peptides to T cells.<SEP>HLA-B*15:01 is a gene that encodes for HLA-B*15:01 protein.<SEP>HLA-B*15:01 is a specific HLA allele.<SEP>HLA-B*15:01 is an HLA gene.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-614333487e4b92705503909d34155179<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 19}]", "id": "HLA-B*15:01"}, {"entity_type": "MHC MOLECULE", "description": "A human leukocyte antigen (HLA) allele that presents peptides to T cells.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-A*02:01"}, {"entity_type": "MHC MOLECULE", "description": "A human leukocyte antigen (HLA) allele that presents peptides to T cells.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-B*15:03"}, {"entity_type": "GENE", "description": "A human leukocyte antigen (HLA) allele that presents peptides to T cells.<SEP>HLA-A*01:01 is an HLA gene.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2", "clusters": "[{level: 0, cluster: 19}]", "id": "HLA-A*01:01"}, {"entity_type": "STUDY GROUP", "description": "A cohort of patients being studied in a research project.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "TARGET COHORT"}, {"entity_type": "SOFTWARE TOOL", "description": "A computational software used for predicting neoepitopes.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PROTECT SOFTWARE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The strength with which a peptide binds to an MHC molecule.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PEPTIDE BINDING AFFINITY"}, {"entity_type": "PEPTIDE", "description": "AQDIYRASY is a nonamer peptide derived from the ALK protein.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "AQDIYRASY"}, {"entity_type": "PEPTIDE", "description": "AQDIYRASYY is a decamer peptide derived from the ALK protein.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "AQDIYRASYY"}, {"entity_type": "MOLECULE", "description": "Tumor neoepitopes are peptides derived from mutated proteins in tumor cells and can be recognized by the immune system.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "TUMOR NEOEPITOPES"}, {"entity_type": "MOLECULE", "description": "Major Histocompatibility Complex (MHC) is a group of cell surface molecules that play a crucial role in immune recognition.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "MHC"}, {"entity_type": "TECHNIQUE", "description": "Liquid chromatography\u2013mass spectrometry (LC-MS) is a technique used to identify and quantify molecules in a sample.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "LIQUID CHROMATOGRAPHY\u2013MASS SPECTROSCOPY (LC-MS)"}, {"entity_type": "TECHNIQUE", "description": "Differential scanning fluorimetry (DSF) is a technique used to measure the thermal stability of proteins.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "DIFFERENTIAL SCANNING FLUORIMETRY (DSF)"}, {"entity_type": "TECHNIQUE", "description": "X-ray crystallography is a technique used to determine the three-dimensional structure of molecules.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "X-RAY CRYSTALLOGRAPHY"}, {"entity_type": "DATABASE", "description": "Protein Data Bank (PDB) is a database of 3D structural information about biological macromolecules.<SEP>The Protein Data Bank (PDB) contains 3D structural data of proteins and nucleic acids.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-614333487e4b92705503909d34155179", "id": "PDB"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ALK R1275Q neoepitopes are peptides that can be recognized by T cells in the context of HLA molecules.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ALK R1275Q NEOEPITOPES"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA (Human Leukocyte Antigen) alleles are genetically diverse variants that bind to peptides and present them to T cells.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA"}, {"entity_type": "PEPTIDE", "description": "A peptide is a short chain of amino acids. Neoepitopes are peptides derived from tumor antigens that can be recognized by the immune system.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PEPTIDE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "TCRs (T cell receptors) are proteins on T cells that recognize and bind to MHC-peptide complexes.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "TCRS"}, {"entity_type": "PROTEIN", "description": "ALK peptides are protein fragments derived from the ALK gene.", "source_id": "chunk-614333487e4b92705503909d34155179", "clusters": "[{level: 0, cluster: 19}]", "id": "ALK PEPTIDES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The binding of peptides to HLA molecules.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PEPTIDE/HLA INTERACTIONS"}, {"entity_type": "PEPTIDE", "description": "A nonamer peptide is a peptide with 9 amino acids.", "source_id": "chunk-614333487e4b92705503909d34155179", "clusters": "[{level: 0, cluster: 19}]", "id": "NONAMER PEPTIDE"}, {"entity_type": "PEPTIDE", "description": "A decamer peptide is a peptide with 10 amino acids.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "DECAMEER PEPTIDE"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA-B*15:84 is a specific HLA allele.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:84"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA-B*15:107 is a specific HLA allele.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:107"}, {"entity_type": "DATABASE", "description": "A database containing information about biological sequences.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "EMBL-EBI DATABASE"}, {"entity_type": "SOFTWARE TOOL", "description": "A computational method for predicting protein structures.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ROSETTA COMPARATIVE MODELING"}, {"entity_type": "GENE", "description": "The ALK gene encodes a receptor tyrosine kinase involved in cell growth and survival.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ALK GENE"}, {"entity_type": "PROTEIN", "description": "A type of protein that binds to signaling molecules outside the cell and triggers intracellular signaling pathways.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "RECEPTOR TYROSINE KINASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which cells increase in size and number.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "CELL GROWTH"}, {"entity_type": "PROTEIN", "description": "A protein present on tumor cells that can be recognized by the immune system.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "TUMOR ANTIGEN"}, {"entity_type": "COMPUTATIONAL METHOD", "description": "A method that uses computer simulations to study biological systems.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "IN SILICO ANALYSIS"}, {"entity_type": "EXPERIMENTAL DATA", "description": "Three-dimensional models of proteins determined using X-ray crystallography.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HIGH-RESOLUTION X-RAY STRUCTURES"}, {"entity_type": "COMPUTATIONAL METHOD", "description": "A computational method for predicting protein structures.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ROSETTA COMPARATIVE MODELING CALCULATIONS"}, {"entity_type": "COMPUTATIONAL METHOD", "description": "A technique used to find the lowest energy configuration of a molecule or system.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ENERGY MINIMIZATION"}, {"entity_type": "PHYSICAL QUANTITY", "description": "A measure of the strength of interaction between two molecules.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "BINDING ENERGIES"}, {"entity_type": "MOLECULAR FEATURE", "description": "The region on an MHC molecule where peptides bind.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PEPTIDE/MHC GROOVE"}, {"entity_type": "NUMERICAL MEASURE", "description": "A measure of similarity between two sequences of DNA, RNA or protein.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "SEQUENCE IDENTITY SCORE"}, {"entity_type": "GRAPHICAL REPRESENTATION", "description": "A plot that summarizes the distribution of amino acids in a multiple sequence alignment.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "KULLBACK\u2013LEIBLER SEQUENCE LOGO"}, {"entity_type": "PEPTIDE", "description": "This is a peptide derived from the SARS coronavirus.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "SARS CORONAVIRUS-DERIVED EPITOPE"}, {"entity_type": "PROTEIN COMPLEX", "description": "MHC tetramers are proteins that bind to specific MHC molecules and peptides.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "MHC TETRAMER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A part of an antigen that is recognized as a target by the immune system.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "IMMUNODOMINANT EPITOPE"}, {"entity_type": "PROTEIN", "description": "A molecule, often a protein or carbohydrate, that triggers an immune response.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "ANTIGEN"}, {"entity_type": "DISEASE", "description": "An organism that can cause disease.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "PATHOGEN"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ALK R1275Q mutation gives rise to neoepitopes recognized by the immune system.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "NEOEPITOPE"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ALK R1275Q mutation is a specific alteration within the ALK gene.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 129}]", "id": "MUTATION IN ALK"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The HLA-B*15:01 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "HLA-B*15:01 BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The HLA-A*02:01 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "HLA-A*02:01 BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The HLA-B*15:03 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "HLA-B*15:03 BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The HLA-A*01:01 molecule binds to specific neoepitopes derived from the NRAS Q61K mutation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 56}, {level: 2, cluster: 128}]", "id": "HLA-A*01:01 BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The TARGET cohort includes samples from primary and relapsed neuroblastoma (NBL) tumors.)", "entity_type": "UNKNOWN", "id": "NBL SAMPLE PAIRS"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The TARGET cohort includes samples from primary and relapsed neuroblastoma (NBL) tumors.)", "entity_type": "UNKNOWN", "id": "PART OF STUDY"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ProTECT software is utilized to predict potential neoepitopes from tumor genomes.)", "entity_type": "UNKNOWN", "id": "NEOEPITOPE PREDICTION"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ProTECT software is utilized to predict potential neoepitopes from tumor genomes.)", "entity_type": "UNKNOWN", "id": "TOOL FUNCTION"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ProTECT software considers the binding affinity of peptides to MHC molecules when predicting neoepitopes.)", "entity_type": "UNKNOWN", "id": "BINDING AFFINITY CONSIDERATION"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "AQDIYRASY binds to HLA-B*15:01/\u03b22m complex.)", "entity_type": "UNKNOWN", "id": "MHC COMPLEX"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "LC-MS was used to identify peptides in the samples.)", "entity_type": "UNKNOWN", "id": "LC-MS"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "LC-MS was used to identify peptides in the samples.)", "entity_type": "UNKNOWN", "id": "PEPTIDE IDENTIFICATION"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "DSF was used to measure the thermal stability of MHC/peptide complexes.)", "entity_type": "UNKNOWN", "id": "DSF"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "X-ray crystallography was used to determine the 3D structure of MHC/peptide complexes.)", "entity_type": "UNKNOWN", "id": "PROTEIN STRUCTURE DETERMINATION"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The PDB contains structural information about the MHC/peptide complexes.)", "entity_type": "UNKNOWN", "id": "STRUCTURE INFORMATION"}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "Peptides bind to the HLA-binding groove.)", "entity_type": "UNKNOWN", "id": "HLA-BINDING GROOVE"}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "Higher sequence identity scores between HLA alleles and the peptides result in lower binding energies.)", "entity_type": "UNKNOWN", "id": "BINDING ENERGY"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "HLA-A*01:01 forms a stable complex with a decamer peptide.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}]", "id": "DECAMER PEPTIDE"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "CD8+ T cells recognize the HLA-B*15:01/SARS tetramer.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 58}]", "id": "HLA-B*15:01/SARS TETRAMER"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "PBMCs from HLA-B*15:01 matched donors were used in the experiments.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}]", "id": "DONOR PBMCS"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "CD8+ T cells were stained with HLA-B*15:01 tetramers to identify those recognizing specific neoepitopes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 57}]", "id": "HLA-B*15:01 TETRAMER"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "Some HLA-B*15:01 tetramers were labeled with allophycocyanin (APC).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 57}]", "id": "APC"}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "Some HLA-B*15:01 tetramers were labeled with phycoerythrin (PE).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 57}]", "id": "PE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs74420772 is a single nucleotide polymorphism (SNP) that achieved genome-wide significance in the TwinGene GWAS for IgM anti-PC.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS74420772"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic region 1p31.3 contains SNPs associated with IgM anti-PC levels, but these were not significant in the validation cohort.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "1P31.3"}, {"entity_type": "GENOMIC VARIANT", "description": "11q24.1 is a chromosomal region that contains rs35923643.<SEP>The genomic region 11q24.1 contains six SNPs associated with IgM anti-PC levels that were successfully replicated in a validation cohort.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b<SEP>chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "11Q24.1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35923643-G is the leading SNP in 11q24.1 associated with IgM anti-PC levels and CLL risk.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS35923643-G"}, {"entity_type": "GENOMIC VARIANT", "description": "rs735665-A is a proxy SNP for rs35923643-G and was also found to be associated with general IgM levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS735665-A"}, {"entity_type": "GENE", "description": "The GRAM domain containing 1B (GRAMD1B) gene overlaps with the LD block containing the six SNPs in 11q24.1.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GRAMD1B"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IgM anti-PC refers to IgM antibodies against phosphocholine, a measure of autoimmune response.<SEP>IgM anti-PC refers to antibodies against phosphorylcholine.<SEP>IgM anti-PC refers to the presence of antibodies against phosphorylcholine.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b<SEP>chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "IGM ANTI-PC"}, {"entity_type": "DISEASE", "description": "CLL (Chronic Lymphocytic Leukemia) is a type of cancer affecting B lymphocytes.<SEP>Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b<SEP>chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "CLL"}, {"entity_type": "STUDY", "description": "The InterLymph consortium conducted a GWAS on CLL.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "INTERLYMPH CONSORTIUM"}, {"entity_type": "STUDY", "description": "A GWAS meta-analysis was performed on IgM anti-PC, combining results from multiple individual studies.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GWAS META-ANALYSIS"}, {"entity_type": "STATISTICAL THRESHOLD", "description": "Genome-wide significance is achieved when a p-value is less than 5.0 \u00d7 10\u22128, indicating strong evidence for association.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GENOME-WIDE SIGNIFICANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35923643 is a genomic variant located at the top locus 11q24.1 shared between IgM anti-PC and CLL.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RS35923643"}, {"entity_type": "PROTEIN", "description": "RUNX3 is a transcription factor that binds to DNA sequences.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RUNX3"}, {"entity_type": "PROTEIN", "description": "SPI1 is a transcription factor that binds to DNA sequences.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "SPI1"}, {"entity_type": "MOLECULAR MODIFICATION", "description": "H3K4Me1 refers to monomethylated histone H3 lysine 4, a histone mark associated with active transcription.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "H3K4ME1"}, {"entity_type": "ENZYME", "description": "DNaseI is an enzyme that cleaves DNA at specific sites. Its hypersensitivity indicates regions of open chromatin.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "DNASEI"}, {"entity_type": "CELL LINE", "description": "GM12878 is a human B-cell line used in the study.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "GM12878"}, {"entity_type": "CELL TYPE", "description": "CD34+ cells are hematopoietic stem/progenitor cells.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CD34+"}, {"entity_type": "CELL LINE", "description": "GM12865 is a human B-cell line used in the study.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "GM12865"}, {"entity_type": "TOOL", "description": "FIMO (Find Individual Motif Occurrences) is a tool used to identify potential binding sites for transcription factors in DNA sequences.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "FIMO"}, {"entity_type": "STUDY DESIGN", "description": "A case-control study compares individuals with a particular condition (cases) to those without the condition (controls).", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CASE-CONTROL STUDY"}], "links": [{"weight": 1.0, "description": "SNP rs543874 in the SEC16B gene affects obesity risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SEC16 HOMOLOG B", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "SNP rs713586 in the DNAJC27 gene affects obesity risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27", "target": "OBESITY RISK"}, {"weight": 3.0, "description": "SNP rs9356744 in the CDKAL1 gene affects obesity risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1", "target": "OBESITY RISK"}, {"weight": 4.0, "description": "SNP in the TFAP2B gene affects obesity risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "TRANSCRIPTION FACTOR AP-2 BETA", "target": "OBESITY RISK"}, {"weight": 1.0, "description": "Higher waist circumference is a characteristic of obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "WAIST CIRCUMFERENCE"}, {"weight": 2.0, "description": "Obese individuals tend to have higher fat mass than non-obese individuals.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "FAT MASS"}, {"weight": 3.0, "description": "While both obese and non-obese groups can have varying muscle mass, obesity is generally associated with lower skeletal muscle mass.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "SKELETAL MUSCLE MASS"}, {"weight": 4.0, "description": "Increased risk of developing metabolic syndrome is linked to obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "METABOLIC SYNDROME"}, {"weight": 5.0, "description": "Higher serum total cholesterol levels are frequently observed in obese individuals.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "SERUM TOTAL CHOLESTEROL"}, {"weight": 2.0, "description": "PRS interacted with early menarche age to influence obesity risk, with a higher BMI in individuals with both early menarche and high PRS.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "OBESITY", "target": "PRS"}, {"weight": 4.0, "description": "Individuals carrying the A-allele of the FTO rs9939609 polymorphism have an increased risk of obesity.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY", "target": "FTO RS9939609"}, {"weight": 6.0, "description": "Higher education levels are associated with a lower risk of obesity.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY", "target": "EDUCATION LEVEL"}, {"weight": 2.0, "description": "The APOBR rs180743 G-allele was nominally associated with obesity (odds ratio (OR) per allele = 1.27; 95% confidence interval (CI): 1.09\u20131.47, p = 0.002).", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "RS180743"}, {"weight": 4.0, "description": "The deletion allele of rs3833080 was nominally associated with obesity (OR = 1.25 per allele; 95%CI: 1.08\u20131.45, p = 0.003).", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "RS3833080"}, {"weight": 6.0, "description": "The deletion rs368546180 resulted in an in-frame shortened amino acid sequence of the repeat region of APOBR with no predicted function. It was identified once heterozygously in an extremely obese child.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "RS368546180"}, {"weight": 7.0, "description": "The rs182549 variant is negatively associated with obesity.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "OBESITY", "target": "RS182549"}, {"weight": 0.7, "description": "Higher BMI is associated with elevated sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "OBESITY", "target": "SUA LEVELS"}, {"weight": 2.0, "description": "The FTO rs1558902 genotype is associated with changes in waist circumference, mirroring the association with weight.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "FTO RS1558902"}, {"weight": 5.0, "description": "Increased waist circumference is associated with poorer metabolic health.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "METABOLIC HEALTH"}, {"weight": 10.0, "description": "Individuals with the rs4988235 variant had a modestly lower HDL cholesterol (\u03b2 -0.017, 95%CI -0.029 to -0.004).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "HDL CHOLESTEROL", "target": "RS4988235"}, {"weight": 10.0, "description": "The rs3025020 minor allele is positively associated with hs-CRP levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "HS-CRP", "target": "RS3025020"}, {"weight": 10.0, "description": "Lower eGFR, indicative of kidney damage, can increase the risk of hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "EGFR", "target": "HYPERTENSION"}, {"weight": 2.0, "description": "The LRP2 gene variant rs57989581 is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "LRP2"}, {"weight": 4.0, "description": "The NFATC1 gene variant rs8096658 is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "NFATC1"}, {"weight": 10.0, "description": "The PDILT-UMOD gene complex variant rs77924615 is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "PDILT-UMOD"}, {"weight": 14.0, "description": "The PRKAG2 gene variant is associated with eGFR in individuals with diabetes.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "PRKAG2"}, {"weight": 12.0, "description": "The GCKR gene is associated with eGFR.)<SEP>Variants in GCKR influence eGFR, suggesting its role in kidney function.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "GCKR"}, {"weight": 9.0, "description": "The SLC34A1 gene is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "SLC34A1"}, {"weight": 10.0, "description": "The DCDC5-MPPED2 gene complex is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "DCDC5-MPPED2"}, {"weight": 2.0, "description": "The SEC16B gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "SEC16B", "target": "OBESITY RISK"}, {"weight": 4.0, "description": "The DNAJC27 gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "DNAJC27", "target": "OBESITY RISK"}, {"weight": 6.0, "description": "The CDKAL1 gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "CDKAL1", "target": "OBESITY RISK"}, {"weight": 6.0, "description": "The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CDKAL1", "target": "RS10946398"}, {"weight": 8.0, "description": "The TFAP2B gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "TFAP2B", "target": "OBESITY RISK"}, {"weight": 10.0, "description": "The BDNF gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "BDNF", "target": "OBESITY RISK"}, {"weight": 12.0, "description": "The MYL2 gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MYL2", "target": "OBESITY RISK"}, {"weight": 3.0, "description": "rs12229654 is a SNP located in the MYL2 gene.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "MYL2", "target": "RS12229654"}, {"weight": 14.0, "description": "The OLFM4 gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OLFM4", "target": "OBESITY RISK"}, {"weight": 16.0, "description": "The FTO gene is strongly associated with obesity risk.)<SEP>The FTO gene strongly influences obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "FTO", "target": "OBESITY RISK"}, {"weight": 1.0, "description": "The rs9939609 SNP in the FTO gene was associated with an increase in BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "FTO", "target": "RS9939609"}, {"weight": 9.0, "description": "The FTO gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "FTO", "target": "CRP"}, {"weight": 13.0, "description": "A novel association of rs1558902 SNP with CRP levels through the FTO gene.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "FTO", "target": "RS1558902"}, {"weight": 18.0, "description": "The MC4R gene acts as a hub gene affecting obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MC4R", "target": "OBESITY RISK"}, {"weight": 12.0, "description": "The MC4R gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "MC4R", "target": "CRP"}, {"weight": 16.0, "description": "A novel association of rs571312 SNP with CRP levels upstream of the MC4R gene.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "MC4R", "target": "RS571312"}, {"weight": 20.0, "description": "The GIPR gene is associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "GIPR", "target": "OBESITY RISK"}, {"weight": 5.0, "description": "SNPs in GIPR are nominally associated with altered AcAc or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GIPR", "target": "ACAC"}, {"weight": 11.0, "description": "Participants with early menarche have higher BMI.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "BMI", "target": "EARLY MENARCHE"}, {"weight": 2.0, "description": "The FTO rs9939609 polymorphism is strongly associated with greater BMI, with a +0.5 unit increase per risk allele.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "BMI", "target": "FTO RS9939609"}, {"weight": 5.0, "description": "BMI was considered as a factor in statistical analyses.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "BMI", "target": "ANALYSIS"}, {"weight": 5.0, "description": "Individuals with IFG/IGT tend to have higher BMI levels compared to those with NGT.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)"}, {"weight": 6.0, "description": "People with T2D often have elevated BMI levels.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "TYPE 2 DIABETES (T2D)"}, {"weight": 1.0, "description": "The rs9939609 SNP was associated with an increase in BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS9939609"}, {"weight": 2.0, "description": "The rs2984618 SNP was associated with an increase in BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS2984618"}, {"weight": 3.0, "description": "The rs7903146 SNP was associated with an increase in BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS7903146"}, {"weight": 3.0, "description": "AcAc levels were predicted by BMI as part of a multivariate analysis.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BMI", "target": "ACAC"}, {"weight": 4.0, "description": "BHB levels were predicted by BMI as part of a multivariate analysis.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BMI", "target": "BHB"}, {"weight": 1.0, "description": "The TMEM18 gene is associated with body mass index (BMI).)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BMI", "target": "TMEM18"}, {"weight": 9.0, "description": "Adjusting for BMI can slightly lower the SNP heritability of snoring.)<SEP>Adjusting for BMI in the analyses slightly lowered the SNP heritability for snoring.)<SEP>BMI was positively correlated with snoring prevalence in both males and females.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "BMI", "target": "SNORING"}, {"weight": 4.0, "description": "Cases were less educated, had slightly higher BMI, were less physically active...)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "BMI", "target": "COLORECTAL CANCER"}, {"weight": 13.0, "description": "Obesity (high BMI) is a risk factor for hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "BMI", "target": "HYPERTENSION"}, {"weight": 2.0, "description": "Participants who consumed coffee were more likely to have a higher BMI.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BMI", "target": "COFFEE CONSUMPTION"}, {"weight": 5.0, "description": "BMI differs significantly according to the rs671 polymorphism in men.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BMI", "target": "ALDH2 RS671"}, {"weight": 1.0, "description": "Patients with IBS-D had a higher BMI compared to IBS-C and HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "IBS-D"}, {"weight": 9.0, "description": "There was a moderate positive correlation between BMI and serum C4 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "SERUM C4"}, {"weight": 8.0, "description": "The patient and the control groups were matched for gender and BMI.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "BMI", "target": "PATIENTS AND CONTROLS"}, {"weight": 0.0, "description": "There was no significant interaction between PRS and menarche age in women after adjusting for covariates.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "MENARCHE", "target": "PRS"}, {"weight": 4.0, "description": "High plant-based diet intake showed an interaction with PRS, providing protection against obesity risk in individuals with high PRS.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "PLANT-BASED DIET"}, {"weight": 6.0, "description": "High fried-food intake interacted with PRS, offsetting the impact of PRS on BMI.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "FRIED FOOD"}, {"weight": 5.0, "description": "An FTO SNP increases the risk of developing obesity.)<SEP>An FTO SNP is associated with an increased risk of obesity, particularly in individuals without university studies.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "OBESITY RISK", "target": "FTO SNP"}, {"weight": 1.0, "description": "The FTO rs1558902 genotype is associated with changes in weight, particularly greater weight loss in individuals consuming a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "WEIGHT"}, {"weight": 3.0, "description": "The FTO rs1558902 genotype influences body composition, leading to greater loss of fat mass and lean mass in those on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "BODY COMPOSITION"}, {"weight": 4.0, "description": "The FTO rs1558902 genotype interacts with protein intake, affecting changes in visceral fat (VAT), subcutaneous fat (SAT), and total abdominal fat (TAT).)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "FAT DISTRIBUTION"}, {"weight": 5.0, "description": "The FTO rs1558902 genotype interacts with high-protein diets, resulting in greater weight loss and changes in body composition.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "HIGH-PROTEIN DIET"}, {"weight": 6.0, "description": "The FTO rs1558902 genotype interacts with low-protein diets, leading to less pronounced changes in body composition.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "LOW-PROTEIN DIET"}, {"weight": 7.0, "description": "The FTO rs1558902 genotype is associated with changes in total fat loss, particularly in those on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "TOTAL FAT"}, {"weight": 8.0, "description": "The FTO rs1558902 genotype is associated with changes in Fat Free Mass,  with greater loss observed in those on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "FFM"}, {"weight": 9.0, "description": "The FTO rs1558902 genotype is associated with changes in FM%, showing greater decrease in high-protein diet groups.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "FM%"}, {"weight": 10.0, "description": "The FTO rs1558902 genotype influences changes in trunk fat percentage, with greater loss in those on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "TRUNK FAT PERCENTAGE"}, {"weight": 11.0, "description": "The FTO rs1558902 genotype interacts with protein intake, leading to greater loss of visceral fat (VAT) in high-protein diet groups.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "VAT"}, {"weight": 12.0, "description": "The FTO rs1558902 genotype affects changes in subcutaneous fat (SAT), with greater loss observed in high-protein groups.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "SAT"}, {"weight": 2.0, "description": "Participants with the AA genotype had a greater decrease in fat distribution in response to the high-protein diet compared to those without this genotype.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "AA GENOTYPE"}, {"weight": 5.0, "description": "The high-protein diet led to greater changes in fat distribution, specifically a decrease in fat mass.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "FAT DISTRIBUTION"}, {"weight": 4.0, "description": "Participants with the AA genotype were associated with less loss in TAT and SAT in response to the low-protein diet.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "AA GENOTYPE"}, {"weight": 6.0, "description": "The low-protein diet resulted in less significant changes in fat distribution compared to the high-protein diet.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "FAT DISTRIBUTION"}, {"weight": 6.0, "description": "A low-protein diet can help manage hypoglycaemia in patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "LOW-PROTEIN DIET", "target": "HYPOGLYCAEMIA"}, {"weight": 10.0, "description": "There were genotype-time interactions on changes in total fat, FM%, and percentage of trunk fat in response to the low-fat diet.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "TOTAL FAT", "target": "LOW-FAT DIET"}, {"weight": 8.0, "description": "The association between the FTO rs9939609 polymorphism and BMI is stronger in individuals with lower education levels, suggesting an interaction between genetic predisposition and environmental factors.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609", "target": "EDUCATION LEVEL"}, {"weight": 4.0, "description": "There was a statistically significant interaction between the FTO SNP and education level in determining obesity risk.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "EDUCATION LEVEL", "target": "FTO SNP"}, {"weight": 2.0, "description": "The results of the SNP-based heritability showed significant correlation across the tested taxa.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "SNP", "target": "GUT MICROBES"}, {"weight": 2.0, "description": "The minor allele of each SNP was inversely associated with type 2 diabetes.)", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "SNP", "target": "TYPE 2 DIABETES"}, {"weight": 5.0, "description": "rs1893217 is an example of a SNP.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "SNP", "target": "RS1893217"}, {"weight": 3.0, "description": "The TCF7L2 gene has been shown to interact with dietary patterns, particularly fiber and whole grain intake, influencing the risk of type 2 diabetes.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2", "target": "DIETARY PATTERN"}, {"weight": 4.0, "description": "Studies have shown that higher fiber intake may modify the effect of TCF7L2 gene variants on type 2 diabetes risk.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2", "target": "FIBER"}, {"weight": 5.0, "description": "Genetic variants in the TCF7L2 gene have been associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2", "target": "TYPE 2 DIABETES"}, {"weight": 7.0, "description": "The rs7903146 SNP in the TCF7L2 gene was associated with an increase in BMI at baseline.)<SEP>The rs7903146 variant is located in the TCF7L2 gene and is associated with an increased risk of type 2 diabetes (OR 1.38).)<SEP>rs7903146 is a genomic variant within the TCF7L2 gene.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TCF7L2", "target": "RS7903146"}, {"weight": 1.0, "description": "Individuals with the rs7903146 CC genotype showed lower T2D risk when consuming higher fiber intake, while those with the risk T-allele showed an increased risk.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER", "target": "RS7903146"}, {"weight": 2.0, "description": "Similar to fiber, individuals with the rs7903146 CC genotype had lower T2D risk with higher whole grain intake compared to those with the risk T-allele.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE GRAIN", "target": "RS7903146"}, {"weight": 1.0, "description": "Risk SNPs for type 2 diabetes are associated with altered BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "TYPE 2 DIABETES", "target": "RS780094"}, {"weight": 7.0, "description": "Higher black coffee consumption was associated with a lower risk of type 2 diabetes.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES", "target": "BLACK COFFEE"}, {"weight": 9.0, "description": "Higher sugared coffee consumption was associated with a lower risk of type 2 diabetes.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES", "target": "SUGARED COFFEE"}, {"weight": 1.0, "description": "The NHS is a prominent example of a cohort study design.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "NURSES\' HEALTH STUDY (NHS)", "target": "COHORT STUDIES"}, {"weight": 2.0, "description": "The HPFS is another well-known cohort study.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "HEALTH PROFESSIONALS FOLLOW\u2010UP STUDY (HPFS)", "target": "COHORT STUDIES"}, {"weight": 3.0, "description": "The MDCS focuses on diet and cancer risk through a cohort study.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "MALM\u00d6 DIET AND CANCER STUDY (MDCS)", "target": "COHORT STUDIES"}, {"weight": 4.0, "description": "EPIC-InterAct is a large-scale European cohort.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)\u2010INTERACT", "target": "COHORT STUDIES"}, {"weight": 5.0, "description": "The Shanghai Diabetes GWAS study utilizes a cohort design to investigate genetic factors in diabetes.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "SHANGHAI DIABETES GWAS STUDY", "target": "COHORT STUDIES"}, {"weight": 6.0, "description": "DESIR uses a cohort approach to understand insulin resistance.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "EPIDEMIOLOGICAL STUDY ON THE INSULIN RESISTANCE SYNDROME (DESIR)", "target": "COHORT STUDIES"}, {"weight": 7.0, "description": "The KOGES combines genetics and epidemiology through a cohort study.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)", "target": "COHORT STUDIES"}, {"weight": 8.0, "description": "The DPS employs a randomized controlled trial design.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "FINISH DIABETES PREVENTION STUDY (DPS)", "target": "RANDOMIZED CONTROLLED TRIALS"}, {"weight": 9.0, "description": "The DPP uses a randomized controlled trial to evaluate diabetes prevention strategies.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "AMERICAN DIABETES PREVENTION PROJECT (DPP)", "target": "RANDOMIZED CONTROLLED TRIALS"}, {"weight": 10.0, "description": "PREDIMED conducts a randomized controlled trial on the Mediterranean diet.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)", "target": "RANDOMIZED CONTROLLED TRIALS"}, {"weight": 11.0, "description": "The Italian study utilizes a randomized controlled trial to examine lifestyle interventions.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "ITALIAN STUDY", "target": "RANDOMIZED CONTROLLED TRIALS"}, {"weight": 4.0, "description": "No interaction was observed between rs7903146 and carbohydrates.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "RS7903146", "target": "CARBOHYDRATES"}, {"weight": 2.0, "description": "rs7903146 is an example of a risk allele.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "RS7903146", "target": "RISK ALLELE"}, {"weight": 3.0, "description": "Variants in the TCF7L2 gene have been linked to an increased risk of developing T2D.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "T2D", "target": "TCF7L2 VARIANTS"}, {"weight": 4.0, "description": "The SNP rs4420638 near the APOC1 gene is associated with a lower risk of type 2 diabetes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "T2D", "target": "RS4420638"}, {"weight": 3.0, "description": "HepG2 cells did not show increased PNPLA3 mRNA expression in response to insulin treatment.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "PNPLA3"}, {"weight": 1.0, "description": "Studies with 3T3-L1 adipocytes showed that insulin regulates PNPLA3 gene expression.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "3T3-L1 ADIPOCYTES"}, {"weight": 2.0, "description": "One study showed that insulin increased promoter activity of the PNPLA3 gene expressed in Chinese hamster ovary cells.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "CHINESE HAMSTER OVARY CELLS"}, {"weight": 3.0, "description": "Incubation of HepG2 cells with insulin did not increase PNPLA3 mRNA compared to control cells.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "HEPG2 CELLS"}, {"weight": 4.0, "description": "Studies conducted with human adipose tissue have shown that PNPLA3 gene expression is regulated by insulin.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "HUMAN ADIPOSE TISSUE"}, {"weight": 5.0, "description": "Incubation of HepG2 cells with insulin induced the expression of FAS by 2-fold.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "FAS"}, {"weight": 5.0, "description": "Glucokinase regulates insulin secretion from pancreatic beta cells in response to glucose.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "INSULIN", "target": "GLUCOKINASE"}, {"weight": 10.0, "description": "Congenital hyperinsulinism (CHI) is characterized by excessive or inappropriate insulin secretion.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "INSULIN", "target": "CHI"}, {"weight": 22.0, "description": "Insulin is used to treat diabetes mellitus.)<SEP>Insulin therapy is essential for managing diabetes mellitus, as it helps regulate blood sugar.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "INSULIN", "target": "DIABETES MELLITUS"}, {"weight": 4.0, "description": "Loss of function in the \u03b2 cell, indicated by decreased insulin staining, contributes to diabetes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "INSULIN", "target": "\u0392 CELL DEATH"}, {"weight": 5.0, "description": "Insulin therapy can potentially delay or prevent \u03b2-cell apoptosis in T1DM by inducing a state of \'\u03b2-cell rest\'.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "INSULIN", "target": "\u0392-CELL APOPTOSIS"}, {"weight": 1.0, "description": "The expression of PPAR\u03b3 mRNA and protein levels are similar in Ctrl and SENP1-deficient adipocytes, suggesting SUMOylation of PPAR\u03b3 may not be significantly affected by SENP1 deletion.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "PPAR\u0393", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 1.0, "description": "rs2074356 is a SNP located in the HECTD4 gene.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "HECTD4", "target": "RS2074356"}, {"weight": 7.0, "description": "SNPs in SLC2A2 are nominally associated with altered AcAc or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "SLC2A2", "target": "ACAC"}, {"weight": 16.0, "description": "Reduced leisure-time physical activity (LTPA) was associated with higher T2D incidence in individuals with specific PPAR\u03b3 variants.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "LTPA", "target": "PPAR\u0393 RS1801282, RS17036314"}, {"weight": 17.0, "description": "Increased LTPA resulted in lower T2D incidence in individuals with certain ADRA2B, ABCC8, and SLC2A2 genetic variations.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "LTPA", "target": "ADRA2B GLU12, ABCC8 RS3758947, SLC2A2 VARIANTS"}, {"weight": 2.0, "description": "The SLC2A2 genotype may influence the response to changes in LTPA (light-to-moderate physical activity).)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "LTPA", "target": "SLC2A2 VARIANTS"}, {"weight": 8.0, "description": "The weight loss intervention was associated with a reduced incidence of T2D in individuals with the ENPP1 rs1044498 diabetogenic variant.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "ENPP1 RS1044498 DIABETOGENIC VARIANT"}, {"weight": 10.0, "description": "There was a trend for interaction between the MC4R rs17066829 variant and weight loss interventions for T2D prevention.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "MC4R RS17066829"}, {"weight": 12.0, "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the PPAR\u03b3 rs1152003 CC genotype.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "PPAR\u0393 RS1152003 CC GENOTYPE"}, {"weight": 14.0, "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the TNF\u03b1 rs1800629 GG genotype.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "TNF\u0391 RS1800629 GG GENOTYPE"}, {"weight": 16.0, "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the ADRA2B Glu9 allele.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "ADRA2B GLU9 ALLELE"}, {"weight": 18.0, "description": "The weight loss intervention resulted in a lower T2D incidence among individuals with the LIPC rs2070895 A allele.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTION", "target": "LIPC RS2070895 A ALLELE"}, {"weight": 1.0, "description": "Women with the HFE rs1799945 variant showed an increased risk of type 2 diabetes (T2D).)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "HFE RS1799945", "target": "T2D RISK"}, {"weight": 2.0, "description": "Women with the HFE rs1800562 variant showed an increased risk of type 2 diabetes.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "T2D RISK", "target": "HFE RS1800562"}, {"weight": 4.0, "description": "The TMPRSS6 rs855791 variant showed borderline significance for association with T2D risk in the total sample.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "T2D RISK", "target": "TMPRSS6 RS855791"}, {"weight": 3.0, "description": "The SLC40A1 rs744653 variant was associated with a modified risk of T2D in men within the EPIC-InterAct study.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "MEN T2D RISK", "target": "SLC40A1 RS744653"}, {"weight": 5.0, "description": "The SLC30A8 variants (rs16889462, 8_118252314, and 8_118252435) showed interaction with zinc intake in DPP.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "SLC30A8 VARIANTS", "target": "ZINC INTAKE"}, {"weight": 6.0, "description": "High intake of red and processed meat increased the risk to develop T2D among men with a high T2D Genetic Risk Score (GRS), but not among men with a low GRS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "RED MEAT/PROCESSED MEAT", "target": "T2D\u2010GRS"}, {"weight": 11.0, "description": "A Western dietary pattern was associated with higher T2D risk only among individuals with a high T2D-GRS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "T2D\u2010GRS", "target": "WESTERN DIET"}, {"weight": 13.0, "description": "The protective effect of physical activity (PA) on T2D risk was weaker among individuals with a high adherence to a T2D-GRS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "T2D\u2010GRS", "target": "PA"}, {"weight": 7.0, "description": "There was a marginally nonsignificant interaction between olive oil intake and the GIPR variant rs10423928 in EPIC-InterAct.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "GIPR VARIANT RS10423928", "target": "OLIVE OIL"}, {"weight": 8.0, "description": "The lactase persistence LCT gene variant rs4988235 influenced the association between dairy consumption and T2D risk.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "DAIRY PRODUCTS", "target": "LCT GENE RS4988235"}, {"weight": 4.0, "description": "Individuals with the rs4988235 variant had higher consumption of dairy products, potatoes, margarine, sugar, non-alcoholic beverages and coffee.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DAIRY PRODUCTS", "target": "RS4988235"}, {"weight": 9.0, "description": "Higher coffee intake had a stronger effect on reducing T2D risk in individuals with the risk allele of the TCF7L2 variant rs12255372.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "COFFEE INTAKE", "target": "TCF7L2 VARIANT RS12255372"}, {"weight": 10.0, "description": "Reduced T2D incidence was observed among coffee consumers with specific alleles (rs4402960, rs7754840, and rs5215) in the KARE study.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "COFFEE INTAKE", "target": "IGF2BP2, CDKAL1, KCNJ11 VARIANTS"}, {"weight": 12.0, "description": "Borderline significant interaction between the CLOCK variant rs4580704 and Mediterranean diet, suggesting lower T2D incidence in individuals with the G allele.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "CLOCK VARIANT RS4580704", "target": "MEDITERRANEAN DIET"}, {"weight": 2.0, "description": "Subjects with no minor alleles in the FADS1/2 gene cluster had lower colon AA concentrations at 6 months in the Mediterranean arm compared to the Healthy Eating arm.)", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "FADS1/2 GENE CLUSTER"}, {"weight": 14.0, "description": "The minor HNF1B rs4430796 A allele weakened or reversed the protective effect of PA on T2D risk.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PA", "target": "HNF1B RS4430796"}, {"weight": 15.0, "description": "Women with the IRS1 rs1522813 A allele and low levels of PA had a higher risk to develop T2D compared with women with the GG genotype.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PA", "target": "IRS1 RS1522813"}, {"weight": 4.0, "description": "Individuals with the TCF7L2 rs12255372 risk TT genotype showed a lower incidence of T2D in intervention groups compared to control groups.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D INCIDENCE", "target": "TCF7L2 RS12255372 RISK ALLELE"}, {"weight": 6.0, "description": "Individuals with the rs7903146 risk T allele had a reduced risk of developing T2D.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D INCIDENCE", "target": "RS7903146 RISK ALLELE"}, {"weight": 4.0, "description": "The rs10010131 variant in the WFS1 gene is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "WFS1", "target": "RS10010131"}, {"weight": 8.0, "description": "The rs864745 variant in the JAZF1 gene is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "JAZF1", "target": "RS864745"}, {"weight": 10.0, "description": "The rs4607103 variant in the ADAMTS9 gene is associated with a decreased risk of type 2 diabetes, opposite to what has been observed in European populations.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "ADAMTS9", "target": "RS4607103"}, {"weight": 3.0, "description": "Age was considered as a factor in statistical analyses.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "AGE", "target": "ANALYSIS"}, {"weight": 5.0, "description": "Age was considered as a covariate in combined analyses to control for potential confounding effects.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "AGE", "target": "COMBINED ANALYSES"}, {"weight": 11.0, "description": "Included as a covariate in sensitivity GWAS to explore the effects of BMI, adiposity and nonlinear effects on associated variants.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "AGE", "target": "SNORING"}, {"weight": 5.0, "description": "Older age is a risk factor for hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "AGE", "target": "HYPERTENSION"}, {"weight": 4.0, "description": "Individuals with the GA genotype tend to be older than those with other genotypes.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "AGE", "target": "ALDH2 RS671"}, {"weight": 15.0, "description": "LCT mRNA levels decrease with age in lactase non-persistent (CC) individuals.)<SEP>LCT mRNA levels decrease with age in lactase non-persistent individuals.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "LCT MRNA"}, {"weight": 5.0, "description": "DNA modifications at LCT and MCM6 increase with age in lactase non-persistent individuals, but decrease with age in lactase persistent individuals.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "DNA MODIFICATIONS"}, {"weight": 4.0, "description": "Increases in CD8+ TEM cell proportions became clinically significant with age in each sibling.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "AGE", "target": "CD8+ TEM CELLS"}, {"weight": 4.0, "description": "Sex was considered as a factor in statistical analyses.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "SEX", "target": "ANALYSIS"}, {"weight": 12.0, "description": "Included as a covariate in sensitivity GWAS to explore the effects of BMI, adiposity and nonlinear effects on associated variants.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SEX", "target": "SNORING"}, {"weight": 1.0, "description": "The effect size of the SNP rs199797821 for snoring differs between males and females, although in the same direction.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SEX", "target": "RS199797821"}, {"weight": 1.0, "description": "The effect size of the SNP rs200391180 for snoring differs between males and females, although in the same direction.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SEX", "target": "RS200391180"}, {"weight": 6.0, "description": "Women are generally at lower risk of developing hypertension than men, though this risk increases after menopause.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "SEX", "target": "HYPERTENSION"}, {"weight": 7.0, "description": "The study samples reflect the general population of African Americans in the southeast, with an average African ancestry proportion of around 0.79.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "AFRICAN ANCESTRY", "target": "STUDY POPULATION"}, {"weight": 6.0, "description": "Degree of African ancestry was considered as a factor in statistical analyses.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "AFRICAN ANCESTRY", "target": "ANALYSIS"}, {"weight": 7.0, "description": "Nominal analysis was conducted to assess the association between variables.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "NOMINAL ANALYSIS", "target": "ANALYSIS"}, {"weight": 8.0, "description": "Ordinal analysis was conducted to assess the association between variables.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "ORDINAL ANALYSIS", "target": "ANALYSIS"}, {"weight": 9.0, "description": "Weighted odds ratios were calculated to assess the association between variables.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "WEIGHTED OR", "target": "ANALYSIS"}, {"weight": 10.0, "description": "Unweighted odds ratios were calculated to assess the association between variables.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "UNWEIGHTED OR", "target": "ANALYSIS"}, {"weight": 12.0, "description": "Individuals with higher cumulative risk scores (based on the number of risk alleles) are more likely to have type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CUMULATIVE RISK SCORE", "target": "T2D CASE"}, {"weight": 3.0, "description": "Individuals with IFG/IGT have elevated blood glucose levels, progressing from a state of normal glucose tolerance (NGT).)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "NORMAL GLUCOSE TOLERANCE (NGT)", "target": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)"}, {"weight": 1.0, "description": "The percentage of individuals with NGT varies across different ethnic groups, such as East Asian, African, European, etc.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "NORMAL GLUCOSE TOLERANCE (NGT)", "target": "ETHNICITY"}, {"weight": 4.0, "description": "T2D is a more severe form of diabetes that often develops after IFG/IGT.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)", "target": "TYPE 2 DIABETES (T2D)"}, {"weight": 2.0, "description": "Similar to NGT, the prevalence of IFG/IGT differs among various ethnicities.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)", "target": "ETHNICITY"}, {"weight": 3.0, "description": "The risk and prevalence of T2D also vary significantly across different ethnic populations.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "ETHNICITY"}, {"weight": 2.0, "description": "The rs2984618 SNP in the TAL1 gene was associated with an increase in BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TAL1", "target": "RS2984618"}, {"weight": 4.0, "description": "The rs1011527 SNP in the LEPR gene interacted with fasting plasma glucose (FPG) to influence BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR", "target": "RS1011527"}, {"weight": 4.0, "description": "The rs1011527 SNP interacted with FPG to influence BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "RS1011527", "target": "FPG"}, {"weight": 3.0, "description": "Fasting AcAc levels correlated negatively with FPG levels.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "FPG", "target": "ACAC"}, {"weight": 3.0, "description": "The MTHFR 1298AC/CC genotypes were associated with a 3.0-fold increased risk of impairment on the DIVERGT battery.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298A>C", "target": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"weight": 0.7, "description": "Homozygosity for the MTHFR 1298A>C minor C allele was associated with male infertility, though not in Hardy-Weinberg equilibrium.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "MTHFR 1298A>C", "target": "MALE INFERTILITY"}, {"weight": 4.0, "description": "The MS 2756AA genotype was associated with a 3.8 times higher likelihood of meeting criteria for impairment on the DIVERGT battery.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756A>G", "target": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"weight": 5.0, "description": "Survivors with the MTHFR 1298AC/CC genotypes had a 3.0-fold increased risk of impairment compared to those with the MTHFR 1298AA genotype.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298AC/CC", "target": "MTHFR 1299AA"}, {"weight": 6.0, "description": "Survivors with the MS 2756AA genotype were 3.8 times as likely to meet criteria for impairment on the battery compared to those with the MS 2756AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "MS 2756AG/GG"}, {"weight": 4.0, "description": "Survivors with the MS 2756AA genotype scored on average 12.2 points lower on TMTA compared to survivors with the MS 2756AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "TMTA SCORE"}, {"weight": 5.0, "description": "Survivors with the MS 2756AA genotype scored on average 5.3 points lower on TMTB compared to survivors with the MS 2756AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "TMTB SCORE"}, {"weight": 6.0, "description": "Survivors with the MS 2756AA genotype had a mean PEGNDH score that was 11.7 points lower than those with the MS 2756AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "PEGNDH SCORE"}, {"weight": 7.0, "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 10 points lower on TMTA and 11.4 points lower on TMTB than those with the TSER 2R/2R genotype.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TSER 2R/3R", "target": "TSER 2R/2R"}, {"weight": 8.0, "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 10 points lower on TMTA and 11.4 points lower on TMTB than those with the TSER 2R/2R genotype.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TSER 3R/3R", "target": "TSER 2R/2R"}, {"weight": 19.0, "description": "Survivors with the MTRR 66AA genotype scored on average 10.7 points lower on PEGNDH and 10.5 points lower on CFL compared to those with the MTRR 66AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTRR 66AA", "target": "MTRR 66AG/GG"}, {"weight": 8.0, "description": "Survivors with the MTRR 66AA genotype scored 10.5 points lower on CFL compared to those with the MTRR 66AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTRR 66AA", "target": "CFL SCORE"}, {"weight": 0.8, "description": "A higher GRS was associated with lower scores on TMTA, suggesting a possible relationship between genetic predisposition and cognitive performance.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "TMTA", "target": "GRS"}, {"weight": 1.0, "description": "A higher GRS was significantly associated with lower scores on TMTB, suggesting a possible relationship between genetic predisposition and cognitive performance.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "TMTB", "target": "GRS"}, {"weight": 0.6, "description": "Methotrexate (MTX) can impact the physiological process of   PEnte-glutamate N-dehydrogenase activity.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "PEGNDH", "target": "MTX"}, {"weight": 0.4, "description": "Methotrexate (MTX) may influence the physiological processes measured by CFL, potentially affecting cognitive or motor function.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "CFL", "target": "MTX"}, {"weight": 0.3, "description": "Methotrexate (MTX) can impact the physiological process of PEGine dehydrolase activity.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "MTX", "target": "PEGDH"}, {"weight": 0.4, "description": "Methotrexate (MTX) may influence the physiological processes measured by DIG, potentially affecting cognitive or motor function.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "MTX", "target": "DIG"}, {"weight": 5.0, "description": "The study aimed to examine whether there was an interaction between genes and diet, represented by the analysis of  smoking status (smoker vs. non-smoker) for various outcomes.)<SEP>The study investigated potential interactions between genes and diet, analyzing smoking status (smoker vs. non-smoker) for various outcomes.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "GENE", "target": "DIET INTERACTION"}, {"weight": 1.0, "description": "The GCK gene can have variants which lead to Maturity Onset Diabetes of the Young (MODY) type 2.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "GCK"}, {"weight": 4.0, "description": "A genomic variant in the GCK gene is associated with a diabetes phenotype.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "DIABETES PHENOTYPE"}, {"weight": 8.0, "description": "Sanger sequencing can be used to detect specific genomic variants in the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "SANGER SEQUENCING"}, {"weight": 9.0, "description": "A MODY gene panel can identify a range of genomic variants associated with MODY.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "MODY GENE PANEL"}, {"weight": 9.0, "description": "HRMA can be used to detect and genotype specific genomic variants, such as c.428_430delAAG and c.1186C\u2009>\u2009T.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "GENOMIC VARIANT", "target": "HRMA"}, {"weight": 4.0, "description": "CYP24A1 mutations, including c.428_430delAAG and c.1186C\u2009>\u2009T, can be associated with diseases such as Idiopathic Intracranial Hypertension (IIH).)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "GENOMIC VARIANT", "target": "DISEASE"}, {"weight": 7.0, "description": "Different melting profiles are indicative of different genotypes.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "GENOMIC VARIANT", "target": "MELTING PROFILE"}, {"weight": 1.0, "description": "A genomic variant in the UBE2T gene causes Fanconi Anemia-T subtype.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "GENOMIC VARIANT", "target": "UBE2T GENE"}, {"weight": 4.0, "description": "The rs478582 variant is a specific SNP within the PTPN2 gene.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "GENOMIC VARIANT", "target": "PTPN2:RS478582"}, {"weight": 6.0, "description": "The transcript of the GCK gene codes for the Glucokinase protein.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "TRANSCRIPT", "target": "GLUCOKINASE"}, {"weight": 12.0, "description": "BrAC (blood alcohol concentration) refers to the amount of alcohol present in the bloodstream.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "PHYSIOLOGICAL PROCESS", "target": "BRAC"}, {"weight": 2.0, "description": "Increased numbers of LPM\u03d5s were associated with enhanced IL-10R\u03b1MdelRag1\u2212/\u2212 disease compared to Rag1\u2212/\u2212 controls.)", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "DISEASE", "target": "LPM\u03a6S"}, {"weight": 5.0, "description": "Increased numbers of LPM\u03d5s in IL-10R\u03b1MdelRag1\u2212/\u2212 mice were associated with increased proliferation rates.)", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "DISEASE", "target": "LPM\u03a6 PROLIFERATION"}, {"weight": 6.0, "description": "IL-6 responsiveness is clinically important in Rag1\u2212/\u2212 colitis.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "IL-6R\u0391"}, {"weight": 8.0, "description": "T cell IL-1 response modulates both Rag1\u2212/\u2212 and IL-10R\u03b1MdelRag1\u2212/\u2212 disease.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "IL-1R\u0391"}, {"weight": 12.0, "description": "Rag1\u2212/\u2212 mice are used as a model for colitis.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "RAG1"}, {"weight": 14.0, "description": "In IL-10R\u03b1MdelRag1\u2212/\u2212 mice, IL-6 plays a more critical role.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "IL-10R\u0391"}, {"weight": 4.0, "description": "SENP1 deficiency leads to the development of type 1 diabetes mellitus in mice.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "DISEASE", "target": "SENP1"}, {"weight": 5.0, "description": "HRMA can be used to identify genetic variations associated with diseases like IIH.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "DISEASE", "target": "HRMA"}, {"weight": 14.0, "description": "The AUDIT questionnaire is a tool for assessing alcohol use disorders.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "DISEASE", "target": "AUDIT"}, {"weight": 5.0, "description": "Type 1 diabetes mellitus is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "TYPE 1 DIABETES MELLITUS"}, {"weight": 6.0, "description": "Autoimmune thyroiditis is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "AUTOIMMUNE THYROIDITIS"}, {"weight": 7.0, "description": "Systemic lupus erythematosus is an autoimmune manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "SYSTEMIC LUPUS ERYTHEMATOSUS"}, {"weight": 8.0, "description": "Osteomalacia is a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "OSTEOMALACIA"}, {"weight": 9.0, "description": "Seizure disorders are a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "SEIZURE DISORDERS"}, {"weight": 10.0, "description": "Down syndrome is a non-autoimmune disease manifestation sometimes seen in patients with Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DISEASE", "target": "DOWN SYNDROME"}, {"weight": 11.0, "description": "Early MTX-related neurotoxicity was predictive of long-term neurocognitive impairment (p=0.03).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "EARLY MTX-RELATED NEUROTOXICITY", "target": "LONG-TERM NEUROCOGNITIVE IMPAIRMENT"}, {"weight": 7.0, "description": "The 7 survivors with a history of early MTX-related neurotoxicity scored on average 15.3 points lower on TMTB than survivors without early neurotoxicity.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "EARLY MTX-RELATED NEUROTOXICITY", "target": "PEGNDH SCORE"}, {"weight": 1.0, "description": "POG 9005 is a protocol developed by the Pediatric Oncology Group.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "POG 9005", "target": "PROTOCOL"}, {"weight": 2.0, "description": "POG 9006 is a protocol developed by the Pediatric Oncology Group.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "PROTOCOL", "target": "POG 9006"}, {"weight": 3.0, "description": "The study involved treatment protocols POG 9005 and POG 9006, both developed by the Pediatric Oncology Group.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "PEDIATRIC ONCOLOGY GROUP PROTOCOLS", "target": "POG 9005 & POG 9006"}, {"weight": 2.0, "description": "The SLC30A8 rs13266634 risk allele was associated with higher fasting proinsulin levels at baseline in the DPP cohort.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "PROINSULIN"}, {"weight": 4.0, "description": "After 1 year of DPP intervention, fasting proinsulin levels were significantly decreased in all active intervention groups compared to placebo.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "DIABETES PREVENTION PROGRAM (DPP)"}, {"weight": 6.0, "description": "The metformin intervention group had similar proinsulin levels at 1 year as the troglitazone group.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "METFORMIN"}, {"weight": 8.0, "description": "The troglitazone intervention group had a significant decrease in proinsulin levels compared to placebo.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "TROGLITAZONE"}, {"weight": 4.0, "description": "Individuals carrying the rs3025020 minor allele have higher fasting insulin levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "FASTING INSULIN", "target": "RS3025020"}, {"weight": 7.0, "description": "Individuals carrying the rs2010963 minor allele have lower fasting insulin levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "FASTING INSULIN", "target": "RS2010963"}, {"weight": 2.0, "description": "Lipid emulsion attenuates the expression of PNPLA3 in mouse liver.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "LIPID EMULSION"}, {"weight": 3.0, "description": "Both SREBP1c and PNPLA3 show a similar expression pattern, correlating with each other.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "SREBP1C"}, {"weight": 4.0, "description": "Both ACC-1 and PNPLA3 show a similar expression pattern, correlating with each other.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "ACC-1"}, {"weight": 7.0, "description": "The expression of ChREBP and PNPLA3 are highly correlated.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "CHREBP"}, {"weight": 8.0, "description": "High glucose increases PNPLA3 gene expression in HepG2 cells.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "HIGH GLUCOSE"}, {"weight": 13.0, "description": "Incubation with citrate increased PNPLA3 levels in cells.)<SEP>Treatment with citrate increases PNPLA3 levels in HepG2 cells.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "CITRATE"}, {"weight": 1.0, "description": "High glucose increases PNPLA3 expression, while 2-deoxy-D-glucose suppresses it.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "GLUCOSE METABOLISM"}, {"weight": 2.0, "description": "PNPLA3 was not regulated by isocitrate, suggesting specificity to citrate.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "ISOCITRATE"}, {"weight": 4.0, "description": "HepG2 cells did not show increased PNPLA3 mRNA expression in response to glucagon treatment.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "GLUCAGON"}, {"weight": 5.0, "description": "Treatment with LA suppressed PNPLA3 gene expression in both low and high glucose conditions.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "LA"}, {"weight": 6.0, "description": "Treatment with OA suppressed PNPLA3 gene expression in both low and high glucose conditions.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "OA"}, {"weight": 7.0, "description": "ALA had no effect on PNPLA3 gene expression under either condition.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "ALA"}, {"weight": 8.0, "description": "Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "EPA"}, {"weight": 9.0, "description": "Both EPA and DHA suppressed PNPLA3 gene expression under both low and high glucose conditions.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "DHA"}, {"weight": 9.0, "description": "2-deoxy-D-glucose suppresses SREBP1c expression.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "SREBP1C", "target": "2-DEOXY-D-GLUCOSE"}, {"weight": 10.0, "description": "The combination of OA, LA, and ALA significantly suppressed gene expression of SREBP1c.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "SREBP1C", "target": "OA, LA, AND ALA"}, {"weight": 6.0, "description": "Exercise reduces hepatic triglyceride levels.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "EXERCISE", "target": "HEPATIC TRIGLYCERIDES"}, {"weight": 11.0, "description": "2-deoxy-D-glucose reduces lipid content in HepG2 cells.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "2-DEOXY-D-GLUCOSE", "target": "LIPID ACCUMULATION"}, {"weight": 11.0, "description": "The combination of OA, LA, and ALA significantly suppressed gene expression of FAS.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "FAS", "target": "OA, LA, AND ALA"}, {"weight": 12.0, "description": "Knockdown of PNPLA3 increased FAS mRNA expression.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "FAS", "target": "PNPLA3 SIRNA"}, {"weight": 9.0, "description": "Heavy alcohol consumption during pregnancy can lead to FAS.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "FAS", "target": "ALCOHOL CONSUMPTION"}, {"weight": 0.6, "description": "Both FAS and PFAS are developmental disorders potentially influenced by prenatal factors.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "FAS", "target": "PFAS"}, {"weight": 6.0, "description": "High glucose conditions increase ACC expression and activity.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "ACC", "target": "HIGH GLUCOSE"}, {"weight": 5.0, "description": "A high-fat diet leads to increased hepatic triglyceride levels.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HEPATIC TRIGLYCERIDES", "target": "HIGH-FAT DIET"}, {"weight": 37.0, "description": "High glucose promotes lipid accumulation in HepG2 cells.)<SEP>High glucose resulted in increased lipid accumulation, whereas 2-deoxy-D-glucose led to reduction of lipid content in cells.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH GLUCOSE", "target": "LIPID ACCUMULATION"}, {"weight": 2.0, "description": "Prenatal stress (PNS) exposure leads to changes in gene expression within the hippocampus.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "HIPPOCAMPUS"}, {"weight": 3.0, "description": "Exposure to PNS causes significant modulation of 916 genes in the hippocampus.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "GENE EXPRESSION"}, {"weight": 2.0, "description": "Prenatal stress (PNS) disrupts various neurodevelopmental processes, including axonal guidance, protein kinase signaling, and synaptic plasticity.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "NEURODEVELOPMENT"}, {"weight": 3.0, "description": "Changes in gene expression within the hippocampus are assessed through transcriptomic analysis following PNS exposure.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "HIPPOCAMPUS", "target": "TRANSCRIPTOMICS ANALYSIS"}, {"weight": 7.0, "description": "Exposure to cortisol affects the function of the hippocampus.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "HIPPOCAMPUS", "target": "CORTISOL"}, {"weight": 4.0, "description": "Fold change (FC) values indicate the extent of upregulation or downregulation of genes following PNS exposure.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "FC", "target": "GENE EXPRESSION"}, {"weight": 5.0, "description": "Genes with a q-value less than 0.05 are considered significantly modulated following PNS exposure.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "Q-VALUE", "target": "GENE EXPRESSION"}, {"weight": 7.0, "description": "The analysis reveals 528 significant genes involved in neurodevelopment and inflammation.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "MRNA-MIRNA COMBINING ANALYSIS", "target": "SIGNIFICANT GENES"}, {"weight": 2.0, "description": "A2M, FoxO1, and TGF-\u03b21 form a single individual cluster of genes interacting with each other.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "A2M", "target": "FOXO1"}, {"weight": 2.0, "description": "A2M, FoxO1, and TGF-\u03b21 form a single individual cluster of genes interacting with each other.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "TGF-\u03921"}, {"weight": 2.0, "description": "Cortisol exposure activates FoxO1 in hippocampal progenitor stem cells.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "CORTISOL"}, {"weight": 4.0, "description": "AS1842856 inhibits the upregulation of FoxO1 induced by cortisol.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "AS1842856"}, {"weight": 8.0, "description": "AS1842856 prevents the cortisol-induced reduction in neuronal proliferation.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "AS1842856", "target": "NEURONAL PROLIFERATION"}, {"weight": 12.0, "description": "AS1842856 counters the cortisol-induced upregulation of SGK-1.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "AS1842856", "target": "SGK-1"}, {"weight": 10.0, "description": "Cortisol upregulates SGK-1 mRNA levels.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "SGK-1", "target": "CORTISOL"}, {"weight": 10.0, "description": "SNPs can be associated with variations in gene expression.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "GENE EXPRESSION", "target": "SNPS"}, {"weight": 6.0, "description": "Exposure to PNS leads to changes in miRNA levels, including both downregulation and upregulation.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "MIRNOME CHANGES", "target": "PNS EXPOSURE"}, {"weight": 6.0, "description": "Cortisol reduces neuronal proliferation in a dose-dependent manner.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "NEURONAL PROLIFERATION"}, {"weight": 1.9, "description": "Additional copies of the minor (G) allele of rs4771122 were associated with a larger percentage weight lost after bariatric surgery.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "LONG TERM WEIGHT LOSS"}, {"weight": 0.8, "description": "Additional copies of the minor (G) allele were associated with a larger percentage weight lost, after adjustment for several variables including pre-surgical BMI.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL BMI"}, {"weight": 0.7, "description": "Additional copies of the minor (G) allele were also significantly associated with increased pre-surgical weight.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL WEIGHT"}, {"weight": 0.6, "description": "SNP rs4771122 was also nominally significantly associated with trajectory group membership, nadir percent weight loss, and 2 year percent weight loss.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "NADIR PERCENT WEIGHT LOSS"}, {"weight": 0.6, "description": "SNP rs4771122 was also nominally significantly associated with trajectory group membership, nadir percent weight loss, and 2 year percent weight loss.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "2 YEAR PERCENT WEIGHT LOSS"}, {"weight": 1.0, "description": "The GCK gene can cause MODY, a type of inherited diabetes.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "MODY"}, {"weight": 4.0, "description": "Glucokinase plays a role in regulating glucose metabolism, and its dysfunction can contribute to diabetes.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GLUCOKINASE", "target": "DIABETES PHENOTYPE"}, {"weight": 4.0, "description": "Glucokinase is expressed in pancreatic beta cells and plays a role in glucose sensing.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GLUCOKINASE", "target": "PANCREATIC BETA CELLS"}, {"weight": 6.0, "description": "Elevated fasting glucose levels are a hallmark of diabetes.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "DIABETES PHENOTYPE", "target": "FASTING HYPERGLYCEMIA"}, {"weight": 7.0, "description": "HbA1c reflects average blood glucose control over time and is used to diagnose and monitor diabetes.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "DIABETES PHENOTYPE", "target": "HBA1C"}, {"weight": 9.0, "description": "Mutations in the ABCC8 gene affect pancreatic beta cell function, leading to impaired insulin regulation.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "PANCREATIC BETA CELLS", "target": "ABCC8 MUTATIONS"}, {"weight": 10.0, "description": "Higher Mediterranean diet adherence was associated with lower HbA1c concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "HBA1C", "target": "MEDITERRANEAN DIET ADHERENCE"}, {"weight": 12.0, "description": "rs4988235 was not associated with baseline HbA1c levels (\u03b2 -0.07 %, 95%CI -0.22 to 0.07, n=12,519).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "HBA1C", "target": "RS4988235"}, {"weight": 2.0, "description": "Higher Mediterranean diet adherence was associated with lower TAG concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "TAG"}, {"weight": 4.0, "description": "Higher Mediterranean diet adherence was associated with higher HDL-C concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "HDL-C"}, {"weight": 6.0, "description": "Higher Mediterranean diet adherence was associated with lower LDL-C concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "LDL-C"}, {"weight": 8.0, "description": "Higher Mediterranean diet adherence was associated with a lower apoB:apoA-1 ratio.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "APOB:APOA-1 RATIO"}, {"weight": 12.0, "description": "Higher Mediterranean diet adherence was associated with a lower risk of hypertriacylglycerolaemia.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "HYPERTRIACYLGLYCEROLAEMIA"}, {"weight": 7.0, "description": "The AA genotype of the GCKR rs780094 SNP was associated with higher TAG concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TAG", "target": "GCKR RS780094 SNP"}, {"weight": 8.0, "description": "The AA genotype of the GCKR rs780094 SNP was associated with higher TC concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "GCKR RS780094 SNP", "target": "TC"}, {"weight": 9.0, "description": "The AA genotype of the GCKR rs780094 SNP was associated with higher apoB levels.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "GCKR RS780094 SNP", "target": "APOB"}, {"weight": 2.0, "description": "The rs927650 SNP had a mean 25(OH)D concentration of 27.5 \u00b1 12.8 ng/ml in individuals with the TC genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "TC", "target": "RS927650"}, {"weight": 2.0, "description": "Smoking status (smoker vs. non-smoker) was analyzed in relation to TAG levels, but no significant gene-diet interactions were found.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "SMOKING STATUS", "target": "TAG LEVELS"}, {"weight": 6.0, "description": "Smoking status trended towards predicting greater self-administration of alcohol, with smokers consuming more drinks than non-smokers.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "SMOKING STATUS", "target": "ALCOHOL SELF-ADMINISTRATION"}, {"weight": 4.0, "description": "Differences in genotype were observed in relation to TAG levels, although no significant gene-diet interactions were found.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "TAG LEVELS", "target": "GENOTYPE"}, {"weight": 5.5, "description": "Genotype influences individual differences in response bias during the probabilistic reward task.)<SEP>Val carriers showed higher response bias than iso homozygotes.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "GENOTYPE", "target": "RESPONSE BIAS"}, {"weight": 6.5, "description": "Genotype may influence individual experiences and reactions to shock intensity.)<SEP>Val carriers selected a lower shock intensity compared to iso homozygotes.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "GENOTYPE", "target": "SHOCK INTENSITY"}, {"weight": 4.0, "description": "The transcriptomes of WT and Card9\u2212/\u2212 mice cluster according to their genotype, indicating differential gene expression.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "GENOTYPE", "target": "COLONIC TRANSCRIPTOME"}, {"weight": 1.0, "description": "There were no significant differences in self-reported ancestry between the TT and CT genotype groups.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "GENOTYPE", "target": "NO DIFFERENCE IN ANCESTRY DISTRIBUTION"}, {"weight": 5.0, "description": "The rs2832407 genetic variant influences the effectiveness of topiramate in treating alcohol use disorder.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "GENOTYPE", "target": "RS2832407"}, {"weight": 4.0, "description": "Diazoxide is a medication used to treat CHI.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "DIAZOXIDE"}, {"weight": 6.0, "description": "Dietary treatment is an alternative approach for managing CHI.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "DIETARY TREATMENT"}, {"weight": 8.0, "description": "Mutations in the ABCC8 gene are a common cause of congenital hyperinsulinism (CHI).)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "ABCC8 MUTATIONS"}, {"weight": 10.0, "description": "Although not identified in this study, mutations in the KCNJ11 gene can also contribute to CHI.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "KCNJ11 MUTATIONS"}, {"weight": 7.0, "description": "Congenital hyperinsulinism (CHI) is associated with persistent hypoglycemia.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "HYPOGLYCEMIA"}, {"weight": 14.0, "description": "Diazoxide can help control blood sugar levels and reduce the severity of hypoglycemia.)<SEP>Diazoxide is a drug used to treat hypoglycaemia in patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE", "target": "HYPOGLYCAEMIA"}, {"weight": 8.0, "description": "Mutations in the GLUD1 gene can lead to hyperinsulinism.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "HYPERINSULINISM", "target": "GLUD1 MUTATIONS"}, {"weight": 2.0, "description": "The p.Arg322His mutation in the GLUD1 gene is linked to hypoglycemia.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.ARG322HIS MUTATION", "target": "HYPOGLYCAEMIA"}, {"weight": 3.0, "description": "The p.Ser498Leu mutation in the GLUD1 gene is linked to hypoglycemia.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.SER498LEU MUTATION", "target": "HYPOGLYCAEMIA"}, {"weight": 4.0, "description": "The p.Asn463Asp mutation in the GLUD1 gene is linked to hypoglycemia.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.ASN463ASP MUTATION", "target": "HYPOGLYCAEMIA"}, {"weight": 17.0, "description": "Octreotide can help manage hyperinsulinemia and reduce the frequency of hypoglycemic episodes.)<SEP>Octreotide is used as a treatment for HI/HA when diazoxide is ineffective.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "OCTREOTIDE", "target": "HYPOGLYCAEMIA"}, {"weight": 12.0, "description": "Pancreatectomy is a surgical option for patients with HI/HA when other treatments are unsuccessful.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "PANCREATECTOMY", "target": "HYPOGLYCAEMIA"}, {"weight": 4.0, "description": "Pancreatectomy involves the surgical removal of part or all of the pancreas.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "PANCREATECTOMY", "target": "PANCREAS"}, {"weight": 5.0, "description": "Pancreatectomy can include subtotal pancreatectomy, where only part of the pancreas is removed.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "PANCREATECTOMY", "target": "SUBTOTAL PANCREATECTOMY"}, {"weight": 2.0, "description": "Mutations in the GLUD1 gene are associated with hypoglycemia.)<SEP>The GLUD1 gene is associated with hypoglycaemia, HI and mild HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCAEMIA", "target": "GLUD1 GENE"}, {"weight": 12.0, "description": "Mutations in the GLUD1 gene are associated with hypoglycemia, hyperinsulinism (HI), and mild hyperammonemia (HA).)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUD1 MUTATIONS", "target": "HI AND MILD HA"}, {"weight": 2.0, "description": "Mutations in the GLUD1 gene are associated with hyperinsulinism.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "GLUD1 GENE", "target": "HI"}, {"weight": 3.0, "description": "Mutations in the GLUD1 gene are associated with hypoglycemia.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "GLUD1 GENE", "target": "HA"}, {"weight": 1.0, "description": "In individuals with IFG, AcAc levels decreased significantly compared to the reference category.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "IFG"}, {"weight": 5.0, "description": "Higher levels of AcAc predicted an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "INCIDENT DIABETES"}, {"weight": 12.0, "description": "Higher insulin sensitivity was associated with lower AcAc levels.)<SEP>Higher insulin sensitivity was associated with lower levels of AcAc.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "INSULIN SENSITIVITY"}, {"weight": 1.0, "description": "Higher levels of AcAc were associated with increased Glucose AUC, indicating poorer blood glucose control.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "GLUCOSE AUC"}, {"weight": 2.0, "description": "The C allele of rs780094 within the GCKR gene is nominally associated with increased AcAc levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAC", "target": "RS780094"}, {"weight": 3.0, "description": "SNPs in FADS1 are nominally associated with altered AcAc or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAC", "target": "FADS1"}, {"weight": 4.0, "description": "SNPs in ANK1 are nominally associated with altered AcAc or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAC", "target": "ANK1"}, {"weight": 6.0, "description": "SNPs in HMGA2 are nominally associated with altered AcAc or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAC", "target": "HMGA2"}, {"weight": 2.0, "description": "BHB levels increased significantly in individuals with newly diagnosed diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "NEWLY DIAGNOSED DIABETES"}, {"weight": 4.0, "description": "BHB levels correlated positively with 2hPG levels.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "2HPG"}, {"weight": 6.0, "description": "Higher levels of BHB predicted an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "INCIDENT DIABETES"}, {"weight": 15.0, "description": "Higher insulin secretion was associated with lower BHB levels.)<SEP>Higher insulin secretion was associated with lower levels of BHB.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "INSULIN SECRETION"}, {"weight": 2.0, "description": "Higher levels of BHB were associated with increased Glucose AUC.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "GLUCOSE AUC"}, {"weight": 6.0, "description": "Higher insulin sensitivity was associated with lower BHB levels.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "INSULIN SENSITIVITY"}, {"weight": 1.0, "description": "The C allele of rs780094 within the GCKR gene is associated with elevated levels of BHB.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "BHB", "target": "RS780094"}, {"weight": 1.5, "description": "The (CA)16 allele was negatively correlated with IFG, meaning that individuals with the (CA)16 allele were less likely to have IFG.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IFG", "target": "(CA)16 ALLELE"}, {"weight": 8.0, "description": "Expression of CPT1A is positively correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "CPT1A"}, {"weight": 10.0, "description": "Expression of HMGCS1 did not correlate significantly with glucose AUC, insulin sensitivity, or insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "HMGCS1"}, {"weight": 11.0, "description": "Expression of HMGCS2 did not correlate significantly with glucose AUC, insulin sensitivity, or insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "HMGCS2"}, {"weight": 12.0, "description": "ACAT1 expression is negatively correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "ACAT1"}, {"weight": 15.0, "description": "BDH1 expression is inversely correlated with glucose AUC and insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "BDH1"}, {"weight": 16.0, "description": "OXCT1 expression is inversely correlated with glucose AUC and insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "OXCT1"}, {"weight": 17.0, "description": "ACSS2 expression is inversely correlated with glucose AUC and insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "ACSS2"}, {"weight": 14.0, "description": "ACAT1 expression is negatively correlated with insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "INSULIN SECRETION", "target": "ACAT1"}, {"weight": 1.0, "description": "SENP1 deficiency leads to reduced insulin secretion.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "INSULIN SECRETION", "target": "SENP1"}, {"weight": 3.0, "description": "The GCKR gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "GCKR", "target": "CRP"}, {"weight": 2.0, "description": "Risk SNPs for hyperglycemia are associated with altered BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "RS780094", "target": "HYPERGLYCEMIA"}, {"weight": 1.0, "description": "The SNP rs17101923 is located near the HMGA2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "HMGA2", "target": "RS17101923"}, {"weight": 1.0, "description": "The SNP rs1472259 is located near the HMGA2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "HMGA2", "target": "RS1472259"}, {"weight": 2.0, "description": "Variants in HMGA2 were found to be associated with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HMGA2", "target": "HEIGHT"}, {"weight": 9.0, "description": "Expression of CPT1A is inversely correlated with Matsuda ISI.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "CPT1A", "target": "MATSUDA ISI"}, {"weight": 13.0, "description": "ACAT1 expression is positively correlated with Matsuda ISI.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAT1", "target": "MATSUDA ISI"}, {"weight": 2.0, "description": "The GTT measures the ability of an individual to clear glucose from their bloodstream. Elevated blood glucose levels after a glucose challenge indicate hyperglycemia.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "HYPERGLYCEMIA", "target": "GLUCOSE TOLERANCE TEST (GTT)"}, {"weight": 5.0, "description": "High Fat Diet (HFD) accelerated hyperglycaemia in SENP1-aP2KO mice, indicating a worsening of metabolic control.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HYPERGLYCEMIA", "target": "HFD"}, {"weight": 25.0, "description": "The A allele of rs4420638 in the APOC1 locus increases serum CRP levels, but decreases total cholesterol, LDL-cholesterol and triglycerides.)<SEP>The SNP rs4420638 is located near the APOC1 gene.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "order": 1, "source": "APOC1", "target": "RS4420638"}, {"weight": 6.0, "description": "The APOC1 gene is associated with CRP levels.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "APOC1", "target": "CRP"}, {"weight": 12.0, "description": "The HNF1A gene is associated with CRP levels.)<SEP>The HNF1A gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HNF1A", "target": "CRP"}, {"weight": 18.0, "description": "The G allele of rs1183910 in the HNF1A locus increases serum CRP levels and is associated with a decline in total cholesterol and LDL-cholesterol.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF1A", "target": "RS1183910"}, {"weight": 4.0, "description": "The IL6R gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "IL6R", "target": "CRP"}, {"weight": 5.0, "description": "The PPP1R3B gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PPP1R3B", "target": "CRP"}, {"weight": 6.0, "description": "The HNF4A gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF4A", "target": "CRP"}, {"weight": 7.0, "description": "The PABPC4 gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PABPC4", "target": "CRP"}, {"weight": 8.0, "description": "The BCL7B gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "BCL7B", "target": "CRP"}, {"weight": 10.0, "description": "The TMEM18 gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "TMEM18", "target": "CRP"}, {"weight": 14.0, "description": "A novel association of rs2867125 SNP with CRP levels near the TMEM18 gene.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "TMEM18", "target": "RS2867125"}, {"weight": 11.0, "description": "The PLTP gene is associated with serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PLTP", "target": "CRP"}, {"weight": 15.0, "description": "A novel association of rs6065906 SNP with CRP levels near PLTP and PCIF1 genes.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PLTP", "target": "RS6065906"}, {"weight": 2.0, "description": "The SNP rs1183910 in the HNF1A gene is associated with a lower risk of coronary artery disease.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "RS1183910", "target": "CAD"}, {"weight": 2.0, "description": "The genomic variant rs20417 influences the percentage of CAD between patients and controls.)", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "CAD", "target": "RS20417"}, {"weight": 8.0, "description": "SENP1-aP2KO mice showed increased CRP levels.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CRP", "target": "SENP1-DEFICIENT MICE"}, {"weight": 6.0, "description": "The patient\'s cholesterol levels were also elevated.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "CHOLESTEROL", "target": "CASE REPORT PATIENT"}, {"weight": 2.0, "description": "The CC genotype of miR-34b/c rs4938723 was significantly associated with a decreased risk of IA.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "INTRACRANIAL ANEURYSM"}, {"weight": 4.0, "description": "Carriers with the combined genotypes of rs4938723CC and TP53 Arg72Pro CG/CC/GG had a 0.27-fold decreased risk of IA.)<SEP>The combined effects of miR-34b/c rs4938723 and TP53 Arg72Pro variants on IA risk were examined.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "TP53 ARG72PRO"}, {"weight": 0.0, "description": "No association was observed between TP53 Arg72Pro and the risk of intracranial aneurysm.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "INTRACRANIAL ANEURYSM"}, {"weight": 3.0, "description": "The Odds Ratio (OR) quantifies the strength of association between genetic variants and the risk of developing ovarian cancer.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OR", "target": "RISK"}, {"weight": 4.0, "description": "The odds ratio (OR) for rs1898671 associated with asthma susceptibility was 1.50 in the overall population.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "OR", "target": "RS1898671"}, {"weight": 2.0, "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "C21ORF34", "target": "RESPIRATORY QUOTIENT"}, {"weight": 2.0, "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "C21ORF34", "target": "RESPIRATORY QUOTIENT (RQ)"}, {"weight": 6.0, "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL7P3 on chromosome 9)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RPL7P3", "target": "LIGHT ACTIVITY"}, {"weight": 8.0, "description": "A variant was identified for sedentary-light activity in 3\u2032UTR of CTCFL on chromosome 20.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CTCFL", "target": "SEDENTARY LIGHT ACTIVITY"}, {"weight": 10.0, "description": "Highly significant variants were identified for total energy expenditure for MATK on chromosome 19)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK", "target": "TOTAL ENERGY EXPENDITURE"}, {"weight": 12.0, "description": "Highly significant variants were identified for sleeping energy expenditure for CHRNA3 on chromosome 15.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3", "target": "SLEEPING ENERGY EXPENDITURE"}, {"weight": 0.9, "description": "The variant rs142786317 is located within the SULT1A1 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A1", "target": "RS142786317"}, {"weight": 0.7, "description": "The Met1Val variant was detected in the SULT1A1 gene but could not be replicated.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A1", "target": "MET1VAL"}, {"weight": 0.8, "description": "The variant rs1136703: p.Ile7Thr is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS1136703: P.ILE7THR"}, {"weight": 0.8, "description": "The variant rs10797300: p.Pro19Leu is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS10797300: P.PRO19LEU"}, {"weight": 0.9, "description": "The variant rs145008170: p.Ser44Asn is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS145008170: P.SER44ASN"}, {"weight": 0.8, "description": "The variant rs4987024: p.Tyr62Phe is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS4987024: P.TYR62PHE"}, {"weight": 0.7, "description": "The variant rs142241142: p.Ala164Val is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS142241142: P.ALA164VAL"}, {"weight": 0.8, "description": "The variant rs1059491: p.Asn235Thr is located within the SULT1A2 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS1059491: P.ASN235THR"}, {"weight": 0.9, "description": "The variant c.3536C>G is located within the TUFM gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "C.3536C>G"}, {"weight": 0.8, "description": "The variant rs7187776: c.-55T>C is located within the TUFM gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "RS7187776: C.-55T>C"}, {"weight": 0.7, "description": "The variant rs4788099: c.817+13T>C is located within the TUFM gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "RS4788099: C.817+13T>C"}, {"weight": 0.9, "description": "The variant rs8061877: c.248\u221218G>A is located within the TUFM gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "RS8061877: C.248\u221218G>A"}, {"weight": 0.8, "description": "The variant rs61737565: c.922+29C>G is located within the TUFM gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "RS61737565: C.922+29C>G"}, {"weight": 2.0, "description": "The genomic variant rs61737565 is located within the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "RS61737565"}, {"weight": 4.0, "description": "The genomic variant rs8061877 is located within the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "RS8061877"}, {"weight": 6.0, "description": "The genomic variant g.28854194C/G is located in the non-coding 3\u2019 UTR of the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "G.28854194C/G"}, {"weight": 8.0, "description": "Disruption of a transcription factor binding site can affect splice enhancer binding sites.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TRANSCRIPTION FACTOR BINDING SITE", "target": "SPLICE ENHANCER BINDING SITE"}, {"weight": 15.0, "description": "IL-1\u03b2 is a proinflammatory cytokine involved in inflammatory responses.)<SEP>Increased Il1b expression suggests enhanced inflammation in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL1B", "target": "INFLAMMATION"}, {"weight": 2.0, "description": "NOS3 rs3918186 SNP is associated with increased risk of childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3", "target": "CHILDHOOD ALL"}, {"weight": 1.0, "description": "rs7596684 is a genomic variant located within the IL1B gene.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL1B (INTERLEUKIN 1, BETA)", "target": "RS7596684"}, {"weight": 6.0, "description": "The rs7596684 variant in IL1B has been associated with an increased risk of ovarian cancer.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL1B (INTERLEUKIN 1, BETA)", "target": "OVARIAN CANCER"}, {"weight": 4.0, "description": "rs2282169 is a genomic variant located within the PTGS1 gene.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "RS2282169"}, {"weight": 8.0, "description": "The rs2282169 variant in PTGS1 has been associated with an increased risk of ovarian cancer.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "OVARIAN CANCER"}, {"weight": 2.0, "description": "The FokI variant was significantly associated with an increased risk of ovarian cancer according to meta-analysis.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER", "target": "FOKI"}, {"weight": 1.0, "description": "There was no significant association between the ApaI variant and ovarian cancer risk.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER", "target": "APAI"}, {"weight": 2.0, "description": "Studies have investigated the association between CDX-2 variations and the risk of developing ovarian cancer.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "CDX-2"}, {"weight": 2.0, "description": "The TaqI variant has been analyzed for its potential influence on ovarian cancer risk.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "TAQI"}, {"weight": 13.0, "description": "Paclitaxel-carboplatin combination therapy is a chemotherapy regimen used to treat ovarian cancer.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "OVARIAN CANCER", "target": "PACLITAXEL-CARBOPLATIN COMBINATION THERAPY"}, {"weight": 2.0, "description": "The ALOX5 rs1864414 SNP is associated with a decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "ALOX5 RS1864414", "target": "OVARIAN CANCER RISK"}, {"weight": 4.0, "description": "The NOS3 rs743507 SNP is associated with a decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "NOS3 RS743507"}, {"weight": 6.0, "description": "The IL1A rs17561 SNP is associated with a decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "IL1A RS17561"}, {"weight": 8.0, "description": "The IL1B rs7596684 SNP is potentially associated with an increased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "IL1B RS7596684"}, {"weight": 10.0, "description": "The PTGS1 rs2282169 SNP is potentially associated with an increased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "PTGS1 RS2282169"}, {"weight": 2.0, "description": "Individuals with the AA/GA genotype have a potentially increased risk of ovarian cancer compared to those with the GG genotype.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER RISK", "target": "AA/GA VS. GG"}, {"weight": 1.0, "description": "MTHFD2 is a folate metabolic gene analyzed for association with childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "MTHFD2", "target": "CHILDHOOD ALL"}, {"weight": 1.0, "description": "BHMT2 is a folate metabolic gene analyzed for association with childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "BHMT2", "target": "CHILDHOOD ALL"}, {"weight": 2.0, "description": "SLC19A1 rs1051266 SNP is associated with a slightly increased risk of childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1", "target": "CHILDHOOD ALL"}, {"weight": 2.0, "description": "The NOS3 rs3918186 SNP was associated with an increased risk of ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "ALL", "target": "NOS3 RS3918186"}, {"weight": 2.0, "description": "The SLC19A1 rs1051266 SNP was associated with a slightly increased risk of ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "ALL", "target": "SLC19A1 RS1051266"}, {"weight": 2.0, "description": "The Healthy Eating diet significantly reduced SFA intake.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "SATURATED FAT"}, {"weight": 6.0, "description": "The Healthy Eating diet significantly increased long chain n-3 PUFA intake.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "LONG CHAIN N-3 PUFA"}, {"weight": 4.0, "description": "The Mediterranean diet significantly reduced SFA intake.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "MEDITERRANEAN", "target": "SATURATED FAT"}, {"weight": 8.0, "description": "The Mediterranean diet significantly increased long chain n-3 PUFA intake.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "MEDITERRANEAN", "target": "LONG CHAIN N-3 PUFA"}, {"weight": 2.0, "description": "The prevalence of sleep apnoea was higher within the snorer group.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SLEEP APNOEA", "target": "SNORING"}, {"weight": 6.0, "description": "Smoking frequency was positively correlated with snoring prevalence in females and, to a lesser extent, in males.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SMOKING FREQUENCY", "target": "SNORING"}, {"weight": 8.0, "description": "Alcohol consumption frequency was correlated with snoring in males and, to a lesser extent, in females.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "ALCOHOL CONSUMPTION FREQUENCY", "target": "SNORING"}, {"weight": 10.0, "description": "Whole-body fat mass is correlated with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "WHOLE-BODY FAT MASS", "target": "SNORING"}, {"weight": 12.0, "description": "A lower SES was associated with increased snoring in males only.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SES", "target": "SNORING"}, {"weight": 14.0, "description": "Minimum SpO2 is a proxy for sleep-disordered breathing and showed moderate significant genetic correlations with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "MINIMUM SPO2", "target": "SNORING"}, {"weight": 16.0, "description": "Perc90, a proxy for sleep-disordered breathing, showed moderate significant genetic correlations with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "PERC90", "target": "SNORING"}, {"weight": 18.0, "description": "Average SpO2 reflects changes in ventilation not necessarily related to sleep apnoea and did not show a significant genetic correlation with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "AVERAGE SPO2", "target": "SNORING"}, {"weight": 20.0, "description": "Used as a covariate in sensitivity GWAS to explore nonlinear effects on associated variants.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "BMI2", "target": "SNORING"}, {"weight": 1.0, "description": "The SNP rs9316505 is located near the DLEU7 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DLEU7", "target": "RS9316505"}, {"weight": 1.0, "description": "The SNP rs199797821 is associated with snoring.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RS199797821", "target": "SNORING"}, {"weight": 1.0, "description": "The SNP rs200391180 is associated with snoring.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RS200391180", "target": "SNORING"}, {"weight": 2.0, "description": "Snoring is more prevalent in males.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "MALE", "target": "SNORING"}, {"weight": 2.0, "description": "Snoring is less prevalent in females compared to males.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "FEMALE", "target": "SNORING"}, {"weight": 4.0, "description": "The AGDS data was used to derive and test a PGS for snoring in an independent sample.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "AUSTRALIAN GENETICS OF DEPRESSION STUDY", "target": "SNORING"}, {"weight": 1.0, "description": "GWAS analysis revealed SNPs associated with snoring in both males and females.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "GWAS"}, {"weight": 1.0, "description": "Higher SNP heritability was observed in females for snoring compared to males.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "SNP HERITABILITY"}, {"weight": 3.0, "description": "A PGS for snoring was derived and significantly associated with recent snoring in an independent sample.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "PGS"}, {"weight": 3.0, "description": "PGS for snoring showed a stronger association with probable OSA, indicating a link between the two conditions.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "OSA"}, {"weight": 1.0, "description": "The GWAS identified 10 variants associated with serum B12 levels and 4 variants associated with serum folate levels.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "GWAS", "target": "VARIANTS (SNPS)"}, {"weight": 2.0, "description": "The GWAS investigated the association between genetic variants and maternal serum B12 levels.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "GWAS", "target": "SERUM B12 LEVELS"}, {"weight": 3.0, "description": "The GWAS investigated the association between genetic variants and maternal serum folate levels.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "GWAS", "target": "SERUM FOLATE LEVELS"}, {"weight": 1.0, "description": "The rs927650 SNP in CYP24A1 was associated with different concentrations of 25(OH)D based on genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "25(OH)D", "target": "RS927650"}, {"weight": 3.0, "description": "There was a statistically significant interaction between the rs2296241 SNP in CYP24A1 and 25(OH)D concentrations regarding adenoma recurrence.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "25(OH)D", "target": "RS2296241"}, {"weight": 1.0, "description": "The rs3025020 variant is a specific location (SNP) within the VEGFA gene.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "VEGFA", "target": "RS3025020"}, {"weight": 1.0, "description": "The rs2010963 variant is a specific location (SNP) within the VEGFA gene.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "VEGFA", "target": "RS2010963"}, {"weight": 2.0, "description": "The minor allele of rs3025020 is associated with an increased risk of PCOS.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "PCOS"}, {"weight": 5.0, "description": "Individuals carrying the rs3025020 minor allele have higher HOMA-IR levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "HOMA-IR"}, {"weight": 6.0, "description": "Individuals carrying the rs3025020 minor allele have higher bioactive testosterone levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "BIOACTIVE TESTOSTERONE"}, {"weight": 2.0, "description": "The minor allele of rs2010963 is associated with a reduced risk of PCOS.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "PCOS"}, {"weight": 8.0, "description": "Individuals carrying the rs2010963 minor allele have lower free testosterone levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "FREE TESTOSTERONE"}, {"weight": 9.0, "description": "Individuals carrying the rs2010963 minor allele have lower bioactive testosterone levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "BIOACTIVE TESTOSTERONE"}, {"weight": 11.0, "description": "The rs2010963 minor allele is negatively associated with ESR levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "ESR"}, {"weight": 18.0, "description": "IL-10 inhibits pro-IL-1\u03b2 production and maturation by LPM\u03d5s.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10", "target": "LPM\u03a6S"}, {"weight": 22.0, "description": "IL-10 directly regulates pro-IL-1\u03b2 production by LPM\u03d5s.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10", "target": "PRO-IL-1\u0392"}, {"weight": 2.0, "description": "Treatment with IL-10 suppressed the production of pro-IL-\u03b2 in Rag1\u2212/\u2212 M\u03d5s, suggesting an inhibitory effect on IL-1\u03b2 maturation.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10", "target": "PRO-IL-\u0392"}, {"weight": 4.0, "description": "IL-10 treatment inhibited caspase-1 activation in Rag1\u2212/\u2212 M\u03d5s, indicating a suppression of inflammatory signaling.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10", "target": "CASPASE-1"}, {"weight": 3.0, "description": "The rs1800896 A/G polymorphism in the promoter region of the IL-10 gene was analyzed. )", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10", "target": "CRC"}, {"weight": 12.0, "description": "IL-6 promotes Th17 cell differentiation and function.)<SEP>IL-6 signaling promotes the differentiation and function of Th17 cells.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-6", "target": "TH17"}, {"weight": 14.0, "description": "Blocking IL-6 signaling partially inhibited Th17 development in cultures with Rag1\u2212/\u2212 LPM\u03d5s, suggesting a lesser role compared to IL-1 in this process.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-6", "target": "TH17 CELL DIFFERENTIATION"}, {"weight": 1.0, "description": "SENP1 deletion in adipocytes increases the secretion of IL-6, contributing to inflammation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "IL-6", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 3.0, "description": "Genotype variations in VEGFA are associated with different levels of VEGF protein in the blood.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "VEGF SERUM LEVELS", "target": "VEGFA GENOTYPE"}, {"weight": 1.0, "description": "Val carriers showed higher response bias compared to iso homozygotes.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "VAL CARRIERS", "target": "RESPONSE BIAS"}, {"weight": 3.0, "description": "Val carriers selected a lower level of shock intensity than iso homozygotes.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "VAL CARRIERS", "target": "SHOCK INTENSITY"}, {"weight": 2.0, "description": "Iso homozygotes exhibited lower response bias compared to val carriers.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "ISO HOMOZYGOTES", "target": "RESPONSE BIAS"}, {"weight": 4.0, "description": "Iso homozygotes selected a higher level of shock intensity compared to val carriers.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "ISO HOMOZYGOTES", "target": "SHOCK INTENSITY"}, {"weight": 1.0, "description": "Participants showed higher discriminability in later blocks of the task, indicating learning.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "BLOCK", "target": "DISCRIMINABILITY"}, {"weight": 1.0, "description": "Participants exhibited lower response bias in Block 1 compared to Blocks 2 and 3.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "RESPONSE BIAS", "target": "BLOCK 1"}, {"weight": 2.0, "description": "Participants showed higher response bias in Block 2 compared to Block 1.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "RESPONSE BIAS", "target": "BLOCK 2"}, {"weight": 3.0, "description": "Participants exhibited the highest response bias in Block 3.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "RESPONSE BIAS", "target": "BLOCK 3"}, {"weight": 1.0, "description": "The val allele leads to a reduction in response bias during the stress condition.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "VAL ALLELE"}, {"weight": 1.0, "description": "Participants exhibit increased response bias in response to stress conditions.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "STRESS"}, {"weight": 1.0, "description": "Participants exhibit increased response bias in response to stress conditions.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "STRESS CONDITION"}, {"weight": 11.0, "description": "Participants showed more non-specific SC responses during the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "SC RESPONSES", "target": "STRESS CONDITION"}, {"weight": 11.0, "description": "Participants reported higher STAI scores during the stress condition than the no-stress condition.)<SEP>Participants reported significantly higher STAI scores during the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "STRESS CONDITION"}, {"weight": 6.0, "description": "Participants reported lower STAI scores during the no-stress condition compared to the stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "NO-STRESS CONDITION"}, {"weight": 14.0, "description": "STAI scores increased significantly over time within both the stress and no-stress conditions.)<SEP>STAI scores significantly increased over time for both the stress and no-stress conditions.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "TIME"}, {"weight": 8.0, "description": "Participants reported elevated PANAS NA scores during the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STRESS CONDITION", "target": "PANAS NA SCORES"}, {"weight": 9.0, "description": "Participants reported lower PANAS NA scores during the no-stress condition compared to the stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "NO-STRESS CONDITION", "target": "PANAS NA SCORES"}, {"weight": 10.0, "description": "PANAS NA scores significantly increased over time for both the stress and no-stress conditions.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "TIME", "target": "PANAS NA SCORES"}, {"weight": 1.0, "description": "The SNP rs1951867 is located near the BMP4 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "BMP4", "target": "RS1951867"}, {"weight": 1.0, "description": "The SNP rs1458991 is located near the BMP4 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "BMP4", "target": "RS1458991"}, {"weight": 2.0, "description": "Variants in BMP4 were found to be associated with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "BMP4", "target": "HEIGHT"}, {"weight": 1.0, "description": "The SNP rs10740993 is located near the CACNB2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS10740993", "target": "CACNB2"}, {"weight": 1.0, "description": "The SNP rs4937076 is located near the CDON gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS4937076", "target": "CDON"}, {"weight": 1.0, "description": "The SNP rs1799922 is located near the CALU and OPN1SW genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS1799922", "target": "CALU/OPN1SW"}, {"weight": 1.0, "description": "The SNP rs997154 is located near the AJUBA and C14orf93 genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS997154", "target": "AJUBA/C14ORF93"}, {"weight": 1.0, "description": "The SNP rs7924176 is located near the ADK gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS7924176", "target": "ADK"}, {"weight": 1.0, "description": "The SNP rs412000 is located near the TEX14 and RAD51C genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS412000", "target": "TEX14/RAD51C"}, {"weight": 1.0, "description": "The SNP rs8069452 is located near the IGF2BP1 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "IGF2BP1", "target": "RS8069452"}, {"weight": 1.0, "description": "The SNP rs9894411 is located near the IGF2BP1 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "IGF2BP1", "target": "RS9894411"}, {"weight": 1.0, "description": "The SNP rs2520397 is located near the FAM155E and EDA genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS2520397", "target": "FAM155E/EDA"}, {"weight": 1.0, "description": "The SNP rs9788982 is located near the KCNJ2 and KCNJ160 genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS9788982", "target": "KCNJ2/KCNJ160"}, {"weight": 1.0, "description": "The SNP rs2804391 is located near the FAM155E and EDA genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RS2804391", "target": "FAM155E/EDA"}, {"weight": 4.0, "description": "SNPs associated with \'Age at first tooth\' and \'Number of teeth\' showed moderate evidence of association with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "SNPS", "target": "HEIGHT"}, {"weight": 0.9, "description": "SNPs are used as instrumental variables in MR Egger regression analysis to estimate causal effects.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "SNPS", "target": "MR EGGER"}, {"weight": 1.0, "description": "CCHCR1 contains three SNPs: rs1576/rs130079/rs746647.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "SNPS", "target": "CCHCR1"}, {"weight": 4.0, "description": "The study investigated whether SNPs were associated with treatment response to different therapies.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SNPS", "target": "TREATMENT RESPONSE"}, {"weight": 3.0, "description": "The SNP rs17101923 in HMGA2 is associated with earlier tooth eruption.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AGE AT FIRST TOOTH", "target": "RS17101923 (HMGA2)"}, {"weight": 5.0, "description": "Alleles associated with increased nose width are also associated with earlier tooth eruption.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AGE AT FIRST TOOTH", "target": "RS7924176 (ADK)"}, {"weight": 7.0, "description": "Several height-associated SNPs showed evidence of association with faster tooth eruption.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AGE AT FIRST TOOTH", "target": "HEIGHT-ASSOCIATED SNPS"}, {"weight": 3.0, "description": "The PMETA score for \'Age at first tooth\' is 0.0012, indicating the strength of its association with other traits.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "AGE AT FIRST TOOTH", "target": "PMETA"}, {"weight": 2.0, "description": "Alleles associated with increased face width are also associated with an increased number of teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "NUMBER OF TEETH", "target": "RS17101923 (HMGA2)"}, {"weight": 8.0, "description": "Several height-associated SNPs showed evidence of association with more teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "NUMBER OF TEETH", "target": "HEIGHT-ASSOCIATED SNPS"}, {"weight": 4.0, "description": "The PMETA score for \'Number of teeth\' is 9.8 \u00d7 10\u22124, indicating the strength of its association with other traits.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "NUMBER OF TEETH", "target": "PMETA"}, {"weight": 1.0, "description": "The SNP rs11077486 is located near the KCNJ2 and KCNJ160 genes.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "KCNJ2/KCNJ160", "target": "RS11077486"}, {"weight": 1.0, "description": "The SNP rs17101923 in HMGA2 is associated with increased face width.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "FACE WIDTH", "target": "RS17101923 (HMGA2)"}, {"weight": 4.0, "description": "The SNP rs7924176 in ADK is associated with nose width.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "NOSE WIDTH", "target": "RS7924176 (ADK)"}, {"weight": 6.0, "description": "The SNP rs997154 in AJUBA is associated with an increase in height and prominence of the mid-brow.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "MID-BROW PROMINENCE", "target": "RS997154 (AJUBA)"}, {"weight": 13.0, "description": "The rs35866622 variant is positively associated with height.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "HEIGHT", "target": "RS35866622"}, {"weight": 1.0, "description": "Deletion of IL-10 receptor alpha in T cells does not impact colitis development.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391TDEL", "target": "COLITIS"}, {"weight": 3.0, "description": "Mice lacking IL-10 receptor alpha in dendritic cells did not show significant differences in colitis severity compared to controls.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391DCDELRAG1\u2212/\u2212 MICE", "target": "COLITIS"}, {"weight": 1.0, "description": "Mice lacking IL-10 receptor alpha in macrophages exhibited more severe colitis, indicating a protective role for M\u03d5 response to IL-10 in this disease.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "COLITIS"}, {"weight": 2.0, "description": "Mice lacking IL-10 receptor alpha specifically in macrophages exhibit accelerated weight loss compared to controls.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "INCREASED WEIGHT LOSS"}, {"weight": 3.0, "description": "Mice lacking IL-10 receptor alpha specifically in macrophages show increased inflammation and tissue damage in the colon.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "INCREASED HISTOPATHOLOGY"}, {"weight": 2.0, "description": "Transfer of specific T cells into Rag1\u2212/\u2212 mice induces colitis.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "COLITIS", "target": "T CELL TRANSFER"}, {"weight": 4.0, "description": "Depletion of neutrophils in Rag1\u2212/\u2212 recipients only mildly impacts disease severity, suggesting a minor protective role for neutrophils.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "COLITIS", "target": "NEUTROPHILS"}, {"weight": 14.0, "description": "Colitis is more severe in IL-10R\u03b1MdelRag1\u2212/\u2212 mice than Rag1\u2212/\u2212 mice.)<SEP>Disruption of IL-10 signaling in IL-10R\u03b1MdelRag1\u2212/\u2212 mice leads to exacerbated colitis.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"weight": 4.0, "description": "T cell transfer colitis is less severe in Rag1\u2212/\u2212 mice compared to WT mice.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "RAG1\u2212/\u2212"}, {"weight": 7.0, "description": "Elevated IL-1\u03b2 expression contributes to colitis in IL-10R\u03b1MdelRag1\u2212/\u2212 mice, potentially overriding the need for IL-6.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1\u0392"}, {"weight": 8.0, "description": "Transferring IL-1R\u2212/\u2212 T cells into IL-10R\u03b1MdelRag1\u2212/\u2212 mice results in milder colitis compared to WT T cell transfers.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1R\u2212/\u2212"}, {"weight": 3.0, "description": "Card9\u2212/\u2212 mice are more susceptible to colitis and have impaired recovery after DSS induction.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "COLITIS", "target": "CARD9\u2212/\u2212 MICE"}, {"weight": 10.0, "description": "Mice colonized with Card9\u2212/\u2212 microbiota exhibit increased susceptibility to colitis and impaired recovery.)<SEP>Mice colonized with Card9\u2212/\u2212 microbiota exhibit increased susceptibility to colitis compared to WT-colonized mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "CARD9\u2212/\u2212\u2192GF"}, {"weight": 9.0, "description": "DSS (Dextran Sulfate Sodium) induces colitis in mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "DSS"}, {"weight": 2.0, "description": "Mice colonized with WT microbiota show normal recovery from DSS-induced colitis.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "WT\u2192GF"}, {"weight": 11.0, "description": "The IL2 gene region is associated with colitis.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "COLITIS", "target": "IL2 GENE"}, {"weight": 3.0, "description": "CD25 expression is upregulated upon activation of Tconv cells.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD25", "target": "TCONV ACTIVATION"}, {"weight": 14.0, "description": "Loss-of-function STAT5B variants impair the maintenance of FOXP3 expression in Tregs over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "CD25", "target": "STAT5B"}, {"weight": 5.0, "description": "IL-6 signaling supports but is not essential for Th17 formation.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17", "target": "IL-6R\u0391\u2212/\u2212"}, {"weight": 6.0, "description": "Actions of IL-10 on M\u03d5s generate a dependency for IL-6 in disease pathogenesis.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "M\u03a6", "target": "IL-6 REQUIREMENT"}, {"weight": 8.0, "description": "EBNA2 binds preferentially to the risk allele of the CD40 locus.)<SEP>EBNA2 preferentially binds to the protective allele of CD40, but EBNA2-TAT inhibition suggests that EBNA2 increases CD40 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "CD40", "target": "EBNA2"}, {"weight": 8.0, "description": "Variations in the CD40 gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "CD40", "target": "MS RISK"}, {"weight": 12.0, "description": "Rag1 deficiency results in a lack of mature T cells.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "RAG1\u2212/\u2212", "target": "T CELLS"}, {"weight": 22.0, "description": "In SENP1-aP2KO mice, reduced Foxp3 expression indicates a decrease in Tregs.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "FOXP3", "target": "SENP1-DEFICIENT MICE"}, {"weight": 13.0, "description": "STAT5B is involved in FOXP3 induction.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "FOXP3", "target": "STAT5B"}, {"weight": 20.0, "description": "IL-1\u03b2 is largely associated with the CD11b+ population in the colon.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1\u0392", "target": "CD11B"}, {"weight": 1.0, "description": "SENP1 deletion in adipocytes increases the secretion of IL-1\u03b2, contributing to inflammation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "IL-1\u0392", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 21.0, "description": "In SENP1-aP2KO mice, Th17 cells produce IL-17, indicating an increased inflammatory response.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "IL-17", "target": "SENP1-DEFICIENT MICE"}, {"weight": 20.0, "description": "In SENP1-aP2KO mice, Th1 cells produce IFN-\u03b3, indicating an increased inflammatory response.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "IFN-\u0393", "target": "SENP1-DEFICIENT MICE"}, {"weight": 4.0, "description": "Elevated IFN-\u03b3 levels are associated with insulitis and pancreatic islet inflammation in NOD mice, a characteristic of T1DM.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "IFN-\u0393", "target": "T1DM"}, {"weight": 3.0, "description": "IFN-\u03b3 is a cytokine that promotes the activation and function of islet-reactive T cells.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "IFN-\u0393", "target": "ISLET-REACTIVE T CELLS"}, {"weight": 2.0, "description": "Expression of IFN-\u03b3 was higher in CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to those without.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "PTPN2:RS478582"}, {"weight": 4.0, "description": "Expression of IFN-\u03b3 was higher in CD subjects with heterozygous or minor alleles in PTPN22:rs2476601 compared to those without.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "PTPN22:RS2476601"}, {"weight": 4.0, "description": "IL-22 was similar in T cells of psoriasiform lesions and classical psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "T CELLS", "target": "IL\u201022"}, {"weight": 10.0, "description": "STAT5B is important for the maintenance of T cell levels. STAT5B deficient patients often manifest T cell lymphopenia.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "T CELLS", "target": "STAT5B"}, {"weight": 9.0, "description": "ROR\u03b3T expression is necessary for the development of Th17 cells.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "ROR\u0393T", "target": "TH17 RESPONSE"}, {"weight": 4.0, "description": "There is a negative correlation between bacterial and fungal biodiversity in WT mice, suggesting competition.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "WT", "target": "BACTERIAL BIODIVERSITY"}, {"weight": 10.0, "description": "T cell IL-1 response leads to a decrease in Th17 cells in the colon.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1R\u0391", "target": "TH17 CELLS"}, {"weight": 16.0, "description": "There are no differences in Th1 and Foxp3+ Treg populations after IL-1R\u2212/\u2212 transfers.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1R\u0391", "target": "FOXP3+ TREG CELLS"}, {"weight": 11.0, "description": "In SENP1-aP2KO mice, Th17 cell populations expanded in the pancreatic lymph nodes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "TH17 CELLS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 24.0, "description": "Caspase-1 cleaves pro-IL-1\u03b2 to convert it into its active form.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "PRO-IL-1\u0392", "target": "CASPASE-1"}, {"weight": 26.0, "description": "Inflammasome stimulation activates caspase-1.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "CASPASE-1", "target": "INFLAMMASOME"}, {"weight": 6.0, "description": "Blocking IL-10R signaling with an antibody elevated pro-IL-\u03b2 levels in Rag1\u2212/\u2212 M\u03d5s, suggesting that IL-10 normally restrains IL-1\u03b2 production.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "PRO-IL-\u0392", "target": "ANTI-IL-10R ANTIBODY"}, {"weight": 3.0, "description": "LPM\u03d5s from IL-10R\u03b1MdelRag1\u2212/\u2212 mice exhibited elevated surface expression of activation markers such as CD40, CD80, and CD86.)", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "ACTIVATION", "target": "CD40, CD80, AND CD86"}, {"weight": 4.0, "description": "Most LPM\u03d5s were phenotypically pro-inflammatory (Ly6Chi), but the proportions did not differ between IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 mice.)", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "DISEASE SEVERITY", "target": "LY6CHI MACROPHAGES"}, {"weight": 6.0, "description": "Transferred Foxp3+ iTregs suppressed disease development in both IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 recipients.)", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "DISEASE SUPPRESION", "target": "FOXP3+ ITREG "}, {"weight": 8.0, "description": "LPM\u03d5s from Rag1\u2212/\u2212 mice supported Th17 cell differentiation to a lesser extent compared to those from IL-10R\u03b1MdelRag1\u2212/\u2212 mice.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "RAG1\u2212/\u2212 LPM\u03a6S", "target": "TH17 CELL DIFFERENTIATION"}, {"weight": 10.0, "description": "LPM\u03d5s from IL-10R\u03b1MdelRag1\u2212/\u2212 mice strongly supported Th17 cell differentiation, suggesting an enhanced capacity to promote this process.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "TH17 CELL DIFFERENTIATION", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212 LPM\u03a6S"}, {"weight": 12.0, "description": "Blocking IL-1 signaling significantly inhibited Th17 development in cultures with IL-10R\u03b1MdelRag1\u2212/\u2212-derived LPM\u03d5s, highlighting the importance of IL-1 in supporting Th17 cell maturation.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "TH17 CELL DIFFERENTIATION", "target": "IL-1"}, {"weight": 3.2, "description": "The Ruminiclostridium 9 genus belongs to the Peptostreptococcaeae family.)<SEP>The Ruminiclostridium 9 genus is a member of the Peptostreptococcaeae family.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "RUMINICLOSTRIDIUM 9", "target": "PEPTOSTREPTOCOCCAEAE"}, {"weight": 1.0, "description": "Peptostreptococcaeae", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "RUMINICLOSTRIDIUM 9", "target": "BACTERIAL FAMILY"}, {"weight": 0.7, "description": "Ruminococcus species are known to produce short-chain fatty acids, beneficial metabolites for gut health.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "RUMINOCOCCUS", "target": "SHORT-CHAIN FATTY ACIDS"}, {"weight": 0.7, "description": "Different DNA extraction methods can lead to variation in microbiome profiles.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "DNA EXTRACTION METHOD", "target": "MICROBIOME COMPOSITION"}, {"weight": 2.0, "description": "The LCT and MCM6 genes are located near each other, and their regulatory regions overlap.)<SEP>The MCM6 gene is located near LCT and its epigenetic modifications may influence LCT mRNA levels.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "LCT", "target": "MCM6"}, {"weight": 1.0, "description": "Enterocytes express LCT, the gene encoding lactase.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LCT", "target": "ENTEROCYTES"}, {"weight": 3.0, "description": "Previous studies have shown a positive correlation of Bifidobacterium abundance with the intake of milk products, but only in individuals homozygous for the low-function LCT haplotype.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "BIFIDOBACTERIUM", "target": "LCT GENE"}, {"weight": 1.0, "description": "The genomic variant rs182549 is associated with an increased abundance of the Bifidobacterium genus in adults.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "BIFIDOBACTERIUM", "target": "RS182549"}, {"weight": 16.0, "description": "Bifidobacterium is nominally correlated with raw vegetable intake.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "BIFIDOBACTERIUM", "target": "NUTRITIONAL PHENOTYPES"}, {"weight": 2.0, "description": "Higher Bifidobacterium abundance is associated with a lower risk of ulcerative colitis.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "BIFIDOBACTERIUM", "target": "ULCERATIVE COLITIS"}, {"weight": 2.0, "description": "The rs182549 genotype showed an age-genotype interaction in the GEM_v12 cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "GEM_V12"}, {"weight": 3.0, "description": "The rs182549 genotype showed an age-genotype interaction in the GEM_ICHIP cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "GEM_ICHIP"}, {"weight": 4.0, "description": "The rs182549 genotype did not show an interaction with age in the GEM_v24 cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "GEM_V24"}, {"weight": 5.0, "description": "The rs182549 genotype showed no LCT mbQTL effect in the PNP cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "PERSONALIZED NUTRITION PROJECT (PNP)"}, {"weight": 6.0, "description": "The rs182549 genotype showed a low LCT effect size in the COPSAC cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "COPENHAGEN PROSPECTIVE STUDIES ON ASTHMA IN CHILDHOOD (COPSAC)"}, {"weight": 22.0, "description": "Genomic variant rs182549 is located near the LCT gene.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS182549", "target": "LCT GENE"}, {"weight": 8.0, "description": "The rs182549 variant is positively associated with Type 2 diabetes mellitus diagnosis.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "TYPE 2 DIABETES MELLITUS"}, {"weight": 9.0, "description": "The rs182549 variant increases the risk of having a family history of Type 2 diabetes mellitus.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "FAMILY HISTORY OF T2DM"}, {"weight": 10.0, "description": "The rs182549 variant is associated with multiple nutritional phenotypes in the UK Biobank cohort.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "NUTRITIONAL PHENOTYPES"}, {"weight": 11.0, "description": "The functional LCT SNP rs4988235 variant is associated with 1,5-anhydroglucitol levels.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS4988235", "target": "1,5-ANHYDROGLUCITOL"}, {"weight": 2.0, "description": "Having one additional LP (T) allele was associated with a higher intake of milk (\u03b2 17.1 g/day, 95%CI 10.6 to 23.6) and milk beverages (\u03b2 2.8 g/day, 95%CI 1.0 to 4.5).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "MILK INTAKE"}, {"weight": 6.0, "description": "Individuals with the rs4988235 variant had higher plasma C15:0 levels (\u03b2 0.003 % of total fats, 95%CI 0.0005 to 0.005).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "C15:0"}, {"weight": 8.0, "description": "A similar association was suggested for C17:0 levels (\u03b2 0.002 % of total fats, 95% CI -0.0007 to 0.005), but this was not statistically significant.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "C17:0"}, {"weight": 12.0, "description": "Individuals with the rs4988235 variant had higher consumption of potatoes (\u03b2 3.0, 95%CI 0.9 to 5.1).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "POTATOES"}, {"weight": 14.0, "description": "Individuals with the rs4988235 variant had lower consumption of cereal products (\u03b2 -3.5, 95% CI -6.7 to -0.3).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "CEREAL"}, {"weight": 16.0, "description": "Individuals with the rs4988235 variant had lower consumption of fruits (\u03b2 -7.0, 95%CI -12.4 to -1.7).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "FRUITS"}, {"weight": 18.0, "description": "Individuals with the rs4988235 variant had lower consumption of poultry (\u03b2 -0.8, 95%CI -1.4 to -0.2).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "POULTRY"}, {"weight": 20.0, "description": "Individuals with the rs4988235 variant had lower consumption of non-alcoholic beverages (\u03b2 -18.0, 95%CI -34.4 to -1.6).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "NON-ALCOHOLIC BEVERAGES"}, {"weight": 22.0, "description": "Individuals with the rs4988235 variant had lower consumption of wine (\u03b2 -4.8, 95%CI -9.1 to -0.6).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "WINE"}, {"weight": 13.0, "description": "rs4988235 was not associated with the risk of developing diabetes (HRper additional LP allele 0.99, 95%CI 0.94,1.04).)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "DIABETES RISK"}, {"weight": 2.0, "description": "The rs4988235 genomic variant is associated with lactase persistence.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "LACTASE PERSISTENCE"}, {"weight": 6.0, "description": "The minor allele frequency of rs4988235 in Romania is 0.28.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "ROMANIA"}, {"weight": 8.0, "description": "The minor allele frequency of rs4988235 in Poland is 0.40.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "POLAND"}, {"weight": 10.0, "description": "The minor allele frequency of rs4988235 in Russia is 0.35.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "RUSSIA"}, {"weight": 12.0, "description": "The minor allele frequency of rs4988235 in the Czech Republic is 0.46.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "CZECH REPUBLIC"}, {"weight": 7.0, "description": "The FUT2-FUT1 locus was associated with a higher abundance of Ruminococcus torques group.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2-FUT1 LOCUS", "target": "RUMINOCOCCUS TORQUES"}, {"weight": 8.0, "description": "The SNP rs35866622, associated with the non-secretor status of FUT2, is linked to a reduced abundance of the Ruminococcus torques group.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS35866622", "target": "RUMINOCOCCUS TORQUES"}, {"weight": 24.0, "description": "The rs35866622 SNP acts as a proxy for the functional variant rs601338 in the FUT2 gene.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS35866622", "target": "FUT2 GENE"}, {"weight": 12.0, "description": "The rs35866622 variant is positively associated with fish intake.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "FISH INTAKE"}, {"weight": 14.0, "description": "Individuals with the secretor allele (rs35866622) have a lower risk of cholelithiasis.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "CHOLELITHIASIS"}, {"weight": 15.0, "description": "The rs35866622 variant is associated with a lower risk of Crohn\'s disease.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "CROHN\u2019S DISEASE"}, {"weight": 9.0, "description": "The functional variant rs601338 causes a stop-codon in the FUT2 gene, leading to non-secretor status.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RS601338", "target": "FUT2 PROTEIN"}, {"weight": 10.0, "description": "Variations in the FUT2 gene affect the secretion of fucosylated mucus glycans and influence the abundance of Ruminococcus torques.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "RUMINOCOCCUS TORQUES"}, {"weight": 11.0, "description": "The FUT2 gene encodes the alpha-1,2-fucosyltransferase enzyme.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "ALPHA-1,2-FUCOSYLTRANSFERASE"}, {"weight": 26.0, "description": "Variations in the FUT2 gene, particularly rs601338, influence an individual\'s non-secretor status.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "NON-SECRETOR STATUS"}, {"weight": 30.0, "description": "The FUT2 gene encodes the alpha-1,2-fucosyltransferase enzyme.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "ALPHA-1,3 FUCOSYLTRANSFERASE"}, {"weight": 12.0, "description": "Ruminococcus torques species are involved in the degradation of complex carbohydrates.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RUMINOCOCCUS TORQUES", "target": "CARBOHYDRATE METABOLISM"}, {"weight": 27.0, "description": "The abundance of Ruminococcus torques group was correlated with fruit intake in the Flemish Gut Flora Project.)<SEP>The abundance of Ruminococcus torques group was correlated with fruit intake in the LifeLines-DEEP cohort.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RUMINOCOCCUS TORQUES", "target": "FRUIT INTAKE"}, {"weight": 15.0, "description": "The PCSK5 gene is located within the 9q21 locus, associated with the abundance of Allisonella.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "PCSKS5 GENE", "target": "9Q21 LOCUS"}, {"weight": 16.0, "description": "The RFK gene is located within the 9q21 locus, associated with the abundance of Allisonella.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RFK GENE", "target": "9Q21 LOCUS"}, {"weight": 17.0, "description": "The GCNT1 gene is located within the 9q21 locus, associated with the abundance of Allisonella.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "GCNT1 GENE", "target": "9Q21 LOCUS"}, {"weight": 18.0, "description": "The CUBN gene is located within the 10p13 locus, associated with Peptostreptococcaceae abundance.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "CUBN GENE", "target": "10P13 LOCUS"}, {"weight": 19.0, "description": "The CUBN gene, involved in cobalamin absorption, is associated with abundance of Peptostreptococcaceae.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "CUBN GENE", "target": "PEPTOSTREPTOCOCCACEAE"}, {"weight": 28.0, "description": "Mutations in the LCT gene lead to lactase deficiency, causing lactose intolerance.)", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "LCT GENE", "target": "LACTOSE INTOLERANCE (LI)"}, {"weight": 1.0, "description": "The genomic variant rs7574352 is associated with Peptococcaceae, indicating a potential link between the variant and this gut bacterial taxon.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "PEPTOCOCCACEAE"}, {"weight": 2.0, "description": "Peptococcaceae levels are negatively correlated with chromogranin A levels in stool, suggesting that Peptococcaceae may play a role in modulating inflammation.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "PEPTOCOCCACEAE", "target": "CHROMOGRANIN A"}, {"weight": 3.0, "description": "Peptococcaceae levels are negatively correlated with calprotectin levels in stool, indicating that Peptococcaceae may have an anti-inflammatory effect.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "PEPTOCOCCACEAE", "target": "CALPROTECTIN"}, {"weight": 4.0, "description": "Individuals with lower levels of Peptococcaceae are more susceptible to ulcerative colitis.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "PEPTOCOCCACEAE", "target": "ULCERATIVE COLITIS"}, {"weight": 1.0, "description": "A higher abundance of Actinobacteria may have a protective effect on ulcerative colitis.|", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "ULCERATIVE COLITIS", "target": "ACTINOBACTERIA"}, {"weight": 1.0, "description": "The SNP rs181206 in the IL27 gene is associated with decreased expression of IRF1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "SNP RS181206"}, {"weight": 3.0, "description": "The ITT measures the sensitivity to insulin. Impaired response to insulin indicates insulin resistance.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "INSULIN RESISTANCE", "target": "INSULIN TOLERANCE TEST (ITT)"}, {"weight": 14.0, "description": "High Fat Diet (HFD) further reduced insulin levels in SENP1-aP2KO mice, contributing to increased insulin resistance.)<SEP>High Fat Diet (HFD) induced insulin resistance in both Ctrl and SENP1-aP2KO mice, but the phenotype was more severe in SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "INSULIN RESISTANCE", "target": "HFD"}, {"weight": 17.0, "description": "Card9\u2212/\u2212 mice show decreased abundance of Actinobacteria compared to WT mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "ACTINOBACTERIA", "target": "BACTERIAL DIVERSITY"}, {"weight": 2.0, "description": "The Card9\u2212/\u2212 microbiota exhibits lower levels of Actinobacteria compared to WT mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "ACTINOBACTERIA", "target": "CARD9\u2212/\u2212"}, {"weight": 3.0, "description": "A higher abundance of the Oxalobacteraceae family may protect against rheumatoid arthritis.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "OXALOBACTERACEAE", "target": "RHEUMATOID ARTHRITIS"}, {"weight": 7.0, "description": "Mutations in the PTPN2 gene are associated with an increased risk of rheumatoid arthritis.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RHEUMATOID ARTHRITIS", "target": "PTP N2 GENE"}, {"weight": 1.0, "description": "The TwoSampleMR package is a software tool used for performing Mendelian Randomization analyses.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "TWOSAMPLEMR PACKAGE", "target": "MENDELIAN RANDOMIZATION"}, {"weight": 0.8, "description": "Sequencing the 16S rRNA gene allows for analysis of bacterial diversity in a sample.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "MICROBIOME COMPOSITION", "target": "16S RRNA GENE"}, {"weight": 18.0, "description": "The FUT1/FUT2 locus is mapped to several nutritional phenotypes.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "NUTRITIONAL PHENOTYPES", "target": "FUT1/FUT2 LOCUS"}, {"weight": 10.0, "description": "Supplemental analyses were conducted to validate and strengthen the findings from the IVW analysis.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "SENSITIVITY ANALYSES", "target": "IVW RESULTS"}, {"weight": 0.9, "description": "Bacteroides are a common component of the human gut microbiome.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BACTEROIDES", "target": "GUT MICROBIOME"}, {"weight": 19.0, "description": "The FUT1/FUT2 locus maps to immune-related signals.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FUT1/FUT2 LOCUS", "target": "IMMUNE-RELATED SIGNALS"}, {"weight": 1.0, "description": "Mothers\' dietary choline intake differed between groups, with more than 70% not meeting the recommended AI for choline.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE", "target": "DIETARY INTAKE"}, {"weight": 2.0, "description": "The PEMT enzyme is involved in choline metabolism and the rs12325817 variant affects its function.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "CHOLINE", "target": "PEMT"}, {"weight": 2.0, "description": "Heavy alcohol consumption during pregnancy is associated with an increased risk of FASDs.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)"}, {"weight": 6.0, "description": "Heavy alcohol consumption was reported by both groups throughout the study period.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "PREGNANCY OUTCOMES"}, {"weight": 1.0, "description": "The ALDH2 rs671 polymorphism is associated with differences in alcohol consumption patterns.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "ALDH2 RS671"}, {"weight": 3.0, "description": "Daily alcohol consumption is positively associated with blood cortisol levels.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "BLOOD CORTISOL LEVEL"}, {"weight": 3.0, "description": "This subgroup was excluded from certain analyses due to their unique drinking history.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "EX-DRINKERS"}, {"weight": 3.0, "description": "The study mentions that some mothers in both groups used methamphetamine during pregnancy.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "METHAMPHETAMINE USE", "target": "PREGNANCY OUTCOMES"}, {"weight": 7.0, "description": "Infants in the choline group demonstrated catch-up growth in weight and head circumference compared to the placebo group.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SOMATIC GROWTH", "target": "CHOLINE SUPPLEMENTATION"}, {"weight": 1.0, "description": "Maternal education levels were similar between the treatment and placebo groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "MATERNAL EDUCATION", "target": "SAMPLE CHARACTERISTICS"}, {"weight": 2.0, "description": "There were no differences in verbal and nonverbal intellectual competence between the groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE", "target": "SAMPLE CHARACTERISTICS"}, {"weight": 3.0, "description": "Stress levels did not differ significantly between the treatment and placebo groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "PERCEIVED STRESS", "target": "SAMPLE CHARACTERISTICS"}, {"weight": 4.0, "description": "There were no group differences in depression scores.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "DEPRESSION", "target": "SAMPLE CHARACTERISTICS"}, {"weight": 5.0, "description": "Both groups had a similar percentage of mothers with poor nutrition based on caloric intake.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "NUTRITIONAL STATUS", "target": "SAMPLE CHARACTERISTICS"}, {"weight": 7.0, "description": "Both groups smoked about \u00bc pack/day on average.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SMOKING", "target": "PREGNANCY OUTCOMES"}, {"weight": 6.0, "description": "Cases smoked more...)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SMOKING", "target": "COLORECTAL CANCER"}, {"weight": 1.0, "description": "Methamphetamine use during pregnancy can have adverse effects on fetal development.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ILLICIT DRUG USE", "target": "PREGNANCY OUTCOMES"}, {"weight": 1.0, "description": "Low birth weight was common, but there were no significant differences in incidence between groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "BIRTH WEIGHT", "target": "PREGNANCY OUTCOMES"}, {"weight": 1.6, "description": "Maternal PEMT genotype influences offspring choline status.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PEMT", "target": "CHOLINE STATUS"}, {"weight": 1.0, "description": "Infants are born to mothers who provide nutrients and influence their development.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "INFANTS", "target": "MOTHERS"}, {"weight": 11.0, "description": "The incidence of LBW was similar between the choline and placebo groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "PREGNANCY OUTCOMES", "target": "LOW BIRTHWEIGHT"}, {"weight": 4.0, "description": "Infants in the choline group showed greater improvement in EBC compared to the placebo group, suggesting potential benefits of choline for cognitive development.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE SUPPLEMENTATION", "target": "EBC"}, {"weight": 6.0, "description": "The incidence of LBW was similar between the choline and placebo groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE SUPPLEMENTATION", "target": "LBW"}, {"weight": 8.0, "description": "Infants in the choline group performed better on the FTII compared to the placebo group, suggesting potential benefits of choline for cognitive function.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE SUPPLEMENTATION", "target": "FTII"}, {"weight": 5.0, "description": "The majority of women had full-term pregnancies, and GA did not differ significantly between groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "BIRTH OUTCOMES", "target": "GA"}, {"weight": 9.0, "description": "There were no significant differences in gestational age at randomization between groups.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SAMPLE CHARACTERISTICS", "target": "WEEKS GESTATION AT RANDOMIZATION"}, {"weight": 1.0, "description": "Adequate maternal dietary choline intake during pregnancy may impact the risk of FAS and PFAS.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "DIETARY CHOLINE", "target": "FAS/PFAS RISK"}, {"weight": 2.0, "description": "The rs10886471 SNP is located in the intronic region of the GRK5 gene.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "RS10886471", "target": "GRK5"}, {"weight": 4.0, "description": "CA repeat sequences within the GRK5 gene may influence its splicing and expression.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5", "target": "CA REPEAT SEQUENCES"}, {"weight": 1.5, "description": "The (CA)16 allele was negatively correlated with IGT, meaning that individuals with the (CA)16 allele were less likely to have IGT.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IGT", "target": "(CA)16 ALLELE"}, {"weight": 1.0, "description": "The (CA)16 allele was not significantly associated with T2DM. )", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "T2DM", "target": "(CA)16 ALLELE"}, {"weight": 8.0, "description": "The NFG group demonstrates normal blood glucose levels.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "NFG", "target": "NORMAL BLOOD GLUCOSE"}, {"weight": 1.0, "description": "The NFG group served as a control compared to three distinct case groups.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "NGF GROUP", "target": "CASE GROUPS"}, {"weight": 0.9, "description": "These include (CA)15, (CA)17, (CA)18, and (CA)19.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)15", "target": "MULTIPLE ALLELES"}, {"weight": 0.9, "description": "These include (CA)15, (CA)17, (CA)18, and (CA)19.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)17", "target": "MULTIPLE ALLELES"}, {"weight": 0.9, "description": "These include (CA)15, (CA)17, (CA)18, and (CA)19.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)18", "target": "MULTIPLE ALLELES"}, {"weight": 0.9, "description": "These include (CA)15, (CA)17, (CA)18, and (CA)19.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)19", "target": "MULTIPLE ALLELES"}, {"weight": 6.0, "description": "Individuals with IFG, IGT, and T2DM exhibit elevated blood glucose levels.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "BLOOD GLUCOSE", "target": "IFG, IGT, T2DM"}, {"weight": 2.0, "description": "The meta-analysis showed a statistically significant inverse association between selenium and colorectal tumor risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SELENIUM", "target": "COLORECTAL CANCER"}, {"weight": 4.0, "description": "Only one SNP in the GPX4 gene (rs8178974) was statistically significantly associated with colorectal cancer risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "GPX4 GENE"}, {"weight": 6.0, "description": "Serum selenium concentration was not associated with the risk of colorectal cancer.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "SERUM SELENIUM CONCENTRATION"}, {"weight": 5.0, "description": "Cases were less educated, had slightly higher BMI, were less physically active...)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "PHYSICAL ACTIVITY"}, {"weight": 6.0, "description": "This study suggests that physical activity may be a factor influencing the relationship between alcohol and cortisol.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "PHYSICAL ACTIVITY", "target": "BLOOD CORTISOL LEVEL"}, {"weight": 6.0, "description": "The CARD9 gene plays a role in shaping both bacterial and fungal composition of the gut microbiota.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9", "target": "GUT MICROBIOTA"}, {"weight": 2.0, "description": "WT mice exhibit better recovery from DSS-induced colitis compared to Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DSS-INDUCED COLITIS", "target": "WT MICE"}, {"weight": 1.0, "description": "Card9\u2212/\u2212 mice show hypersusceptibility to DSS-induced colitis due to impaired IL-22 production and AHR activation.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "DSS-INDUCED COLITIS", "target": "CARD9\u2212/\u2212 MICE"}, {"weight": 9.0, "description": "Card9\u2212/\u2212 mice exhibit decreased expression of Il22, Reg3g, Reg3b, and Il17a.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CARD9\u2212/\u2212 MICE", "target": "REDUCED IL-22 PRODUCTION"}, {"weight": 3.0, "description": "The gut microbiota of Card9\u2212/\u2212 mice exhibits impaired tryptophan metabolism, leading to decreased AHR ligand production.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9\u2212/\u2212 MICE", "target": "TRYPTOPHAN METABOLISM"}, {"weight": 1.0, "description": "Mice with a knockout mutation in the Card9 gene exhibit impaired IL-22 production.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9\u2212/\u2212 MICE", "target": "IL-22 PRODUCTION"}, {"weight": 1.0, "description": "Decreased Ki67 staining indicates reduced epithelial cell proliferation in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "KI67", "target": "EPITHELIAL CELL PROLIFERATION"}, {"weight": 2.0, "description": "Increased cleaved caspase 3 staining indicates increased apoptosis in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CLEAVED CASPASE 3", "target": "APOPTOSIS"}, {"weight": 3.0, "description": "DSS administration induces colitis in mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DSS", "target": "COLITIS INDUCTION"}, {"weight": 12.0, "description": "Administration of exogenous IL-22 normalizes AHR ligand production and colitis susceptibility in Card9\u2212/\u2212 mice.)<SEP>IL-22 is involved in regulating the production of AHR ligands by the gut microbiota.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-22", "target": "AHR LIGAND PRODUCTION"}, {"weight": 4.0, "description": "Two IL-22 polymorphisms were studied in Saudi patients with CRC and compared to the controls.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22", "target": "CRC"}, {"weight": 12.0, "description": "Card9\u2212/\u2212 mice exhibit altered fungal microbiota composition and increased susceptibility to fungal infection.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "FUNGAL MICROBIOTA", "target": "DYSBIOSIS"}, {"weight": 13.0, "description": "Card9\u2212/\u2212 mice show alterations in the composition and stability of their bacterial microbiota.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "BACTERIAL MICROBIOTA", "target": "DYSBIOSIS"}, {"weight": 14.0, "description": "Ascomycota is one of the dominant phyla in the gut fungal microbiota of both WT and Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "ASCOMYCOTA", "target": "DOMINANT FUNGAL PHYLA"}, {"weight": 15.0, "description": "Basidiomycota is one of the dominant phyla in the gut fungal microbiota of both WT and Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "BASIDIOMYCOTA", "target": "DOMINANT FUNGAL PHYLA"}, {"weight": 16.0, "description": "Zygomycota is one of the dominant phyla in the gut fungal microbiota of both WT and Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "ZYGOMYCOTA", "target": "DOMINANT FUNGAL PHYLA"}, {"weight": 1.0, "description": "The Card9\u2212/\u2212 microbiota shows a decrease in Adlercreutzia abundance compared to WT mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "ADLERCREUTZIA"}, {"weight": 3.0, "description": "The Card9\u2212/\u2212 microbiota has a reduced abundance of Lactobacillus reuteri compared to WT mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "LACTOBACILLUS REUTERI"}, {"weight": 5.0, "description": "There is a positive correlation between bacterial and fungal biodiversity in Card9\u2212/\u2212 mice, indicating abnormal interactions within the gut ecosystem.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "BACTERIAL BIODIVERSITY"}, {"weight": 18.0, "description": "Card9\u2212/\u2212 mice exhibit reduced abundance of Adlercreutzia compared to WT mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "ADLERCREUTZIA", "target": "BACTERIAL DIVERSITY"}, {"weight": 10.0, "description": "Mice colonized with Card9\u2212/\u2212 microbiota show impaired recovery from DSS-induced epithelial damage.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212\u2192GF", "target": "IMPAIRED RECOVERY FROM DSS-INDUCED INJURY"}, {"weight": 5.0, "description": "Indole derivatives act as ligands for the aryl hydrocarbon receptor (AHR).)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "INDOLE DERIVATIVES", "target": "AHR ACTIVATION"}, {"weight": 8.0, "description": "IL-22 is a cytokine that promotes tissue repair and immune response against pathogens.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL22", "target": "IMMUNE RESPONSE"}, {"weight": 9.0, "description": "IL-22 has a protective role in colitis.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL22", "target": "PROTECTIVE ROLE"}, {"weight": 13.0, "description": "IL-22 is involved in epithelial cell proliferation and plays a role in intestinal homeostasis.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL22", "target": "EPITHELIAL CELL PROLIFERATION"}, {"weight": 6.0, "description": "Expression of Reg3g is induced by IL-22, contributing to antimicrobial defense.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "REG3G", "target": "ANTIMICROBIAL DEFENSE"}, {"weight": 7.0, "description": "Expression of Reg3b is induced by IL-22, contributing to antimicrobial defense.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "REG3B", "target": "ANTIMICROBIAL DEFENSE"}, {"weight": 2.0, "description": "The gut microbiota modulates IL-22 production by T cells and ILCs in the colon.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "GUT MICROBIOTA", "target": "IL-22 PRODUCTION"}, {"weight": 4.0, "description": "The gut microbiota influences AHR activation through the production of ligands like IAA.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "GUT MICROBIOTA", "target": "AHR ACTIVATION"}, {"weight": 1.0, "description": "The CARD9 gene plays a role in mediating immune responses, particularly against pathogens.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CARD9 GENE", "target": "IMMUNE RESPONSE"}, {"weight": 12.0, "description": "The gut microbiota composition is altered in Card9\u2212/\u2212 mice, suggesting a role for CARD9 in shaping the microbiota.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CARD9 GENE", "target": "MICROBIOTA"}, {"weight": 5.0, "description": "REGIII-\u03b3 is an antimicrobial protein induced by IL-22, playing a role in immune defense.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IMMUNE RESPONSE", "target": "REG3G (ENCODING REGIII-\u0393)"}, {"weight": 6.0, "description": "REGIII-\u03b2 is an antimicrobial protein induced by IL-22, contributing to immune defense.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IMMUNE RESPONSE", "target": "REG3B (ENCODING REGIII-\u0392)"}, {"weight": 10.0, "description": "IL-22+ cells are immune cells that produce IL-22.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IMMUNE RESPONSE", "target": "IL-22+ CELLS"}, {"weight": 11.0, "description": "The CD3\u2212CD4\u2212NKp46\u2212 subset is a type of immune cell that is reduced in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IMMUNE RESPONSE", "target": "CD3\u2212CD4\u2212NKP46\u2212 SUBSET"}, {"weight": 5.0, "description": "NFATC1 plays a central role in inducible gene transcription during immune response.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "IMMUNE RESPONSE", "target": "NFATC1"}, {"weight": 3.0, "description": "Mice lacking IL-22 exhibit alterations in their gut microbiota composition.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "MICROBIOTA", "target": "IL22\u2212/\u2212 MICE"}, {"weight": 4.0, "description": "Comparing transcriptomes between WT and Card9\u2212/\u2212 mice revealed differentially expressed genes.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DIFFERENTIAL GENE EXPRESSION", "target": "TRANSCRIPTOMIC DATA ANALYSIS"}, {"weight": 5.0, "description": "Card9\u2212/\u2212 mice showed a dominance of immune-related pathways, indicating stronger immune activation.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DIFFERENTIAL GENE EXPRESSION", "target": "IMMUNE-RELATED PATHWAYS"}, {"weight": 10.0, "description": "IL-17A plays a protective role in colitis, working in concert with IL-22.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "PROTECTIVE ROLE", "target": "IL17A"}, {"weight": 11.0, "description": "The population of CD3\u2212CD4\u2212NKp46\u2212 cells is reduced in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CD3\u2212CD4\u2212NKP46\u2212 CELLS", "target": "REDUCED POPULATION"}, {"weight": 2.0, "description": "Specific Lactobacillus strains are known to activate AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION", "target": "LACTOBACILLUS STRAINS"}, {"weight": 6.0, "description": "Administration of Ficz, an AHR agonist, reduces colitis severity in Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS SEVERITY", "target": "FICZ"}, {"weight": 7.0, "description": "Supplementation with specific Lactobacillus strains rescues colitis susceptibility in Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS SUSCEPTIBILITY", "target": "LACTOBACILLUS STRAINS"}, {"weight": 2.0, "description": "Elevated \u03b22M concentration is associated with an increased risk of developing hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "HYPERTENSION"}, {"weight": 2.0, "description": "\u03b22 microglobulin associates with HLA-B*15:01 to form a functional MHC class I complex.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "\u03922M", "target": "HLA-B*15:01"}, {"weight": 16.0, "description": "HLA-A*01:01 forms a complex with \u03b22m.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "\u03922M", "target": "HLA-A*01:01"}, {"weight": 4.0, "description": "The rs3184504 polymorphism influences both SH2B3 expression and \u03b22M levels.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "RS3184504", "target": "SH2B3 EXPRESSION"}, {"weight": 7.0, "description": "Diabetes is a risk factor for hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "DIABETES"}, {"weight": 8.0, "description": "Smoking is a risk factor for hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "CIGARETTE SMOKING"}, {"weight": 9.0, "description": "Statins may help lower blood pressure and reduce the risk of hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "STATIN USE"}, {"weight": 11.0, "description": "High LDL-cholesterol levels are a risk factor for hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "LDL-CHOLESTEROL"}, {"weight": 12.0, "description": "Higher HDL-cholesterol levels may be protective against hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "HDL-CHOLESTEROL"}, {"weight": 0.6, "description": "Individuals with hypertension have elevated sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERTENSION", "target": "SUA LEVELS"}, {"weight": 6.0, "description": "Decreased SH2B3 expression is causally linked to higher \u03b22M levels.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "SH2B3 EXPRESSION", "target": "\u03922M LEVELS"}, {"weight": 8.0, "description": "Sh2b3\u2212/\u2212 mice exhibit increased \u03b22M expression in response to angiotensin II, suggesting SH2B3 normally constrains \u03b22M expression.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "SH2B3 DEFICIENCY", "target": "\u03922M EXPRESSION"}, {"weight": 4.0, "description": "PATs from SENP1-aP2KO mice exhibited elevated levels of proinflammatory cytokines before the onset of diabetes, suggesting a link between adipose tissue inflammation and diabetic development.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "DIABETES", "target": "PATS"}, {"weight": 4.0, "description": "The polymorphism rs2236225 is located in the MTHFD1 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "RS2236225"}, {"weight": 11.0, "description": "The MTHFD1 enzyme converts tetrahydrofolate to 5,10-methylenetetrahydrofolate.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)"}, {"weight": 1.0, "description": "The polymorphism rs1979277 is located in the SHMT1 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "RS1979277"}, {"weight": 2.0, "description": "The Leu435Phe amino acid change is caused by the rs1979277 polymorphism in the SHMT1 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "LEU435PHE"}, {"weight": 3.0, "description": "The polymorphism rs638416 is located in the promoter region (5\'-UTR) of the SHMT1 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "RS638416"}, {"weight": 8.0, "description": "The SHMT1 enzyme catalyzes the conversion of serine to glycine.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "SERINE"}, {"weight": 9.0, "description": "The SHMT1 enzyme catalyzes the conversion of serine to glycine.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "GLYCINE"}, {"weight": 10.0, "description": "The SHMT1 enzyme transfers methyl groups to tetrahydrofolate (THF).)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "TETRAHYDROFOLATE (THF)"}, {"weight": 1.6, "description": "There is a small causal effect of folate levels on B12 levels, as observed in the IVW analysis (0.155 SD change in B12 per 1 SD higher folate).)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "FOLATE", "target": "B12"}, {"weight": 1.0, "description": "Infants with CT genotype in MTHFD1 SNPs rs2236224 and rs2236225 had a 1.5-fold increased risk of NTDs when folate intake was low.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW FOLATE INTAKE", "target": "MTHFD1 SNPS RS2236224, RS2236225"}, {"weight": 3.0, "description": "Mothers with heterozygous MTHFR SNPs had a decreased risk of NTD-affected pregnancies compared to those with common homozygous genotypes when folate intake was low.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW FOLATE INTAKE", "target": "MTHFR SNPS RS1476413, RS1801131, AND RS1801133 IN HETEROZYGOUS MOTHERS"}, {"weight": 5.0, "description": "An interaction effect was observed for risk of NTDs in infants with the SHMT1 SNP rs12939757 AG genotype that were in the low folate intake group compared to those with the AA genotype that were in the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW FOLATE INTAKE", "target": "SHMT1 SNP RS12939757 AG GENOTYPE"}, {"weight": 6.0, "description": "The gene-folate interaction was associated with a reduced risk of NTDs for mothers in the low folate intake group with TYMS SNP rs502396 or rs699517 heterozygous genotype compared to the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW FOLATE INTAKE", "target": "TYMS SNPS RS502396 OR RS699517 HETEROZYGOUS GENOTYPE"}, {"weight": 7.0, "description": "The interaction effect in infants was also protective for risk for SNP rs2847153 (OR[int GG vs. AG] = 0.73, 80% CI: 0.37, 1.45 (LRT P = 0.14)).)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW FOLATE INTAKE", "target": "TYMS SNP RS2847153 AG GENOTYPE"}, {"weight": 2.0, "description": "The AG genotype in MTHFD1 SNP rs11627387 was associated with a four-fold increase in NTD risk when maternal folate intake was low.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "LOW MATERNAL FOLATE INTAKE", "target": "MTHFD1 SNP RS11627387 AG GENOTYPE"}, {"weight": 4.0, "description": "A maternal gene-only effect for SHMT1 SNP rs669340 CG genotype appeared to be associated with a reduced risk of NTDs.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "REDUCED RISK OF NTDS", "target": "SHMT1 SNP RS669340 CG GENOTYPE"}, {"weight": 3.0, "description": "Homozygosity for the G allele of rs641153 was associated with increased odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "RS641153 (CFB/C2)", "target": "AMD"}, {"weight": 1.0, "description": "Women with two copies of the Y402H CFH risk allele had 2.4 times greater odds of AMD compared to those with zero copies.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "CFH GENOTYPE (Y402H)"}, {"weight": 2.0, "description": "Women with two copies of the A69S CFH risk allele had 2.2 times greater odds of AMD compared to those with zero copies.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "A69S CFH GENOTYPE"}, {"weight": 4.0, "description": "Women with low HLS scores had higher odds of AMD compared to those with high scores.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "LOW HLS"}, {"weight": 7.0, "description": "Women with at least one ARMS2 risk allele and low HLS had higher odds of AMD compared to those with zero risk alleles and high HLS.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "ARMS2 RISK ALLELES"}, {"weight": 8.0, "description": "Adjusting for omega-3 fatty acids intake did not significantly influence the association between HLS and AMD in women with the high risk CC genotype.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "OMEGA-3 FATTY ACIDS"}, {"weight": 6.0, "description": "Better status for LZ partially explained the association between HLS and AMD in women with the high risk CC genotype.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "LZ", "target": "CFH GENOTYPE (CC)"}, {"weight": 2.0, "description": "The ARMS2 gene has been identified as a risk factor for age-related macular degeneration (AMD).)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "ARMS2 GENE", "target": "AMD RISK"}, {"weight": 2.0, "description": "The study investigated the combined effects of ARMS2 genotype and healthy lifestyle score on AMD risk.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "ARMS2 GENE", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 2.0, "description": "Variants in the complement pathway genes CFB and C2 have been associated with AMD risk, although the main effects were not significant in this study.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AMD RISK", "target": "CFB/C2"}, {"weight": 2.0, "description": "The study investigated the potential role of C3 rs2230199 in AMD risk, but no main effects were observed.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AMD RISK", "target": "C3 RS2230199"}, {"weight": 2.0, "description": "The study investigated the potential role of CFI rs10033900 in AMD risk, but no main effects were observed.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AMD RISK", "target": "CFI RS10033900"}, {"weight": 5.0, "description": "The joint effect of both a high-risk CFH genotype and low HLS was more than additive, increasing the odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "LOW HLS", "target": "HIGH-RISK CFH GENOTYPE (CC)"}, {"weight": 1.0, "description": "CFB and C2 are genes involved in the complement pathway.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "CFB/C2", "target": "COMPLEMENT PATHWAY GENES"}, {"weight": 2.0, "description": "rs11066015 is a SNP located in the ACAD10 gene.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "ACAD10", "target": "RS11066015"}, {"weight": 4.0, "description": "rs11065828 is an imputed SNP associated with coffee consumption.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "RS11065828", "target": "COFFEE CONSUMPTION"}, {"weight": 5.0, "description": "rs79105258 is an imputed SNP associated with coffee consumption.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "RS79105258", "target": "COFFEE CONSUMPTION"}, {"weight": 6.0, "description": "Higher black coffee consumption was associated with a lower risk of prediabetes.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE", "target": "PREDIABETES"}, {"weight": 8.0, "description": "Higher sugared coffee consumption was associated with a lower risk of prediabetes.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "SUGARED COFFEE", "target": "PREDIABETES"}, {"weight": 10.0, "description": "The association between TLR7 polymorphisms and alcohol consumption in HIV-infected individuals has been studied.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "ALCOHOL", "target": "TLR7 POLYMORPHISMS"}, {"weight": 1.0, "description": "SENP1 deficient mice develop type-1-like diabetic phenotypes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SENP1", "target": "TYPE-1-LIKE DIABETIC PHENOTYPES"}, {"weight": 1.0, "description": "The deletion of the SENP1 gene in mice leads to an increased susceptibility to type 1 diabetes.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "T1DM"}, {"weight": 3.0, "description": "SENP1 deletion in mice leads to increased levels of proinflammatory cytokines, contributing to T1DM development.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "PROINFLAMMATORY CYTOKINES"}, {"weight": 6.0, "description": "Treatment with JSH-23, an NF-\u03baB inhibitor, ameliorates diabetes phenotypes in SENP1-deficient mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "JSH-23"}, {"weight": 7.0, "description": "High-fat diet (HFD) further augments diabetic phenotypes in SENP1-deficient mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "HFD"}, {"weight": 1.0, "description": "SENP1-AdipoqKO mice develop a type-1-like diabetic phenotype.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1-ADIPOQKO", "target": "T1DM"}, {"weight": 2.0, "description": "SENP1-PdgfRKO mice develop a type-1-like diabetic phenotype.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1-PDGFRKO", "target": "T1DM"}, {"weight": 5.0, "description": "SENP1-aP2KO mice develop a type-1-like diabetic phenotype.)<SEP>SENP1-deficient mice develop T1DM at an earlier age and with greater severity compared to wild-type controls.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1-AP2KO", "target": "T1DM"}, {"weight": 1.0, "description": "High Fat Diet (HFD) was administered to SENP1-aP2KO mice to induce metabolic changes and disease phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "HFD"}, {"weight": 2.0, "description": "Perigonadal Adipose Tissue (PATs) is a tissue of interest in SENP1-aP2KO mice due to its altered characteristics compared to Ctrl mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "PATS"}, {"weight": 7.0, "description": "SENP1-aP2KO mice exhibited significantly reduced basal and glucose-stimulated insulin levels compared to Ctrl mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "INSULIN LEVELS"}, {"weight": 9.0, "description": "SENP1-aP2KO mice are genetically modified compared to Ctrl mice, lacking expression of SENP1 in adipocytes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "CTRL"}, {"weight": 2.0, "description": "NOD mice are a widely used model for studying type 1 diabetes.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "T1DM", "target": "NOD MOUSE"}, {"weight": 2.0, "description": "SENP1 deficient mice show autoimmune mediated damages and develop insulin-dependent diabetes mellitus.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "INSULIN-DEPENDENT DIABETES MELLITUS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 3.0, "description": "Immune cell invasion, indicative of insulitis, damages pancreatic islet \u03b2 cells.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "PANCREATIC ISLET \u0392 CELLS", "target": "IMMUNE CELL INVASION"}, {"weight": 5.0, "description": "In SENP1-aP2KO mice, CD8+ T cell infiltration into the islets occurs by 12 weeks of age.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CD8+ T CELLS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 24.0, "description": "CD8+ T cells recognize neoepitopes presented by HLA molecules.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "NEOEPITOPE"}, {"weight": 26.0, "description": "CD8+ T cells recognize the HLA-B*15:01/SARS tetramer.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "HLA-B*15:01/SARS TETRAMER"}, {"weight": 15.0, "description": "CD8+ T cells were stained with HLA-B*15:01 tetramers to identify those recognizing specific neoepitopes.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "HLA-B*15:01 TETRAMER"}, {"weight": 6.0, "description": "In SENP1-aP2KO mice, there is infiltration of CD4+ T cells into the islets.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CD4+ T CELLS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 3.0, "description": "Higher expression levels of IL27RA and IL6ST genes are observed in CD4+ T cells compared to CD8+ T cells, suggesting specific receptor expression for IL-27.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "CD4+ T CELLS", "target": "IL27RA & IL6ST"}, {"weight": 9.0, "description": "SENP1-aP2KO mice had elevated levels of \u03b2-hydroxybutyrate.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "\u0392-HYDROXYBUTYRATE", "target": "SENP1-DEFICIENT MICE"}, {"weight": 10.0, "description": "In SENP1-aP2KO mice, Th1 cell populations expanded in the pancreatic lymph nodes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "TH1 CELLS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 13.0, "description": "In SENP1-aP2KO mice, activated dendritic cells were increased in the lymph nodes of pancreases.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "DENDRITIC CELLS", "target": "SENP1-DEFICIENT MICE"}, {"weight": 15.0, "description": "Both Ctrl and SENP1-aP2KO mice exhibited similar skin rejection responses, indicating SENP1-aP2KO mice are not immunodeficient.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CTRL MICE", "target": "SKIN TRANSPLANTATION"}, {"weight": 16.0, "description": "Skin was transplanted from BALB/C mice to both Ctrl and SENP1-aP2KO mice.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "BALB/C MICE", "target": "SKIN TRANSPLANTATION"}, {"weight": 17.0, "description": "Analysis of immune cell populations in pancreatic lymph nodes revealed changes associated with autoimmune responses in SENP1-deficient mice.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "PANCREATIC LYMPH NODES", "target": "IMMUNE CELL ANALYSIS"}, {"weight": 18.0, "description": "Analysis of immune cell populations in the spleen revealed changes associated with autoimmune responses in SENP1-deficient mice.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SPLEEN", "target": "IMMUNE CELL ANALYSIS"}, {"weight": 19.0, "description": "Increased numbers of these macrophages were found in the pancreases of SENP1-aP2KO mice.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "MHCII+CD11B+CD11C\u2212 MACROPHAGES", "target": "SENP1-DEFICIENT MICE"}, {"weight": 1.0, "description": "SENP1 deletion in adipocytes increases the secretion of TNF, contributing to inflammation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "TNF", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 2.0, "description": "CCL5 expression induced by SENP1-aP2KO adipocytes attracts immune cells to the pancreas.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "CCL5", "target": "IMMUNE CELL RECRUITMENT"}, {"weight": 3.0, "description": "Cytokines from SENP1-aP2KO adipocytes directly induce \u03b2 cell death and pancreatic disruption.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "\u0392 CELL", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 2.0, "description": "SENP1-aP2KO adipocytes express reduced differentiation markers, including fatty acid synthase.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "FATTY ACID SYNTHASE", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 2.0, "description": "SENP1-aP2KO adipocytes express reduced differentiation markers, including adipose triglyceride lipase.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "ADIPOSE TRIGLYCERIDE LIPASE", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 2.0, "description": "SENP1-aP2KO adipocytes express reduced differentiation markers, including lipoprotein lipase.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 3.0, "description": "SENP1 deletion in adipocytes increases the phosphorylation of IKK, leading to increased NF-\u03baB activation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "IKK", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 3.0, "description": "SENP1 deletion in adipocytes reduces total I\u03baB\u03b1 levels and increases its phosphorylation, contributing to NF-\u03baB activation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "I\u039aB\u0391", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 4.0, "description": "SENP1 deletion does not affect the phosphorylation and total levels of ERK1/2 in adipose tissues.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "ERK1/2", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 3.0, "description": "SENP1 deletion increases NF-\u03baB activation as evidenced by increased phosphorylation of IKK, I\u03baB\u03b1, and p65/RelA subunit.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB", "target": "SENP1-AP2KO ADIPOCYTES"}, {"weight": 3.0, "description": "High Fat Diet (HFD) significantly increased cytokine production, particularly IL-6, TNF-\u03b1 and IL-1\u03b2 in PATs of SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "CYTOKINE PRODUCTION"}, {"weight": 10.0, "description": "High Fat Diet (HFD) increased body weight in SENP1-aP2KO mice compared to their counterparts on a standard chow diet.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "BODY WEIGHT"}, {"weight": 7.0, "description": "SENP1-aP2KO mice exhibited elevated levels of IAA.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SENP1-DEFICIENT MICE", "target": "IAA"}, {"weight": 12.0, "description": "In SENP1-aP2KO mice, Tregs populations decreased in the pancreatic lymph nodes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SENP1-DEFICIENT MICE", "target": "TREGS"}, {"weight": 14.0, "description": "In SENP1-aP2KO mice, NRP-V7-positive CD8+ T cells were detected targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SENP1-DEFICIENT MICE", "target": "NRP-V7-POSITIVE CD8+ T CELLS"}, {"weight": 2.0, "description": "SENP1 knockdown in adipocytes led to significantly higher expression of proinflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "PROINFLAMMATORY CYTOKINE EXPRESSION", "target": "SENP1 KNOCKDOWN"}, {"weight": 9.0, "description": "NEMO SUMOylation mutants affected the protein expression of proinflammatory cytokines in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "PROINFLAMMATORY CYTOKINE EXPRESSION", "target": "NEMO MUTATIONS"}, {"weight": 2.0, "description": "Knockdown of SENP1 increased the phosphorylation of I\u03baB\u03b1.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1 KNOCKDOWN", "target": "I\u039aB\u0391 PHOSPHORYLATION"}, {"weight": 3.0, "description": "Overexpression of SENP1 decreased phospho-p65/RelA and cytokine production in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "PHOSPHO-P65/RELA AND CYTOKINE PRODUCTIONS", "target": "SENP1 OVEREXPRESSION"}, {"weight": 4.0, "description": "Deletion of SENP1 resulted in increased NEMO SUMOylation in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO SUMOYLATION", "target": "SENP1 DELETION"}, {"weight": 6.0, "description": "Deletion of SENP1 enhanced both basal and stress-induced IKK and p65/RelA activation in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1 DELETION", "target": "STRESS-INDUCED IKK AND P65/RELA ACTIVATION"}, {"weight": 7.0, "description": "Deletion of SENP1 also enhanced both basal and stress-induced NEMO SUMOylation in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1 DELETION", "target": "STRESS-INDUCED NEMO SUMOYLATION"}, {"weight": 4.0, "description": "Deletion of SENP1 enhances both basal and stress-induced IKK and p65/RelA activation in adipocytes, suggesting a role in inflammatory responses.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1 DELETION", "target": "INFLAMMATORY STIMULI"}, {"weight": 5.0, "description": "Etoposide VP16 induced phosphorylation of IKK and p65/RelA in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "DNA DAMAGE AGENT ETOPOSIDE VP16", "target": "IKK AND P65/RELA ACTIVATION"}, {"weight": 8.0, "description": "SUMO-deficient NEMO mutants (K277R, K309R, and DM) decreased NF-\u03baB p65/RelA phosphorylation.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO K309R OR NEMO DM MUTANTS", "target": "NF-\u039aB P65/RELA PHOSPHORYLATION"}, {"weight": 3.0, "description": "Expression of WT NEMO slightly increased NF-\u03baB p65/RelA phosphorylation.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NF-\u039aB P65/RELA PHOSPHORYLATION", "target": "NEMO-WT"}, {"weight": 5.0, "description": "The rs2296241 SNP had an OR for recurrent adenoma with villous histology of 1.98 for individuals with the GG genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "GG", "target": "RS2296241"}, {"weight": 1.0, "description": "rs731236 and rs1544410 show high linkage disequilibrium (r2 value\u2009=\u20090.93) in the study population.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS731236", "target": "RS1544410"}, {"weight": 1.0, "description": "rs731236 and rs7975232 show high linkage disequilibrium in the study population.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS731236", "target": "RS7975232"}, {"weight": 3.0, "description": "rs731236 is a specific SNP within the VDR gene.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "RS731236", "target": "VDR TAQI"}, {"weight": 2.0, "description": "The allele frequency of rs2228570 differed significantly between seronegative and seropositive individuals, suggesting a possible protective effect against infection.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "INFECTION BY T. CRUZI"}, {"weight": 3.0, "description": "The frequency of the rs2228570*A allele was reduced in asymptomatic patients compared to CCC patients, suggesting a putative protective role against CCC development.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "CCC"}, {"weight": 6.0, "description": "The TT genotype of IL-1A -889C>T was 1.37 more frequent in HNP patients than controls.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "HERNIATED NUCLEUS PULPOSUS (HNP)"}, {"weight": 8.0, "description": "CT genotype and T allele of TNF-A 238G>A were both 1.6 times more frequent in healthy controls than in HNP cases.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "HERNIATED NUCLEUS PULPOSUS (HNP)"}, {"weight": 2.0, "description": "rs361525 is a specific SNP within the TNF-A gene.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "RS361525"}, {"weight": 10.0, "description": "No difference in the distribution of alleles or genotypes between HNP and controls was observed in VDR TaqI.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR TAQI", "target": "HERNIATED NUCLEUS PULPOSUS (HNP)"}, {"weight": 1.0, "description": "The T allele was present at a lower frequency in CRC patients compared to controls, though this difference was not statistically significant.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "T ALLELE", "target": "CRC"}, {"weight": 6.0, "description": "The IVW analysis assessed the causal effect of maternal B12 levels on offspring birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "IVW ANALYSIS", "target": "MATERNAL B12 LEVELS"}, {"weight": 7.0, "description": "The IVW analysis assessed the causal effect of fetal B12 levels on their own birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "IVW ANALYSIS", "target": "FETAL B12 LEVELS"}, {"weight": 8.0, "description": "The IVW analysis assessed the causal effect of maternal folate levels on offspring birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "IVW ANALYSIS", "target": "MATERNAL FOLATE LEVELS"}, {"weight": 9.0, "description": "The IVW analysis assessed the causal effect of fetal folate levels on their own birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "IVW ANALYSIS", "target": "FETAL FOLATE LEVELS"}, {"weight": 1.0, "description": "Maternal B12 levels were not causally associated with offspring birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "B12 LEVELS (MATERNAL)"}, {"weight": 2.0, "description": "Maternal folate levels had a positive causal effect on offspring birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "FOLATE LEVELS (MATERNAL)"}, {"weight": 3.0, "description": "Fetal folate levels had a negative causal effect on their own birthweight, although smaller than the maternal folate effect.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "FOLATE LEVELS (FETAL)"}, {"weight": 0.2, "description": "There is no evidence of a causal effect of maternal folate levels on gestational duration.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "GESTATIONAL DURATION", "target": "MATERNAL FOLATE"}, {"weight": 0.2, "description": "There is no evidence of a causal effect of fetal B12 levels on gestational duration.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "GESTATIONAL DURATION", "target": "FETAL B12"}, {"weight": 0.2, "description": "There is no evidence of a causal effect of fetal folate levels on gestational duration.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "GESTATIONAL DURATION", "target": "FETAL FOLATE"}, {"weight": 4.0, "description": "The identified SNPs explained a proportion of variance in serum B12 concentrations.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "VARIANTS (SNPS)", "target": "B12 LEVELS"}, {"weight": 5.0, "description": "The identified SNPs explained a portion of the variation in serum folate concentration.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "VARIANTS (SNPS)", "target": "FOLATE LEVELS"}, {"weight": 0.6, "description": "There is no evidence of a causal effect of maternal folate levels on offspring birthweight.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "MATERNAL FOLATE", "target": "OFFSPRING BIRTHWEIGHT"}, {"weight": 0.6, "description": "There is no evidence of a causal effect of maternal B12 levels on offspring birthweight.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "OFFSPRING BIRTHWEIGHT", "target": "MATERNAL B12"}, {"weight": 8.0, "description": "25 out of 129 LV patients tested positive for the homozygous TT genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR C677T", "target": "HOMOZYGOUS CARRIER"}, {"weight": 1.0, "description": "MTHFR C677T is found in LV patients at varying carrier rates across different populations.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "MTHFR C677T", "target": "LV PATIENT"}, {"weight": 2.0, "description": "MTHFR A1298C was assessed in two studies and one case report concerning LV patients.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR A1298C", "target": "LV PATIENTS"}, {"weight": 9.0, "description": "29 out of 82 LV patients tested positive for the AC genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR A1298C", "target": "HETEROZYGOUS CARRIER"}, {"weight": 10.0, "description": "7 out of 82 LV patients tested positive for the CC genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR A1298C", "target": "HOMOZYGOUS CARRIER"}, {"weight": 2.0, "description": "MTHFR A1298C is found in LV patients at varying carrier rates across different populations.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "MTHFR A1298C", "target": "LV PATIENT"}, {"weight": 3.0, "description": "PAI\u20101 \u2010675 4G/5G was assessed in three studies and two case reports in a total of 95 LV patients.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 \u2010675 4G/5G", "target": "LV PATIENTS"}, {"weight": 11.0, "description": "53 out of 95 LV patients tested positive for the heterozygous 4G/5G genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 \u2010675 4G/5G", "target": "HETEROZYGOUS CARRIER"}, {"weight": 12.0, "description": "28 out of 95 LV patients tested positive for the homozygous 4G/4G genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 \u2010675 4G/5G", "target": "HOMOZYGOUS CARRIER"}, {"weight": 2.0, "description": "PAI\u20101 \u2010675 4G/5G is found in LV patients at varying carrier rates across different populations.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PAI\u20101 \u2010675 4G/5G", "target": "LV PATIENT"}, {"weight": 4.0, "description": "PAI\u20101 A844G was assessed in two articles, including one study and one case report, reporting a total of 18 LV patients.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 A844G", "target": "LV PATIENTS"}, {"weight": 13.0, "description": "9 out of 18 LV patients tested positive for the AG genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 A844G", "target": "HETEROZYGOUS CARRIER"}, {"weight": 14.0, "description": "1 out of 18 LV patients tested positive for the GG genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 A844G", "target": "HOMOZYGOUS CARRIER"}, {"weight": 5.0, "description": "Prothrombin G20210A was evaluated in 85 LV patients from 15 studies or case reports.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PROTHROMBIN G20210A", "target": "LV PATIENTS"}, {"weight": 15.0, "description": "9 out of 85 LV patients tested positive for the GA genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PROTHROMBIN G20210A", "target": "HETEROZYGOUS CARRIER"}, {"weight": 2.0, "description": "Prothrombin G20210A is found in LV patients at varying carrier rates across different populations.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PROTHROMBIN G20210A", "target": "LV PATIENT"}, {"weight": 6.0, "description": "Factor V G1691A was assessed in 135 LV patients from 23 articles.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FACTOR V G1691A", "target": "LV PATIENTS"}, {"weight": 16.0, "description": "19 out of 135 LV patients tested positive for the GA genotype.)", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FACTOR V G1691A", "target": "HETEROZYGOUS CARRIER"}, {"weight": 2.0, "description": "Factor V G1691A is found in LV patients at varying carrier rates across different populations.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "FACTOR V G1691A", "target": "LV PATIENT"}, {"weight": 0.9, "description": "Homozygosity for the PEMT M175V minor V allele was positively associated with male infertility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "PEMT M175V", "target": "MALE INFERTILITY"}, {"weight": 0.8, "description": "Heterozygous subjects carrying the TCblR rs173665 variant had a lower risk of male infertility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "TCBLR RS173665", "target": "MALE INFERTILITY"}, {"weight": 0.1, "description": "This variant was not associated with male infertility in this study population.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "MTHFR 677C>T", "target": "MALE INFERTILITY"}, {"weight": 0.9, "description": "Infertile men exhibit significantly lower semen quality compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILE MEN", "target": "POORER SEMEN QUALITY"}, {"weight": 0.8, "description": "Infertile subjects had a lower mean semen concentration compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SEMEN CONCENTRATION", "target": "INFERTILE SUBJECTS"}, {"weight": 0.7, "description": "Infertile subjects had a lower sperm number compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SPERM NUMBER", "target": "INFERTILE SUBJECTS"}, {"weight": 0.6, "description": "Infertile subjects had a lower percentage of total progressive sperm compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "TOTAL PROGRESSIVE SPERM", "target": "INFERTILE SUBJECTS"}, {"weight": 0.5, "description": "Infertile subjects had a lower percentage of normal sperm morphology compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "NORMAL SPERM MORPHOLOGY", "target": "INFERTILE SUBJECTS"}, {"weight": 0.4, "description": "Infertile subjects had a higher percentage of non-motile sperm compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "NON-MOTILE SPERM", "target": "INFERTILE SUBJECTS"}, {"weight": 0.3, "description": "Infertile subjects had a higher mean semen volume compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SEMEN VOLUME", "target": "INFERTILE SUBJECTS"}, {"weight": 0.2, "description": "Infertile subjects exhibited more incidences of DNA fragmentation compared to fertile controls.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "DNA FRAGMENTATION", "target": "INFERTILE SUBJECTS"}, {"weight": 5.0, "description": "The GSTM1-null polymorphism is a deletion of the GSTM1 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "GSTM1", "target": "GSTM1-NULL"}, {"weight": 6.0, "description": "The polymorphism rs1801394 is located in the MTRR gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTRR", "target": "RS1801394"}, {"weight": 12.0, "description": "The MTRR enzyme regenerates Methionine Synthase (MTR).)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTRR", "target": "METHIONINE SYNTHASE (MTR)"}, {"weight": 7.0, "description": "The DRD4-48bptr polymorphism is located in the DRD4 gene.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "DRD4", "target": "DRD4-48BPTR"}, {"weight": 1.0, "description": "The CDC MBA and CDC HPLC-MS/MS are two methods used to measure serum folate.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "CDC MBA", "target": "CDC HPLC-MS/MS"}, {"weight": 2.0, "description": "A Pearson correlation was calculated between the CDC MBA and CDC HPLC-MS/MS results for 23 serum samples.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "PEARSON CORRELATION", "target": "SERUM SAMPLES"}, {"weight": 3.0, "description": "Different laboratories showed varying levels of imprecision when measuring serum folate.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "IMPRECISION", "target": "LABORATORIES"}, {"weight": 4.0, "description": "Laboratories used spectrophotometry to assign values to their folate calibrators by creating calibration curves.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "CALIBRATION CURVE", "target": "SPECTROPHOTOMETRY"}, {"weight": 2.0, "description": "Laboratories measured the difference between their S-FOL results and the CDC MBA target value.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "S-FOL", "target": "CDC MBA TARGET VALUE"}, {"weight": 4.0, "description": "Laboratories measured the difference between their WB-FOL results and the CDC MBA target value.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "WB-FOL", "target": "CDC MBA TARGET VALUE"}, {"weight": 4.0, "description": "Group 1 laboratories use CDC reagents for folate analysis.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "GROUP 1 LABORATORIES", "target": "CDC REAGENTS"}, {"weight": 5.0, "description": "Group 2 laboratories use a folic acid calibrator for folate analysis.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "GROUP 2 LABORATORIES", "target": "FOLIC ACID CALIBRATOR"}, {"weight": 6.0, "description": "Laboratories used either CDC or IH reagents for folate analysis.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC REAGENTS", "target": "IH REAGENTS"}, {"weight": 1.0, "description": "The use of IH reagents (IH-CAL) compared to CDC reagents (CDC-CAL) resulted in significant differences in serum and whole-blood folate measurements.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "CDC-CAL", "target": "IH-CAL"}, {"weight": 2.0, "description": "Comparison of laboratories using IH reagents (IH-MO) versus those using CDC reagents (CDC-MO) revealed varying effects on serum and whole-blood folate.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "CDC-MO", "target": "IH-MO"}, {"weight": 2.0, "description": "The rs1695 polymorphism is associated with an increased risk of breast cancer (OR=3.1532).)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "RS1695", "target": "BREAST CANCER"}, {"weight": 0.0, "description": "The rs1138272 polymorphism is not associated with an increased risk of breast cancer.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "RS1138272", "target": "BREAST CANCER"}, {"weight": 2.0, "description": "The Ile105Val SNP affects the function of the GSTP1 protein.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL", "target": "GSTP1"}, {"weight": 4.0, "description": "All SNPs obeyed the Hardy-Weinberg Equilibrium (p>0.05) except for the TGF-\u00df1 (rs1800469 C/T) SNP.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "GENOTYPING"}, {"weight": 20.0, "description": "Variants in the GSTP1 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "GSTP1", "target": "USE OF COLONY-STIMULATING FACTORS (CSFS)"}, {"weight": 2.0, "description": "p.R778L is a pathogenic variant in the WD gene.)", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.R778L", "target": "WD"}, {"weight": 1.0, "description": "The most prevalent pathogenic variant p.R778L was found to associate with Haplogroup A.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP A"}, {"weight": 1.0, "description": "The pathogenic variant p.R778L was found more frequently on WD chromosomes compared to control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "WD CHROMOSOMES"}, {"weight": 4.0, "description": "p.P992L is a pathogenic variant in the WD gene.)<SEP>p.P9992L is a pathogenic variant in the WD gene.)", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "WD"}, {"weight": 2.0, "description": "The pathogenic variant p.P992L was more frequently associated with Haplogroup E.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E"}, {"weight": 2.0, "description": "The pathogenic variant p.P992L was also found more commonly on WD chromosomes than control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "WD CHROMOSOMES"}, {"weight": 6.0, "description": "p.T935M is a pathogenic variant in the WD gene.)", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "WD"}, {"weight": 3.0, "description": "The pathogenic variant p.T935M presented a uniform state, characterized by the presence of only Haplogroup J.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J"}, {"weight": 3.0, "description": "All identified cases of p.T935M were found on WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "WD CHROMOSOMES"}, {"weight": 4.0, "description": "Variant A1 is the most common haplotype within Haplogroup A.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP A", "target": "HAPLOTYPE VARIANT A1"}, {"weight": 2.0, "description": "These CYP2C9 variants affect warfarin metabolism.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9*2, *3, *5, *8, AND *11", "target": "WARFARIN"}, {"weight": 4.0, "description": "Warfarin is often prescribed to prevent or treat DVT/PE.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "WARFARIN", "target": "DVT/PE"}, {"weight": 5.0, "description": "The results suggest a relationship between SNPs in CYP24A1 and odds for both any adenoma recurrence and advanced adenoma recurrence.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP24A1", "target": "ADENOMA RECURRENCE"}, {"weight": 1.0, "description": "The c.428_430delAAG variant is a mutation in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "C.428_430DELAAG"}, {"weight": 2.0, "description": "The c.1186C\u2009>\u2009T variant is a mutation in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "C.1186C\u2009>\u2009T"}, {"weight": 1.0, "description": "The rs927650 SNP had a mean 25(OH)D concentration of 26.9 \u00b1 8.5 ng/ml in individuals with the CC genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS927650", "target": "CC"}, {"weight": 3.0, "description": "The rs927650 SNP had a mean 25(OH)D concentration of 29.1 \u00b1 11.3 ng/ml in individuals with the TT genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS927650", "target": "TT"}, {"weight": 2.0, "description": "Individuals with the minor allele (A) of rs35051736 in CYP24A1 were absent among those with advanced adenomas.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS35051736", "target": "ADVANCED ADENOMA RECURRENCE"}, {"weight": 4.0, "description": "The rs2296241 SNP had an OR for recurrent adenoma with villous histology of 1.19 for individuals with the AG genotype.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS2296241", "target": "AG"}, {"weight": 4.0, "description": "There was a statistically significant interaction between the rs2762939 SNP in CYP24A1 and 1,25(OH)2D concentrations regarding adenoma recurrence.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS2762939", "target": "1,25(OH)2D"}, {"weight": 8.0, "description": "HRMA is performed on DNA samples to analyze their genetic variations.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "HRMA", "target": "DNA"}, {"weight": 1.0, "description": "The P1001L mutation in the ATP7A gene causes Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "P1001L", "target": "MENKES DISEASE"}, {"weight": 2.0, "description": "The ATP7A gene product is required for the function of dopamine-b-hydroxylase, a copper-dependent enzyme.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "ATP7A", "target": "DOPAMINE-B-HYDROXYLASE"}, {"weight": 3.0, "description": "Elevated cerebrospinal fluid copper levels are characteristic of Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MENKES DISEASE", "target": "CEREBROSPINAL FLUID COPPER"}, {"weight": 5.0, "description": "Caco-2 cells grown in Se depleted medium are more sensitive to tert-butylhydroperoxide.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "CACO-2 CELLS", "target": "SE DEPLETED MEDIUM"}, {"weight": 2.0, "description": "Deiodinase (ID1) may influence the production of selenoproteins like GPx and TR1.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "ID1", "target": "SELENOPROTEINS"}, {"weight": 1.0, "description": "The ID1 gene encodes for the deiodinase enzyme, responsible for converting thyroid hormones.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "ID1", "target": "DEIODINASE ACTIVITY"}, {"weight": 1.0, "description": "The IDI transcript variants are linked to the GPX4 3\u2032UTR for expression.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T", "target": "GPX4 3\u2032UTR"}, {"weight": 3.0, "description": "Both IDI-T and IDI-C are variants of the ID1 gene, differing in their 3\u2032UTR sequence.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T", "target": "IDI-C"}, {"weight": 3.0, "description": "GPx4 plays a crucial role in protecting cells from oxidative damage.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "GPX4", "target": "ANTIOXIDANT DEFENSE"}, {"weight": 1.0, "description": "The expression level of GPx4 was greater in IDI-C cells when sufficient Se was present.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX4", "target": "IDI-C CELLS"}, {"weight": 4.0, "description": "tert-butylhydroperoxide induces oxidative stress in cells.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "TERT-BUTYLHYDROPEROXIDE", "target": "OXIDATIVE STRESS"}, {"weight": 5.0, "description": "When grown in Se-depleted medium, IDI-C cells exhibited greater oxidative stress than IDI-T cells after tert-butylhydroperoxide challenge.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "OXIDATIVE STRESS", "target": "IDI-C AND IDI-T CELLS"}, {"weight": 2.0, "description": "A high GSH level indicates a lower oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "GSH"}, {"weight": 3.0, "description": "A high GSSG level indicates higher oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "GSSG"}, {"weight": 2.0, "description": "Methylation patterns of CpGs can be associated with oxidative stress markers.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "CPG"}, {"weight": 7.0, "description": "IDI-C and IDI-T clones expressing similar IDI transgene levels showed significant differences in GPx activity, with higher activity observed in the IDI-C clones.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX ACTIVITY", "target": "IDI-C AND IDI-T CLONES"}, {"weight": 6.0, "description": "IDI-C cells exhibit greater increases in reactive oxygen species (ROS) compared to IDI-T cells.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-C CELLS", "target": "INCREASED ROS"}, {"weight": 7.0, "description": "IDI-C cells display significantly lower glutathione peroxidase (GPx) activity compared to IDI-T cells.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-C CELLS", "target": "LOWER GPX ACTIVITY"}, {"weight": 3.0, "description": "Selenoprotein H mRNA levels were significantly lower in IDI-C cells compared to IDI-T cells, regardless of selenium supply.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C CELLS", "target": "SELENOPROTEIN H MRNA"}, {"weight": 1.0, "description": "IDI-C cells express the IDI gene.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C CELLS", "target": "IDI GENE"}, {"weight": 2.0, "description": "IDI-T cells do not express the IDI gene.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-T CELLS", "target": "IDI GENE"}, {"weight": 9.0, "description": "Selenoprotein levels are influenced by selenium (Se) availability.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "SELENOPROTEINS", "target": "SE STATUS"}, {"weight": 8.0, "description": "In Se-supplemented conditions, IDI-C cells show a higher content of GPx4 protein compared to IDI-T cells.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "INCREASED GPX4 PROTEIN", "target": "SE SUPPLEMENTED MEDIUM"}, {"weight": 2.0, "description": "Different 3\u2032UTR variants of ID1 may compete for selenium incorporation machinery.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T/C VARIANTS", "target": "SE INCORPORATION"}, {"weight": 4.0, "description": "Selenium deficiency leads to decreased activity of selenoproteins like GPx.)", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "REDUCED GPX ACTIVITY", "target": "SE DEPLETION"}, {"weight": 2.0, "description": "Real-time PCR showed similar levels of TR1, GPx1, and GPx4 mRNA in both IDI-T and IDI-C cells grown in either Se-depleted or supplemented medium.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-T AND IDI-C CELLS", "target": "TR1, GPX1, AND GPX4 MRNAS"}, {"weight": 4.0, "description": "In Se-depleted medium, IDI-C cells showed less viability than IDI-T cells. As Se concentration increased, IDI-C cells demonstrated greater viability compared to IDI-T cells.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "CELL VIABILITY", "target": "SE CONTENT"}, {"weight": 6.0, "description": "IDI-C clones showed a greater increase in ROS levels compared to IDI-T clones after tert-butylhydroperoxide exposure.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C CLONES", "target": "ROS LEVELS"}, {"weight": 3.0, "description": "The level of IDI transcript varied between different IDI-C and IDI-T clones.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C AND IDI-T CLONES", "target": "IDI TRANSCRIPT"}, {"weight": 4.0, "description": "GAPDH is used as a reference for normalizing mRNA expression levels.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GAPDH", "target": "HOUSEKEEPING GENE"}, {"weight": 1.0, "description": "The text focuses on analyzing mutations within the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "MUTATION ANALYSIS"}, {"weight": 2.0, "description": "The study identified 12 missense mutations in the CHAT gene across multiple families.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "MISSENSE MUTATION"}, {"weight": 3.0, "description": "Patient 10 carried a nonsense mutation on one of her CHAT alleles.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "NONSENSE MUTATION"}, {"weight": 4.0, "description": "This mutation was observed in three patients.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "P.VAL136MET", "target": "PATIENT"}, {"weight": 5.0, "description": "This mutation was observed in five patients, with one being homozygous for the variant.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "P.ALA557THR", "target": "PATIENT"}, {"weight": 6.0, "description": "The CHAT gene encodes for the ChAT protein.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT PROTEIN", "target": "CHAT GENE"}, {"weight": 5.0, "description": "The CHAT protein structure is conserved between humans and Drosophila.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT PROTEIN", "target": "DROSOPHILA CONSERVATION"}, {"weight": 6.0, "description": "The CHAT protein structure is conserved between humans and C. elegans.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT PROTEIN", "target": "C. ELEGANS CONSERVATION"}, {"weight": 7.0, "description": "The spinal cord ChAT transcript produces a 70 kDa and a 74 kDa ChAT protein.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT PROTEIN", "target": "SPINAL CORD CHAT TRANSCRIPT"}, {"weight": 7.0, "description": "Mutant and wild-type CHAT cDNAs were engineered into Bosc 23 cells to analyze protein expression.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "BOSC 23 CELLS", "target": "CHAT PROTEIN EXPRESSION"}, {"weight": 8.0, "description": "Wild-type and mutant ChAT cDNAs were transformed into E. coli to purify the enzymes for kinetic analysis.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "E. COLI", "target": "CHAT PROTEIN PURIFICATION"}, {"weight": 1.0, "description": "This amino acid residue is conserved across various species and mutated in some patients.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "MET202", "target": "MUTATION"}, {"weight": 2.0, "description": "This amino acid residue is conserved across various species and mutated in some patients.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "TRP421", "target": "MUTATION"}, {"weight": 3.0, "description": "This amino acid residue is conserved across various species and mutated in some patients.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "THR553", "target": "MUTATION"}, {"weight": 4.0, "description": "This amino acid residue is conserved across various species and mutated in some patients.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "ALA557", "target": "MUTATION"}, {"weight": 8.0, "description": "Immunoblotting was used to analyze the expression levels of wild-type and mutant ChAT proteins.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "IMMUNOBLOT", "target": "CHAT PROTEIN EXPRESSION"}, {"weight": 9.0, "description": "E. coli expressing ChAT was purified using a Ni-NTA column.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "NI-NTA COLUMN", "target": "CHAT PURIFICATION"}, {"weight": 10.0, "description": "ChAT was purified using fast protein liquid chromatography after Ni-NTA column purification.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "FAST PROTEIN LIQUID CHROMATOGRAPHY", "target": "CHAT PURIFICATION"}, {"weight": 9.0, "description": "The study evaluated the kinetic parameters of wild-type and mutant ChATs to understand their functional differences.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT FUNCTION", "target": "KINETIC PROPERTIES"}, {"weight": 10.0, "description": "Thermal stability is an important factor for protein function, and this study analyzed the impact of mutations on ChAT thermal stability.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT FUNCTION", "target": "THERMAL STABILITY"}, {"weight": 3.0, "description": "DSF was used to measure the thermal stability of MHC/peptide complexes.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "THERMAL STABILITY", "target": "DSF"}, {"weight": 4.0, "description": "Homocysteine (HCY) is involved in lipid metabolism and signaling pathways.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "HCY", "target": "LIPID-RELATED PROCESSES"}, {"weight": 5.0, "description": "Oxidation of LDL cholesterol is a risk factor for cardiovascular disease.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXLDL", "target": "CARDIOVASCULAR DISEASE"}, {"weight": 6.0, "description": "CD measures products of lipid peroxidation, indicating oxidative damage.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "CD", "target": "LIPID PEROXIDATION"}, {"weight": 1.0, "description": "Chronic diarrhea is a common clinical symptom of Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "CHRONIC DIARRHEA"}, {"weight": 2.0, "description": "Abdominal pain is a common clinical symptom of Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "ABDOMINAL PAIN"}, {"weight": 3.0, "description": "Anorexia is a common clinical symptom of Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "ANOREXIA"}, {"weight": 4.0, "description": "Abdominal distension is a common clinical symptom of Crohn\'s disease.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "ABDOMINAL DISTENSION"}, {"weight": 2.0, "description": "The rs478582 variant in PTPN2 is significantly associated with Crohn\'s Disease, as indicated by an increased frequency of heterozygous (TC) or homozygous (CC) alleles in CD patients.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD", "target": "PTPN2:RS478582"}, {"weight": 7.0, "description": "BCD-LDL also reflects the extent of lipid peroxidation.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "BCD-LDL", "target": "LIPID PEROXIDATION"}, {"weight": 2.0, "description": "The study found an association between methylation at the BCL2L11 gene and oxidative stress markers.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "BCL2L11", "target": "METHYLATION AT CPG SITE CG07547695, RS726430"}, {"weight": 1.0, "description": "CpGs are located within the genome.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "CPG", "target": "GENOME"}, {"weight": 4.0, "description": "The study found an association between methylation at the CEP55 gene and oxidative stress markers.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CEP55", "target": "METHYLATION AT CPG SITE CG24371383, RS12782691"}, {"weight": 6.0, "description": "The study found an association between methylation at the CPB1 gene and oxidative stress markers.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CPB1", "target": "METHYLATION AT CPG SITE CG04072156, RS16861015"}, {"weight": 8.0, "description": "Hypomethylation in HIST1H4D was associated with a higher risk of T2D.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "HIST1H4D", "target": "METHYLATION AT CPG SITE CG08170869"}, {"weight": 10.0, "description": "Hypomethylation in DVL1 was associated with a higher risk of T2D.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "DVL1", "target": "METHYLATION AT CPG SITE CG03465880"}, {"weight": 12.0, "description": "The methylation levels at the ZNF341 gene were associated with heart failure.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "ZNF341", "target": "METHYLATION AT CPG SITE CG11842944"}, {"weight": 3.0, "description": "MT-ATP6 encodes a subunit of complex V (ATP synthase), which is essential for mitochondrial function.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6", "target": "COMPLEX V"}, {"weight": 3.0, "description": "The 8993T>G variant is located within the MT-ATP6 gene.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6", "target": "8993T>G"}, {"weight": 2.0, "description": "The p.Leu156Arg amino acid change in ATP synthase 6 leads to Leigh syndrome.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "P.LEU156ARG", "target": "LEIGH SYNDROME"}, {"weight": 1.0, "description": "CMH000067 has Leigh Syndrome, diagnosed based on the detected 8993T>G variant in MT-ATP6.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "LEIGH SYNDROME", "target": "CMH000067"}, {"weight": 9.0, "description": "The c.736G>A variant leads to an amino acid change Glu246Lys in the NDUFV1 protein.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "GLU246LYS", "target": "C.736G>A"}, {"weight": 4.0, "description": "NDUFV1 encodes a protein that functions in the electron transport chain by releasing electrons from NADH.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "ELECTRON TRANSPORT CHAIN", "target": "NDUFV1"}, {"weight": 6.0, "description": "The c.349G>A variant results in the amino acid substitution Ala117Thr in the NDUFV1 protein.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "ALA117THR", "target": "C.349G>A"}, {"weight": 2.0, "description": "Exome sequencing was performed to discover genetic variants in CMH000067.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "EXOME SEQUENCING", "target": "VARIANT DISCOVERY"}, {"weight": 2.0, "description": "Variations in the OPRM1 gene have been associated with differences in alcohol craving.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "OPRM1", "target": "ALCOHOL CRAVING"}, {"weight": 4.0, "description": "The ALDH2 gene encodes an enzyme involved in alcohol metabolism.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALDH2", "target": "ALCOHOL METABOLISM"}, {"weight": 8.0, "description": "Naltrexone is a medication used to treat alcohol use disorder.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NALTREXONE", "target": "MEDICATION"}, {"weight": 10.0, "description": "Placebo is a control treatment with no active ingredients.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "PLACEBO", "target": "MEDICATION"}, {"weight": 6.0, "description": "The NNT for topiramate was 5.29 compared to the placebo group in the full sample.)<SEP>Topiramate was compared to a placebo in the study to determine its efficacy.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "PLACEBO", "target": "TOPIRAMATE"}, {"weight": 6.0, "description": "The ADH1B gene encodes an enzyme involved in alcohol metabolism.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALCOHOL METABOLISM", "target": "ADH1B"}, {"weight": 2.0, "description": "ALDH2 genotype was a significant covariate in the analysis of alcohol self-administration, indicating its potential influence on drinking behavior.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALCOHOL SELF-ADMINISTRATION", "target": "ALDH2 GENOTYPE"}, {"weight": 4.0, "description": "Asp40 carriers consumed significantly fewer drinks compared to Asn40 homozygotes, suggesting an association between OPRM1 genotype and alcohol consumption.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALCOHOL SELF-ADMINISTRATION", "target": "OPRM1 GENOTYPE"}, {"weight": 8.0, "description": "Asn40 homozygotes had a significantly shorter latency to first drink compared to other genotypes.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "OPRM1 GENOTYPE", "target": "LATENCY TO FIRST DRINK"}, {"weight": 2.0, "description": "The ALDH2 rs671 polymorphism influences blood cortisol levels, particularly in men.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALDH2 RS671", "target": "CORTISOL LEVEL"}, {"weight": 2.0, "description": "Similar to men, the ALDH2 rs671 polymorphism influenced alcohol consumption and cortisol levels in women but with weaker associations.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALDH2 RS671", "target": "WOMEN"}, {"weight": 7.0, "description": "These factors were considered in multivariate models to assess their influence on the relationship between alcohol consumption and blood cortisol levels.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BLOOD CORTISOL LEVEL", "target": "SMOKING STATUS, HYPERTENSION, DIABETES, EDUCATION STATUS"}, {"weight": 4.0, "description": "The rs2231142 variant increases the risk of hyperuricemia.)", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142", "target": "HYPERURICEMIA"}, {"weight": 2.0, "description": "The C risk allele in SLC2A9 rs3733591 was associated with an increased risk of HUA.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HUA", "target": "SLC2A9 RS3733591"}, {"weight": 3.0, "description": "The T allele of the ABCG2 rs2231142 variant was associated with an increased risk of HUA.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HUA", "target": "ABCG2 RS2231142"}, {"weight": 1.0, "description": "The T allele of the ABCG2 rs2231142 variant was associated with increased serum uric acid (sUA) levels.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SUA LEVEL", "target": "ABCG2 RS2231142"}, {"weight": 2.0, "description": "The C risk allele in SLC2A9 rs3733591 was associated with increased sUA levels.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SUA LEVEL", "target": "SLC2A9 RS3733591"}, {"weight": 1.6, "description": "Individuals carrying the C allele of the SLC2A9 rs3733951 polymorphism have higher sUA levels compared to those with the T allele.)<SEP>The SLC2A9 rs3733951 C allele is associated with higher sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SLC2A9 RS3733951", "target": "SUA LEVELS"}, {"weight": 1.8, "description": "Each copy of the T allele in the ABCG2 rs2231142 polymorphism increases the risk of HUA.)<SEP>The ABCG2 rs2231142 T allele increases the risk of HUA.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "ABCG2 RS2231142", "target": "HUA RISK"}, {"weight": 0.5, "description": "There was no significant association between each genotype of the SLC22A12 rs893006 polymorphism and sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SLC22A12 RS893006", "target": "SUA LEVELS"}, {"weight": 1.6, "description": "Elevated TG levels are associated with higher sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA LEVELS", "target": "HIGH TG"}, {"weight": 1.2, "description": "Individuals with low HDL levels have an increased risk of HUA.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HUA RISK", "target": "LOW HDL"}, {"weight": 0.7, "description": "Individuals with high LDL levels have an increased risk of HUA.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HUA RISK", "target": "HIGH LDL"}, {"weight": 12.0, "description": "NFATC1 is a downstream target of the immunosuppression drug cyclosporine A.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "NFATC1", "target": "CYCLOSPORINE A"}, {"weight": 6.0, "description": "The UNCX gene variant rs62435145 is associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "UNCX", "target": "CKD"}, {"weight": 8.0, "description": "The ALMS1 gene variant rs7587577 is associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "ALMS1", "target": "CKD"}, {"weight": 12.0, "description": "The PDILT-UMOD gene complex variant rs77924615 is associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PDILT-UMOD", "target": "CKD"}, {"weight": 2.0, "description": "This variant has been functionally linked to increased risk of CKD by altering triglyceride and cholesterol synthesis and export.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "CHRONIC KIDNEY DISEASE (CKD)", "target": "GCKR P.PRO446LEU (RS1260326)"}, {"weight": 9.0, "description": "RGS14 encodes a member of the regulator of G protein signaling family.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "LOCO", "target": "G PROTEIN SIGNALING"}, {"weight": 16.0, "description": "Reduced expression of RGS14 ortholog \'loco\' in Drosophila melanogaster is associated with increased lifespan and stress resistance.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RGS14", "target": "STRESS RESISTANCE"}, {"weight": 8.0, "description": "Lead SNPs at the 20 eGFR loci are associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "CKD", "target": "LEAD EGFR SNPS"}, {"weight": 6.0, "description": "This lead SNP overlaps DHSs in RPTECs, indicating its potential regulatory effect on these cells.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)", "target": "RS35716097"}, {"weight": 9.0, "description": "This lead SNP overlaps DHSs in fetal kidney cells, suggesting a role in kidney development.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "FETAL KIDNEY CELL DHSS", "target": "RS8096658"}, {"weight": 2.0, "description": "Quinolone-resistant Campylobacter causes infection.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTION", "target": "QUINOLONE-RESISTANT CAMPYLOBACTER"}, {"weight": 4.0, "description": "Erythromycin-resistant Campylobacter causes infection.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTION", "target": "ERYTHROMYCIN-RESISTANT CAMPYLOBACTER"}, {"weight": 6.0, "description": "Traveling to other countries is associated with a higher prevalence of quinolone-resistant Campylobacter.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER", "target": "FOREIGN TRAVEL"}, {"weight": 4.0, "description": "Eating fresh poultry other than chicken and turkey increases the risk of infection with quinolone-resistant Campylobacter.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER", "target": "FRESH POULTRY (OTHER THAN CHICKEN AND TURKEY)"}, {"weight": 5.0, "description": "Eating fresh chicken from Denmark decreases the risk of infection with quinolone-resistant Campylobacter.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER", "target": "CHICKEN (DANISH ORIGIN)"}, {"weight": 6.0, "description": "Swimming is associated with an increased risk of infection with quinolone-resistant Campylobacter.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER", "target": "SWIMMING"}, {"weight": 0.8, "description": "The study identified 12 cases of domestically acquired quinolone-resistant infections.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "QUINOLONE-RESISTANT INFECTION", "target": "DOMESTICALLY ACQUIRED INFECTION"}, {"weight": 0.7, "description": "Thirteen (8.5%) of 153 C. jejuni isolates and 8 (29.6%) of 27 C. coli isolates were resistant to nalidixic acid.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTER JEJUNI", "target": "NALIDIXIC ACID RESISTANCE"}, {"weight": 0.6, "description": "Three (2.0%) of 153 C. jejuni isolates and 5 (18.5%) of 27 C. coli isolates were resistant to erythromycin.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTER JEJUNI", "target": "ERYTHROMYCIN RESISTANCE"}, {"weight": 0.5, "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTER JEJUNI", "target": "RETAIL FOOD PRODUCTS"}, {"weight": 0.7, "description": "In 10 (11.9%) of 84 domestically acquired infections, patients reported eating fresh poultry other than chicken and turkey compared with 4 (9.5%) of 42 infections in persons with travel-related infections.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "DOMESTICALLY ACQUIRED INFECTION", "target": "POULTRY CONSUMPTION"}, {"weight": 0.9, "description": "Patients with domestically acquired quinolone-sensitive C. jejuni infections were more likely to have a C. jejuni subtype that was also identified among retail food products and broiler chickens than were patients with domestically acquired quinolone-resistant infections.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "DOMESTICALLY ACQUIRED INFECTION", "target": "QUINOLONE-SENSITIVE INFECTION"}, {"weight": 0.7, "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CHICKEN", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.7, "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "TURKEY", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.7, "description": "Most (63%) food isolates were from Danish-bred food animals; the remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "PORK", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.6, "description": "The remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "FRANCE", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.6, "description": "The remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "ITALY", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.6, "description": "The remaining isolates were from imported food from France, Italy, and the United Kingdom.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "UNITED KINGDOM", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.7, "description": "49 isolates from broiler chicken fecal samples obtained from the same geographic area and time period as the human isolates.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "BROILER CHICKENS", "target": "CAMPYLOBACTER JEJUNI INFECTION"}, {"weight": 0.6, "description": "Forty patients (32.8%) were treated with antimicrobial agents for their campylobacteriosis; of these, 33 patients (27%) received a fluoroquinolone.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTERIOSIS TREATMENT", "target": "FLUOROQUINOLONES"}, {"weight": 0.5, "description": "Of these, 6 patients (4.9%) received a macrolide for the C. jejuni infection.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTERIOSIS TREATMENT", "target": "MACROLIDE"}, {"weight": 2.0, "description": "The minor allele of rs9534511 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION"}, {"weight": 4.0, "description": "The minor allele of rs9534511 is associated with an increase in the social disinhibition score by 0.32 points.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 4.0, "description": "The minor allele of rs4938056 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION"}, {"weight": 6.0, "description": "The minor allele of rs4938056 is associated with an increase in the social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 6.0, "description": "The minor allele of rs1998220 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1998220", "target": "SOCIAL DISINHIBITION"}, {"weight": 2.0, "description": "The minor allele of rs1998220 is associated with an increase in the social disinhibition score by 0.19 points.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1998220", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 8.0, "description": "The minor allele of rs1003921 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION"}, {"weight": 12.0, "description": "The minor allele of rs1003921 is associated with a decrease in the social disinhibition score by 0.64 points.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 10.0, "description": "The minor allele of rs16116 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION"}, {"weight": 8.0, "description": "The minor allele of rs16116 is associated with a decrease in the social disinhibition score by 0.29 points.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 12.0, "description": "The minor allele of rs16870286 was associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16870286", "target": "SOCIAL DISINHIBITION"}, {"weight": 10.0, "description": "The minor allele of rs16870286 is associated with a decrease in the social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16870286", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 1.0, "description": "The rs2023239 genotype influences CB1 receptor binding levels in postmortem human prefrontal cortex.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239", "target": "CB1 BINDING"}, {"weight": 3.0, "description": "The rs2023239 genotype was associated with differences in CB1 binding levels within postmortem PFC tissue.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239", "target": "CB1 BINDING IN POSTMORTEM PFC"}, {"weight": 1.0, "description": "Individuals with the CT genotype of rs2023239 reported greater reward from alcoholic beverages when treated with olanzapine.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "OLANZAPINE"}, {"weight": 2.0, "description": "There were no significant differences between individuals with the CT genotype and those with the TT genotype for the olanzapine condition.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "CYPROHEPTADINE HYDROCHLORIDE"}, {"weight": 1.0, "description": "The rs2023239 variant interacts with the dopamine system, influencing reward and craving.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "DOPAMINE SYSTEM"}, {"weight": 2.0, "description": "Olanzapine can influence reward pathways, potentially modifying the subjective experience of reward from alcohol.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "OLANZAPINE", "target": "REWARD"}, {"weight": 5.0, "description": "Treatment with olanzapine reduced cue-elicited craving in individuals with the CT genotype compared to placebo.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "OLANZAPINE", "target": "CUE-ELICITED CRAVING"}, {"weight": 3.0, "description": "Individuals with the CT genotype reported greater reward from alcoholic beverages.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "REWARD", "target": "CT GENOTYPE"}, {"weight": 3.0, "description": "Individuals with the CT genotype reported greater positive affect after drinking.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "POSITIVE AFFECT", "target": "CT GENOTYPE"}, {"weight": 4.0, "description": "Individuals with the CT genotype who received the active control medication (cyproheptadine) reported the greatest high after the third drink.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "SELF-REPORTED HIGH", "target": "CT GENOTYPE"}, {"weight": 5.0, "description": "Individuals with the CT genotype reported greater drinks per drinking day compared with individuals with the TT genotype when treated with placebo vs olanzapine.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "DRINKS PER DRINKING DAY", "target": "CT GENOTYPE"}, {"weight": 6.0, "description": "Olanzapine is a medication used in the treatment of alcohol dependence.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "ALCOHOL DEPENDENCE", "target": "OLANZAPINE TREATMENT"}, {"weight": 2.0, "description": "Individuals with the CT genotype for rs2023239 demonstrate significantly greater CB1 binding compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "GREATER CB1 BINDING"}, {"weight": 3.0, "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the NAcc when exposed to alcohol cues compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED NACC ACTIVATION"}, {"weight": 4.0, "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the VMPFC when exposed to alcohol cues compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED VMPFC ACTIVATION"}, {"weight": 5.0, "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the VTA when exposed to alcohol cues compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED VTA ACTIVATION"}, {"weight": 6.0, "description": "Individuals with at least 1 copy of the C allele in rs2023239 demonstrated greater activation in the OFC when exposed to alcohol cues compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED OFC ACTIVATION"}, {"weight": 9.0, "description": "Individuals with the CT genotype reported significantly greater reward and positive affect after drinking alcohol compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "REWARD AND POSITIVE AFFECT"}, {"weight": 2.0, "description": "Individuals with the CT genotype for rs2023239 demonstrated significantly greater CB1 binding in Brodmann areas 9 and 10 compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED CB1 BINDING IN BRODMANN AREAS 9 AND 10"}, {"weight": 4.0, "description": "Individuals with at least one copy of the C allele in rs2023239 demonstrated greater activation in brain regions associated with reward and motivation during exposure to alcohol cues compared to those with the TT genotype.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "GREATER ACTIVATION DURING ALCOHOL CUE EXPOSURE"}, {"weight": 1.0, "description": "In the CT group, greater activation was observed in brain regions during the alcohol vs. litchi juice comparison compared to the TT group.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "INCREASED ACTIVATION DURING ALCOHOL VS. LITCHI COMPARISON"}, {"weight": 1.0, "description": "In the CT group, higher AUDIT scores were significantly correlated with activation in the VMPFC.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "CORRELATION WITH VMPFC ACTIVATION"}, {"weight": 8.0, "description": "In the CT group, higher AUQ scores were significantly correlated with activation in both the VMPFC and OFC.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CT GENOTYPE", "target": "CORRELATION WITH OFC AND VMPFC ACTIVATION"}, {"weight": 4.0, "description": "Individuals with the CT genotype reported greater cue-elicited craving when treated with placebo vs olanzapine.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT GENOTYPE", "target": "CUE-ELICITED CRAVING"}, {"weight": 7.0, "description": "In the CT group, the AUDIT score was significantly correlated with activation of the VMPFC.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "ALCOHOL USE DISORDER SCORE", "target": "VMPFC ACTIVATION"}, {"weight": 8.0, "description": "In the CT group, the AUQ score was significantly correlated with activation of the VMPFC and OFC.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "URGE TO CONSUME ALCOHOL", "target": "VMPFC AND OFC ACTIVATION"}, {"weight": 1.0, "description": "The National Center for Biotechnology Information provided data used in the analysis of the CNR1 gene.)", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "DATA SOURCE", "target": "NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION"}, {"weight": 2.0, "description": "Exogenous lipid metabolism involves packaging of dietary fat into chylomicrons.)<SEP>Exogenous lipid metabolism involves the packaging of dietary fat into chylomicrons.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "EXOGENOUS LIPID METABOLISM", "target": "CHYLOMICRON"}, {"weight": 3.0, "description": "The initial step of endogenous lipid metabolism involves the hydrolysis of chylomicrons.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "ENDOGENOUS LIPID METABOLISM", "target": "CHYLOMICRON"}, {"weight": 2.0, "description": "Lipoprotein lipase (LPL) hydrolyzes chylomicrons.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "CHYLOMICRON"}, {"weight": 3.0, "description": "LPL deficiency is caused by decreased LPL activity.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "LPL DEFICIENCY"}, {"weight": 4.0, "description": "Individuals with LPL deficiency often present with moderate or severe hypertriglyceridemia.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 5.0, "description": "Clinical features of LPL deficiency can include eruptive xanthomas.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "ERUPTIVE XANTHOMAS"}, {"weight": 6.0, "description": "Clinical features of LPL deficiency can include hepato-splenomegaly.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "HEPATO-SPLENOMEGALY"}, {"weight": 7.0, "description": "Clinical features of LPL deficiency can include lipemia retinalis.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "LIPEMIA RETINALIS"}, {"weight": 8.0, "description": "Clinical features of LPL deficiency can include recurrent pancreatitis.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "PANCREATITIS"}, {"weight": 9.0, "description": "Dietary fat restriction is a primary treatment strategy for LPL deficiency.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "DIETARY FAT RESTRICTION"}, {"weight": 10.0, "description": "Gene therapy trials are ongoing as a potential treatment for LPL deficiency.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "GENE THERAPY"}, {"weight": 1.0, "description": "The patient presented with episodes of coffee-ground emesis.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "COFFEE-GROUND EMESIS", "target": "CASE REPORT PATIENT"}, {"weight": 2.0, "description": "The patient experienced an episode of melena.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "MELENA", "target": "CASE REPORT PATIENT"}, {"weight": 3.0, "description": "The patient had a papular rash that spread from his extremities to his trunk.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "PAPULAR RASH", "target": "CASE REPORT PATIENT"}, {"weight": 4.0, "description": "A CBC revealed a hematocrit of 17% in the patient.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "CBC", "target": "CASE REPORT PATIENT"}, {"weight": 5.0, "description": "The patient had dramatically elevated triglycerides (TG) levels.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "TRIGLYCERIDES (TG)", "target": "CASE REPORT PATIENT"}, {"weight": 7.0, "description": "Genomic DNA was isolated from whole blood for analysis.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "BLOOD DNA", "target": "GENOMIC ANALYSIS"}, {"weight": 2.0, "description": "Topiramate treatment leads to a reduction in the number of heavy drinking days (HDDs).)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "HDDS"}, {"weight": 6.0, "description": "Patients receiving topiramate reported more adverse events than those receiving placebo.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "ADVERSE EVENTS"}, {"weight": 8.0, "description": "Patients homozygous for the rs2832407*C allele experienced greater benefit from topiramate treatment in terms of HDD reduction.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "RS2832407*C-HOMOZYGOTES"}, {"weight": 9.0, "description": "The effect of topiramate was not observed in patients carrying the rs2832407*A allele.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "RS2832407*A-ALLELE CARRIERS"}, {"weight": 2.0, "description": "Patients treated with topiramate reported significantly higher mean adverse event severity compared to the placebo group.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "ADVERSE EVENT SEVERITY"}, {"weight": 3.0, "description": "Topiramate is used as a medication for the treatment of alcohol use disorder.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "ALCOHOL USE DISORDER"}, {"weight": 6.0, "description": "Variants in the ABCB1 gene are associated with an increased risk of grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCB1", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 2.0, "description": "Heterozygotes for the ABCB1 variant rs1045642 reported more severe acute nausea compared to wild-type and homozygous variant genotypes.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "RS1045642", "target": "ACUTE NAUSEA"}, {"weight": 2.0, "description": "The promoter of the long non-coding RNA LOC100507600 is located within the LCT intron 5.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LOC100507600", "target": "LCT INTRON 5"}, {"weight": 1.0, "description": "Silencing of LOC100507600 lncRNA reduced LCT mRNA levels by 25%.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LOC100507600", "target": "LCT MRNA"}, {"weight": 3.0, "description": "Differential DNA modifications were observed at the MCM6 intron 13 region between individuals with different LCT-MCM6 haplotypes.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "DNA MODIFICATION", "target": "MCM6 INTRON 13"}, {"weight": 2.0, "description": "The jejunum is a tissue where LCT expression is investigated.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "JEJUNUM", "target": "LCT EXPRESSION"}, {"weight": 3.0, "description": "White blood cells do not express LCT mRNA, indicating cell-type specific regulation.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "WHITE BLOOD CELLS", "target": "LCT MRNA"}, {"weight": 2.0, "description": "Differences in DNA modification levels between MCM6 exon 16 carrying haplotypes are observed based on C-13910 and T-13910 genotypes.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "MCM6 EXON 16", "target": "C-13910/T-13910 GENOTYPES"}, {"weight": 17.0, "description": "LCT mRNA levels are highest in lactase persistent individuals and lower in lactase non-persistent individuals.)<SEP>LCT mRNA levels are not significantly affected by age in lactase persistent (TT) individuals.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "LACTASE PERSISTENCE GENOTYPE"}, {"weight": 8.0, "description": "LOC100507600 lncRNA positively correlates with LCT mRNA levels.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "LNCRNA LOC100507600"}, {"weight": 2.0, "description": "A higher frequency of the CC genotype was associated with an increased occurrence of CRC.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CC GENOTYPE", "target": "CRC"}, {"weight": 10.0, "description": "DNA modifications are believed to be erased during embryogenesis.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "EMBRYOGENESIS", "target": "DNA MODIFICATIONS"}, {"weight": 2.0, "description": "CTCF binding site overlaps the lncRNA promoter.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CTCF", "target": "LNCRNA PROMOTER"}, {"weight": 1.0, "description": "DNA modifications at MCM6 intron 13 differ between individuals with different C-13910/T-13910 genotypes.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "MCM6 INTRON 13", "target": "C-13910/T-13910 GENOTYPES"}, {"weight": 9.0, "description": "DNA modification differences between CC, CT and TT genotypes at MCM6 intron 13 are observed in sperm samples, suggesting that modifications are erased during embryogenesis.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "MCM6 INTRON 13", "target": "CC GENOTYPE/TT GENOTYPE"}, {"weight": 4.0, "description": "The LCT exon 1 region has characteristics of an active promoter, indicated by histone marks like H3K4me3 and H3K27ac.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE PROMOTER", "target": "LCT EXON 1"}, {"weight": 5.0, "description": "Histone marks characteristic of active enhancers (H3K4me1 and H3K27ac) were detected at the LCT introns 2 and 3.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE ENHANCER", "target": "LCT INTRON 2 & 3"}, {"weight": 6.0, "description": "Histone marks characteristic of active enhancers (H3K4me1 and H3K27ac) were detected at the MCM6 intron 13 and exon 16.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE ENHANCER", "target": "MCM6 INTRON 13 & EXON 16"}, {"weight": 7.0, "description": "The MCM6 3\'-UTR region displays histone marks characteristic of active enhancers.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE ENHANCER", "target": "MCM6 3\'-UTR"}, {"weight": 6.0, "description": "LCT intron 2 is highly conserved across mammals.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "EVOLUTIONARY CONSERVATION", "target": "LCT INTRON 2"}, {"weight": 7.0, "description": "LCT intron 2 is an important regulatory element for lactase non-persistence.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT INTRON 2", "target": "LACTASE NON-PERSISTENCE"}, {"weight": 3.0, "description": "Increased DNA methylation inhibits CTCF binding at insulator sites.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CTCF BINDING", "target": "DNA METHYLATION"}, {"weight": 4.0, "description": "Deletion of Lct intron 2 caused a significant downregulation of LCT mRNA in mice.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT INTRON 2 DELETION", "target": "LCT MRNA REDUCTION"}, {"weight": 5.0, "description": "Deletion of Mcm6 intron 13 resulted in less pronounced LCT mRNA reduction in mice.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA REDUCTION", "target": "MCM6 INTRON 13 DELETION"}, {"weight": 6.0, "description": "Deletion in MCM6 intron 13 or LCT intron 2 resulted in a decrease in LCT mRNA levels in differentiated Caco-2 cells.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA REDUCTION", "target": "CACO-2 CELLS, DIFFERENTIATED STATE"}, {"weight": 4.0, "description": "Individuals with lactase persistence are more likely to consume milk.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "LACTASE PERSISTENCE", "target": "MILK"}, {"weight": 7.0, "description": "There was an elevated risk of RCC among those consuming milk compared to those who never consumed it.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "MILK CONSUMPTION", "target": "RCC"}, {"weight": 2.0, "description": "Hydroxyurea (HU) treatment leads to improvements in HbF levels.)<SEP>Hydroxyurea treatment leads to improvements in several hematological parameters, including HbF levels.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HU TREATMENT", "target": "HBF"}, {"weight": 5.0, "description": "The T-A-C haplotype of the BCL11A SNPs is associated with increased baseline and MTD HbF.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "T-A-C HAPLOTYPE", "target": "HBF"}, {"weight": 7.0, "description": "The C-A haplotype of the HMIP-2 SNPs is associated with increased baseline HbF.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "C-A HAPLOTYPE", "target": "HBF"}, {"weight": 0.2, "description": "There was no association observed between any HMIP-2 haplotypes, including the C-A haplotype, and delta HbF levels.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "C-A HAPLOTYPE", "target": "DELTA HBF"}, {"weight": 5.0, "description": "The C-A haplotype, formed by the combination of heterozygous or minor/heterozygous or minor alleles in rs478582 and rs2476601, is associated with an increased risk of MAPbacteremia in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "C-A HAPLOTYPE", "target": "MAPBACTEREMIA"}, {"weight": 6.0, "description": "The BCL11A rs1427407 SNP is associated with increased baseline and MTD HbF levels.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBF", "target": "BCL11A RS1427407"}, {"weight": 3.0, "description": "The BCL11A rs4671393 SNP is associated with increased baseline and MTD HbF levels.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBF", "target": "BCL11A RS4671393"}, {"weight": 9.0, "description": "The BCL11A rs11886868 SNP is associated with MTD and delta HbF.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBF", "target": "BCL11A RS11886868"}, {"weight": 6.0, "description": "The HMIP-2 rs9402686 SNP is associated with increased baseline and MTD HbF levels.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBF", "target": "HMIP-2 RS9402686"}, {"weight": 2.0, "description": "There was a correlation between baseline HbF and MTD HbF following hydroxyurea treatment.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BASELINE HBF", "target": "MTD HBF"}, {"weight": 1.4, "description": "The C-A haplotype of the HMIP-2 gene was associated with MTD HbF levels.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "MTD HBF", "target": "HMIP-2"}, {"weight": 3.0, "description": "There was an inverse correlation between delta HbF and HbF at baseline.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "DELTA HBF", "target": "HBF AT BASELINE"}, {"weight": 1.0, "description": "The association between HMIP-2 and MTD HbF lost significance when corrected for baseline HbF, suggesting a potential influence of baseline levels on delta HbF.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "DELTA HBF", "target": "HMIP-2"}, {"weight": 2.0, "description": "FANCD2 is a key protein involved in the Fanconi Anemia (FA) pathway.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCD2", "target": "FANCONI ANEMIA PATHWAY"}, {"weight": 3.0, "description": "Overexpression of UBE2T restored monoubiquitination of FANCD2 and FANCI.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "FANCD2", "target": "UBE2T PROTEIN"}, {"weight": 14.0, "description": "The URD domain binds to FANCD2.)<SEP>URD interacts with FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCD2", "target": "URD"}, {"weight": 4.0, "description": "FANCI is another protein involved in the FA pathway.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCI", "target": "FANCONI ANEMIA PATHWAY"}, {"weight": 12.0, "description": "The URD domain binds to FANCI.)<SEP>URD interacts with FANCI.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCI", "target": "URD"}, {"weight": 6.0, "description": "UBE2T is involved in DNA repair processes.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T", "target": "DNA REPAIR"}, {"weight": 3.0, "description": "The catalytic cysteine of Ube2T is involved in thioester bond formation with ubiquitin.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "UBE2T", "target": "CYSTEINE"}, {"weight": 2.0, "description": "The URD does not interact with Ube2T, but the RING domain binds Ube2T.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "UBE2T", "target": "URD"}, {"weight": 4.0, "description": "The RING domain interacts with Ube2T with a Kd of 454 nM.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "UBE2T", "target": "RING DOMAIN"}, {"weight": 8.0, "description": "FANCA is a protein crucial for normal FA pathway function.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCA", "target": "FANCONI ANEMIA PATHWAY"}, {"weight": 2.0, "description": "FAAP20 binds to FANCA through its N-terminal region.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FANCA", "target": "FAAP20"}, {"weight": 10.0, "description": "Fibroblasts are hypersensitive to MMC, indicating potential FA.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "MMC", "target": "CELLULAR SENSITIVITY"}, {"weight": 2.0, "description": "Overexpression of UBE2T rescued cellular hypersensitivity to crosslinking agents like MMC.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "MMC", "target": "UBE2T PROTEIN"}, {"weight": 12.0, "description": "Similar to MMC, DEB sensitivity suggests a possible FA phenotype.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "DEB", "target": "CELLULAR SENSITIVITY"}, {"weight": 7.0, "description": "Fibroblasts are used as a model system to study cell function and disease.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FIBROBLAST", "target": "STUDY MODEL"}, {"weight": 9.0, "description": "AluYa5 repeats can mediate genetic recombination events.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "ALUYA5 REPEAT", "target": "GENETIC RECOMBINATION"}, {"weight": 10.0, "description": "The wild type allele usually encodes a functional protein.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "WILD TYPE", "target": "FUNCTIONAL PROTEIN"}, {"weight": 11.0, "description": "A mutant allele may result in a non-functional or altered protein.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "MUTANT ALLELE", "target": "DISRUPTED FUNCTION"}, {"weight": 12.0, "description": "Compound heterozygosity often leads to loss of gene function.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "COMPOUND HETEROZYGOUS MUTATIONS", "target": "LOSS OF FUNCTION"}, {"weight": 2.0, "description": "Overexpression of UBE2T rescued cellular defects in RA2627 cells, suggesting that UBE2T deficiency is the cause of the disorder.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "UBE2T PROTEIN", "target": "RA2627 CELLS"}, {"weight": 1.0, "description": "A mutation in the UBE2T gene causes Fanconi Anemia-T subtype.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "FANCONI ANEMIA-T SUBTYPE", "target": "UBE2T GENE"}, {"weight": 8.0, "description": "LCLs are derived from blood cells and can be used to study hematopoiesis (blood cell formation).)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "HEMATOPOIESIS", "target": "LCLS"}, {"weight": 2.0, "description": "Mutations in RPS19 affect aminoacyl-tRNA biosynthesis pathways.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19", "target": "AMINOACYL-TRNA BIOSYNTHESIS"}, {"weight": 4.0, "description": "Mutations in RPS19 affect glycine, serine and threonine metabolism pathways.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19", "target": "GLYCINE, SERINE AND THREONINE METABOLISM"}, {"weight": 6.0, "description": "Mutations in RPS19 affect death receptor signaling pathways.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19", "target": "DEATH RECEPTOR SIGNALING"}, {"weight": 1.0, "description": "RPL22 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL22", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL27A is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL27A", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL29 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL29", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL31 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL31", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL14 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL14", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL18A is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL18A", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPS3 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPS3", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL18 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL18", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL13 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL13", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL3 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL3", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL34 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL34", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPS2 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPS2", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPS12 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPS12", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL15 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL15", "target": "PROTEIN SYNTHESIS"}, {"weight": 1.0, "description": "RPL28 is involved in protein synthesis.)", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL28", "target": "PROTEIN SYNTHESIS"}, {"weight": 5.0, "description": "Studies have shown a significant association between the BDNF rs6265 (G/A) polymorphism and an increased risk of migraine.)<SEP>The BDNF rs6265 polymorphism was studied as a potential risk factor for migraine.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF RS6265 (G/A)", "target": "MIGRAINE"}, {"weight": 5.0, "description": "The rs2049046 polymorphism in the BDNF gene was also investigated for its association with migraine susceptibility.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "RS2049046 (A/T)", "target": "MIGRAINE"}, {"weight": 2.0, "description": "The BDNF rs2049046 (A/T) polymorphism is also associated with a higher susceptibility to migraine.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "MIGRAINE", "target": "BDNF RS2049046 (A/T)"}, {"weight": 2.0, "description": "Another database utilized in the search for studies included in the meta-analysis.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "WEB OF SCIENCE", "target": "META-ANALYSIS"}, {"weight": 3.0, "description": "A source of systematic reviews on migraine, potentially informing the meta-analysis.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "COCHRANE DATABASES", "target": "META-ANALYSIS"}, {"weight": 7.0, "description": "Begg\u2019s test was used to evaluate publication bias in the meta-analysis results.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "META-ANALYSIS", "target": "BEGG\u2019S TEST"}, {"weight": 8.0, "description": "Egger\u2019s test was employed as an alternative method for detecting publication bias in the meta-analysis.)", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "META-ANALYSIS", "target": "EGGER\u2019S TEST"}, {"weight": 1.0, "description": "Adalimumab is used to treat HS.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "ADALIMUMAB", "target": "HS"}, {"weight": 2.0, "description": "Paradoxical psoriasis, a psoriasiform reaction, can develop as a side effect of adalimumab treatment in some patients with HS.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "ADALIMUMAB", "target": "PSORIASIS"}, {"weight": 1.0, "description": "Nodules are a common feature of HS.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "NODULES"}, {"weight": 2.0, "description": "Fistulas are a characteristic finding in HS.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "FISTULAS"}, {"weight": 3.0, "description": "Sinus tracts often occur in conjunction with fistulas in HS.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "SINUS TRACTS"}, {"weight": 4.0, "description": "Patient 1 developed erythematous-scaly lesions on their lower limbs.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 1", "target": "ERYTHEMATOUS-SCALY LESIONS"}, {"weight": 5.0, "description": "Patient 2 experienced pustular lesions in the palmo-plantar regions.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 2", "target": "PUSTULAR LESIONS"}, {"weight": 22.0, "description": "IFN-\u03b2 expression was also detected in cells with a T-cell- and DC-like morphology, as well as in endothelial cells.)<SEP>Type I IFN-\u03b2 was expressed in paradoxical skin lesions, mainly in keratinocytes.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "KERATINOCYTES", "target": "TYPE I IFN\u2010\u0392"}, {"weight": 10.0, "description": "The epidermis of psoriasiform reactions was immunoreactive for IFN-\u03ba.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "KERATINOCYTES", "target": "IFN\u2010\u039a"}, {"weight": 1.0, "description": "The SNP rs1576 is located within the CCHCR1 gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1", "target": "RS1576"}, {"weight": 2.0, "description": "The SNP rs130079 is located within the CCHCR1 gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1", "target": "RS130079"}, {"weight": 3.0, "description": "The SNP rs746647 is located within the CCHCR1 gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1", "target": "RS746647"}, {"weight": 2.0, "description": "The SNP rs11209026 is located in the IL23R gene and was previously associated with paradoxical psoriasiform reactions to anti-TNFs.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS11209026"}, {"weight": 3.0, "description": "The SNP rs72676067 is located in the IL23R gene and was detected in patient 2.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS72676067"}, {"weight": 4.0, "description": "The SNP rs1004819 is located in the IL23R gene and was detected in patient 1.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS1004819"}, {"weight": 2.0, "description": "Paradoxical psoriasis manifests as psoriasiform or eczematous skin lesions.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "SKIN LESIONS"}, {"weight": 12.0, "description": "The inflammatory infiltrate pattern in paradoxical psoriasis strongly resembles that present in acute psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "ACUTE PSORIASIS"}, {"weight": 16.0, "description": "The type I IFN\u2010\u03b2 was expressed at levels significantly higher than classical psoriasis (~1.9-fold increase).)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "CLASSICAL PSORIASIS"}, {"weight": 6.0, "description": "HS patients showed enriched CD8+, but not CD4+ cells in skin biopsies compared to PBMCs.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "CD3+ CELLS FROM SKIN BIOPSIES", "target": "HS PATIENTS"}, {"weight": 2.0, "description": "The FANCL protein contains a DRWD domain.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "FANCL", "target": "DRWD DOMAIN"}, {"weight": 4.0, "description": "Human FANCL and DmFANCL are structurally similar proteins.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HUMAN FANCL", "target": "DMFANCL"}, {"weight": 4.0, "description": "The URD protein was tested for its ability to form a thioester bond with ubiquitin.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "UBIQUITIN", "target": "URD"}, {"weight": 12.0, "description": "Mutation of residues L248, F252, L254, and I265 in the URD reduces binding to both FANCI and FANCD2.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "L248A/F252A/L254A/I265A", "target": "FANCI,FANCD2"}, {"weight": 4.0, "description": "The L248A/F252A/L254A/I265A mutation reduces the binding strength of URD to FANCI and FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "L248A/F252A/L254A/I265A", "target": "BINDING STRENGTH"}, {"weight": 14.0, "description": "Mutation of residues W212 and L214 in the URD reduces binding to both FANCI and FANCD2.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "W212A/L214A", "target": "FANCI,FANCD2"}, {"weight": 4.0, "description": "The W212A/L214A mutation reduces the binding strength of URD to FANCI and FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "W212A/L214A", "target": "BINDING STRENGTH"}, {"weight": 10.0, "description": "Mutation of residues L149 and F166 in the URD reduces binding to both FANCI and FANCD2.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCI,FANCD2", "target": "L149A/F166A"}, {"weight": 1.0, "description": "The FGFR4 rs351855 genomic variant causes the Gly388Arg amino acid change in the FGFR4 protein.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "GLY388ARG", "target": "FGFR4 RS351855"}, {"weight": 4.0, "description": "The KLB rs4975017 genotype influences the effect of colesevelam treatment on GC24. CA/AA genotype group shows a lower GC24 value compared to placebo.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM", "target": "RS4975017"}, {"weight": 5.0, "description": "The KLB rs17618244 genotype showed numerical but not statistically significant differential colesevelam treatment effects on AC t1/2 and GC24. Modest treatment effects were observed in the GG genotype.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM", "target": "RS17618244"}, {"weight": 2.0, "description": "Colesevelam treatment significantly delays AC t1/2 in participants with the FGFR4 rs351855 GA/AA genotype.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM", "target": "AC T1/2"}, {"weight": 3.0, "description": "Colesevelam treatment significantly decreases GC24 in participants with the FGFR4 rs351855 GA/AA genotype.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM", "target": "GC24"}, {"weight": 3.0, "description": "The FGFR4 rs376618 SNP did not satisfy Hardy-Weinberg equilibrium in this study.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS376618", "target": "HWE"}, {"weight": 2.0, "description": "Patients with IBS-D had higher serum C4 levels compared to IBS-C and HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "SERUM C4"}, {"weight": 3.0, "description": "Patients with IBS-D had higher stool bile acid (BA) levels compared to IBS-C, but not HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "STOOL BA"}, {"weight": 1.0, "description": "23% of IBS-D patients had a history of cholecystectomy.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "CHOLECYSTECTOMY"}, {"weight": 4.0, "description": "There was a negative correlation between serum C4 and FGF19 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "FGF19", "target": "SERUM C4"}, {"weight": 2.0, "description": "Previous cholecystectomy was associated with serum C4 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "CHOLECYSTECTOMY", "target": "SERUM C4"}, {"weight": 3.0, "description": "Previous cholecystectomy was associated with stool bile acid (BA) levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "CHOLECYSTECTOMY", "target": "STOOL BA"}, {"weight": 5.0, "description": "There was a positive correlation between stool weight and serum C4 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL WEIGHT", "target": "SERUM C4"}, {"weight": 7.0, "description": "There was a strong positive correlation between total stool BA and stool weight.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL WEIGHT", "target": "TOTAL STOOL BA"}, {"weight": 8.0, "description": "There was a moderate positive correlation between total stool BA and stool fat.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL FAT", "target": "TOTAL STOOL BA"}, {"weight": 6.0, "description": "There was a strong positive correlation between total stool bile acid (BA) and serum C4 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "SERUM C4", "target": "TOTAL STOOL BA"}, {"weight": 10.0, "description": "The genetic variant FGFR4 rs1966265 was marginally associated with stool BA.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA", "target": "FGFR4 RS1966265"}, {"weight": 4.0, "description": "The crystal structure reveals FAAP20-UBZ interacting with K63-linked ubiquitin chains.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "K63-UB2", "target": "FAAP20-UBZ"}, {"weight": 9.0, "description": "The side chain of Met415 in NEMO-UBZ cannot fit the Ile44-centered hydrophobic patch on Ub, suggesting a different mode of interaction.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "ILE44", "target": "NEMO-UBZ"}, {"weight": 6.0, "description": "The distance between Leu71 of one ubiquitin and Lys63 of its neighboring ubiquitins is 34.0 \u00c5 and 34.8 \u00c5, indicating limited interaction.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ", "target": "LEU71 OF UBIQUITIN"}, {"weight": 9.0, "description": "FAAP20-UBZ binds to ubiquitin with an affinity (K d = 19.9 \u03bcM).)<SEP>The FAAP20-UBZ protein domain binds to ubiquitin (Ub).)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "UB"}, {"weight": 10.0, "description": "FAAP20-UBZ binds to different types of ubiquitin chains (K63, K48, and M1) with varying affinities.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ", "target": "K63-UB2, K48-UB2, M1-UB2"}, {"weight": 12.0, "description": "The Asp164 O\u03b4 atoms of FAAP20-UBZ hydrogen bond with the main-chain amide groups of Ala46 and Gly47 of Ub.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ", "target": "ASP164"}, {"weight": 2.0, "description": "These amino acids in Ub form a hydrophobic patch that interacts with FAAP20-UBZ.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "LEU8, ILE44, VAL70, THR66, HIS68"}, {"weight": 4.0, "description": "FAAP20-UBZ and Pol\u03b7-UBZ bind to Ubiquitin in a similar manner.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "POL\u0397-UBZ"}, {"weight": 5.0, "description": "FAAP20-UBZ and RAD18-UBZ interact with Ubiquitin through different mechanisms.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "RAD18-UBZ"}, {"weight": 7.0, "description": "The \u03b1-helix of FAAP20-UBZ interacts with Ubiquitin in a similar way to the UIM domain of Vps27.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "UIM"}, {"weight": 8.0, "description": "The \u03b1-helix of FAAP20-UBZ interacts with Ubiquitin in a manner similar to the MIU domain of Rabex5.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "MIU"}, {"weight": 4.0, "description": "The Trp180 residue in FAAP20-UBZ interacts with Ile44 of ubiquitin through hydrophobic interactions.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "TRP180", "target": "ILE44 OF UB"}, {"weight": 3.0, "description": "The NEMO-UBZ and Pol\u03b7-UBZ proteins interact with Ubiquitin differently from RAD18-UBZ and WRNIP1-UBZ.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "NEMO-UBZ", "target": "POL\u0397-UBZ"}, {"weight": 16.0, "description": "Both WRNIP1 and RAD18 UBZs interact with Ubiquitin through their \u03b2-loops.)<SEP>WRNIP1-UBZ and RAD18-UBZ both interact with Ubiquitin through their \u03b2-loops.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "WRNIP1-UBZ", "target": "RAD18-UBZ"}, {"weight": 3.0, "description": "The Asp164 residues in FAAP20-UBZ form hydrogen bonds with Ala46 and Gly47 in ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ALA46, GLY47 OF UB", "target": "ASP164 O\u0394 ATOMS OF FAAP20-UBZ"}, {"weight": 5.0, "description": "The N\u03b5 atom of Trp180 in FAAP20-UBZ forms a hydrogen bond with the Gly47 residue in ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "GLY47 OF UB", "target": "TRP180 N\u0395 ATOM"}, {"weight": 6.0, "description": "The main-chain CO group of Leu171 in FAAP20-UBZ interacts with Arg72 in ubiquitin through a hydrogen bond.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ARG72 OF UB", "target": "LEU171"}, {"weight": 7.0, "description": "The main-chain CO groups of Ser174 and Thr175 in FAAP20-UBZ form hydrogen bonds with the N\u03b7 atoms of Arg72 in ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ARG72 OF UB", "target": "SER174, THR175"}, {"weight": 8.0, "description": "The O\u03b4 atoms of Asp177 in FAAP20-UBZ interact with the N\u03b5 and N\u03b7 atoms of Arg42 in ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ARG42 OF UB", "target": "ASP177"}, {"weight": 9.0, "description": "The main-chain CO group of Val178 in FAAP20-UBZ forms a hydrogen bond with the N\u03b5 atom of Gln49 in ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "GLN49 OF UB", "target": "VAL178"}, {"weight": 2.0, "description": "These mutations disrupt the interaction between FAAP20-UBZ and ubiquitin.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "A168L, W180A, D164A", "target": "UB BINDING"}, {"weight": 3.0, "description": "These mutations impair the ability of FAAP20 to localize to DNA damage sites.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20 LOCALIZATION TO ICL SITES", "target": "L161A, A172L, D177A"}, {"weight": 1.0, "description": "rs2395182 is a specific HLA-tagSNP identified in the study.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-TAGSNPS", "target": "RS2395182"}, {"weight": 2.0, "description": "rs7775228 is a specific HLA-tagSNP identified in the study.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-TAGSNPS", "target": "RS7775228"}, {"weight": 3.0, "description": "rs2187668 is a specific HLA-tagSNP identified in the study.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-TAGSNPS", "target": "RS2187668"}, {"weight": 4.0, "description": "rs7454108 is a specific HLA-tagSNP identified in the study.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-TAGSNPS", "target": "RS7454108"}, {"weight": 5.0, "description": "DQ2.5 is a specific HLA-DQ haplotype.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DQ2.5", "target": "HLA-DQ HAPLOTYPE"}, {"weight": 7.0, "description": "DQ2.2 is a specific HLA-DQ haplotype.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DQ2.2", "target": "HLA-DQ HAPLOTYPE"}, {"weight": 8.0, "description": "DQX represents the absence of specific high-risk HLA haplotypes.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "DQX", "target": "HLA-DQ HAPLOTYPE"}, {"weight": 2.0, "description": "STAT5B deficiency has been linked to an increased risk of autoimmune thyroiditis.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "AUTOIMMUNE THYROIDITIS", "target": "STAT5B"}, {"weight": 6.0, "description": "DQ8 is a specific HLA-DQ haplotype.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-DQ HAPLOTYPE", "target": "DQ8"}, {"weight": 16.0, "description": "Paclitaxel-carboplatin combination therapy increases the risk of Grade 3\u20134 anemia.)<SEP>Paclitaxel-carboplatin combination therapy is associated with an increased risk of grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "PACLITAXEL-CARBOPLATIN COMBINATION THERAPY", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 4.0, "description": "Carboplatin monotherapy is associated with a lower risk of grade 3\u20134 anemia compared to paclitaxel-carboplatin combination therapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "CARBOPLATIN MONOTHERAPY", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 8.0, "description": "Variants in the ABCC2 gene are associated with a decreased risk of grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCC2", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 18.0, "description": "Variants in the ABCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCC2", "target": "USE OF COLONY-STIMULATING FACTORS (CSFS)"}, {"weight": 2.0, "description": "The ABCC2 gene was significantly associated with PFI in ovarian cancer patients, particularly when adjusted for multiple factors.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ABCC2", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 10.0, "description": "Variants in the ABCA1 gene are associated with an increased risk of grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCA1", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 12.0, "description": "Variants in the ERCC1 gene are associated with an increased risk of grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ERCC1", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 14.0, "description": "Variants in the CYP3A4 gene are associated with an increased risk of thrombocytopenia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "CYP3A4", "target": "THROMBOCYTOPENIA"}, {"weight": 16.0, "description": "Variants in the ABCC1 gene are associated with an increased need for erythropoiesis-stimulating agents during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCC1", "target": "USE OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)"}, {"weight": 22.0, "description": "Variants in the ERCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ERCC2", "target": "USE OF COLONY-STIMULATING FACTORS (CSFS)"}, {"weight": 24.0, "description": "The rs1799793 variant is significantly associated with a longer progression-free interval.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1799793", "target": "PROGRESSION-FREE INTERVAL (PFI)"}, {"weight": 18.0, "description": "The rs1799793 variant is significantly associated with a longer progression-free interval.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1799793", "target": "PFI"}, {"weight": 1.0, "description": "The rs1799793 variant in ERCC2 was significantly associated with PFI in ovarian cancer patients.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS1799793", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 15.0, "description": "Variants in the CYP3A4 gene are associated with an increased risk of thrombocytopenia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "THROMBOCYTOPENIA", "target": "CYP3A4 VARIANTS"}, {"weight": 3.0, "description": "The rs12762549 variant in ABCC2 was significantly associated with PFI in ovarian cancer patients, particularly when adjusted for multiple factors.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS12762549", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 4.0, "description": "The SERPINB2 gene was significantly associated with PFI in ovarian cancer patients, particularly when adjusted for multiple factors.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "SERPINB2", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 19.0, "description": " FIGO stage is a factor considered in Cox regression analysis to predict patient outcomes.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "FIGO STAGE", "target": "COX REGRESSION ANALYSIS"}, {"weight": 20.0, "description": "Tumor grade is a factor considered in Cox regression analysis to predict patient outcomes.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "TUMOR GRADE", "target": "COX REGRESSION ANALYSIS"}, {"weight": 21.0, "description": "Tumor histology is a factor considered in Cox regression analysis to predict patient outcomes.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "TUMOR HISTOLOGY", "target": "COX REGRESSION ANALYSIS"}, {"weight": 22.0, "description": "Residual disease after debulking surgery is a factor considered in Cox regression analysis to predict patient outcomes.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RESIDUAL DISEASE AFTER DEBULKING SURGERY", "target": "COX REGRESSION ANALYSIS"}, {"weight": 16.0, "description": "Variants in the ABCC1 gene are associated with an increased need for erythropoiesis-stimulating agents during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCC1 VARIANTS", "target": "USE OF ESAS"}, {"weight": 17.0, "description": "Variants in the ABCC2 gene are associated with a decreased need for colony-stimulating factors during chemotherapy.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ABCC2 VARIANTS", "target": "USE OF CSFS"}, {"weight": 1.0, "description": "The TGF\u03b21 (rs1800469 C/T) polymorphism in the promoter region was assayed, and a decrease in the CT genotype and TT genotype was observed in CRC patients compared to controls.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TGF-SS1", "target": "CRC"}, {"weight": 2.0, "description": "The rs4073 T/A polymorphism in the promoter region of the IL-8 gene was assayed in samples from patients with CRC and controls.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "INTERLEUKIN-8", "target": "CRC"}, {"weight": 5.0, "description": "The frequencies of the IL-27 (rs17855750 T/G) promoter SNP were analyzed.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-27", "target": "CRC"}, {"weight": 1.0, "description": "The TaqMan (ViiA\u2122 7 Real-Time PCR) method was used for genotyping.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TAQMAN", "target": "GENOTYPING"}, {"weight": 2.0, "description": "The TaqMan (ViiA\u2122 7 Real-Time PCR) method was used for genotyping.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "VIIA\u2122 7", "target": "GENOTYPING"}, {"weight": 3.0, "description": "Genotyping was carried out by an allele discrimination assay.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "ALLELE DISCRIMINATION ASSAY", "target": "GENOTYPING"}, {"weight": 5.0, "description": "Demographic and clinical characteristics of patients and control participating in this study are reported for CRC.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CRC", "target": "PATIENTS AND CONTROLS"}, {"weight": 6.0, "description": "Demographic and clinical characteristics of patients and control participating in this study are reported.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CONTROL GROUP", "target": "PATIENTS AND CONTROLS"}, {"weight": 7.0, "description": "The limited population of subjects with the study (Riyadh city only) may explain the deviation from Hardy-Weinberg Equilibrium for TGF-\u00df1.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "RIYADH CITY", "target": "POPULATION"}, {"weight": 4.0, "description": "Elevated IL-8 serum levels are associated with asthma in patients compared to healthy controls.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 SERUM LEVELS"}, {"weight": 6.0, "description": "Elevated IL-8 mRNA levels are found in patients with asthma compared to healthy controls.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 MRNA LEVELS"}, {"weight": 12.0, "description": "Elevated IL-8 protein levels are associated with asthma severity.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 PROTEIN"}, {"weight": 2.0, "description": "The SNP rs1898671 in the TSLP gene was nominally associated with asthma susceptibility.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "RS1898671", "target": "ASTHMA SUSCEPTIBILITY"}, {"weight": 4.0, "description": "The risk of asthma associated with the SNP rs1898671 was increased in ex-smokers.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "RS1898671", "target": "EX-SMOKERS"}, {"weight": 6.0, "description": "The association between the SNP rs1898671 and asthma risk was not significant in never-smokers.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "RS1898671", "target": "NEVER-SMOKERS"}, {"weight": 8.0, "description": "The C10orf11 gene was associated with FEV1 in a meta-analysis of lung function GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1", "target": "C10ORF11"}, {"weight": 18.0, "description": "The IL37 gene was associated with FEV1 in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1", "target": "IL37"}, {"weight": 20.0, "description": "The ASXL3 gene was associated with FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FVC", "target": "ASXL3"}, {"weight": 4.0, "description": "The UACA gene at the THSD4-UACA-TLE3 locus was significantly associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "UACA"}, {"weight": 6.0, "description": "The TLE3 gene at the THSD4-UACA-TLE3 locus was significantly associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "TLE3"}, {"weight": 10.0, "description": "The CCL23 gene was associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "CCL23"}, {"weight": 12.0, "description": "The CCL18 gene was associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "CCL18"}, {"weight": 14.0, "description": "The PITPNC1 gene was associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "PITPNC1"}, {"weight": 16.0, "description": "The CHAF1B gene was associated with FEV1/FVC in the GWAS.)", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "CHAF1B"}, {"weight": 10.0, "description": "The CC or CT genotypes of the rs2227306 polymorphism are associated with increased susceptibility to asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA SUSCEPTIBILITY", "target": "RS2227306 GENOTYPE"}, {"weight": 5.0, "description": "There were differences in self-reported race/ethnicity between cases and controls.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "NEVER-SMOKERS", "target": "SELF-REPORTED RACE/ETHNICITY"}, {"weight": 6.0, "description": "The combined effects of MAPbacteremia presence and either PTPN2:rs478582 or PTPN22:rs2476601 SNPs are associated with increased IFN-\u03b3 expression in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "PTPN2", "target": "IFN-\u0393 EXPRESSION"}, {"weight": 4.0, "description": "rs1893217 is a SNP located in the PTPN2 gene.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS1893217", "target": "PTP N2 GENE"}, {"weight": 1.0, "description": "Heterozygous (TC) alleles in rs478582 are associated with an increased risk of MAPbacteremia in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "RS478582", "target": "MAPBACTEREMIA"}, {"weight": 2.0, "description": "Heterozygous (GA) alleles in rs2476601 are associated with an increased risk of MAPbacteremia in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "RS2476601", "target": "MAPBACTEREMIA"}, {"weight": 6.0, "description": "The rs2476601 variant in PTPN22 is significantly associated with various inflammatory autoimmune diseases.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN22:RS2476601", "target": "INFLAMMATORY AUTOIMMUNE DISEASES"}, {"weight": 3.0, "description": "The C-G haplotype, formed by the combination of heterozygous or minor/major alleles in rs478582 and rs2476601, is associated with an increased risk of MAPbacteremia in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "C-G HAPLOTYPE"}, {"weight": 4.0, "description": "The T-A haplotype, formed by the combination of major/heterozygous or minor alleles in rs478582 and rs2476601, is associated with an increased risk of MAPbacteremia in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "T-A HAPLOTYPE"}, {"weight": 10.0, "description": "T-cells from CD subjects with MAPbacteremia showed a higher fold change in response to PHA and MAP PPD-like compared to those without MAPbacteremia.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAPBACTEREMIA", "target": "T-CELL PROLIFERATION"}, {"weight": 8.0, "description": "Treatment with MAP PPD-like stimulated T-cell proliferation in both CD and healthy control subjects.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAP PPD-LIKE", "target": "T-CELL PROLIFERATION"}, {"weight": 6.0, "description": "Treatment with PHA stimulated T-cell proliferation in both CD and healthy control subjects.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PHA", "target": "T-CELL PROLIFERATION"}, {"weight": 7.0, "description": "The combined effects of MAPbacteremia presence and either PTPN2:rs478582 or PTPN22:rs2476601 SNPs are associated with increased IFN-\u03b3 expression in CD patients.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "IFN-\u0393 EXPRESSION", "target": "PTPN22"}, {"weight": 12.0, "description": "T-cells from healthy control subjects showed a lower fold change in response to PHA and MAP PPD-like compared to CD subjects.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELL PROLIFERATION", "target": "HEALTHY CONTROL SUBJECTS"}, {"weight": 7.0, "description": "Overexpression of LYP-620R reduces T cell activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620R", "target": "T CELL ACTIVATION"}, {"weight": 9.0, "description": "Overexpression of LYP-620R modulates TCR signaling.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620R", "target": "TCR SIGNALING"}, {"weight": 1.0, "description": "Overexpressed LYP-620R significantly repressed Tresp proliferation.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TREG-MEDIATED SUPPRESSION"}, {"weight": 8.0, "description": "The LYP-620W variant has a weaker effect on T cell activation compared to LYP-620R.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620W", "target": "T CELL ACTIVATION"}, {"weight": 2.0, "description": "The LYP-620W variant has a weaker effect on T cell proliferation compared to LYP-620R.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620W", "target": "T CELL PROLIFERATION"}, {"weight": 2.0, "description": "Overexpression of LYP-620W dramatically reduced Tresp repression across the Treg:Tresp range.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TREG-MEDIATED SUPPRESSION"}, {"weight": 3.0, "description": "The Tconv-intrinsic susceptibility conferred by LYP-620W is due to reduced control over activation, proliferation, and effector mechanisms.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TCONV-INTRINSIC SUSCEPTIBILITY"}, {"weight": 4.0, "description": "Overexpression of LYP-620W slightly increased Treg suppressive capacity.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TREG SUPPRESSIVE CAPACITY"}, {"weight": 20.0, "description": "The nonamer peptide is recognized by TCRs.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "TCR", "target": "NONAMER PEPTIDE"}, {"weight": 22.0, "description": "The decamer peptide is recognized by TCRs.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "TCR", "target": "DECAMER PEPTIDE"}, {"weight": 1.0, "description": "CD69 expression is upregulated upon activation of Tconv cells.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD69", "target": "TCONV ACTIVATION"}, {"weight": 2.0, "description": "ICOS expression is upregulated upon activation of Tconv cells.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "ICOS", "target": "TCONV ACTIVATION"}, {"weight": 4.0, "description": "CD226 expression is upregulated upon activation of Tconv cells.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD226", "target": "TCONV ACTIVATION"}, {"weight": 5.0, "description": "PD-1 expression is upregulated upon activation of Tconv cells.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PD-1", "target": "TCONV ACTIVATION"}, {"weight": 6.0, "description": "CTLA-4 expression is upregulated upon activation of Tregs.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CTLA-4", "target": "TREG ACTIVATION"}, {"weight": 5.0, "description": "The CD4 transmembrane domain is incorporated into the TAG72-BB\u03b6 CAR construct.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD4", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 16.0, "description": "Production of IL-2 by TAG72-BB\u03b6 CAR T cells reflects their activation.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "IL-2", "target": "TAG72-BB\u0396 CAR T CELL ACTIVATION"}, {"weight": 4.0, "description": "TAG72-BB\u03b6 CAR T cells produced IL-2 in response to OAS4 cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "IL-2", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 15.0, "description": "Production of IFN\u03b3 by TAG72-BB\u03b6 CAR T cells indicates their activation and antitumor activity.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "IFN\u0393", "target": "TAG72-BB\u0396 CAR T CELL ACTIVATION"}, {"weight": 3.0, "description": "TAG72-BB\u03b6 CAR T cells produced IFN\u03b3 in response to OAS4 cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "IFN\u0393", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 3.0, "description": "The CC49 scFv antibody fragment binds specifically to the TAG72 antigen.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72", "target": "CC49"}, {"weight": 8.0, "description": "OVCAR3 ovarian cancer cells express the TAG72 antigen.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72", "target": "OVCAR3"}, {"weight": 9.0, "description": "OV90 ovarian cancer cells express high levels of the TAG72 antigen.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72", "target": "OV90"}, {"weight": 10.0, "description": "LS174T colon cancer cells express the TAG72 antigen.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72", "target": "LS174T"}, {"weight": 1.0, "description": "TAG72-positive OAS4 ascites were targeted by CAR T cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "OAS4"}, {"weight": 2.0, "description": "TAG72-positive OAS7 ascites were targeted by CAR T cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "OAS7"}, {"weight": 3.0, "description": "OVCAR8 cells do not express TAG72, MUC16, or very low levels of MUC1.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72", "target": "OVCAR8 CELLS"}, {"weight": 2.0, "description": "The 4-1BB co-stimulatory domain is incorporated into the TAG72-BB\u03b6 CAR construct to enhance T cell activation.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "4-1BB", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 4.0, "description": "The IgG4 Fc extracellular spacer is part of the TAG72-BB\u03b6 CAR construct.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "IGG4 FC", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 6.0, "description": "The CD3\u03b6 cytolytic domain is incorporated into the TAG72-BB\u03b6 CAR construct to mediate T cell killing.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD3\u0396", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 7.0, "description": "The truncated CD19 protein (CD19t) is used for tracking TAG72-BB\u03b6 CAR T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD19T", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 22.0, "description": "OVCAR3 cells are a target for TAG72-BB\u03b6 CAR T cell therapy and show heterogeneous expression of TAG72.)<SEP>TAG72-BB\u03b6 CAR T cells effectively controlled OVCAR3 tumors in mice.)<SEP>TAG72-BB\u03b6 CAR T cells kill OVCAR3 ovarian cancer cells expressing the TAG72 antigen.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR3"}, {"weight": 25.0, "description": "OV90 cells are a target for TAG72-BB\u03b6 CAR T cell therapy and show reduction in TAG72 expression after treatment.)<SEP>TAG72-BB\u03b6 CAR T cells kill OV90 ovarian cancer cells expressing the TAG72 antigen.)<SEP>TAG72-BB\u03b6 CAR T cells were effective in controlling OV90 tumors in mice.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90"}, {"weight": 13.0, "description": "TAG72-BB\u03b6 CAR T cells kill LS174T colon cancer cells expressing the TAG72 antigen.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "LS174T"}, {"weight": 11.0, "description": "Increased anti-tumor responses compared to intravenous delivery.)<SEP>Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells resulted in more potent anti-tumor effects than intravenous delivery.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "REGIONAL I.P. DELIVERY"}, {"weight": 1.0, "description": "TAG72-BB\u03b6 CAR T cells lysed TAG72-positive OAS4 cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OAS4"}, {"weight": 2.0, "description": "TAG72-BB\u03b6 CAR T cells lysed TAG72-positive OAS7 cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OAS7"}, {"weight": 7.0, "description": "Limited anti-tumor response in comparison to regional i.p. delivery.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "I.V. DELIVERY"}, {"weight": 4.0, "description": "OVCAR3 cells are a target for TAG72-BB\u03b6 CAR T cell therapy.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR3 CELLS"}, {"weight": 5.0, "description": "OV90 cells are a target for TAG72-BB\u03b6 CAR T cell therapy.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90 CELLS"}, {"weight": 19.0, "description": "Anti-tumor activity of TAG72-BB\u03b6 CAR T cells is observed, but tumor recurrences due to antigen escape occur.)<SEP>While TAG72-BB\u03b6 CAR T cells show initial anti-tumor activity, tumor recurrences occur due to antigen escape.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TUMOR RECURRENCE"}, {"weight": 15.0, "description": "High levels of TAG72 expression were detected in ascites from mice with recurrent tumors.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "ASCITES"}, {"weight": 16.0, "description": "High levels of TAG72 expression were detected in solid tumors at later time points.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "SOLID TUMOR"}, {"weight": 14.0, "description": "Activation of TAG72-BB\u03b6 CAR T cells is measured by upregulation of CD137.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD137", "target": "TAG72-BB\u0396 CAR T CELL ACTIVATION"}, {"weight": 5.0, "description": "OVCAR3 cells were transduced with eGFP/ffluc for tumor tracking.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "OVCAR3 CELLS", "target": "EGFP/FFLUC"}, {"weight": 10.0, "description": "OVCAR3 cells express MUC1.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OVCAR3 CELLS", "target": "MUC1"}, {"weight": 11.0, "description": "OVCAR3 cells express MUC16.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OVCAR3 CELLS", "target": "MUC16"}, {"weight": 7.0, "description": "Tumors in mice receiving mock treatment show heterogeneous expression of TAG72 and eventually recur.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "MOCK TREATMENT", "target": "TUMOR RECURRENCE"}, {"weight": 12.0, "description": "OVCAR8 cells express low levels of MUC1.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "MUC1", "target": "OVCAR8 CELLS"}, {"weight": 14.0, "description": "Tumor recurrences in this study are associated with reduced TAG72 expression in recurrent tumors.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TUMOR RECURRENCE", "target": "ANTIGEN ESCAPE"}, {"weight": 8.0, "description": "More durable tumor control compared to single dosing.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "REPEAT TAG72-BB\u0396 CAR T CELL DOSING", "target": "TUMOR CONTROL"}, {"weight": 0.7, "description": "The CCL23-CCL18 locus was significantly connected to \u03b2-defensin genes in the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES", "target": "CCL23-CCL18"}, {"weight": 0.6, "description": "The CCL23-CCL18 locus was significantly connected to CXCL12 in the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CXCL12", "target": "CCL23-CCL18"}, {"weight": 0.5, "description": "The CCL23-CCL18 locus was significantly connected to TNFRSF13B in the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "TNFRSF13B", "target": "CCL23-CCL18"}, {"weight": 2.0, "description": "The IKBKE gene plays an essential role in regulating inflammatory responses to viral infections.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "IBKBKE GENE", "target": "INFLAMMATORY RESPONSES TO VIRAL INFECTIONS"}, {"weight": 4.0, "description": "STAT6 is a transcriptional activator involved in T cell differentiation.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STAT6", "target": "T CELL DIFFERENTIATION"}, {"weight": 8.0, "description": "The CTLA4 gene is associated with T1D and RA.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 GENE", "target": "T1D AND RA"}, {"weight": 2.0, "description": "Binding of IL-27 to its receptor (IL27RA) activates the STAT1/STAT3 pathway, which induces transcription of IRF1 and STAT1 genes.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27", "target": "IRF1 & STAT1"}, {"weight": 2.0, "description": "IL-27 forms a heterodimer with EBI3 to exert its biological effects.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27", "target": "EBI3"}, {"weight": 5.0, "description": "Binding of IL-27 to its receptor activates the STAT1/STAT3 pathway, leading to phosphorylation and nuclear translocation of these transcription factors.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27", "target": "STAT1/STAT3 PATHWAY"}, {"weight": 1.0, "description": "The SNP rs181206 in the IL27 gene is associated with decreased expression of STAT1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "STAT1", "target": "SNP RS181206"}, {"weight": 1.0, "description": "The SNP rs181206 affects the expression levels of both IRF1 and STAT1, suggesting a potential regulatory mechanism.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "SNP RS181206", "target": "IRF1 & STAT1"}, {"weight": 8.0, "description": "STAT5B deficient patients exhibit normal to elevated levels of B cells with increased immunoglobulin production.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "B CELLS", "target": "STAT5B"}, {"weight": 6.0, "description": "STX2 is involved in intracellular transport of vesicles.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "INTRACELLULAR TRANSPORT OF VESICLES", "target": "STX2"}, {"weight": 4.0, "description": "The expression levels of IRF1 and STAT1 show a strong positive correlation.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1 & STAT1", "target": "POSITIVE CORRELATION"}, {"weight": 3.0, "description": "IL-27 binds to its receptor, IL27RA, triggering downstream signaling pathways.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27 & IL27RA", "target": "INTERACTION"}, {"weight": 4.0, "description": "EBI3 associates with IL-27 to form a functional cytokine complex.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "EBI3 & IL27", "target": "HETERODIMER FORMATION"}, {"weight": 6.0, "description": "Activated STAT proteins can bind to ISREs and promote the transcription of target genes, including IRF1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "STAT1 & IRF1", "target": "TRANSCRIPTIONAL REGULATION"}, {"weight": 2.0, "description": "The IL-8 protein is encoded by the IL-8 mRNA transcript.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 MRNA", "target": "IL-8 PROTEIN"}, {"weight": 8.0, "description": "The homozygous TT genotype of the rs4073 polymorphism is associated with an increased risk of developing asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA RISK", "target": "RS4073 GENOTYPE"}, {"weight": 12.0, "description": "The rs4073 TT genotype is associated with a higher risk of developing atopic asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ATOPIC ASTHMA", "target": "RS4073 TT GENOTYPE"}, {"weight": 14.0, "description": "The rs2227306 CC genotype is associated with an increased risk of developing atopic asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ATOPIC ASTHMA", "target": "RS2227306 CC GENOTYPE"}, {"weight": 16.0, "description": "Individuals carrying at least one copy of the rs4073 T allele have a higher risk of experiencing severe asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA SEVERITY", "target": "RS4073 T ALLELE"}, {"weight": 1.0, "description": "The ASAH1 gene consists of 86 HapMap SNPs and 14 typed SNPs.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1", "target": "TYPED SNPS"}, {"weight": 0.8, "description": "Simulations using imputed data were conducted to assess the performance of different kernel methods for detecting the effect of the ASAH1 gene.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1", "target": "IMPUTED DATA"}, {"weight": 0.8, "description": "The kernel machine SNP-set test was applied to assess the overall effect of the ASAH1 gene.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1", "target": "SNP-SET TEST"}, {"weight": 0.6, "description": "Simulations compared the performance of the min test to other methods, particularly when analyzing the ASAH1 gene.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1", "target": "MIN TEST"}, {"weight": 2.0, "description": "The NAT2 gene has 22 HapMap SNPs and only 4 typed SNPs from the transcription start to end of the gene.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2", "target": "TYPED SNPS"}, {"weight": 3.0, "description": "The HLA-B gene has 6 HapMap SNPs.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B", "target": "HAPMAP SNPS"}, {"weight": 4.0, "description": "The HLA-B gene has 2 typed SNPs (rs1058026 and rs2523608).)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B", "target": "TYPED SNPS"}, {"weight": 0.7, "description": "Both the linear kernel and min test were compared, with the kernel machine method often outperforming the min test.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "MIN TEST", "target": "LINEAR KERNEL"}, {"weight": 0.6, "description": "The weighted IBS kernel (0.358) had a higher power than the linear kernel (0.214) when rare variants were important.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "LINEAR KERNEL", "target": "WEIGHTED IBS KERNEL"}, {"weight": 0.7, "description": "The IBS kernel (0.712) showed higher power when rs2523608, a common SNP with high MAF, was the causal SNP.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "RS2523608"}, {"weight": 0.6, "description": "Both the weighted IBS kernel and the IBS kernel were compared, with the IBS kernel generally having higher power when rare variants were not as influential.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "WEIGHTED IBS KERNEL"}, {"weight": 0.7, "description": "The weighted IBS kernel had higher power compared to other kernels in certain scenarios.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "WEIGHTED IBS KERNEL", "target": "POWER"}, {"weight": 0.6, "description": "rs2523608 has a higher MAF (Minor Allele Frequency), meaning it is a common SNP.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "MAF", "target": "RS2523608"}, {"weight": 0.7, "description": "The power analysis was conducted both when the causal SNPs were typed and untyped but in good LDs with typed SNPs.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "TYPED SNPS", "target": "UNTYPED SNPS"}, {"weight": 2.0, "description": "Anti-CTLA-4 therapy is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-CTLA-4", "target": "METASTATIC MELANOMA"}, {"weight": 2.0, "description": "Anti-CTLA-4 is one type of therapy used in combination with others.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-CTLA-4", "target": "COMBINATION-THERAPY"}, {"weight": 4.0, "description": "Anti-PD-1 therapy is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-PD-1", "target": "METASTATIC MELANOMA"}, {"weight": 2.0, "description": "Anti-PD-1 is one type of therapy used in combination with others.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-PD-1", "target": "COMBINATION-THERAPY"}, {"weight": 6.0, "description": "Combination therapy is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "COMBINATION THERAPY", "target": "METASTATIC MELANOMA"}, {"weight": 5.0, "description": "Mutations in the PTPN2 gene are associated with an increased risk of celiac disease.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "PTP N2 GENE", "target": "CELIAC DISEASE"}, {"weight": 6.0, "description": "Mutations in the PTPN2 gene are associated with an increased risk of inflammatory bowel disease.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "PTP N2 GENE", "target": "INFLAMMATORY BOWEL DISEASE"}, {"weight": 8.0, "description": "Mutations in the PTPN2 gene are associated with an increased risk of type 1 diabetes.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "PTP N2 GENE", "target": "TYPE 1 DIABETES"}, {"weight": 9.0, "description": "rs17388568 is a SNP located in the IL2 gene.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "IL2 GENE", "target": "RS17388568"}, {"weight": 10.0, "description": "The IL2 gene region is associated with allergy.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "IL2 GENE", "target": "ALLERGY"}, {"weight": 6.0, "description": "Samples for anti-CTLA-4 treated patients were obtained from NYULH.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "NYULH", "target": "ANTI-CTLA-4 TREATMENT SAMPLES"}, {"weight": 7.0, "description": "Samples for anti-PD-1 treated patients were obtained from UCLA.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "UCLA", "target": "ANTI-PD-1 TREATMENT SAMPLES"}, {"weight": 8.0, "description": "Samples for anti-CTLA-4 treated patients were obtained from UCLA.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "UCLA", "target": "ANTI-CTLA-4 TREATMENT SAMPLES"}, {"weight": 9.0, "description": "Samples for combination therapy treated patients were obtained from UCLA.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "UCLA", "target": "COMBINATION THERAPY TREATMENT SAMPLES"}, {"weight": 4.0, "description": "25 autoimmune risk SNPs were tested for their association with response after passing quality control measures.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "25 AUTOIMMUNE RISK SNPS", "target": "QUALITY CONTROL (QC)"}, {"weight": 2.0, "description": "EBNA2 binds preferentially to the risk allele of the TRAF3/RCOR1 locus.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "TRAFA3/RCOR1"}, {"weight": 13.0, "description": "EBNA2 binds to the protective allele of the TNFAIP8 locus.)<SEP>EBNA2 preferentially binds to the protective allele of TNFAIP8, but EBNA2-TAT inhibition suggests that EBNA2 increases TNFAIP8 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "TNFAIP8"}, {"weight": 17.0, "description": "EBNA2 binds to the protective allele of the TNFRSF1A locus.)<SEP>EBNA2 preferentially binds to the protective allele of TNFRSF1A, but EBNA2-TAT inhibition suggests that EBNA2 decreases TNFRSF1A expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "TNFRSF1A"}, {"weight": 11.0, "description": "EBNA2 binds to the protective allele of the TBX6 locus.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "TBX6"}, {"weight": 17.0, "description": "EBNA2 binding at MS risk loci is associated with an increased risk of multiple sclerosis.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "MULTIPLE SCLEROSIS (MS)"}, {"weight": 15.0, "description": "EBNA2 inhibits the expression of CLECL1 in LCLs.)<SEP>EBNA2 preferentially binds to one allele of CLECL1, and EBNA2-TAT inhibition suggests that EBNA2 increases CLECL1 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6<SEP>chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "CLECL1"}, {"weight": 2.0, "description": "EBNA2 preferentially binds to the risk allele of TRAF3, leading to decreased expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TRAF3"}, {"weight": 10.0, "description": "EBNA2 preferentially binds to one allele of RCOR1, but the effect on expression is unclear.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "RCOR1"}, {"weight": 9.0, "description": "Variations in the TNFAIP8 gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFAIP8", "target": "MS RISK"}, {"weight": 10.0, "description": "Variations in the TNFRSF1A gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFRSF1A", "target": "MS RISK"}, {"weight": 13.0, "description": "EBNA2-TAT inhibits the expression of LMP1, an EBV gene.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "LMP1"}, {"weight": 15.0, "description": "EBNA2-TAT binds to RBP-J\u03ba, disrupting the interaction between EBNA2 and RBP-J\u03ba.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "RBP-J\u039a"}, {"weight": 12.0, "description": "Variations in the CLECL1 gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "CLECL1", "target": "MS RISK"}, {"weight": 7.0, "description": "Variations in the TRAF3 gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TRAF3", "target": "MS RISK"}, {"weight": 11.0, "description": "Variations in the RCOR1 gene are associated with increased risk of Multiple Sclerosis (MS).)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "RCOR1", "target": "MS RISK"}, {"weight": 4.0, "description": "The genomic variant rs1126643 is a significant source of heterogeneity for averaged platelet number.)", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "RS1126643", "target": "PLATELET NUMBER"}, {"weight": 1.0, "description": "Mutations in the STAT5B gene can lead to growth hormone deficiency, as it is involved in growth hormone signaling.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B", "target": "GROWTH HORMONE DEFICIENCY"}, {"weight": 3.0, "description": "Individuals with STAT5B deficiency often develop eczema.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B", "target": "ECZEMA"}, {"weight": 4.0, "description": "STAT5B deficiency can contribute to reactive airway disease.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B", "target": "REACTIVE AIRWAY DISEASE"}, {"weight": 5.0, "description": "The role of STAT5B in GERD is currently under investigation.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B", "target": "GASTROESOPHAGEAL REFLUX DISEASE (GERD)"}, {"weight": 2.0, "description": "LOF STAT5B mutations result in various immune defects, including reduced NK cell function, elevated B cells with increased immunoglobulin production, and T cell lymphopenia.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "IMMUNE DEFECTS"}, {"weight": 6.0, "description": "STAT5B deficient patients typically have reductions in NK cell numbers and function.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "NK CELLS"}, {"weight": 12.0, "description": "STAT5B is involved in FOXP3 induction, Treg function, and self-tolerance. Loss-of-function STAT5B variants impair the maintenance of FOXP3 expression in Tregs over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "REGULATORY T CELLS"}, {"weight": 14.0, "description": "STAT5B deficient patients often have reduced na\u00efve T cells and elevations in memory/activation phenotype T cells.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "MEMORY T CELLS"}, {"weight": 15.0, "description": "Loss-of-function STAT5B variants impair the maintenance of FOXP3 expression in Tregs over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "CD127"}, {"weight": 16.0, "description": "Sustained IgE elevations in STAT5B deficient patients are associated with the development of chronic eczema.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "ECZEMA", "target": "STAT5B DEFICIENCY"}, {"weight": 18.0, "description": "Sustained IgE elevations in STAT5B deficient patients are associated with the development of reactive airway disease.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "REACTIVE AIRWAY DISEASE", "target": "STAT5B DEFICIENCY"}, {"weight": 2.0, "description": "Severe pneumonia can lead to sepsis, a life-threatening complication.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "PNEUMONIA", "target": "SEPSIS"}, {"weight": 3.0, "description": "Premature infants with bronchopulmonary dysplasia often experience failure to thrive due to breathing difficulties and increased energy expenditure.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "BRONCHOPULMONARY DYSPLASIA", "target": "FAILURE TO THRIVE"}, {"weight": 4.0, "description": "Both conditions result in growth retardation, but GH deficiency involves insufficient production of growth hormone, while GH insensitivity involves an inability to respond to it.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "SHORT STATURE (GH DEFICIENCY)", "target": "GROWTH HORMONE INSENSITIVITY SYNDROME"}, {"weight": 20.0, "description": "Sustained B cell hyperactivity in STAT5B deficient siblings is associated with atopy and autoimmunity.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "ATOPY", "target": "STAT5B DEFICIENCY"}, {"weight": 22.0, "description": "Sustained B cell hyperactivity in STAT5B deficient siblings is associated with atopy and autoimmunity.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "AUTOIMMUNITY", "target": "STAT5B DEFICIENCY"}, {"weight": 24.0, "description": "In early childhood, each sibling carried anti-thyroglobulin and anti-thyroid peroxidase antibodies associated with autoimmune thyroiditis.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "THYROIDITIS", "target": "STAT5B DEFICIENCY"}, {"weight": 3.0, "description": "No alterations in the proportion of CD4+ TEM cells were identified across sibling comparisons.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEM CELLS", "target": "SIBLINGS"}, {"weight": 5.0, "description": "Elevations in the percentage of CD8+ TEMRA cells detected during infancy in P2 and P3 normalized around age 4.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEMRA CELLS", "target": "INFANCY"}, {"weight": 6.0, "description": "Elevations in the percentage of CD8+ TEMRA cells detected during infancy in P2 and P3 normalized around age 4.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEMRA CELLS", "target": "AGE 4"}, {"weight": 4.0, "description": "The STAT5B variant appears to play a role in dysregulating CD8+ T cell activation and homeostasis.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B DEFICIENCY", "target": "CD8+ T CELL ACTIVATION AND HOMEOSTASIS"}, {"weight": 7.0, "description": "The text refers to three siblings, P1, P2, and P3.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "SIBLINGS", "target": "P1, P2, P3"}, {"weight": 1.0, "description": "Having consanguineous parents increases the risk of inheriting recessive genetic disorders that can cause growth failure.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "CONSANGUINEOUS PARENTS", "target": "SEVERE POST-NATAL GROWTH FAILURE"}, {"weight": 4.0, "description": "The STAT5B p.W631* variant disrupts STAT5B function and leads to immune system dysregulation.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "IMMUNE SYSTEM", "target": "STAT5B P.W631* VARIANT"}, {"weight": 1.0, "description": "The HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype is associated with E. coli ASP hypersensitivity.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "E. COLI ASP HYPERSENSITIVITY", "target": "HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"weight": 2.0, "description": "Algorithm V is a surrogate marker for the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "HLA-DRB1*07:07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"weight": 1.0, "description": "Algorithm V achieved higher sensitivity compared to other algorithms.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "SENSITIVITY"}, {"weight": 2.0, "description": "Algorithm V demonstrated a greater negative predictive value compared to algorithms III and IV.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "NEGATIVE PREDICTIVE VALUE"}, {"weight": 3.0, "description": "Algorithm V exhibited higher specificity than algorithm II.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "SPECIFICITY"}, {"weight": 4.0, "description": "Algorithm V displayed a superior positive predictive value compared to algorithm II.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "POSITIVE PREDICTIVE VALUE"}, {"weight": 2.0, "description": "HLA-DRB1*07:01 is part of the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA\u2010DRB1*07:01", "target": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"weight": 1.0, "description": "The TLR7 gene has been studied for its association with HIV infection and disease progression.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7", "target": "HIV-INFECTED INDIVIDUALS"}, {"weight": 2.0, "description": "rs179008 is a polymorphism located within the TLR7 gene.)", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7", "target": "RS179008"}, {"weight": 4.0, "description": "rs179009 is a polymorphism located within the TLR7 gene.)", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7", "target": "RS179009"}, {"weight": 6.0, "description": "The study investigated the correlation between TLR7 polymorphisms and HIV disease progression.)", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7", "target": "HIV DISEASE PROGRESSION"}, {"weight": 2.0, "description": "The rs179008 polymorphism in the TLR7 gene has been associated with HIV infection and disease progression.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "RS179008", "target": "HIV-INFECTED INDIVIDUALS"}, {"weight": 3.0, "description": "The rs179009 polymorphism in the TLR7 gene has been associated with HIV infection and disease progression.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "RS179009", "target": "HIV-INFECTED INDIVIDUALS"}, {"weight": 8.0, "description": "The association between TLR7 polymorphisms and tobacco consumption in HIV-infected individuals has been studied.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TOBACCO", "target": "TLR7 POLYMORPHISMS"}, {"weight": 13.0, "description": "Individuals with specific TLR7 polymorphisms (rs179008 and rs179009) may be more susceptible to certain stages of HIV disease.)<SEP>Individuals with specific TLR7 polymorphisms may be more susceptible to certain stages of HIV disease.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HIV DISEASE STAGES", "target": "TLR7 POLYMORPHISMS"}, {"weight": 4.0, "description": "This analysis was used to determine if age, sex, tobacco use, alcohol consumption, baseline CD4 counts, and TLR7 polymorphisms were independent risk factors for HIV disease progression.)", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS", "target": "AGE, SEX, TOBACCO, ALCOHOL, BASELINE CD4 COUNTS, AND TLR7 POLYMORPHISMS"}, {"weight": 3.0, "description": "The ALK R1275Q mutation gives rise to neoepitopes recognized by the immune system.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "NEOEPITOPE"}, {"weight": 1.0, "description": "The ALK R1275Q mutation is a specific alteration within the ALK gene.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "MUTATION IN ALK"}, {"weight": 4.0, "description": "The NRAS Q61K mutation gives rise to neoepitopes recognized by the immune system.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NRAS Q61K", "target": "NEOEPITOPE"}, {"weight": 5.0, "description": "The ALK F1174L/I/C mutations give rise to neoepitopes recognized by the immune system.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK F1174L/I/C", "target": "NEOEPITOPE"}, {"weight": 6.0, "description": "The ZNF717 Q716 mutation gives rise to neoepitopes recognized by the immune system.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ZNF717 Q716", "target": "NEOEPITOPE"}, {"weight": 18.0, "description": "Neoepitopes are derived from the ALK gene.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "ALK", "target": "NEOEPITOPE"}, {"weight": 3.0, "description": "HLA-B*15:01 was used as a template for modeling peptide/HLA interactions.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B*15:01", "target": "ALK PEPTIDES"}, {"weight": 12.0, "description": "HLA-B*15:01 has a higher affinity for the decamer peptide compared to HLA-A*01:01.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "DECAMER PEPTIDE"}, {"weight": 14.0, "description": "HLA-B*15:01 has a higher affinity for the nonamer peptide compared to HLA-A*01:01.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "NONAMER PEPTIDE"}, {"weight": 14.0, "description": "PBMCs from HLA-B*15:01 matched donors were used in the experiments.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "DONOR PBMCS"}, {"weight": 8.0, "description": "HLA-A*01:01 forms a stable complex with a decamer peptide.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-A*01:01", "target": "DECAMER PEPTIDE"}, {"weight": 10.0, "description": "HLA-A*01:01 forms a stable complex with a nonamer peptide.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-A*01:01", "target": "NONAMER PEPTIDE"}, {"weight": 3.0, "description": "AQDIYRASY binds to HLA-B*15:01/\u03b22m complex.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "AQDIYRASY", "target": "MHC COMPLEX"}, {"weight": 4.0, "description": "AQDIYRASYY binds to HLA-B*15:01/\u03b22m complex.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "AQDIYRASYY", "target": "MHC COMPLEX"}, {"weight": 4.0, "description": "X-ray crystallography was used to determine the 3D structure of MHC/peptide complexes.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "X-RAY CRYSTALLOGRAPHY", "target": "PROTEIN STRUCTURE DETERMINATION"}, {"weight": 5.0, "description": "The PDB contains structural information about the MHC/peptide complexes.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "PDB", "target": "STRUCTURE INFORMATION"}, {"weight": 1.0, "description": "T cell responses to ALK R1275Q neoepitopes are dependent on HLA alleles that can present them.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "ALK R1275Q NEOEPITOPES", "target": "HLA"}, {"weight": 4.0, "description": "Peptides bind to the HLA-binding groove.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "PEPTIDE", "target": "HLA-BINDING GROOVE"}, {"weight": 2.0, "description": "TCRs bind to MHC-peptide complexes, which include peptides presented by HLA molecules.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "TCRS", "target": "PEPTIDE/HLA INTERACTIONS"}, {"weight": 5.0, "description": "Higher sequence identity scores between HLA alleles and the peptides result in lower binding energies.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "SEQUENCE IDENTITY SCORE", "target": "BINDING ENERGY"}, {"weight": 2.0, "description": "The HLA-B*15:01 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE", "target": "HLA-B*15:01 BINDING"}, {"weight": 3.0, "description": "The HLA-A*02:01 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE", "target": "HLA-A*02:01 BINDING"}, {"weight": 4.0, "description": "The HLA-B*15:03 molecule binds to specific neoepitopes derived from the ALK R1275Q mutation.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE", "target": "HLA-B*15:03 BINDING"}, {"weight": 5.0, "description": "The HLA-A*01:01 molecule binds to specific neoepitopes derived from the NRAS Q61K mutation.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE", "target": "HLA-A*01:01 BINDING"}, {"weight": 6.0, "description": "The TARGET cohort includes samples from primary and relapsed neuroblastoma (NBL) tumors.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NBL SAMPLE PAIRS", "target": "PART OF STUDY"}, {"weight": 7.0, "description": "The ProTECT software is utilized to predict potential neoepitopes from tumor genomes.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE PREDICTION", "target": "TOOL FUNCTION"}, {"weight": 8.0, "description": "The ProTECT software considers the binding affinity of peptides to MHC molecules when predicting neoepitopes.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEOEPITOPE PREDICTION", "target": "BINDING AFFINITY CONSIDERATION"}, {"weight": 2.0, "description": "LC-MS was used to identify peptides in the samples.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "LC-MS", "target": "PEPTIDE IDENTIFICATION"}, {"weight": 16.0, "description": "Some HLA-B*15:01 tetramers were labeled with allophycocyanin (APC).)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01 TETRAMER", "target": "APC"}, {"weight": 17.0, "description": "Some HLA-B*15:01 tetramers were labeled with phycoerythrin (PE).)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01 TETRAMER", "target": "PE"}, {"weight": 6.0, "description": "The study found that IgM anti-PC levels were lower in prevalent CLL cases compared to matched controls.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC", "target": "CLL"}, {"weight": 2.0, "description": "The genomic variant rs35923643 overlaps with a RUNX3 binding motif, and switching from the major allele T/A to the minor allele C/G reduces the predicted binding affinity of RUNX3.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "RUNX3"}, {"weight": 4.0, "description": "The genomic variant rs35923643 is located within a region where SPI1 binding was detected.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "SPI1"}]}